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1. Small GTPase proteins 
 
 
 
The Rat sarcoma (Ras) superfamily of small GTPases is made up of a plethora of 20 
to 40 kDa proteins that share the ability to bind to a GTP nucleotide and hydrolyze it to 
GDP, which determines their activation state. The Ras, Rho, Rab, Arf and Ran protein 
families represent the majority of proteins in this family (Figure 1), which share some 
similar domains but also contain specific structural determinants that endow each 
protein with unique conformational and signaling characteristics, as reviewed in (Takai 
et al., 2001). This superfamily is named after the first small GTPases that were studied: 
the Ras proteins (Barbacid, 1987). Some of the first oncogenes identified are part of this 
family and play crucial roles in cell survival, proliferation and signaling, as reviewed in 
(Ridley, 2001; Schmitz et al., 2000). 
The Rho protein family was identified as containing sequences homologous to Ras 
(Ras homolog) and includes three Rho isoforms (RhoA, B and C), three Rac isoforms 
(Rac1, 2 and 3) as well as Cdc42, among others (Bustelo et al., 2007; Madaule and Axel, 
1985). Rho proteins regulate cytoskeletal functions such as actin stress fiber induction 
(RhoA) or lamellipodia and filopodia formation (Rac and Cdc42, respectively), as 
reviewed in (Hall, 2005; Matozaki et al., 2000). Another member, RhoB, is known to 
induce stress fibers but also plays a role in vesicular transport (Aspenström et al., 2004; 
Gampel et al., 1999), as will be discussed below in detail. The Rab GTPases (Ras-related 
in brain) comprise the largest of the Ras families, with more than 60 isoforms identified 
in humans (Touchot et al., 1987). They are responsible for membrane trafficking 
processes including endocytosis, exocytosis, transcytosis, and general vesicle 
maturation, as reviewed in (Stenmark, 2009). 
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Figure 1. Human Ras superfamily phylogenetic tree.  
Representation of the different Ras families from a phylogenetic standpoint, as represented by 
the tree inside the circle. The major Ras groups are shown in different colors, i.e. blue for the 
Ras family, green for Rho, red for Rab, cyan for Arf, and yellow for Ran. ©Rojas et al., 2012. 
Originally published in The Journal of Cell Biology. doi: 10.1083/jcb.201103008. (Rojas et 
al., 2012) 
 
Small GTPases act as molecular switches, transitioning between a GDP-bound, 
inactive state and a GTP-bound, active state, as depicted in Figure 2. Their activation is 
mediated by varied stimuli, which can initiate signaling cascades affecting guanine 
nucleotide exchange factors (GEF), which favor GTP incorporation, as reviewed in 
(Geyer and Wittinghofer, 1997). Active states of small GTPases arise from 
conformational changes that allow these proteins to bind to effectors and hence 
propagate signals intracellularly. Considering that the intrinsic GTPase activity of these 
proteins is rather low, they require GTPase activating proteins (GAP) to effectively 
hydrolyze GTP to GDP, returning to their inactive state. A further level of regulation 
involves specific GDP dissociation inhibitors (GDI), which bind to inactive Ras 
superfamily proteins to detach them from membranes, thus retaining them in the 
cytosol (Figure 2).  
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Figure 2. Small GTPase GDP/GTP cycle.  
The inactive form of the Ras superfamily protein (square Ras) is bound to GDP. For some 
GTPases, binding to RhoGDI stabilizes this inactive form. Small GTPase binding to GTP is 
facilitated by GEF and allows interaction with effectors to induce signal transduction (circular 
Ras). Enzymatic hydrolysis of GTP for GDP is stimulated by GAP and leads to GTPase 
inactivation, terminating its effector binding and activation. 
 
GEF, GAP and GDI proteins are inherent to the process of Ras protein regulation, 
so that each subfamily is modulated by a specific subset of activators, inhibitors or 
overall modulators, each with their feedback or feed-forward regulation. Thus, this 
complex network of Ras protein-related effectors generates fine-tuned signaling 
cascades within the cell, as reviewed extensively in (Cherfils and Zeghouf, 2013). It is 
therefore evident that small GTPases entail tight regulatory mechanisms to correctly 
carry out their intracellular functions (Matozaki et al., 2000). 
 
1.1 Endolysosomal GTPases 
 
Numerous members of the Ras superfamily appear at endolysosomal 
compartments, particularly Rab proteins, as well as the Ras proteins Rap2A, Rap2B, and 
H-Ras, or the Rho proteins TC10 and RhoB (Valero et al., 2010), as will be described 
throughout this work. Specific members of the Rab protein family associate at defined 
vesicles along the endocytic pathway and assist in the maturation of these membrane 
compartments by mediating vesicle budding, fusion, motility, coating and uncoating, 
which endows endomembranes with an extremely dynamic quality (Stenmark, 2009). 
The core endosomal Rabs may be laterally segregated into specific domains of the same 
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vesicles, which allows for a flexible flow of compartments within the cell. Except in the 
case of Ran proteins, which contain a nuclear import signal, lipids modify proteins 
belonging to the Ras superfamily posttranslationally in order to associate with 
membranes. The combination of these lipid anchors and other structural determinants 
gives rise to subcellular localizations at specific membrane compartments, as discussed 
below for RhoB in greater detail. 
 
1.2 RhoB 
 
RhoB is located on the cytoplasmic side of the plasma membrane and late 
endosomes, from which it plays important roles in trafficking of signaling molecules 
(Gampel et al., 1999). It is a short-lived protein with a half-life of approximately 2-3 
hours, which differs from the relative stability of other Rho proteins (24-hour half-lives) 
(Engel et al., 1998; Stamatakis et al., 2002). RhoB is an immediate early response gene 
that is rapidly induced by DNA damage or growth factors (Fritz and Kaina, 1997; 
Malcolm et al., 2003). Therefore, maintaining a high RhoB turnover ensures the rapid 
response of RhoB levels to various stimuli. Though in vitro studies have shown similar 
effectors for RhoA and RhoB, cellular approaches have shown that each has its own set 
of interactors to carry out specific functions. As summarized in Figure 3, RhoB presents 
unique functions that set it apart from other Rho proteins by controlling endocytic 
traffic and affecting the sorting of growth factor receptors or signaling kinases 
(Fernández-Borja et al., 2005; Huang et al., 2007b; Mellor et al., 1998; Sandilands et al., 
2004; Wherlock et al., 2004). Hence, there are associated consequences for growth factor 
signaling, cell survival, proliferation, and apoptosis, which contribute to the proposed 
dual role of RhoB as both a tumor suppressor and an angiogenesis inducer (Gerald et 
al., 2013; Huang et al., 2006; Liu et al., 2001). RhoB is involved in modulating cell death 
through genotoxic stress (Fritz and Kaina, 2000; Liu et al., 2001) and controlling c-myc 
stability (Huang et al., 2006), as well as signaling and trafficking of Akt kinase (Adini et 
al., 2003). Furthermore, RhoB could play a role in apoptosis following Ras inhibition 
(Kamasani et al., 2004; Liu et al., 2001). RhoB has also been shown to mediate actin 
dynamics upstream of Dia1 (Diaphanous-related formin 1), which is necessary for actin 
coat formation around endosomes (Fernández-Borja et al., 2005). Additionally, reduced 
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cell spreading and adhesion to different substrates was noted in several RhoB-depleted 
cell types, which could be due to the concomitant reduction of surface β1 integrin levels 
in these cells and accountable for decreased focal adhesions, resulting in increased 
migration rates (Vega et al., 2012).  
 
 
Figure 3. Schematic of RhoB functions. 
A ribbon diagram of the RhoB structure attached to an isoprenoid moiety (curved, gray chain) 
and two palmitates (straight chains) is shown in the center. The small GTP-binding protein 
RhoB performs specific tasks within the cell that set it apart from other proteins of the Ras 
superfamily, including roles in cancer progression related to angiogenesis or apoptosis, 
regulating receptor trafficking or actin polymerization at endosomes, and cell migration. See 
text for details. 
 
RhoB is highly homologous to RhoA in structural terms, though under resting 
conditions, RhoGDI retains RhoA in the cytosol (Dransart et al., 2005) whereas RhoB is 
bound to the plasma membrane or endolysosomal membranes (Oeste et al., 2014; 
Pérez-Sala et al., 2009; Stamatakis et al., 2002). These differences in localization are 
related to the distinct residues present at the carboxy-terminal (C-terminal) 
hypervariable region (Chiu et al., 2002; Gorfe et al., 2007), which contains the –CAAX 
box and could bear phosphorylation sites as well as sites for additional lipidation 
(Hancock et al., 1989; Wennerberg and Der, 2004), as will be described in detail below. 
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In the case of RhoB, upon isoprenylation of its –CAAX box cysteine (C193), two nearby 
cysteines (C189 and C192) are further modified by palmitate moieties (Wang and Sebti, 
2005), whereas RhoA fosters a polybasic sequence. 
RhoB therefore presents several distinguishing features that endow it with 
unique cellular behavior. The specific lipidation sequence at its C-terminus acts as a 
plasma membrane and endolysosomal anchor. Furthermore, these lipid modifications 
determine RhoB degradation through a lysosomal pathway distinct from the 
proteasomal degradation typical of other GTPases of its family (Pérez-Sala et al., 2009; 
Stamatakis et al., 2002).  
 
 
 
2. Posttranslational modifications of GTPases 
 
 
 
Posttranslational modifications constitute an essential regulatory mechanism for 
protein function, activation, localization and half-life. Most of these changes result in 
conformational shifts that alter activation states, allow modified proteins to interact 
with effectors or expose otherwise hidden motifs within their sequence. Common 
posttranslational modifications include processes such as phosphorylation, 
hydroxylation and nitrosylation (inorganic residue addition), ubiquitination and 
glutathionylation (peptide addition), or isoprenylation, myristoylation and 
palmitoylation (lipid addition), among many others, as reviewed in (Walsh et al., 2005). 
The resulting functional outcomes range from marking proteins to be degraded, as in 
ubiquitination, to direct activation for effector interaction, i.e. phosphorylation. 
Ras superfamily proteins undergo several posttranslational modifications, including 
irreversible alteration of their carboxy-terminal sequence by isoprenylation and 
proteolysis, as well as methylation and further lipidation by palmitate moieties in some 
instances. Other residues within these proteins can undergo other modifications such as 
peptidyl-prolyl isomerization, phosphorylation, ubiquitination, glycosylation, 
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nitrosylation, and ADP ribosylation, as reviewed in (Ahearn et al., 2012). As will be 
discussed below, some of these modifications alter Ras protein localization, in turn 
determining the effectors with which they can interact and ultimately their activation 
patterns. 
 
2.1 Lipidation at C-terminal ends 
 
Lipidation involves covalent attachment of lipids to protein residues and can take 
place spontaneously or through enzymatic mechanisms. Isoprenylation and 
myristoylation are irreversible enzymatic modifications that significantly increase 
protein hydrophobicity, thus elevating the probability of their interaction with 
membranes. Whereas myristoylation takes place at a glycine residue located in the first 
position of the protein sequence (after methionine removal), isoprenylation occurs at 
cysteines in the C-terminal segment. Palmitoylation usually takes place at cysteines that 
are in the vicinity of isoprenylated or myristoylated residues and confers a more flexible, 
reversible mode of regulation of protein localization, as reviewed in (Aicart-Ramos et 
al., 2011). Several Ras proteins become palmitoylated following isoprenylation to better 
anchor them to membranes, as will be discussed below in further detail. Protein 
modification by lipids is therefore a crucial tool to modulate subcellular localization and 
hence site-specific activation and recruitment of proteins, affecting a myriad of signaling 
platforms. 
 
2.1.1 Isoprenylation 
 
Isoprenylation is an enzymatic process affecting more than 300 proteins in 
humans by which isoprenoid lipids bind to cysteines through a thio-ether bond, as 
reviewed in (McTaggart, 2006). Specific prenyl transferases recognize particular 
sequences to catalyze farnesylation, in the case of farnesyl transferase (FT) or 
geranylgeranylation, in the case of geranylgeranyl transferases (GGT) I and II. Many Ras 
proteins contain a “-CAAX box” at their C-terminus, where “C” is the cysteine 
amenable to isoprenylation, “A” stands for aliphatic residues and “X” can be any amino 
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acid (Hancock et al., 1989). As depicted in Figure 4, -CAAX boxes undergo 
modifications including isoprenylation, proteolysis and methylation. 
 
 
Figure 4. Protein isoprenylation and CAAX box processing. 
Proteins containing a CAAX box undergo posttranslational processing, beginning with 
isoprenylation by prenyl transferases. An endopeptidase cleaves the last three amino acids (-
AAX), and methylation of the C-terminal end is brought about by a methyl transferase. Shown 
here is farnesyl pyrophosphate (C15), though some proteins become geranylgeranylated by 
GGT using a geranylgeranyl pyrophosphate moiety (C20) as a substrate. See text for details. 
 
In the case of FT- and GGT I-mediated isoprenylation, the X residue in –
CAAX boxes of target proteins determines whether the cysteine will be modified by a 
farnesyl or geranylgeranyl isoprenoid. FT modifies proteins in which the X residue is 
methionine, serine, alanine or glutamine, whereas GGT I acts on proteins bearing a 
leucine residue. However, certain proteins can be modified by either FT or GGT I 
depending on other biochemical features of the –CAAX box surroundings (Hartman et 
al., 2005) or on isoprenoid availability (Whyte et al., 1997). FT and GGT-I share an α 
subunit and possess specific β subunits that recognize CAAX motifs and transfer either 
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farnesyl pyrophosphate or geranylgeranyl pyrophosphate, respectively. In contrast, 
GGT II requires an accessory protein, Rab escort protein (Rep) that recognizes whole 
Rab proteins and presents them to the catalytic subunit (Nguyen et al., 2010). GGT II is 
responsible for single or double geranylgeranylation of Rab proteins at their C-terminal 
–CAC, -CC, -CCX, -CCXX, -CCXXX or –CXXX motif cysteines (Desnoyers et al., 1996; 
Leung et al., 2006; Maurer-Stroh et al., 2003). Once isoprenylation has taken place, the 
amino acids that remain at the carboxy end of the isoprenylated cysteine are cleaved by 
a specific endoprotease and the carboxyl group of the cysteine is methylated by a 
specific methyltransferase for isoprenylated proteins (Pérez-Sala et al., 1991; Sinensky, 
2000; Tan et al., 1991).  
 
2.1.2 Palmitoylation 
 
Palmitoylation is the addition of a palmitate moiety (C16:0) to a cysteine 
residue through a thioester bond, as reviewed in (Dietrich and Ungermann, 2004). As 
shown in Figure 5, the cysteine sulfhydryl group needs to be in its thiolate form, i.e. 
unprotonated, in order to carry out a nucleophilic attack on the α carbon of palmitoyl-
CoA. This reaction can occur spontaneously depending on the cysteine pKa, which is 
determined by the intra- and intermolecular surroundings, but is greatly enhanced 
when catalyzed by palmitoyl transferases (PAT), a.k.a. protein acyl transferases, which 
contain a conserved aspartate-histidine-histidine-cysteine (DHHC) active site rich in 
cysteine residues, as reviewed in (Aicart-Ramos et al., 2011). These enzymes and the 
substrate palmitoyl-CoA are present on membranes, so that proteins that are to be 
palmitoylated need to come in close contact with PAT-containing membranes (Dunphy 
et al., 1996). Isoprenylation increases the probability of a protein to bind to membranes, 
and palmitoylation presents a further structural determinant that stabilizes membrane 
association, as reviewed in (Smotrys and Linder, 2004; Smotrys et al., 2005). 
Depalmitoylation is mediated by palmitoyl-protein thioesterases (Verkruyse and 
Hofmann, 1996), allowing proteins to undergo repeated cycles of 
palmitoylation/depalmitoylation (Aicart-Ramos et al., 2011). 
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Figure 5. Protein palmitoylation. 
In red, a random protein structure with its palmitoylation cysteine depicted chemically. The 
cysteine thiolate group produces a nucleophilic attack on the electrophilic carbon on the 
palmitoyl-CoA chain to yield a palmitoylated protein and free CoA. This reaction can take 
place spontaneously or be catalyzed by palmitoyl transferases. Depalmitoylation is catalyzed 
by palmitoyl-protein thioesterases. Adapted from (www.lipidlibrary.aocs.org). 
 
Many protein families provide examples of palmitoylation-mediated membrane 
association. Such is the case of a multitude of integral membrane proteins such as 
heterotrimeric G-proteins, tetraspanins, the mannose 6-phosphate (M6P) receptor, or 
synaptotagmins, all involved in general endocytic trafficking processes (Schweizer et al., 
1996; Stipp et al., 2003; Veit et al., 1996). These proteins, though already spanning the 
membrane, are able to associate at specific microdomains such as lipid rafts and hence 
form signaling platforms, as is the case for transmembrane adaptor proteins, e.g. LAT 
(Linker of Activation for T cells) (Stepanek et al., 2014). Furthermore, membrane 
anchors of peripheral membrane proteins often consist in palmitoylation either close to 
myristoylated residues, as for Src tyrosine kinases, or in the vicinity of previously 
isoprenylated cysteines, as is the case for the Ras protein superfamily (Aicart-Ramos et 
al., 2011), and is described as follows.  
Within the Ras family of proteins, H-Ras is palmitoylated at two cysteine 
residues present in the hypervariable domain (C181 and C184), N-Ras contains a single 
palmitoylation site (C181) and K-Ras4B possesses no cysteine residues but its 
interaction with cellular membranes is favored by the presence of a polybasic domain 
that is attracted to negatively charged polar head groups of membrane phospholipids, 
much like RhoA. In the case of H-Ras, localization is mainly at the plasma membrane 
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and various intracellular structures, including the endoplasmic reticulum (ER), the 
Golgi complex, recycling endosomes (Gómez and Daniotti, 2005; Hancock and Parton, 
2005) and to randomly moving nanoparticles known as rasosomes (Rotblat et al., 2006). 
These differences are critical to determine the specific trafficking and site of action of 
the different Ras proteins, as reviewed in (Omerovic et al., 2007; Pérez-Sala, 2007). 
Other proteins that also contain additional cysteines close to the isoprenylation site that 
are amenable to palmitoylation include TC10, Rap2, or RhoB (Aicart-Ramos et al., 2011; 
Michaelson et al., 2001; Uechi et al., 2009). TC10 has been detected at the plasma and 
perinuclear membranes, identified as components of secretory or endosomal 
compartments (Michaelson et al., 2001; Watson et al., 2003), whereas Rap2 has been 
detected in secretory granules (Mollinedo et al., 1993) and recycling endosomes (Uechi 
et al., 2009). Fully lipidated RhoB is both isoprenylated and bipalmitoylated (Wang and 
Sebti, 2005), which is required for its association with endolysosomes (Pérez-Sala et al., 
2009).  
 
2.2 Cyclopentenone prostaglandins 
 
 
In addition to lipidation by isoprenoid or palmitate moieties, proteins may suffer 
modification by reactive lipid species of varied structure. Cell metabolism under both 
basal and pathological conditions gives rise to products derived from lipid peroxidation 
that can form stable adducts with particular protein residues (Bogatcheva et al., 2005). 
Oxidative and nitrosative stress produce many of these products, which play a role in 
numerous pathologies such as neurodegenerative diseases (Dianzani, 2003), vascular 
alterations (Lee and Park, 2013), and cancer (Garzón et al., 2011). Amongst the many 
electrophilic lipids that are produced in cells, cyclopentenone prostaglandins (cyPG) are 
a family of reactive lipid species with anti-inflammatory, anti-viral and anti-tumoral 
effects, which makes them a forthcoming option as exogenous therapeutic compounds 
(Sánchez-Gómez et al., 2004; Straus and Glass, 2001). cyPG generation is increased in 
cells undergoing oxidative stress, whereas cyPG production in homeostatic cells is low 
(Ceaser et al., 2004; Koenitzer and Freeman, 2010). The electrophilic nature of cyPG 
allows them to react with nucleophilic residues including cysteines, in turn eliciting 
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structural changes within the whole protein that provide new reactivity and 
electrophilicity. cyPG of different structural characteristics present specificity towards 
particular cysteine residues, so that different cyPG enter distinctive intramolecular 
binding pockets even within the same protein. Moreover, cyPG bind to proteins 
involved in a multitude of different cellular tasks (Garzón et al., 2011; Renedo et al., 
2007). These features account for dual actions: cyPG modification of proteins involved 
in redox regulation can modulate oxidative stress pathways, whereas binding and 
subsequent inhibition of NF-κB (nuclear factor kappa-light-chain-enhancer of activated 
B cells) pathway proteins contributes to cyPG anti-inflammatory effects (Díez-Dacal 
and Pérez-Sala, 2010; Kim and Surh, 2006). The pleiotropic behavior of these 
electrophilic lipids is therefore a reflection of the variety of intracellular targets, many of 
which have been discovered in the past decade through proteomic studies, as reviewed 
in (Garzón et al., 2011; Oeste and Pérez-Sala, 2014). Interestingly, Ras proteins are 
included in this expanding list of cyPG targets (Oeste et al., 2011; Stamatakis and Pérez-
Sala, 2006), as discussed below in further detail. 
As shown in Figure 6, cyPG are derived from peroxidation of membrane fatty 
acids, in particular arachidonic acid, through the action of cyclooxygenases (COX) or 
non-enzymatically through the isoprostane pathway (Funk, 2001; Gao et al., 2003). In 
the case of the COX pathway, prostaglandin synthases act on the precursor PGH2 to give 
rise to PGD2 and PGE2 (Funk, 2001). The latter two PG can also be formed by non-
enzymatic epimerization of isoprostanes through the isoprostane pathway (Gao et al., 
2003), which gives rise to trans isomers of PG, i.e. isoprostanes such as iso-PGJ2 and iso-
PGA2. J series cyPG arise from dehydration of PGD2 to PGJ2, which can be further 
dehydrated to form 15d-PGJ2 (15-deoxy-Δ12,14-Prostaglandin J2) or give rise to Δ12-PGJ2 
through an albumin-dependent mechanism (Narumiya and Fukushima, 1985; Shibata 
et al., 2002). cyPG of the A series are produced upon dehydration of PGE1 or PGE2 
(Ohno et al., 1986). 
cyPG synthesized in this manner contain an α, β-unsaturated carbonyl group 
within their cyclopentane ring, which renders highly electrophilic -β carbons. Therefore, 
they are amenable to forming Michael adducts through nucleophilic attack by thiol 
moieties from cysteines, as seen at the bottom of Figure 6. The cysteine residues to 
which cyPG bind present structural characteristics allowing for the entry and 
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positioning of specific cyPG to form the stable, covalent Michael adducts with 
consequences on biological functions. 
 
 
 
Figure 6. Cyclopentenone prostaglandin formation and covalent binding to proteins through 
Michael addition. 
cyPG (blue shaded boxes) are formed by spontaneous dehydration of their PG precursors 
(gray shaded boxes). These precursors are generated in turn from unsaturated fatty acids such 
as arachidonic acid by the action of cyclooxygenases (COX) or through non-enzymatic 
processes, i.e. the isoprostane pathway (dashed arrows). Arachidonic acid is formed as a 
product of phospholipase A2 or C cleavage of membrane-bound phospholipids. cyPG 
contain electrophilic carbons (asterisks) that can undergo attack by nucleophilic groups such 
as cysteine thiolates and form Michael adducts (green arrows), as shown at the bottom for 
15d-PGJ2. See text for details. 
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2.2.1 Cyclopentenone prostaglandin modification of Ras proteins 
 
cyPG containing either one or two electrophilic carbons, i.e. single enones or 
dienones, can bind to different subsets of proteins depending on the steric attributes of 
the cysteines in the protein to be modified. Several studies have shown that the dienone 
cyPG 15d-PGJ2 can establish Michael adducts with cysteine residues of proteins as 
structurally and functionally different as actin, vimentin (Stamatakis et al., 2006), NF-
κB, PPARγ (Peroxisome proliferator-activated receptor gamma) (Cernuda-Morollón et 
al., 2001; Shiraki et al., 2005), Keap1 or GSTP1-1 (Glutathione S-transferase P) 
(Levonen et al., 2004; Sánchez-Gómez et al., 2007). The fact that electrophilic carbon 
count is particularly important for selectivity is reflected by cyPG binding to Ras 
proteins. Various cyPG have been found to modify and activate Ras proteins in an 
isoform- and site-selective manner (Oliva et al., 2003). Specifically, single enone cyPG, 
e.g. PGA1 or PGJ2 bind preferentially to C118, which is present in the GTP binding site 
in all three Ras proteins, namely H-Ras, K-Ras and N-Ras. However, the dienone 15d-
PGJ2 can bind two cysteine residues simultaneously (C181 and C184), located at the H-
Ras C-terminus (Renedo et al., 2007). Since other Ras proteins such as N- or K-Ras do 
not contain this sequence, they are not preferential targets for dienone cyPG binding. 
Interestingly, modification of the H-Ras C-terminal sequence by cyPG or other small 
reactive molecules elicits changes in its membrane partitioning and distribution along 
the endocytic pathway (Oeste et al., 2011). It is thus apparent that cyPG selectivity can 
fine-tune intracellular pathways by modifying not only specific proteins, but also 
particular cysteine residues within the same protein, which can have consequences on 
its subcellular sorting and localization. 
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3. Endolysosomal sorting and degradation 
 
 
 
Endocytosis is the means by which cells internalize extracellular material as well 
as plasma membrane proteins and lipids, among many other substances. As 
summarized in Figure 7, this material is engulfed by plasma membrane and pinched off 
to produce endocytic vesicles, which undergo multiple maturation processes on their 
way towards lysosomes, recycling compartments, autophagosomes, or other 
intracellular destinations. Trafficking of these endocytic vesicles involves signaling 
through membrane receptors from the outside-in and recycling these components for 
further receptor-effector cascades or producing metabolic building blocks, hence 
contributing to overall cell functions, as reviewed in (Huotari and Helenius, 2011). 
During their maturation process, these vesicles evolve through dynamic interaction of 
non-discrete compartments that are in constant flow from one to another. However, 
distinct proteins and lipids attach to vesicles at different points in the endocytic route, 
aiding in their categorization into specific types of endosomes. Interestingly, 
accumulating evidence points at site-selective signaling within the cell, for certain 
signaling molecules bind to different effectors depending on their subcellular 
localization (Schmidt-Glenewinkel et al., 2008), and some signaling processes require 
previous endocytosis of their components to regulate the specificity, duration and 
magnitude of the signal, as reviewed in (Sadowski et al., 2009). The components that 
attach to vesicles during their internalization will hence define their ultimate subcellular 
destination and function, such as traveling back to the plasma membrane for recycling 
or inclusion into multivesicular bodies (MVB) for secretion or degradation (Huotari 
and Helenius, 2011; Platta and Stenmark, 2011).  
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Figure 7. The endocytic pathway. 
Cellular components residing at the plasma membrane such as signaling receptors (red rods) 
are internalized along with extracellular material during endocytosis. The vesicles that pinch 
off can be sent along recycling endosomes back to the plasma membrane in a process that 
recycles receptors for a new round of outside-in signaling at the cell surface. Alternatively, 
endocytic vesicles undergo a series of maturation steps from early endosomes to late 
endosomes/MVB, including membrane invagination to form intraluminal vesicles (ILV). 
Fusion with lysosomes elicits macromolecule degradation by specific enzymes working at 
low pH levels within these compartments, resulting in receptor down-regulation and 
signaling termination. Autophagosomes containing damaged organelles and cellular material 
for degradation also fuse to lysosomes to produce simpler components that can be reused by 
the cell. See text for details. 
 
Degradation of endocytosed material implies macromolecule breakdown into its 
constituent parts, e.g. proteins into amino acids to use in protein synthesis. It is 
therefore essential for cells to be endowed with several degradation machineries. The 
first protein-specific degradation mechanism described within the cell was the 
proteasome, which is a cytosolic protease that degrades misfolded and short-lived 
regulatory proteins in the cytoplasm (Schwartz and Ciechanover, 2009). Proteins that 
are destined towards this degradation machinery are modified by several ubiquitin 
moieties forming a chain that is recognized by the proteasome. Ubiquitination can also 
mark proteins for other subcellular outcomes and is a complex, target-specific process 
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involving several enzymes (Sadowski et al., 2012). In the case of transmembrane 
proteins, a single ubiquitin molecule marks them for degradation, though this process 
must necessarily occur via vesicular transport, in particular through endosomes to the 
lysosome or vacuole, where degradation takes place. Lysosomes are acidic organelles 
containing hydrolytic enzymes and are at the crossroads of several degradation 
processes, for they degrade proteins with long half-lives arriving in endosomes or aid in 
clearing away larger elements packaged in phagosomes or autophagosomes (de Duve, 
1969; Fader and Colombo, 2009; Saftig and Klumperman, 2009). It is indeed vital for 
cell homeostasis to tightly coordinate the complex processes encompassing vesicular 
biogenesis, membrane trafficking and the degradation of cellular components by means 
of precise macromolecular machineries.  
 
3.1 Protein machineries involved in sorting  
 
Intense research in the past decades on the proteins involved in endosomal 
sorting has uncovered a plethora of interaction networks and transport systems to 
shuttle cargo to and fro within the cell, as reviewed in (Bishop, 2003). Vesicle biogenesis 
is a topologically complicated process in which the membrane must curve forcefully and 
still accommodate transmembrane or peripheral membrane proteins and their effectors 
(McMahon and Gallop, 2005). Proteins responsible for inducing curvature, coating of 
developing omegas and membrane scission at the plasma membrane are key players in 
the initial steps of vesicle generation (Stachowiak et al., 2013). However, once 
endosomes are formed, their destination is tightly regulated by other sets of proteins 
such as Rab proteins that assemble onto the newly formed vesicles and help in their 
uncoating, trafficking (i.e. along microtubules), tethering, and fusion with one another 
(Stenmark, 2009). Furthermore, extensive maturation gives rise to vesicles that suffer 
internal processes of their own, such as the production of intraluminal vesicles (ILV) 
from the membrane of MVB mediated by the ESCRT (endosomal sorting complex 
required for transport) protein machinery (Raiborg and Stenmark, 2009) or acquisition 
of acidic pH values. The relatively recent discoveries of tethering protein complexes, 
namely, HOPS (homotypic fusion and vacuole protein sorting complex) (Seals et al., 
2000) and CORVET (class C core vacuole/endosome tethering complex) (Peplowska et 
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al., 2007) unveil the role of these multi-protein machineries in homotypic fusion of 
endocytic compartments prior to SNARE (Soluble NSF (N-ethylmaleimide-sensitive 
factor) Attachment Protein Receptor) participation, as reviewed extensively in (Solinger 
and Spang, 2013). Furthermore, anterograde transport from the Golgi to late endosomes 
or lysosomes and vacuoles is mediated by carboxypeptidase Y and AP-3 
(heterotetrameric adaptor protein complex 3) pathways, whereas retromer governs 
retrograde trafficking within these compartments with the help of other proteins such as 
sorting nexins (Cullen and Korswagen, 2012; Epp et al., 2011). However, these 
complexes are beyond the scope of this dissertation, in which attention will be focused 
on the Rab and ESCRT protein machineries involved in endolysosomal trafficking and 
MVB biogenesis, to contextualize the localization of the endosomal GTPases under 
study.   
 
3.1.1 Rab proteins  
 
As described above and seen in Figure 1, Rab proteins constitute the largest of 
the Ras subfamilies. Membrane tethering is determined by their two C-terminal 
geranylgeranyl moieties and the immediate upstream protein sequence (Chavrier et al., 
1991), as well as binding to specific GDI or GDI recycling factors (Dirac-Svejstrup et al., 
1997; Ullrich et al., 1994; Ullrich et al., 1993). The multitude of Rab proteins contained 
in human cells and the processes in which they are involved are reflected in Table 1. 
Rab functions that are basic to cell homeostasis include trafficking between the 
ER, plasma membrane or endosomes and the Golgi apparatus, as well as intra-Golgi 
trafficking. Distinct Rab proteins also mediate early and late endosome biogenesis, 
maturation and fusion with lysosomes, as shown in Table 1. Endocytic recycling, 
exocytosis or phagosome dynamics also involve members of this protein family. 
Furthermore, Rab proteins also mediate other more specific, cell-type dependent 
transport mechanisms, such as melanosome biogenesis and transport, ciliogenesis, or 
tight junction assembly in epithelial cells (Stenmark, 2009). Many of these Rab proteins 
mediate trafficking steps, which are controlled by feedback mechanisms involving their 
effectors: sorting adaptors, motor adaptors for vesicle transport on actin or tubulin, 
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tethering factors or simply their respective GAP, GDI or GEF. These interactions are at 
the core of Rab protein involvement in vesicle budding, motility or fusion (Stenmark, 
2009).  
 
 
Table 1. Functions of Rab GTPases. 
Rab GTPases are crucial for a wide variety of intracellular tasks, which they perform at 
specific subcellular localizations. Where indicated, several Rab proteins act in concert to 
regulate a particular trafficking or biogenesis event. See text for details. 
 
Amongst the trafficking routes mediated by Rab proteins, the most important 
step in endosome biogenesis is the exchange of Rab5 for Rab7 on early endosomes 
maturing to late endosomes. In this process, early endosomes derived from 
internalization the plasma membrane are covered by Rab5, which is replaced by Rab7 
following an exchange of their GEF (Poteryaev et al., 2010; Rink et al., 2005). Switching 
Rab5 for Rab7 implies that recycling Rabs such as Rab4 and Rab11 are lost, whereas late 
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endosomal Rab9 is recruited. Other concomitant endosomal maturation steps include 
phosphatidylinositol species turnover, acquisition of hydrolases and other proteins from 
the trans-Golgi network, lumen acidification by V-ATPases, and morphological or size 
variations (Huotari and Helenius, 2011).  
Due to the importance of Rab proteins in intracellular trafficking, mutations in 
several of these proteins give rise to pathological scenarios including congenital 
disorders such as Griscelli Syndrome 2, in which Rab27a is mutated (Menasche et al., 
2003; Mitra et al., 2011), or X-linked choroideremia, arising from Rep-1 mutation and 
subsequent deficits in Rab27a geranylgeranylation (D'Adamo et al., 1998; Seabra et al., 
1993; Seabra et al., 1995). In addition, Rabs can mediate tumorigenesis (Recchi and 
Seabra, 2012) and are involved in infectious processes, since many pathogens hijack Rab 
pathways either during endocytosis while entering the cell, e.g. Salmonella enterica 
serovar Typhimurium or coxsackie virus (Coyne et al., 2007; Smith et al., 2007), or 
interfering with endosome maturation steps once inside the cell, e.g. Lysteria 
monocytogenes and Helicobacter pylori (Prada-Delgado et al., 2005; Terebiznik et al., 
2006).  
The concerted action of Rab proteins with other machineries adds further 
complexity to endosomal sorting. For example, late endosomes that have acquired Rab7 
undergo internal rearrangements such as acquisition of material from the Golgi, 
homotypic fusion instead of fusion with early endosomes, or ILV formation giving rise 
to MVB (Huotari and Helenius, 2011). This latter process is catalyzed by yet another 
multi-protein sorting machinery, the ESCRT proteins. 
 
3.1.2 ESCRT proteins in MVB biogenesis 
There is a multitude of proteins involved in the formation of MVB that function 
sequentially from cargo recognition, deformation of the membrane, to internalization of 
cargo into ILV of MVB (Raiborg and Stenmark, 2009). The components involved in 
recognizing ubiquitin on cargo to be degraded were studied in yeast and termed Class E 
Vacuolar protein sorting (Vps) proteins (Raymond et al., 1992). It was soon determined 
that Vps proteins combine at MVB membranes to form the multi-subunit ESCRT 
machinery represented in Figure 8 to mediate ILV biogenesis. 
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Figure 8. Schematic of the ESCRT protein machinery. 
The ESCRT machinery aids in sorting endosomal cargo and MVB biogenesis through ILV 
production. Dark blue rods bound to light blue circles represent receptors bound to their 
ligand that have been internalized from the plasma membrane and arrive at the MVB limiting 
membrane during endocytosis. Ubiquitin binds to these receptors and is recognized by 
ESCRT-0 (green components) through binding of Hrs to PI(3)P (red phospholipid). ESCRT-I 
(red shapes) is recruited by this machinery and cargo is transferred along the pathway such 
that ESCRT-I together with ESCRT-II (orange shapes) gives rise to MVB membrane 
invagination. ESCRT-III (purple spiral) binds to ESCRT-II along with other associated proteins 
responsible for deubiquitinating cargo. ESCRT-III forms spiral filaments surrounding the 
forming vesicle neck to induce its pinching off from the limiting membrane to form an ILV. 
Ultimately, the ATPase Vps4 (teal hexagon) is recruited by ESCRT-III and promotes its 
disassembly to recycle components. The nomenclature used here refers mostly to yeast 
proteins, though alternative nomenclatures have developed for mammalian orthologues. 
Adapted from (Rusten et al., 2012).  
 
As addressed above, protein complexes aid vesicles in diverse maturation steps 
along the endocytic route (see Figure 7), including membrane budding events that elicit 
multivesicular compartment formation. The ESCRT –I, -II and –III complexes were 
described as assemblies of Vps proteins, each involved in a specific step of MVB 
biogenesis (Babst et al., 2002a; Babst et al., 2002b; Katzmann et al., 2001). A fourth 
complex, ESCRT-0, was defined later on, though it is the first to act by recognizing 
ubiquitinated cargo such as monoubiquitinated cytosolic domains of membrane 
receptors and forming a protein mesh on endosomes (Raiborg et al., 2001; Raiborg and 
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Stenmark, 2009). The fundamental ESCRT-0 protein is Vps27p, or Hrs (Hepatocyte 
growth factor-regulated tyrosine kinase substrate) in humans (Figure 8, green). Hrs 
recognizes ubiquitinated cargo and also contains a phosphoinositol-3-phosphate 
(PI(3)P) binding domain termed FYVE. ESCRT-I is responsible for binding to 
ubiquitinated cargo and ESCRT-0 simultaneously (Katzmann et al., 2001). Vps23p or its 
homolog in humans, Tsg101 (Figure 8, red), is at the core of ESCRT-I, for it directly 
binds to cargo and Hrs. Once ESCRT-0 is recycled, ESCRT-I can interact with ESCRT-
II (Figure 8, orange), which aids in early steps of membrane curvature and in 
assembling the next complex (Babst et al., 2002b). ESCRT-III function is one of the 
most important steps in MVB biogenesis, since a subset of its subunits is in charge of 
generating membrane curvature to accommodate ILV production, while other proteins 
in this complex aid in vesicle abscission (Babst et al., 2002a; Hanson et al., 2008). 
Currently, there is still debate as to how ESCRT-III subunits (in humans, charged 
multivesicular proteins, or CHMP) assemble to deform membranes, with two main 
hypotheses still standing, i.e. the helical and dome models, represented by purple spirals 
in Figure 8, as reviewed in (Henne et al., 2013). In turn, several ESCRT-associated 
proteins perform crucial tasks such as deubiquitinating cargo or aiding in membrane 
deformation (Clague and Urbe, 2006). Vps4 is an ATPase that is in charge of 
terminating ILV formation by providing energy for membrane scission at the vesicle 
neck and promoting ESCRT-III dissociation from the MVB (Shim et al., 2008). 
Interestingly, ESCRT machineries do not accompany cargo into ILV, but rather are all 
recycled for subsequent rounds of endolysosomal sorting (Babst et al., 1998; Williams 
and Urbe, 2007). 
Though the canonical ESCRT sorting pathway begins with cargo ubiquitination, 
several studies have shown that this route can also be responsible for ubiquitin-
independent sorting. In yeast, acid trehalase is targeted to lysosomes via MVB in an 
ubiquitin-independent manner (Huang et al., 2007a). In mammalian cells, several 
cytokine receptors and the G-protein coupled receptors (GPCR) DOR (delta opioid 
receptor) and PAR1 (protease-activated receptor 1) are similarly sorted into MVB 
through ubiquitin-independent mechanisms involving at least part of the ESCRT 
machinery (Amano et al., 2011; Dores et al., 2012; Hislop et al., 2004). A recent study 
further suggests that binding to any ESCRT protein can mediate ubiquitin-independent 
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sorting, such that weak affinity for ESCRT and strong membrane association will 
mediate internalization into MVB, whereas a strong interaction with ESCRT but weaker 
membrane binding will send proteins along the recycling pathway to the plasma 
membrane, regardless of their ubiquitination state (Mageswaran et al., 2014). Therefore, 
some MVB cargo contains structural determinants that allow for ESCRT-dependent 
sorting into ILV in the absence of ubiquitin.  
The ILV inside MVB can have different fates. If retained in the endosomal route, 
they will be taken to the lysosome to be degraded (Futter et al., 1996). Alternatively, ILV 
can be liberated to the extracellular space after fusion of MVB with the plasma 
membrane, hence becoming exosomes, as reviewed in (Simons and Raposo, 2009). 
Whether degradative and exocytic ILV are contained within distinct MVB or can be 
found in the same MVB has been the subject of much debate. Recently, two 
subpopulations of ILV have been shown to coexist within the same MVB (Edgar et al., 
2014), as depicted in Figure 9.  
 
Figure 9. ILV biogenesis and destination. 
The limiting membrane of MVB invaginates to form either large ILV through ESCRT-
dependent mechanisms (machinery shown in green, red and purple) or to form small ILV in a 
process involving CD63 (shown in orange). In this model, the same MVB holds both types of 
ILV, as described recently (Edgar et al., 2014); however, it is not yet clear whether this is the 
case or if specific MVB exist for each type of ILV. Small ILV containing CD63 and material to 
be secreted (blue squares) are released into the extracellular milieu upon fusion of the MVB 
with the plasma membrane during exocytosis. On the other hand, large ILV containing cargo 
such as signaling receptors (red rods) fuse with lysosomes to elicit degradation of ILV content. 
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The two types of ILV differ in size, biogenesis and cellular fate. Large, sorting 
ILV are formed Hrs-dependently, whereas small, exocytic ILV appear due to sorting 
mediated by the tetraspanin CD63, as will be explained below. It is therefore possible 
that both ESCRT-dependent and -independent ILV generation occur simultaneously 
within the cell, giving rise to specific types of vesicles with unique destinations. This 
point is further substantiated by the fact that CD63-positive ILV still appear in the 
absence of members of all ESCRT complexes, suggesting that ESCRT-independent 
mechanisms of MVB biogenesis are still operative in this setting (Stuffers et al., 2009). 
Indeed, the major histocompatibility complex-II (MHC-II) in dendritic cells can be 
sorted to lysosomal ILV when ubiquitinated under resting conditions via an ESCRT-
dependent process, whereas cell activation abolishes MHC-II ubiquitination and 
promotes its internalization into exosomal ILV that are liberated towards the T cells 
with which they interact (Buschow et al., 2009). 
Though represented as distinct processes in Figure 9, crosstalk most likely exists 
between degradative or exocytic ILV biogenesis pathways, as reflected in a recent report 
presenting an RNA interference screen of 23 ESCRT proteins.  Several ESCRT proteins, 
e.g. Hrs or Tsg101, were found necessary not only for degradative ILV formation but 
also for exosome biogenesis, suggesting that exosomes can be formed by the ESCRT 
machinery as well as by ESCRT–independent pathways (Colombo et al., 2013). 
 
3.1.3 CD63-mediated sorting 
The role of CD63 in formation of exosomal ILV highlights the fact that this 
tetraspanin is inextricably involved in late endosomal trafficking, as reviewed in (Pols 
and Klumperman, 2009). Tetraspanins are a family of proteins containing four 
transmembrane domains, glycosylated residues and most contain cysteines amenable to 
palmitoylation, as is the case for CD63, as reviewed in (Hemler, 2005). These 
posttranslational modifications aid in homo- and heteroligomerization to produce 
tetraspanin-enriched microdomains (TEM) in which tetraspanins of several types along 
with receptors, integrins, metalloproteinases and cholesterol occupy a tightly packed 
area of membrane, particularly on the plasma membrane (Yang et al., 2002). In fact, as 
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shown in Figure 10, a cholesterol-palmitoyl interaction is also established by the 
palmitates bound to tetraspanins, further stabilizing these TEM (Charrin et al., 2003). 
 
Figure 10. CD63 tetraspanin-enriched microdomains. 
Zoom-in of a membrane from an ILV destined for exosomal release. CD63 molecules are 
shown in orange, containing four transmembrane domains and two loop domains. Cysteine 
residues at their N- and C-termini become palmitoylated (blue zigzags), which allows for 
interaction with membrane-embedded cholesterol (black structures). The C-terminal YXXΦ 
motifs that interact with AP complexes for intracellular shuttling are also depicted. 
Tetraspanins associate with each other to form oligomers, as shown here for four CD63 
molecules, to form tetraspanin-enriched microdomains (TEM). 
 
In the case of CD63, its association with late endosomes and ILV usually 
predominates over plasma membrane localization.  Specifically, ILV destined for 
exosome formation are enriched in several tetraspanins including CD63 (Escola et al., 
1998). This tetraspanin contains the lysosomal targeting sequence “YEVM”, which 
follows a “YXXΦ” pattern recognized by adaptor protein complexes, in which a crucial 
tyrosine residue is followed by any two amino acids (X) and an aliphatic, bulky residue 
(Φ), as reviewed in (Bonifacino and Traub, 2003). Therefore, CD63 contains several 
structural determinants that direct it to the late endocytic pathway. 
A newly synthesized CD63 polypeptide chain undergoes glycosylation and 
palmitoylation at the Golgi prior to export to the plasma membrane, cycling back 
inward when its sorting signal is recognized by AP-2 and traveling further from 
recycling endosomes to late endosomes/MVB and lysosomes via AP-3 binding, as 
reviewed in (Pols and Klumperman, 2009). Following these pathways, it has been 
Introduction 
 
 26 
reported that CD63 could be involved in trafficking of MHC-II in dendritic cells (Vogt 
et al., 2002) or recycling of the H+/K+ ATPase pump in gastric parietal cells (Duffield et 
al., 2003). Additionally, a truncated form of CD63 was shown to down-regulate 
chemokine receptor CXCR4 plasma membrane levels due to receptor internalization in 
T lymphocytes (Yoshida et al., 2008). Once localized at late endosomes/MVB, CD63 can 
mediate ESCRT-independent sorting of certain proteins, as is the case for specific 
domains of the melanosomal protein Pmel17 (Theos et al., 2006; van Niel et al., 2011). 
Furthermore, CD63 plays a central role in ESCRT-independent exosome biogenesis, as 
described above, which is also reflected by its use as an exosomal marker, as reviewed in 
(Andreu and Yáñez-Mo, 2014). Recently, the direct role of TEM in exosome formation 
has been set forth by a comprehensive high-throughput proteomic analysis that 
highlights their importance in selecting receptors and signaling proteins for exosomal 
packaging (Pérez-Hernández et al., 2013). It is interesting to note that though CD63 is 
involved in sorting proteins of various origins, its knock-out (KO) mouse model is 
viable and displays normal lysosomal function, though these mice suffer kidney 
pathologies. However, considering the amount of tetraspanins expressed in cells, there 
could be redundancies such that other members of this protein family could 
compensate for CD63 loss (Schröder et al., 2009).  
Though MVB biogenesis and cargo sorting require proteins such as CD63 or 
ESCRT components, it also depends on the lipid composition in which membrane 
proteins are embedded. It has been proposed that specific membrane domains and the 
lipids contained therein can play a part in the invagination of the MVB limiting 
membrane to form ILV (Matsuo et al., 2004). Moreover, it has been described that 
certain lipid compositions favor the formation of MVB in the absence of protein 
components, both in liposome models and in cells (Matsuo et al., 2004; Trajkovic et al., 
2008), as will be described in the following section. 
 
3.2 Lipid involvement in endosomal sorting 
 
Lipids are distributed unevenly among cellular membranes and hence play a 
significant role in the distribution of membrane proteins in different organelles. As 
schematized in Figure 11, intracellular membranes have been proposed to be divided 
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into two distinct environments according to lipid properties: the biosynthetic, pre-Golgi 
system that includes the ER, and the secretory-endocytic, post-Golgi system that 
includes the plasma membrane and endocytic vesicles (Lippincott-Schwartz and Phair, 
2010). Following this model, ER/cis-Golgi membranes contain monounsaturated lipids 
usually with neutral head groups that favor interactions with cytosolic proteins 
preferring lipid-packing defects. On the other hand, the trans-Golgi, plasma membrane 
and endocytic compartments include more negatively charged lipids packed tightly (i.e. 
phospholipids with more saturated acyl chains) to favor electrostatic interactions 
(Figure 11). Other specialized lipids appear at specific subcellular locations. For 
instance, cholesterol and glycosphingolipids reside on both leaflets of the plasma 
membrane, while phosphatidylethanolamine (PE) and phosphatidylserine (PS) remain 
at its inner leaflet, as reviewed in (Bigay and Antonny, 2012). Furthermore, scarce but 
highly specialized phosphoinositides appear at different membrane sites throughout the 
cell. The plasma membrane contains PI(4,5)P2 and PI(3,4,5)P3 whereas PI(3)P appears 
at early endosomes and controls many endocytic processes through proteins with 
PI(3)P binding domains (Gillooly et al., 2000; Schink et al., 2013). The specialized 
phospholipid, 2,2’-dioleoyl lysobisphosphatidic acid (LBPA, a.k.a. BMP) (Kolter and 
Sandhoff, 2005) is exclusively localized to late endosomes, particularly ILV of MVB 
(Kobayashi et al., 1999), and has the ability to deform membranes in vitro, thus possibly 
playing a role in MVB invagination, as discussed below (Matsuo et al., 2004). Therefore, 
the dynamic nature of membrane trafficking depends not only on protein-based sorting 
complexes, but also on organelle identity conferred to specific endomembranes by lipids 
of varied acyl composition, head group charge and overall physicochemical structure.  
Lipid gradients exist along the biosynthetic pathway, so that there is more 
cholesterol density and sphingolipids from the ER towards the PM (Maxfield and van 
Meer, 2010), as depicted in Figure 11. Cholesterol and sphingolipids are responsible for 
thickening the membrane bilayer, which is reflected by the transmembrane span of 
proteins (Sharpe et al., 2010). In particular, cholesterol is enriched in recycling 
endosomes, as well as in ILV of MVB (Möbius et al., 2003). Cholesterol has been found 
to appear at particularly high curvature regions (Wang et al., 2007), which could explain 
its concentration in ILV. This sterol also stabilizes fluid phosphoinositide domains, 
which could be involved in forming signaling platforms that require concentrating these 
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scarce phospholipids into an area that accommodates interactions between signaling 
proteins (Jiang et al., 2014). Furthermore, in the context of signaling receptors, several 
GPCR have been shown to directly interact with cholesterol through their palmitoyl 
moieties (Cherezov et al., 2007; Zheng et al., 2012), similarly to tetraspanins (Charrin et 
al., 2003).  
 
Figure 11. Lipid properties defining membrane environments within the cell. 
Studies based on lipidomics and probe detection point to two distinct membrane 
environments within the cell. As shown to the left of the dashed line (blue structures), the ER 
and cis-Golgi membranes are characterized by lipid-packing defects due to the unsaturated 
chains that their phospholipids contain, whose head groups are weakly charged. 
Furthermore, they present low levels of cholesterol and sphingolipids, producing thin 
membranes. In contrast, trans-Golgi, endosomal and plasma membranes (orange and red 
components to the right of the dashed line) are characterized by inner leaflet phospholipids 
with negatively charged polar groups (high electrostatics) and saturated chains, as well as 
elevated cholesterol and sphingolipid levels, rendering them thicker and more tightly packed. 
Adapted from (Bigay and Antonny, 2012). 
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Regarding the formation of ILV of MVB, several in vitro studies have shown that 
lipids alone can mediate membrane invagination on liposomes with particular 
compositions (Matsuo et al., 2004; Trajkovic et al., 2008). The specialized lipid LBPA 
could be involved in the ESCRT-dependent formation of degradative ILV (Matsuo et al., 
2004), whereas the sphingolipid ceramide induces the formation of ILV destined to 
become exosomes (Trajkovic et al., 2008) (see Figure 9). These findings are in line with 
studies describing high levels of LBPA in ILV of MVB within the cell, whereas exosomes 
are not enriched in this lipid (Laulagnier et al., 2004; Wubbolts et al., 2003). Another 
report suggests that cholesterol-rich MVB are destined for exosome formation and 
cholesterol-poor vesicle populations are sent to the lysosome to be degraded (Möbius et 
al., 2003). Furthermore, ILV have been shown to undergo back-fusion and blend back 
into the MVB limiting membrane via an LBPA-mediated process employed by certain 
pathogens to escape their degradation, as reviewed in (Falguières et al., 2009). However, 
there is still debate regarding whether exosome biogenesis is dependent on ESCRT and 
its associated proteins, e.g. Hrs, Alix (Baietti et al., 2012; Colombo et al., 2013; Gibbings 
et al., 2009) or mostly lipid-based and perhaps involving CD63 (Trajkovic et al., 2008). 
It is therefore probable that ILV themselves or even specific microdomains of the MVB 
limiting membrane, though thoroughly dependent on their lipid composition, are 
regulated by tight interplay with complex protein machineries owing to their highly 
dynamic nature (Bissig and Gruenberg, 2013).  
Lipid composition also has its effects on peripheral membrane proteins such as 
Ras and Rho proteins, since their trafficking depends on lipid modifications, as 
described above. In the case of proteins that are both isoprenylated and palmitoylated, 
isoprenylation could be responsible for a weak interaction with the membrane, whereas 
single or double palmitoylation would aid in its binding to membranes with a particular 
composition (Rocks et al., 2005). These palmitate moieties are saturated chains that 
occupy a small space and can therefore force their way into tightly packed membranes 
containing saturated phospholipids, such as the plasma membrane and late endocytic 
vesicles. An elegant in silico model suggests that H-Ras forms clusters at the interface of 
lipid domains with its palmitate chains preferentially oriented towards liquid ordered 
domains (Lo, cholesterol-rich, with saturated phospholipids), whereas its 
polyunsaturated farnesyl moiety is directed towards the liquid disordered membrane 
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domain (Ld), hence increasing membrane curvature (Janosi et al., 2012). H-Ras was 
indeed found to cycle between Ld and Lo domains in its GTP- or GDP-bound form, 
respectively, underscoring the importance of lateral segregation of peripheral proteins 
on their function (Prior et al., 2001). Lipid packing, electrostatics or curvature could 
play a further role in membrane selectivity, as is the case for members of the Rho family 
(Rac1 and Rac2) or the Ras protein, K-Ras4B, which contain basic residues at their C-
terminus that allow electrostatic interactions with PS on membranes (Ahearn et al., 
2012; Bigay and Antonny, 2012). It is therefore apparent that lipid composition is 
crucial for peripheral membrane proteins to accomplish their biological roles at distinct 
subcellular locations.  
 
3.3 Other sorting and degradation pathways 
 
Early stages of protein sorting within the cell involve bulk flow of many proteins 
towards the cis Golgi upon translation at the ER. However, post-Golgi trafficking events 
become increasingly specialized for the proteins to be sorted, so that more cargo-specific 
sorting machineries appear further along the endocytic route towards lysosomes, 
secretion or recycling. Along with the pivotal Rab and ESCRT protein sorting 
machineries described above, other mechanisms act in parallel to coordinate the busy 
flow of material in later stages of protein shuttling within the cell. Many proteins 
contain sequences that are recognized by sorting entities (Bonifacino and Traub, 2003), 
as exemplified by soluble acid hydrolases, which are modified by M6P and recognized 
by M6P receptors in the Golgi apparatus that will accompany them to the lysosome, as 
reviewed in (Ghosh et al., 2003). However, other M6P-independent mechanisms 
involving the sorting proteins sortilin or lysosomal integral membrane protein 2 (LIMP-
2) also work in the cell to transfer soluble proteins into lysosomes (Coutinho et al., 2012; 
Ghosh et al., 2003). As for lysosomal transmembrane proteins, their targeting sequences 
contain tyrosines (such as the “YXXΦ” motif in CD63 mentioned above) or dileucine 
motifs that are recognized by specific AP complexes, as extensively reviewed in 
(Bonifacino and Traub, 2003). Distinct AP complexes are present on membranes such 
as the plasma membrane, Golgi, endosomes and others, from which they recognize 
motifs in cargo proteins and mediate their transport (Bonifacino and Traub, 2003). 
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Additionally to protein-specific sorting, cell type-dependent processes are responsible 
for the formation and transport of certain specialized vesicles, such as lysosome-related 
organelles (LRO), e.g. melanosomes for pigmentation; basophil, azurophil and lytic 
granules or MHC class II compartments for immune responses; and platelet-dense 
granules for coagulation, as reviewed in (Dell'Angelica et al., 2000). Their biogenesis is 
mediated by yet another protein machinery termed BLOC 1-3 (biogenesis of lysosome-
related organelles complex), containing proteins that are mutated in the lysosomal 
disorder Hermansky-Pudlak syndrome (HPS), which will be considered below, as 
reviewed in (Dell'Angelica, 2004).  
 
3.3.1 Autophagy  
The term “autophagy”, literally “self-eating”, originally was designated for a 
process in which proteins and even organelles are surrounded by double membranes of 
varied origin called phagophores, which mature to autophagosomes and fuse with 
lysosomes to degrade these large amounts of cellular material (Mizushima et al., 2008). 
The explosion of research in this field has led to the discovery of numerous autophagic 
pathways, so that the original term is now referred to as macroautophagy, to 
differentiate it from the other two main forms of autophagy, i.e. microautophagy, 
implying direct lysosomal internalization, and chaperone-mediated autophagy, in which 
the chaperone Hsc70 unfolds proteins prior to their internalization into the lysosome to 
be degraded (Cuervo and Dice, 1996; Lee et al., 2012). Cells undergo these degradation 
processes to redeliver the necessary biosynthetic building blocks to the cytosol when 
they detect a nutrient or energetic shortage, or under stress conditions including 
pathogen invasion and excessive protein aggregation, as reviewed in (Yang and 
Klionsky, 2010). The autophagy-related proteins (Atg) are the core molecular 
machinery of canonical autophagy and work together in sequential complexes during 
phagophore maturation towards autophagosomes, as reviewed in (Mizushima et al., 
2011). Though autophagy was first regarded as a degradation and cell death mechanism, 
numerous reports now corroborate its role in survival, bioenergetics, cell differentiation, 
immunity, and tumor suppression, as reviewed in (Boya et al., 2013). 
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Interaction between autophagy and endolysosomal sorting is obvious at the 
point of autophagosome-lysosome fusion, but some instances of autophagosome fusion 
to early and late endosomes have been documented (Berg et al., 1998; Dunn, 1994; Liou 
et al., 1997). In fact, the fusion of endocytic vesicles such as MVB and autophagosomes 
gives rise to structures called amphisomes, which further fuse to lysosomes for 
degradation (Eskelinen, 2005). Moreover, some studies suggest that Rab11 could play a 
role in MVB-autophagosome fusion to form amphisomes, whereas Rab7 would mediate 
the next step of fusing to lysosomes, as reviewed in (Fader and Colombo, 2009). Other 
members of the Rab family also appear at the crossroads of endolysosomal and 
phagocytic pathways, such as Rab1 at the initial formation of the phagophore and Rab9 
during non-canonical Atg5/Atg7-independent autophagy, among others, as reviewed in 
(Chua et al., 2011). Studies both in mammalian cells and Drosophila lacking certain 
ESCRT proteins showed impaired autophagy and accumulation of ubiquitin-positive 
aggregates, again revealing that correct MVB function is necessary for autophagy 
progression (Rusten and Simonsen, 2008).  It has also recently come to light that it is 
common for autophagic cargo to become ubiquitinated and sorted by autophagy 
receptors containing ubiquitin-binding domains (Boya et al., 2013). Furthermore, 
connections between autophagy and exosomal MVB have been established, since 
autophagy induction by several methods inhibits exosome release and points to a 
selective MVB fate depending on cellular energy needs (Baixauli et al., 2014). Once 
again, the boundaries between distinct organelles are often blurred during crosstalk 
between intracellular trafficking pathways. 
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4. Lysosomal storage diseases 
 
 
 
Lysosomal storage diseases are quite a numerous group of rare inherited 
metabolic disorders resulting from mutations in specific lysosome-related genes 
(Ballabio and Gieselmann, 2009; Fuller et al., 2006). Though initially attributed to acid 
hydrolases of the lysosomal lumen, it has become evident that both lysosomal integral 
membrane and luminal proteins, among others, are involved in certain lysosomal 
storage disorders (Saftig and Klumperman, 2009). There are as many as 60 lysosomal 
protein deficiencies that give rise to accumulation of material from incomplete 
degradation or trafficking in degradative compartments (Sagne and Gasnier, 2008). 
Some of these disorders arise from problems in LRO biogenesis, mediated by 
transporters and tethering or sorting factors (Huizing et al., 2008). In most cases, 
manifestations appear during childhood and often include varying degrees of 
neurodegeneration and immune deficiencies that can cause death at a relatively early 
age unless palliated by bone marrow transplantation or recently developed treatments 
such as enzyme replacement therapy, as reviewed in (Platt et al., 2012). Table 2 
summarizes several lysosomal storage diseases and the proteins altered by mutations in 
their respective genes. 
There are many pathological scenarios involving malfunction of lipid transport 
routes, but here the focus will be on alterations of late endosome lipids. In Niemann-
Pick type C (NPC) disease, a set of lysosomal integral membrane proteins that act as 
cholesterol transporters at late endosomes (NPC1/NPC2) are deficient (Table 2). Late 
endosomes and lysosomes in NPC patients accumulate massive amounts of cholesterol 
and glycosphingolipids due to abnormal low-density lipoprotein processing within the 
endocytic pathway (Mukherjee and Maxfield, 2004). Furthermore, this cholesterol 
buildup induces Rab9 sequestration, possibly in its inactive form, which disrupts M6P 
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receptor trafficking (Ganley and Pfeffer, 2006). It has been described that NPC1 cells 
could be inducing the release of exosomes loaded with cholesterol, perhaps as a means 
of circumventing the cytotoxic effects of generalized cholesterol buildup within the cell 
(Strauss et al., 2010). Alterations of lipid homeostasis are quite severe due to cholesterol 
and LBPA accumulation in late endosomes and subsequent endolysosomal dilation in 
several cell types (Carstea et al., 1997; Kobayashi et al., 1999). In fact, this phenotype can 
be mimicked by treatment with the hydrophobic amine U18666A that has therefore 
been used to generate NPC-like cells (Mukherjee and Maxfield, 2004; Sobo et al., 2007).  
 
 
Table 2. Lysosomal storage diseases and mutated proteins. 
Lysosomal storage diseases are caused by point mutations in genes that code for proteins 
involved in late endocytic trafficking. NPC proteins are involved in cholesterol transport, 
whereas proteins responsible for the various forms of HPS mediate vesicular transport of 
lysosome-related organelles (BLOC) or general late endosomal trafficking (AP-3). Many point 
mutations have been described for the Lyst gene, all of which give rise to CHS of varying 
degrees of severity. 
 
Mutations in several LRO biogenesis-related proteins give rise to recognizable 
hypopigmentation disorders due to malfunction of melanosome biogenesis or 
trafficking, as reviewed in (Dessinioti et al., 2009). Such is the case for Hermansky-
Pudlak syndrome (HPS), in which mutation of several specific proteins can elicit similar 
phenotypes, and Chediak-Higashi syndrome (CHS), resulting from mutations in the 
Lysosomal trafficking regulator (Lyst) protein, as will be discussed in detail below. There 
are eight human HPS subtypes (Table 2), which arise from mutations in key LRO 
trafficking and maturation machinery proteins, i.e. BLOC-3 mutations in HPS-1 and 
HPS-4, AP-3 in HPS-2, BLOC-2 in HPS-3, HPS-5 and HPS-6, and BLOC-1 in HPS-7 
and HPS-8, as reviewed in (Wei, 2006). Apart from LRO machineries, certain Rab 
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family proteins have been shown to play a role in HPS mouse models and perhaps in 
human pathology, for BLOC-3 acts as a Rab-GEF for Rab38 and Rab32 to recruit these 
proteins to premelanosomal membranes.  Furthermore, Rab38 co-localizes with BLOC-
2 and AP-3 at endosomal membranes, suggesting a role for this Rab in cargo trafficking 
during LRO biogenesis, as reviewed in (Krzewski and Cullinane, 2013). 
 
4.1 Chediak-Higashi Syndrome 
 
CHS is a rare autosomal recessive lysosomal storage disorder characterized by 
enlarged granules in many cell types, including melanocytes, neutrophils, leukocytes 
and neurons, among others. The large, dense granules are either lysosomes or LRO 
destined for secretion and involved in diverse cellular functions such as immune 
responses, pigmentation or coagulation. These functions are compromised in CHS 
patients, as reflected by their clinical manifestations which include partial 
oculocutaneous albinism, bleeding disorders, neutropenia, recurrent infection and 
neurological dysfunction, that can lead to death associated to a severe phase due to 
uncontrolled proliferation of cytotoxic T lymphocytes (Ward et al., 2000).  
The genetic defects that underlie CHS consist of mutations in the CHS1/LYST 
gene, homologous to the beige gene in mice. This gene codifies a cytosolic protein of 
3801 amino acids (approximately 429 kDa) with still unclear functions (Huizing et al., 
2001). The LYST protein is a member of the BEACH (BEige And Chediak–Higashi) 
protein family and mutations that are phenotypically similar to CHS have been found in 
numerous mammalian species (Ward et al., 2000). Enlarged lysosomes and LRO are 
found mainly at the perinuclear region of CHS cells, pointing to a disruption in vesicle 
trafficking (Burkhardt et al., 1993).  
There are several functional studies on CHS cells or murine beige models that 
describe alterations in late vesicular traffic and their cellular impact. Similarly to HPS, 
deficiency in CHS melanosome secretion underlies oculocutaneous albinism in these 
patients (Stinchcombe et al., 2004). Under physiological conditions, it has been 
established that cells are able to use their lysosomes as Ca2+-regulated secretory 
compartments to “parch” the plasma membrane after wounding, making them crucial 
in membrane resealing (Reddy et al., 2001). In CHS and beige cells, lysosomal exocytosis 
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and consequent plasma membrane repair are defective (Huynh et al., 2004). Also in line 
with these findings, other exocytic organelles seem to be responsible for CHS immune 
deficiencies. CHS patients suffer from a loss of secretion at the immunological synapse, 
where CTL normally discharge proteins such as perforin via secretory lysosomes 
(Stinchcombe et al., 2000). Furthermore, CHS B lymphocytes present deficient peptide 
loading onto MHC class II as well as delayed antigen presentation as a result of defects 
in MHC-II transport from the TGN into MVB (Faigle et al., 1998). It has been proposed 
that LYST could act as a scaffold for complexes involved in LRO biogenesis that are 
defective in HPS pathogenesis as well, such as AP-3 or BLOC-1 (Callahan et al., 2009). 
Yeast two-hybrid screens using truncated forms of LYST revealed direct interaction 
with several proteins involved in late endosomal dynamics such as Hrs and several 
SNARE proteins (Tchernev et al., 2002). Rab14 interaction with a LYST homolog (LsvB) 
has been observed in the amoeba Dictyostelium discoideum, proposing that LsvB 
regulates lysosomal size and maturation through Rab14, though these studies are yet to 
be replicated in human cells (Kypri et al., 2013). Recent findings using small interfering 
RNA-depletion of LYST in cancer cells also point to a role for this protein in lysosome 
size and quantity, which could be regulated by fission or fusion events, instead of being 
directly responsible for LRO biogenesis or general degradation pathways (Holland et al., 
2014). Indeed, in Dictyostelium, LsvB has been found to have an inhibitory role in 
vacuole fusion (Falkenstein and De Lozanne, 2014), whereas previous studies in beige 
mouse cells suggested that LYST promotes lysosomal fission (Durchfort et al., 2012). 
Clearly, the exact function of this remarkably large protein in endolysosomal biogenesis 
or sorting still warrants further studies.  
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Small GTPases control crucial cellular functions from specific membrane 
localizations. Among the factors involved in their regulation, modifications at C-
terminal sequences play key roles, though the involvement of lipidation and its interplay 
with other structural determinants in subcellular targeting of GTPases has not been fully 
elucidated. Therefore, the work presented in this dissertation is focused on analyzing the 
role of lipid modifications of RhoB cysteine residues on its intracellular sorting and 
determining whether its lipidation motif per se is able to reproduce the behavior of the 
full-length protein. Furthermore, the possibility that lipidation sequences could be 
targeted by other structurally diverse modifications, including reactive species arising in 
pathological scenarios, has not been explored. Therefore, the following objectives were 
projected: 
 
! To study endosomal GTPase C-terminal sorting signals involved in subcellular 
localization. 
! To evaluate the importance of C-terminal isoprenylation and palmitoylation in 
attachment to intracellular vesicles. 
! To determine the subcellular localization of chimeras bearing the RhoB C-
terminal lipidation motif. 
! To assess whether the latent sorting mechanisms for the RhoB C-terminus are 
conserved in cells from different species. 
! To explore the potential role of key molecular machineries, i.e. ESCRT 
complexes, CD63 or lipid dynamics, in sorting of RhoB and related chimeras. 
! To set the basis for studying the potential alteration of endosomal GTPase 
localization and modification in experimental models of disease.  
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1. Materials 
 
1.1 General reagents 
 
1.1.1 Cell culture reagents 
Cell culture medium including DMEM, RPMI 1640, and TC100 as well as 
Newborn calf serum, penicillin/streptomycin, glutamine and trypsin-EDTA were from 
Gibco Life Technologies. NCTC 109 medium was from Sigma. Fetal bovine serum 
(FBS) was from Lonza Inc. Sterile plastic material for cell culture was obtained from 
Falcon (Beckton Dickinson). For cell imaging of live cells, 35-mm glass bottom dishes 
(p35) from MatTek Corp. were used. 
 
1.1.2 Electrophoresis and Western Blotting reagents 
For protein separation through polyacrylamide gel electrophoresis (PAGE), 
electrophoresis purity acrylamide, N,N’-methylenebisacrylamide, ammonium 
persulfate, N,N,N’,N’-tetramethylethylenediamine (TEMED), sodium dodecyl sulfate 
(SDS), glycine and Tris were acquired from Bio-Rad. For DNA separation, molecular 
biology grade agarose from Pronadisa was used for gels. Polyvinylidene fluoride (PVDF) 
Immobilon-P membranes were from Millipore, the bicinchoninic acid (BCA) Protein 
Assay Kit for measuring protein concentration in cell lysates was from Pierce and the 
enhanced chemiluminescence (ECL) detection system was from Amersham Biosciences. 
 
1.1.3 Other reagents 
High purity salts, buffers and other reagents used for preparing solutions were 
mainly from Sigma and Merck. Milli-Q distilled water was from Millipore. 
Lipofectamine 2000, Lipofectamine RNAiMax, Lysotracker Red (LTR), 7-amino-4-
chloromethylcoumarin (CMAC, a.k.a. CellTracker Blue), scrambled siRNA and siRNA 
against Hrs or Tsg101 were from Life Technologies. Chloroquine, 2-bromopalmitate, 
phenylarsine oxide (PAO), dibromobimane (DBB), leupeptin, filipin, carbobenzoxy-L-
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leucyl-L-leucyl-L-leucinal (Z-LLL, a.k.a. MG-132), C6 ceramide, dihydroceramide C6, 
and ethidium bromide were from Sigma. U18666A, simvastatin and zaragozic acid 
(ZGA) were from Merck. Cyto-ID Green Detection Reagent for autophagy monitoring 
and Lyso-ID Red Detection Reagent were from Enzo Life Sciences. All prostanoids were 
from Cayman Chemical. Human recombinant proteins were from Calbiochem-
Novabiochem (H-Ras), Jena Bioscience (RhoB and K-Ras4B) or Abcam (N-terminal 
His-tagged Rap2B). GFP-Trap agarose beads were from ChromoTek.  
 
1.2 Antibodies 
 
Antibodies for immunoblotting were: Anti-RhoB (mainly sc-180 but also sc-
8048), anti-RhoGDI (sc-360), anti-Rab7 (sc-10767), anti-ubiquitin (sc-8017), anti-
Hsp90 (sc-7947), and anti-LAMP1 (sc-20011) from Santa Cruz Biotechnology; anti-
Tsg101 from Abcam; antiserum against Hrs, as described in (Raiborg et al., 2001); anti-
pan Ras (Ab-3) from Merck; anti-Rap2 form BD Biosciences; anti-GFP from Clontech 
or Roche; secondary anti-mouse and anti-rabbit Immunoglobulins (Ig) conjugated with 
horseradish peroxidase (HRP) from Dako. Streptavidin-HRP was from GE Healthcare 
Life Sciences. For immunofluorescence, anti-giantin from Covance and anti-rabbit 568 
from Invitrogen were used.  
 
1.3 Primers 
 
The primers used for sequencing or to generate plasmids by mutagenesis or PCR 
were synthesized automatically at the Protein Chemistry Facility at CIB-CSIC in an 
Applied Biosystems 3400 synthesizer and purified in Sephadex G25, NAPTM columns 
from Amersham. 
 
1.4 Plasmids 
 
Small-scale plasmid DNA preparation was carried out using the High Pure 
Plasmid Isolation Kit from Roche whereas large-scale plasmid isolation was performed 
with the EndoFree Plasmid Maxi Kit from Qiagen. All restriction enzymes are from 
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Promega. Digestion products were separated by electrophoresis on 1% agarose gels with 
5 ng/ml ethidium bromide in Tris-acetate-EDTA (TAE) buffer prior to visualization 
under UV light on a Gel-Doc XR Imaging System (Bio-Rad). DNA fragment 
purification from agarose gels was performed with the Geneclean Turbo Kit from MP 
Biomedicals. The LigaFast Rapid DNA Ligation System from Promega was used for 
plasmid ligation. In the case of point mutations, primer pairs were designed and used 
with the QuikChange II XL Site-Directed Mutagenesis Kit from Agilent Technologies. 
All plasmids were sequence verified at the DNA Sequencing Service, Secugen S.A. at 
CIB-CSIC. 
 
1.4.1 Donated and commercial plasmids 
 
The following plasmids were kindly provided by various colleagues: 
• pcDNA3-HA-RhoB (Prof. G.C. Prendergast, Lankenau Institute for Medical 
Research, Wynnewood, PA) 
• Lamp1-GFP (Prof. J. Lippincott-Schwartz, NIH, MD) 
• GFP-Rab7 (Prof. C. Bucci, University of Copenhagen, Denmark) 
• GFP-Vps4 WT and E334Q (Prof. P. Woodman, University of Manchester, UK) 
• GFP-Rab5 (Prof. J. Bonifacino, NIH, MD) 
• GFP-2xFYVE and mCherry-2xFYVE (Prof. H. Stenmark, Radium Hospital, 
Oslo, Norway) 
• GFP-H-Ras (Dr. J.M. Rojas, ISCIII, Majadahonda, Spain) 
• RFP-LC3 (Prof. T. Yoshimori, Research Institute for Microbial Diseases, Osaka, 
Japan) 
 
Other plasmids were obtained from commercial sources: 
• GFP-Rab11, GFP-Rab9A, GFP-Rap2A, GFP-Rap2B, GFP-CD63 (all in a pEZ-
M29 backbone for N-terminal GFP fusion) and mCherry-CD63 (pEZ-M55 
backbone) were from Genecopoeia. 
• pEGFP-C1, pmCherry-C1 and pDendra2-C were from Clontech. 
• pTagRFP-C was from Evrogen. 
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The following constructs were generated by Genewiz Inc. (South Plainfield, NJ) by 
oligonucleotide synthesis and cloning into parent vectors: 
 
• GFP-CINCSKVL (GFP-8-C244S, isoprenylation defective GFP-8 mutant) 
• GFP-SINSCKVL (GFP-8-C240,243S, palmitoylation defective GFP-8 mutant) 
• tRFP-T-CINCSKVL (tRFP-T-8-C242S) 
• tRFP-T-SINSCKVL (tRFP-T-8-C238,241S) 
• GFP-HA-RhoB X (expressing RhoB from Xenopus laevis) 
• tRFP-T-HA-RhoB X 
• GFP-CINCCKVL Asp (GFP-8 for Aspergillus nidulans transformation using 
p1902 as template) (Pantazopoulou and Peñalva, 2009)  
• GFP-SINSCKVL Asp (GFP-8-C239,242S, palmitoylation defective GFP-8 for A. 
nidulans transformation) 
 
1.4.2 Previously generated plasmids 
 
Using some of the plasmids above, several constructs were previously generated and 
described in publications from the Pérez-Sala laboratory and colleagues: 
 
• pEGFP-C1-HA-RhoB WT (GFP-RhoB) (Stamatakis et al., 2002) 
• pcDNA3.0-GFP-CINCCKVL (GFP-8), GFP plus the last 22 amino acids of RhoB 
(GFP-22), and GFP-CINCCLIT (GFP-8-TC10, from the TC10 C-terminus) 
(Pérez-Sala et al., 2009) 
• pTagRFP-RhoB (tRFP-RhoB) and pTagRFP-CINCCKVL (tRFP-8), tRFP 
plasmids containing a S162T mutation to improve photostability (Shaner et al., 
2008): tRFP-T-RhoB and tRFP-T-8, as well as the triple mutants of GFP-HA-
TC10 (K194N, K195Q, H196N; GFP-TC10-NQN) and GFP-HA-RhoB 
(insertion of KKH after L179, GFP-RhoB-KKH) (Valero et al., 2010) 
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1.4.3 Plasmids generated for this work 
1.4.3.1 mCherry-8 
 
Analogously to GFP-8, pmCherry-CINCCKVL was generated as described (Pérez-Sala 
2009) using pmCherry-C1 as a template, by attaching the last eight amino acids of 
RhoB, a stop codon, and an EcoRI site to the C-terminus of mCherry cDNA by PCR 
with the following forward and reverse primers, respectively:  
5’-GAGTAGAAGCTTATGGTGAGCAAGGGCGAGGAG-3’ 
5’-CCGAATTCTAGAGGACCTTGCAACAGTTGATACACTTGTACAGCTCGTC- 
CATGC-3’  
PCR products were digested with HindIII and EcoRI and cloned into pcDNA3.0. 
 
1.4.3.2 pDendra2-CINCCKVL (Dendra-8) 
 
Analogously to mCherry-8, pDendra2-8 was generated using pDendra2-C as a template, 
by attaching the last eight amino acids of RhoB and an EcoRI site to the C-terminus of 
Dendra2 cDNA by PCR with the following forward and reverse primers, respectively:  
5’-GCGCTAGCTCGAGGTACCGC-3’ 
5’-CCGAGCTCTAGAGGACCTTGCAACAGTTGATACACCACACCTGGCTGG-3’  
PCR products were digested with HindIII and EcoRI and cloned into pDendra2-C. 
 
1.4.3.3 mCherry-HA-RhoB 
 
The cDNA of HA-RhoB was obtained from pEGFP-HA-RhoB by digestion with BglII 
and EcoRI. The fragment was purified and ligated with pmCherry-C1 previously 
digested with the same restriction enzymes. 
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1.4.3.4 Plasmids generated by site-directed mutagenesis 
 
• pEZ-mCh-CD63 Y235A and pEZ-GFP-CD63 Y235A: Mutation of the YXXΦ 
motif tyrosine in CD63 was performed in both pEZ-mCherry-CD63 and pEZ-
GFP-CD63 WT plasmids using the following oligonucleotides: 
5’-CTCGAGCTACATCACCTCGGCGCCACTTCTGATACTCTTC-3’ 
5’-GAAGAGTATCAGAAGTGGCGCCGAGGTGATGTAGCTCGAG-3’ 
 
2. Methods 
 
2.1 Cell culture 
 
The following cell lines were used throughout this work and cultured as described: 
 
• HeLa adenocarcinoma cells from the American Type Culture Collection 
(ATCC) were cultured in DMEM supplemented with 10% FBS, 100 U/ml 
penicillin and 100 µg/ml streptomycin at 37ºC in an atmosphere with 5% CO2. 
• Bovine aortic endothelial cells (BAEC) were obtained from Lonza and cultured 
in RPMI1640 medium supplemented with penicillin/streptomycin and 10% calf 
serum at 37ºC, 5% CO2. BAEC were used between passages 5 and 12 and were 
grown to near confluence for experiments. 
• Human primary fibroblasts from healthy subjects (AG09309 and AG10803), 
CHS patients (GM02075), NPC1 patients (GM03123) and HPS-2 patients 
(GM17890) were obtained from the NIGMS Human Genetic Cell Repository at 
the Coriell Institute for Medical Research, cultured in DMEM supplemented 
with 10% FBS and penicillin/ streptomycin at 37ºC, 5% CO2 and used up to 
passage 20.  
• Xenopus laevis A6 cells were obtained from Sigma and cultured at 28ºC in NCTC 
109 medium supplemented with 15% distilled H2O, 2 mM glutamine, 10% FBS 
and penicillin/ streptomycin. 
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• High Five cells, derived from ovarian cells of the cabbage looper Trichoplusia ni, 
were from Invitrogen. These cells were cultured at 28ºC in TC100 medium 
supplemented with 10% FBS, penicillin/ streptomycin and 10 μg/ml gentamycin. 
 
All cell lines were passaged by trypsin-EDTA detachment, complete medium wash and 
centrifugation at 1000xg for 5 min, suspension in fresh medium, and plating at the 
desired dilution. 
 
2.1.1 Aspergillus nidulans culture 
Aspergillus nidulans was cultured in complete medium (MCA) or synthetic complete 
medium (SC) containing 1% glucose and 5 mM ammonium tartrate (i.e. 10 mM NH4+) 
as carbon and nitrogen sources, respectively. GFP-8 and GFP-8-C239S,C242S were 
expressed under the control of the gpdAmini promoter, using a single-copy integration 
construct targeted to pyroA, as described previously (Pantazopoulou and Peñalva, 
2009). 
 
Strains used in this work: 
 
• MAD690: yA2; argB2::[argB*-alcAP::GFP]; pantoB100 
• MAD4689: wA2; pyroA4::[pyroA*-gpdAmini::GFP-8]; pantoB100 
• MAD4688: wA2; pyroA4::[pyroA*-gpdAmini::GFP-8-C239S,C242S]; pantoB100 
 
2.2 Cell treatments 
 
Treatments with the various agents described in each section were performed in 
the absence of serum, unless otherwise stated. As has been described for BAEC, this 
situation induces a near-quiescent state and does not reduce cell viability (Hernández-
Perera et al. 1998). Control cells received an equivalent amount of vehicle as required.  
 
• Inhibition of GTPase isoprenylation was elicited by treatment with 10 µM 
simvastatin for 24 h. 
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• Palmitoylation was inhibited using 2-bromopalmitate (2-BP) at 20 µM for 6 h.  
• In order to disrupt the endolysosomal pathway, cells were treated with 10 µM 
chloroquine or U18666A for 20 h. 
• For proteasome blockage, Z-LLL at 5 µM was used for 24 h. 
• For cholesterol depletion, ZGA was added at 50 or 100 µM for 24 h, as indicated. 
• Secretion was induced by treatment with C6 ceramide at 10 µM for 24h, using 
dihydroceramide C6 at the same concentration as control. 
• For induction of autophagy, cells were incubated in amino acid-free medium 
(EBSS) for the times indicated. All further treatments and staining procedures 
were performed also in this medium to avoid autophagy reversion.  
 
2.3 Transient transfections 
 
Transient cell transfection was carried out at 80% confluence with Lipofectamine 
2000 following the instructions of the manufacturer, i.e. using 1 μg of DNA and 3 μl 
(single transfections) or 4.5 μl (double transfections) of Lipofectamine per p35 dish. 
Unless otherwise indicated, after transfection, cells were allowed to recover for 24 h in 
complete medium before treatment with the indicated agents in the absence of serum. 
Imaging of live cells or biochemical analysis was performed 48 h after transfection to 
minimize its effects.  
 
2.4 Cell lysis 
 
2.4.1 Lysis of mammalian cells 
In preparation for SDS-PAGE, cells were homogenized by forced passes through 
a 26½-gauge needle in lysis buffer containing 50 mM Tris, pH 7.5, 0.1 mM EDTA, 0.1 
mM EGTA, 0.5% SDS, 0.1 mM β-mercaptoethanol, 50 mM sodium fluoride and 0.1 
mM sodium orthovanadate with 2 µg/ml of the protease inhibitors leupeptin and 
aprotinin as well as 1.3 mM Pefabloc prior to boiling at 95ºC for 5 min. Lysates for 
subcellular fractionation were obtained in the same buffer, without SDS. Alternatively, 
cells were scraped with a rubber scraper and directly lysed in Laemmli sample buffer 
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containing the protease and phosphatase inhibitors mentioned above by boiling at 95ºC 
for 5 min prior to gel loading. 
For immunoprecipitation procedures, cells were lysed in 
radioimmunoprecipitation assay (RIPA) buffer, i.e. 10 mM Tris/Cl pH 7.5, 150 mM 
NaCl, 0.5 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% deoxycholate plus protease and 
phosphatase inhibitors.  
 
2.4.2 Aspergillus nidulans lysis 
Total protein extracts of the A. nidulans strains used in this work were obtained 
from 200-250 mg of mycelium filtered through Miracloth (22-25 μm pore), drained, 
frozen in dry ice and lyophilized. The lyophilized mycelium was ruptured by a 10 
second pulse in the FP120 Fast Prep Cell Disruptor (BIO101/Savant) at 4ºC using a 0.55 
cm ceramic sphere. Pulverized mycelium was resuspended in alkaline lysis buffer 
containing 0.2 M NaOH and 0.2% β-mercaptoethanol. Proteins were precipitated by 
adding trichloroacetic acid to 7.5% and incubation on ice for 10 min. Samples were 
centrifuged at 14000 rpm for 5 min at 4 ºC and the resulting pellet was neutralized with 
Tris Base at 1 M. Laemmli sample buffer with protease inhibitors was added to samples, 
which were vortexed and boiled at 100ºC for 2 min prior to loading on 12.5% 
polyacrylamide gels containing 0.1% SDS.  
 
2.5 Western blotting (WB) 
 
Protein concentration was estimated by the BCA method. Volumes equivalent to 
20 µg of protein were run on 12.5 or 15% SDS-polyacrylamide electrophoresis gels and 
transferred to Immobilon-P membranes using a semi-dry, Whatman filter-based 
method. The proteins of interest were visualized using an ECL detection system. Protein 
levels were estimated by image scanning of the ECL exposures and their values were 
corrected by the band intensities of the signal given by an antibody against a non-related 
protein, where indicated. Blots were quantified using ImageJ software (US National 
Institutes of Health, Bethesda, MD, USA). 
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Direct binding of DBB to recombinant proteins was assessed by visualization of 
the gel under UV light on a Gel-Doc XR Imaging System (Bio-Rad), as described (Sinz 
and Wang, 2001). Unbound DBB, which is essentially non-fluorescent, becomes 
fluorescent upon cysteine cross-linking (excitation maximum=385 nm, emission=477 
nm). 
 
2.6 Subcellular fractionation 
 
For S100/P100 fractionation, total cell lysates were obtained by disrupting cells 
in the detergent-free buffer described above. Lysates were centrifuged at 1000xg for 5 
min at 4 °C. Post-nuclear supernatants were further subjected to ultracentrifugation at 
100,000xg for 1 h at 4 °C to obtain soluble and membrane cellular fractions. 
Supernatants (S100) were collected and pellets (P100) were resuspended in lysis buffer 
containing 1% NP-40 and 0.1% SDS. These fractions were loaded onto gels for WB, as 
described above.  
 
2.7 Gene knock-down using siRNA 
 
HeLa cells were depleted of ESCRT components the day after plating by 
transfection with 75 nM Hrs siRNA or 25 nM Tsg101 siRNA, and control cells were 
transfected with 50 nM scrambled (scr) siRNA using Lipofectamine RNAiMax 
according to the manufacturer’s instructions. Cells were re-plated after 3 days, 
transfected with fluorescent constructs and grown for an additional 2 days before either 
live microscopy visualization or cell lysis and WB. 
 
The following siRNA sequences were used: 
 
Hrs: 5’-CGACAAGAACCCACACGUC-3’ 
Tsg101: 5’-CCGUUUAGAUCAAGAAGUAUU-3’ 
 
Scrambled siRNA was a double-stranded 21-mer RNA that does not correspond 
to any sequence encoded in the human genome.  
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2.8 Pull-down assays 
 
GFP fusion proteins were immunoprecipitated using GFP-Trap agarose beads. 
After the described lysis, incubation with GFP-Trap took place for 1 h at 4ºC. Beads 
were washed three times with detergent-free lysis buffer and eluted with Laemmli 
sample buffer for 10 min at 95ºC. WB was performed on non-bound (not shown) and 
eluates as well as total lysates to assess protein retention. 
 
2.9 Live cell microscopy 
 
2.9.1 Confocal microscopy 
For live visualization, cells were cultured on glass-bottom dishes, transfected 
with fluorescent constructs, treated with the indicated agents and visualized directly on 
a confocal microscope, either Leica DMRE2, Leica SP5 or Zeiss LSM 810 equipped with 
405, 488, 568 and 642 nm diode lasers. Unless otherwise stated, images shown are single 
channels or overlays of single Z-sections for co-localization visualization. All 
experiments were repeated at least three times and representative results are shown. 
Scale bars represent 20 μm. 
For live lysosome tracking, cells were stained with 25 nM LTR for 15 min at 
37ºC. When staining with other lysosomal or autophagosomal probes such as Lyso-ID 
or Cyto-ID, images were obtained shortly after staining to minimize loss of 
fluorescence. Care was taken to briefly observe cells under the UV lamp before imaging 
to minimize fading of the probes. Lyso-ID and Cyto-ID were diluted in the total volume 
of serum-free culture medium to be used for staining at 37 °C for 30 min to maintain 
endothelial cell morphology and viability during cell imaging. In experiments in which 
autophagy was induced by incubation of cells in EBSS, staining and washing (for 
autophagy reversion experiments) was also performed in this medium. In the case of 
Cyto-ID/LTR co-staining, LTR was added to the medium of cells that had been 
incubated with Cyto-ID for 15 min, left for an additional 15 min to co-stain and 
visualized immediately afterwards.  
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2.9.2 Super-resolution microscopy 
In vivo super-resolution 3D structured illumination microscopy (SIM) imaging 
was performed on a Deltavision OMX V4 system (Applied Precision, GE Healthcare) 
equipped with an Olympus 60x NA 1.42 objective, cooled sCMOS cameras and 405, 
488, 568 and 642 nm diode lasers. Z-stacks covering the whole cell were recorded with a 
Z-spacing of 125 nm. A total of 15 raw images (5 phases, 3 rotations) per plane were 
collected. Reconstruction and alignment of these raw images was performed using 
Softworx software (Applied Precision, GE Healthcare company). 
 
2.9.3 Photoswitchable fluorescent protein tracking 
Dendra-8 photoswitching and isoprenylation inhibition-and-release 
experiments were performed on transfected BAEC on glass-bottom dishes. The 
transfection medium was removed after 5 hours and replaced with serum-free medium 
with or without 10 μM simvastatin. Cells were observed 24 hours post-treatment on the 
Leica SP2 confocal microscope and photoswitching was performed by exposure to 405 
nm UV light. The resulting green-to-red conversion was recorded in both channels. 
Simvastatin was either added or removed to the corresponding dishes in serum-free 
medium and photoconverted, red Dendra-8 was tracked 24 hours later by confocal 
microscopy.  
 
2.9.4 Aspergillus nidulans microscopy 
For microscopy experiments in Aspergillus, hyphae were cultured in Lab-Tek 
chambers (Thermo Fischer Scientific, 115411; 0.3 ml of medium per well) at 25–28°C in 
pH 6.5 ‘watch minimal medium’ (WMM) containing 100 mM sodium acetate and 5 
mM ammonium tartrate as carbon and nitrogen sources, respectively. Hyphae were 
visualized on an inverted fluorescence microscope (Leica DMI6000B) equipped with an 
EL6000 external light source with metal halide lamp epifluorescence excitation, driven 
by Metamorph® software (Molecular Dynamics) and coupled to a CCD camera (ORCA 
ER-II; Hamamatsu). Vacuoles were detected with CMAC. 
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2.9.5 Image analysis 
Co-localization analysis was performed with LAS-AF software from Leica on 
single z-sections of images to obtain co-localization rates (expressed as percentages) and 
Pearson coefficients (coefficient r x 100). Alternatively, ImageJ (Fiji) software was used 
to obtain Pearson coefficients. At least 30 cells were analyzed per experimental 
condition. For stained cells, whole-field images were analyzed, whereas in the case of 
transfected cells, regions of interest (ROI) including transfected cells and excluding 
non-transfected cells were delimited prior to image analysis. Results are presented as 
mean co-localization rates or Pearson coefficients ± standard error of mean (SEM).  
 
2.10 Immunofluorescence 
 
For immunofluorescence with anti-giantin antibody, cells grown on glass 
bottom p35 were fixed in 4% paraformaldehyde for 20 min at room temperature (r.t.), 
washed twice in PBS and permeabilized with 0.05% saponin in PEM buffer (80 mM 
PIPES, 5 mM EGTA, 1 mM MgCl2 pH 6.8) for 5 min. Incubation with anti-giantin at 
1:500 dilution was carried out in PBS containing 0.05% saponin for 1h. After PBS 
washes, cells were incubated with anti-rabbit-Alexa 568 at 1:200 in 1% BSA in PBS for a 
further hour. 
For filipin staining, fixed cells were washed 3× with PBS, incubated with 1.5 
mg/mL glycine in PBS for 10 min at room temperature and subsequently with 0.05 
mg/mL filipin in 10% normal goat serum in PBS for 2 h. 
 
2.11 Mass spectrometry 
 
Full-length H-Ras or RhoB protein or the H-Ras K170-K185 peptide were 
incubated at 5 µM in the presence of prostanoids, DBB or PAO at 50 µM or vehicle 
(DMSO) for 1 h. For some experiments, full-length protein incubation mixtures were 
then subjected to digestion with trypsin for 4 h at 37ºC. Purification on ZipTip C18 
(Millipore) was carried out prior to MALDI-TOF MS analysis on an AUTOFLEX III 
MALDI-TOF-TOF instrument (Bruker-Franzen Analytik) operated in the positive 
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mode, as reported in detail (Renedo et al., 2007). Selected peptides were further analyzed 
by MALDI-TOF-TOF MS-MS. 
 
2.12 Statistical analysis 
 
Data for WB quantification or co-localization analysis is shown as mean ± SEM 
of at least three independent experiments. Statistical significance was calculated by 
Student's t test for unpaired observations. A p value of less than 0.05 was considered 
significant and marked by asterisks, where indicated. 
 
  
RESULTS 
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1. Structural determinants involved in RhoB endolysosomal 
localization 
 
1.1 Subcellular localization of endosomal GTPases 
Previous studies from the laboratory explored the subcellular localization of the 
small GTPase RhoB, as well as the pathways responsible for its degradation. In 
endothelial cells, RhoB is degraded through a lysosomal pathway, as discerned by 
treating cells with selective inhibitors of the major degradation pathways prior to 
protein analysis and microscopy studies (Pérez-Sala et al., 2009). Experiments with 
specific organelle markers using fluorescent RhoB fusion constructs showed RhoB 
association with late endosomal compartments, though their precise nature elicited 
further studies that are included within this section. 
 
1.1.1 RhoB localization at endolysosomes 
Several reports have shown that RhoB has a varied cell-type, activation- and 
lipidation-state dependent subcellular localization that comprises the plasma 
membrane, Golgi apparatus, early or late endosomes, MVB and lysosomes (Michaelson 
et al., 2001; Pérez-Sala et al., 2009; Rondanino et al., 2007; Wherlock et al., 2004). 
Therefore, studies were performed to define the basal subcellular localization of this 
GTPase under varying conditions in different cell types, as well as the structural 
determinants that elicit this pleiotropic distribution (Pérez-Sala et al., 2009; Valero et al., 
2010). In order to do so, several fluorescent constructs of wild-type RhoB, i.e. GFP-
RhoB, tRFP-T-RhoB, and mCherry-RhoB were transiently transfected into cells such as 
BAEC, human primary fibroblasts, HeLa cells, and others. 
In BAEC, GFP-RhoB as well as a variety of specific organelle markers was 
employed to outline the subcellular fate of this GTPase, as shown in Figure 12. Cells 
were treated with the amphiphilic amino-steroid, U18666A, as a pharmacological tool 
to alter late endocytic lipid dynamics and induce membrane invagination into MVB, 
which results in enlarged endolysosomes (Marchetti et al., 2004; Sobo et al., 2007). 
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Figure 12. Subcellular distribution of GTPases following U18666A treatment. 
(A) BAEC transfected with the indicated constructs were treated with U18666A as described 
in Methods, stained with LTR and observed live by confocal microscopy. Insets show zoom-
ins of areas with dashed lines, from which profiles are derived (right panels). (B) GFP and LTR 
co-localization in U18666A-treated cells is used as an indicator of internalization into acidic 
compartments, expressed as percentage of the values compared to untreated cells. *p < 0.05 
versus the same condition in the absence of U18666A. 
 
Staining of the endolysosomal lumen is commonly performed using 
LysoTracker® Red (LTR), which is a widely used cationic amphiphilic drug that marks 
acidic compartments (Chazotte, 2011). GFP-RhoB amply co-localizes with this probe in 
many cell types including BAEC (Figure 12), particularly after treatment with U18666A. 
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In sharp contrast, a fusion protein of the early endosomal Rab5 (Bucci et al., 1992), used 
to mark membranes of early endosomes, does not appear at dilated endolysosomes 
induced by U18666A, as shown in Figure 12 by its lack of co-localization with LTR. In 
line with the above results, GFP-Rab5 does not co-localize with RhoB constructs (Pérez-
Sala et al., 2009). However, fluorescently tagged Rab7, which has been shown to 
accumulate at late endocytic vesicles (Bucci et al., 2000), is present on endolysosomes, 
though retained at their limiting edge (Figure 12A, see profiles). As summarized from 
several works in Figure 13, endolysosomes containing RhoB constructs are also marked 
by late endocytic markers such as GFP-Rab9, Lamp1-GFP, LBPA, or cholesterol, but not 
considerably by the recycling endosome component, GFP-Rab11 (Patterson and 
Lippincott-Schwartz, 2002; Pérez-Sala et al., 2009; Ullrich et al., 1996; Valero et al., 
2010).  
 
 
 
Figure 13. Schematic summary of GFP-RhoB subcellular localization. 
A summary of previous work is shown here for conciseness. Full-length RhoB tagged with 
GFP is present at localizations depicted in green but not at those in gray. An orthogonal 
section of a model MVB shows its luminal content, where GFP-RhoB co-localizes with LBPA 
antibodies and cholesterol (stained by filipin). Likewise, the limiting membranes of both MVB 
and lysosomes have been found to be marked by fluorescent constructs of Rab7, Rab9 and 
Lamp1 that coincide with the presence of GFP-RhoB. In the lumen of MVB and lysosomes, 
LTR is found to co-localize with GFP-RhoB, eliciting a patchy, yellowish, red-to-green varied 
coloration. However, RhoB constructs tend not to overlap with the early endosomal 
component Rab5 or with Rab11 residing at recycling endosomes. See text for further details. 
ER, endoplasmic reticulum; N, nucleus. 
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Making use of these varied protein and lipid markers, it becomes evident that 
RhoB constructs appear at very specific subcellular sites, namely late endocytic vesicles 
such as MVB, as well as the lysosomal lumen, with varying degrees of plasma membrane 
localization (Figure 13). 
 
1.1.2 Small GTPase C-terminal sequences in subcellular localization 
Previous studies from our group established that RhoB degradation via the 
endolysosomal pathway is dependent on the full lipidation of its hypervariable C-
terminus, i.e. isoprenylation and bipalmitoylation (Pérez-Sala et al., 2009; Stamatakis et 
al., 2002). However, several other small GTPases are similarly modified by these three 
lipids at their C-terminal sequences, as shown in Table 3, namely TC10, H-Ras, Rap2A 
or Rap2B.  
 
 
Table 3. C-terminal sequences of isoprenylated and bipalmitoylated GTPases. 
Hypervariable regions of several small GTPases that are isoprenylated at their CAAX cysteine, 
shown in green, and palmitoylated at two other cysteines further upstream, shown in red. 
Residues removed by CAAX box proteolysis are shown in gray and basic residues are 
depicted in blue. 
 
The spacing of cysteines amenable to lipidation, as well as the nature of the 
amino acids between them, differs among these proteins (Table 3). To explore the 
subcellular destination of these GTPases, fluorescent constructs were expressed in 
BAEC and observed by confocal microscopy. Figure 14 shows the localization of these 
constructs under basal conditions and upon treatment with U18666A compared to that 
of GFP-RhoB. An H-Ras construct shows predominant plasma membrane localization 
instead of accumulation at endolysosomes (Figure 14). This behavior could be due to 
the fact that the two amino acids between the palmitoylatable cysteines in H-Ras are 
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different than those of RhoB. In the case of Rap2 proteins, they become palmitoylated at 
contiguous cysteines, whereas RhoB contains two amino acids that separate these 
cysteines. As shown in Figure 14, this sequence elicits GFP-Rap2B accumulation at the 
limiting membrane of dilated endolysosomes, resulting in lower co-localization with 
LTR compared to GFP-RhoB. Therefore, though these GTPases are all isoprenylated 
and bipalmitoylated, differences in their lipidation sequences or other determinants 
could confer differential subcellular localization. 
 
 
Figure 14. Localization of isoprenylated and bipalmitoylated GTPases. 
BAEC transfected with the indicated constructs were treated as in Figure 12. Zoom-ins are 
shown in the insets. Co-localization of GFP and LTR signals was assessed as in Figure 12. *p 
< 0.05 versus the same condition in the absence of U18666A by Student’s t-test. 
 
RhoB and TC10 are highly homologous proteins (68% homology, 52% identity) 
with obvious differences in the –AAX amino acids of the CAAX box, as well as in the 
hypervariable region, with more basic residues present in TC10 but not RhoB. 
Nevertheless, their lipidation sequences are highly similar. Remarkably, when 
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comparing these proteins, TC10 is retained at the limiting membrane of late endocytic 
vesicles, instead of inside their lumen, as seen for RhoB constructs (Figure 14). 
In order to study the structural determinants responsible for the differences 
observed between TC10 and RhoB constructs, protein chimeras of GFP fused to the last 
eight amino acids of these GTPases at its C-terminus were generated. Taking into 
account that the last three amino acids of these sequences would be cleaved after 
isoprenylation, the remaining sequences would be identical, as seen in Table 3. 
Moreover, since both CAAX boxes can undergo isoprenylation by either farnesyl or 
geranylgeranyl, the resulting lipidated chimeric proteins could become completely alike. 
Therefore, the chimeric proteins GFP-CINCCKVL (a.k.a. GFP-8, derived from RhoB, 
extensively described in the next section) and GFP-CINCCLIT (referred to as GFP-8-
TC10) become identical once the cysteines have been lipidated. Indeed, as shown in 
Figure 15, the localization patterns of GFP-8 and GFP-8-TC10 are indistinguishable 
both in control cells and after U18666A treatment.  
 
 
Figure 15. Localization of chimeric proteins derived from the RhoB or TC10 C-terminus.  
BAEC were transfected with constructs obtained by fusing the last eight amino acids of RhoB 
(GFP-8) or TC10 (GFP-8-TC10) to the C-terminus of GFP, treated with U18666A, stained with 
LTR and visualized live by confocal microscopy. The graph shows GFP and LTR co-
localization, as above. *p < 0.05 versus the same condition in the absence of U18666A. 
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In light of the results above, the TC10 sequence must contain a sorting motif 
upstream of these last amino acids that is responsible for full-length TC10 accumulation 
at the limiting membrane of MVB, as opposed to GFP-8-TC10 predominant 
localization inside endolysosomes. Indeed, TC10 contains a basic amino acid patch, “-
KKH”, that hinders its entry into the lumen of late endocytic compartments (Table 3). 
As seen in Figure 16, mutation of the basic amino acid patch in TC10 (TC10 NQN, 
Figure 16A) promotes entry into the endolysosomal lumen, as reflected by a significant 
increase in co-localization with LTR upon U18666A treatment (Figure 16C). 
Conversely, insertion of the basic amino acid patch into the RhoB sequence (RhoB 
KKH, Figure 16A) retains this chimera at the limiting membrane of endolysosomes 
(Figure 16B).  
 
 
Figure 16. Role of basic residues in the hypervariable regions of TC10 and RhoB in 
subcellular localization. 
(A) Sequences of the GTPase mutants generated by introducing either a basic residue patch 
(blue, in brackets) into RhoB (RhoB KKH) or a neutral amino acid patch (in yellow) into TC10 
(TC10 NQN). Isoprenylation cysteines are shown in green and palmitoylation cysteines in 
red. (B) BAEC transfected with the indicated constructs were treated as above. Insets show 
zoom-ins of areas with dashed lines, from which profiles are derived (right panels). (C) GFP 
and LTR co-localization in U18666A-treated cells was assessed as above. *p < 0.05 versus 
the same condition in the absence of U18666A. 
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Therefore, fine-tuned regulation of small GTPase subcellular localization is 
determined by isoprenylation or palmitoylation cysteines and charged or uncharged 
amino acids positioned at strictly specific positions within their hypervariable C-
terminal regions. The basic amino acids in TC10 “rescue” the protein from lysosomal 
degradation. Since this motif is not present in RhoB, it is constitutively sent towards the 
lysosome. However, posttranslational modifications altering the charge or the 
interactions of the hypervariable sequence of RhoB could hinder its entry into the 
degradative compartments and change its localization and/or degradation patterns. 
 
 
1.2 RhoB C-terminus: CINCCKVL 
 
1.2.1 Co-localization with endocytic markers 
Studies from the laboratory using BAEC and chimeric fluorescent proteins 
bearing sequentially smaller parts of the RhoB sequence at their C-terminal end, from 
the last 22, 8 to 4 amino acids, determined that the minimum sequence eliciting 
endolysosomal localization and degradation corresponds to the motif that includes all 
three lipidated cysteines and the –CAAX box, namely –CINCCKVL (GFP-8) (Pérez-
Sala et al., 2009). Since subcellular localization mechanisms are finely regulated and may 
be cell type-dependent, localization of GFP-8 was studied in greater detail in several 
additional cell types.  
As shown in Figure 17, in human primary fibroblasts under resting conditions, 
co-transfection of tRFP-T-CINCCKVL (tRFP-T-8) with the fluorescent constructs of 
several endocytic components highlighted the appearance of tRFP-T-8 inside vesicles 
surrounded by GFP-Rab7 and Lamp1-GFP. Only marginal co-localization of tRFP-T-8 
was observed with GFP-Rab11, which is used as a recycling endosome marker (Ullrich 
et al., 1996). Co-localization with the early endosome marker, GFP-Rab5 was negligible. 
Therefore, as seen for GFP-8 in BAEC, tRFP-T-8 in human fibroblasts displays a 
predominantly luminal endolysosomal localization, as deduced from the profiles in 
Figure 17.  
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Figure 17. Localization of CINCCKVL chimeras in human primary fibroblasts 
Human primary fibroblasts were co-transfected with tRFP-T-8 and the indicated endocytic 
membrane markers and observed live by confocal microscopy after 16 h in serum-depleted 
medium. Zoom-ins of original pictures and fluorescence intensity profiles along a section 
(marked by dotted lines and asterisks) appear to the right of every condition. F.I., 
fluorescence intensity. 
 
The association of CINCCKVL chimeras with endolysosomal compartments was 
also confirmed in the widely used human adenocarcinoma cell line, HeLa. Similarly to 
the results shown in primary fibroblasts, tRFP-T-8 appeared inside Lamp1-GFP-positive 
vesicles in this cell line (Oeste et al., 2014). The specific localization of CINCCKVL 
chimeras in the context of endolysosomes was further pinpointed by co-transfecting 
HeLa with GFP-8 and the mCherry fluorescent construct of CD63, which is used as a 
marker of ILV of MVB. As described in the Introduction, different populations of ILV 
could exist within MVB (Edgar et al., 2014). However, the resolution provided by 
confocal microscopy is not able to discern discrete ILV, so that localization at these 
small vesicles appears as luminal fluorescence within endolysosomes. As seen in Figure 
18, of all the probes and fluorescent proteins used to characterize CINCCKVL chimeras, 
mCherry-CD63 displayed the highest degree of co-localization (Pearson coefficient = 
0.77 ± 0.015).  
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Figure 18. GFP-8 co-localization with the MVB marker, mCherry-CD63. 
HeLa cells were co-transfected with GFP-8 and mCherry-CD63 and cultured in serum-
depleted medium for 16 h prior to live confocal fluorescence microscopy. Fluorescence 
intensity profiles along a section (marked by dotted lines and asterisks) appear to the right of 
the overlay. F.I., fluorescence intensity. 
 
A closer look at these specific structures was obtained using higher resolution in 
vivo three-dimension structured illumination microscopy (SIM), which provides super-
resolution imaging, as seen in Figure 19.  
 
 
Figure 19. Super-resolution imaging of CINCCKVL chimeras. 
HeLa cells were transiently transfected with the indicated constructs and stained with LTR as 
indicated in the Methods section, prior to live super-resolution microscopy. Lower panels 
show zoom-ins of compartments with internal vesicles marked by CINCCKVL constructs. 
 
HeLa cells transfected with either GFP-8 or tRFP-T-8 revealed the unequivocal 
presence of these chimeras in vesicles consistent with ILV of MVB (Figure 19). Inside 
these compartments, whereas tRFP-T-8 showed a more diffuse pattern, GFP-8 outlined 
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the inner membranes, which could be due to the decrease in GFP fluorescence resulting 
from its quenching in acidic pH environments (Kneen et al., 1998). It is thus apparent 
that the –CINCCKVL sequence can target proteins to specific domains of 
endolysosomes, some of which are ultimately internalized to form vesicles inside MVB. 
 
1.2.2 Lack of –CINCCKVL chimera co-localization with autophagy 
markers 
As mentioned earlier, -CINCCKVL-mediated RhoB sorting to endolysosomes 
results in rapid lysosomal degradation, a behavior that also holds for other chimeras 
with this sequence attached to their C-terminal ends (Pérez-Sala et al., 2009). 
Considering the lysosomal degradation fate of RhoB and CINCCKVL chimeras as well 
as the high degree of intracellular crosstalk between endolysosomal and autophagic 
pathways, autophagy could be involved in breakdown of this GTPase and related 
constructs. This degradation pathway is often monitored by microscopy in live cells 
using constructs of the microtubule-associated protein 1 light chain 3 protein, LC3 
(Bampton et al., 2005), as shown in Figure 20.  
 
 
Figure 20. Lack of co-localization between GFP-8 and the autophagic probe, RFP-LC3. 
BAEC were co-transfected with GFP-8 and RFP-LC3 and incubated in serum-free medium 
(control) or amino acid-depleted medium (EBSS) for 20 h prior to live confocal visualization. 
The right panels show fluorescence intensity of the single channels along the lines pictured in 
the images. 
 
Results 
 
 70 
Upon autophagy induction by e.g. amino acid depletion, LC3 becomes lipidated 
by a phosphatidylethanolamine moiety, forming LC3-II (Barth et al., 2010; Kabeya et al., 
2000; Mizushima and Yoshimori, 2007), which attaches to autophagosomal membranes 
that can be readily detected by fluorescence microscopy (Barth et al., 2010; Mizushima 
et al., 2010). Taking advantage of this behavior, RFP-LC3 was co-transfected with GFP-8 
in BAEC (Figure 20), in which the autophagic pathway had not yet been described or 
characterized. We observed that, under normal cell culture conditions, RFP-LC3 
showed a diffuse distribution. Following autophagy induction by incubation in the 
amino-acid free medium, Earle’s Balanced Salt Solution (EBSS), RFP-LC3 adopted a 
punctate pattern characteristic of autophagosome formation. Remarkably, co-
localization of GFP-8 with RFP-LC3 was negligible under both conditions, as shown in 
Figure 20. A similar lack of co-localization with other autophagy markers such as 
monodansylcadaverine or CytoID was also observed (Oeste et al., 2013). These results 
indicate that GFP-8 and LC3-positive vesicles are distinct entities, namely 
endolysosomes and autophagosomes, so that GFP-8 incorporation into the autophagic 
pathway is unlikely. 
 
1.2.3 CINCCKVL chimera endolysosomal localization depends on lipid 
modifications  
Membrane association of full-length, endogenous RhoB depends on a series of 
modifications at its C-terminus, including irreversible isoprenylation and reversible 
bipalmitoylation (Adamson et al., 1992). To confirm whether this is the case for 
CINCCKVL chimeras, mutants corresponding to the cysteine residues amenable to lipid 
modification were used in fractionation and microscopy studies. Cells transfected with 
GFP constructs of these mutants were subjected to whole cell lysis (Figure 21, upper 
panels) or subcellular fractionation (Figure 21, lower panels) into S-100 (soluble) or P-
100 (membrane) fractions to assess the extent of membrane attachment. WB analysis 
showed that untagged GFP was fully soluble, whereas GFP-8 was detectable only in the 
membrane fraction. Cysteine mutants that cannot be isoprenylated (GFP-8-C244S) or 
palmitoylated (GFP-8-C241,243S) and therefore have restricted access to membranes 
appear mostly in the soluble fraction, with minimal membrane association. Of note, 
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lower levels of GFP-8 than of GFP or the mutated constructs were detected in whole cell 
lysates (Figure 21, upper panels), consistent with a rapid turnover of this endolysosome-
targeted protein.  
 
Figure 21. Subcellular fractionation of GFP-8 posttranslational modification mutants. 
HeLa cells were transfected with GFP-8 or its indicated lipidation-deficient cysteine mutants. 
Cell lysis and fractionation were performed as described in the Methods section. Upper 
panels show total cell lysates whereas lower panels correspond to chimeric protein levels in 
the soluble (S-100) or particulate (P-100) fraction, assessed by WB with an anti-GFP 
antibody. Hsp90 was used as a loading control and 25 or 100 kDa markers are shown for 
electrophoretic mobility reference. 
 
In order to study membrane localization of CINCCKVL cysteine mutants, 
confocal microscopy studies were carried out. In contrast to the high degree of 
localization between GFP-8 and LTR (co-localization rate: 62.6±2.5%), the 
palmitoylation-deficient mutant GFP-8-C241,243S presents a cytosolic distribution that 
excludes the nucleus (Figure 22), as expected for a mono-prenylated construct bearing 
only a CAAX box (Pérez-Sala et al., 2009). Furthermore, the isoprenylation mutant 
(GFP-8-C244S) appears as a cytosolic, non-lipidated protein that excludes some small 
organelles, thus following a pattern indistinguishable from that of untagged GFP (Figure 
22, last two panels). This last construct does indeed contain the palmitoylation cysteines, 
but the fact that it does not associate with membranes indicates the dependence of 
palmitoylation on previous isoprenylation and CAAX processing (Wang and Sebti, 
2005).  
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Figure 22. Endolysosomal localization of GFP-8 depends on posttranslational lipidation. 
HeLa cells were transfected with GFP-8, its palmitoylation-deficient mutant (GFP-8-
C240,243S), the isoprenylation-deficient mutant (GFP-8-C244S), or untagged GFP. Cells 
were stained with LTR prior to live confocal microscopy observation.  
 
It has been previously described for several Ras family members that they shuttle 
from the plasma membrane to the Golgi in a palmitoylation-dependent manner (Rocks 
et al., 2005). Indeed, whereas GFP-8 did not present high co-localization with the Golgi 
protein giantin (Figure 23, first panel), in the case of the isoprenylated but 
palmitoylation-deficient mutant GFP-8-C241,243S, cells contained cytoplasmic 
accumulations that co-localized to a greater extent with the Golgi (Figure 23, second 
panel). In turn, the isoprenylation mutant as well as untagged GFP showed a similar 
pattern in which Golgi localization was only partial and collateral to its diffuse 
distribution (Figure 23, last two panels). Therefore, Golgi localization of GFP-8 
probably occurs transiently when its CAAX motif has been isoprenylated and awaits 
further processing through bipalmitoylation. 
 
 
Figure 23. Golgi staining of cells transfected with GFP-8 and its lipidation mutants. 
HeLa cells were transfected with the indicated constructs and fixed after 16 h in serum-
depleted medium. The Golgi compartment was marked by immunofluorescence using anti-
giantin antibodies, as explained in Methods. 
 
As a proof of concept, GFP-8 isoprenylation and palmitoylation inhibition were 
carried out pharmacologically rather than through cysteine mutation.  Treatment with 
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2-bromopalmitate to block palmitoylation elicited a GFP-8 subcellular localization 
similar to the corresponding mutant, i.e. diffuse cytosolic and excluding the nucleus 
(Figure 24A, left panel). Similarly, simvastatin treatment for inhibition of isoprenoid 
biosynthesis resulted in a totally diffuse pattern, as observed for the equivalent cysteine 
mutation (Figure 24A, right panel). It is hence possible to pharmacologically modulate 
the selective localization of CINCCKVL proteins to subcellular membranes by 
inhibiting lipidation of the C-terminal cysteines.   
 
 
Figure 24. Lipidation inhibition by pharmacological treatment of cells expressing 
CINCCKVL-chimeras. 
(A) HeLa cells were transfected with GFP-8 and treated with 2-bromopalmitate to inhibit 
palmitoylation or simvastatin to block isoprenylation, as described in Methods, prior to LTR 
staining and live observation under a confocal microscope. (B) BAEC were transfected with 
Dendra-8 and treated with simvastatin for 24 h (left panel) prior to UV light exposure to 
induce green-to-red photoswitching (middle panel). Simvastatin was removed directly after 
photoswitching and 24 h later subcellular localization of the photoconverted red protein was 
monitored (right panel). 
 
A question that remains unanswered in this field is whether lipid 
posttranslational modifications occur only on newly synthesized proteins, or whether a 
previously existing pool of non-lipidated protein in the cytosol can be processed and 
subsequently attach to membranes. As seen above, simvastatin treatment elicits a fully 
cytosolic population of GFP-8 and can therefore be used to address this issue. 
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Furthermore, the photoswitchable fluorescent protein Dendra2 switches from green to 
red fluorescence emission after UV light exposure and can be used to track transfected 
cells before and after photoexcitation. Taking advantage of these tools, BAEC were 
transfected with a Dendra2-CINCCKVL fusion protein (Dendra-8) and treated with 
simvastatin to obtain a pool of green, fully cytosolic construct with no lipid 
modifications (Figure 24B, left). Specific cells were then exposed to UV light on a 
confocal microscope for photoswitching, providing a pool of red, unprocessed Dendra-8 
to be followed (Figure 24B, middle). Simvastatin was removed immediately following 
green to red conversion to release isoprenylation inhibition, which, as shown in Figure 
24, right, allowed endolysosomal targeting of the red protein that had previously been 
diffuse throughout the cytosol. Therefore, pre-existing cytosolic CINCCKVL proteins 
may be sorted to endolysosomal localizations upon C-terminal processing, indicating 
that this process does not need to occur directly on nascent proteins.  
 
1.3 CINCCKVL sorting is conserved from fungi to human cell models 
 
We have shown that RhoB and CINCCKVL-chimeric proteins are targeted to 
endolysosomal membranes in several mammalian cell types, including human primary 
fibroblasts, HeLa cells or BAEC. This behavior is consistent with the fact that the C-
terminal sequence of RhoB is conserved in mammalian species and birds (Table 4), 
which must necessarily contain the cellular machinery required for RhoB sorting. 
However, organisms from other branches of evolution contain either a RhoB protein 
with a different C-terminal sequence or Ras- or Rho-related proteins with similarities to 
RhoB that have not been identified as bona fide RhoB homologs (Table 4). These 
proteins contain CAAX boxes and nearby cysteines that could become palmitoylated, 
but the different spacing between these residues along with other structural 
determinants could elicit unique subcellular localization patterns, as seen in Section 1.1 
for other GTPases. It was therefore uncertain whether non-mammalian organisms that 
do not present the CINCCKVL sequence in any of their proteins could sort these 
chimeras to their specific endolysosomal/MVB destinations. 
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 Table 4. C-terminal sequences of CINCCKVL chimeras, RhoB homologs and related 
proteins from diverse species. 
On top, the C-terminal sequences of GFP-8 and tRFP-T-8 are shown. Below, several RhoB 
homologs or related proteins along with their PubMed accession numbers and their C-
terminal sequences. In red, potential palmitoylation sites. In green, isoprenylation cysteines. 
 
1.3.1 CINCCKVL sorting in amphibian and insect cells 
 
Within the genome of the amphibian Xenopus laevis, an endogenous RhoB 
protein is encoded with a C-terminal sequence that encloses several distinct structural 
features (Table 4). Though it presents a very similar CAAX box and two cysteines 
spaced similarly to human RhoB, the two amino acids between the palmitoylatable 
cysteines differ. Where human RhoB reads “IN”, Xenopus RhoB contains the amino 
acids “MS”, similarly to the H-Ras sequence that elicits binding to the plasma 
membrane, primarily. Furthermore, Xenopus RhoB contains the basic amino acid patch 
“KKH” upstream of the lipidated cysteines, reminiscent of the human TC10 protein, 
which is retained at the limiting membrane of endolysosomes. The effect of these 
unique structural determinants was assessed by transfection of Xenopus epithelial A6 
cells with GFP tagged Xenopus RhoB (GFP-RhoB X), as seen in Figure 25A, left panel. 
Compared to the typical endolysosomal localization of GFP-8 (Figure 25A, middle 
panel) and consistent with its H-Ras- and TC10-like motifs, GFP-RhoB X appears 
mainly at the plasma membrane and scarcely at endolysosomes, as underscored by its 
low co-localization with LTR (Figure 25A, right panel). However, human GFP-RhoB 
and tRFP-T-8 are still sorted to endolysosomes, as gathered from their mutual co-
localization as well as overlap of the latter with Lamp1-GFP (Figure 25B). 
Species Protein Accession no. C-terminal sequence
(synthetic construct) GFP-8 N/A TAAGITLGMDELYKCINCCKVL!
(synthetic construct) tRFP-T-8 N/A RYCDLPSKLGHKLNCINCCKVL!
Homo sapiens RhoB NM_004040 TRAALQKRYGSQNGCINCCKVL!
Bos taurus RhoB NM_001077922 TRAALQKRYGSQNGCINCCKVL!
Mus musculus RhoB AF481943 TRAALQKRYGSQNGCINCCKVL!
Gallus gallus RhoB NM_204909.1 TRAALQKRYGTQNGCINCCKVL!
Xenopus laevis RhoB NM_001096461.1 TRAALQKKHGRSGECMSCCKLL!
Drosophila mojavensis uncharacterized CH933808.1 TRASLQVKKRKKRSGCWSLSCKLL !
Schizosaccharomyces pombe Rho2 NM_001019998.3 TRAALTVRDSENDKSSTKCCIIS!
Aspergillus fumigatus RasA XM_748433 TRAPEGKMDVSEPGDNAGCCGKCVIM!
Aspergillus nidulans uncharacterized AN4953 TRAALLTFDKRKSSCCIVL!
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It is thus apparent that the combination of sorting motifs in Xenopus RhoB 
elicits a localization pattern distinct from both human RhoB and CINCCKVL chimeras. 
Nevertheless, Xenopus cells are able to sort proteins derived from the human RhoB C-
terminus though they do not code for this sequence endogenously.  
 
 
 
Figure 25. Localization of RhoB-related proteins in amphibian cells. 
(A) Xenopus laevis A6 cells were transfected with Xenopus laevis RhoB (GFP-RhoB X) or GFP-
8 and stained with LTR. GFP/LTR co-localization is shown in the right panel as Pearson 
coefficients (x100) or co-localization rates (in percentages). Asterisks represent p<1 x 10-6 
versus GFP-8 (B) A6 cells were co-transfected with human GFP-RhoB or Lamp1-GFP and 
tRFP-T-8. 
 
Going further down the evolutionary scale to assess the ability of different 
organisms to sort CINCCKVL chimeras to the late endocytic pathway, cells of the 
invertebrate Trichoplusia ni were transfected with tRFP-T-8. The High Five insect cell 
line showed tRFP-T-8 sorted into vesicles surrounded by Lamp1-GFP, marking their 
lysosomal character (Figure 26). 
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Figure 26. Localization of tRFP-T-8 in High Five insect cells. 
High Five cells derived from the cabbage looper Trichoplusia ni were co-transfected with 
Lamp1-GFP and tRFP-T-8 before live observation by confocal microscopy. The left panel 
shows overlays of single fluorescent channels to which the Differential Interference Contrast 
(DIC) image has been juxtaposed in the right panel. 
 
In the insect species Drosophila mojavensis, an uncharacterized protein 
containing a CAAX box, an extended basic amino acid patch and only one 
palmitoylatable cysteine among heterogeneous residues may be found (see Table 4). 
However, Trichoplusia ni, from which High Five cells are derived, does not encode an 
endogenous RhoB protein. Nonetheless, the structural determinants of the CINCCKVL 
sequence are robust enough to bestow endolysosomal localization upon its chimeras in 
this organism, as well.  
 
1.3.2 CINCCKVL localization in Aspergillus nidulans 
Though palmitoylation occurs on a multitude of proteins and is highly 
conserved throughout evolution, the mechanisms responsible for this process have 
remained elusive (Aicart-Ramos et al., 2011). Actually, palmitoyl transferases were 
discovered roughly a decade ago in yeast (Lobo et al., 2002; Roth et al., 2002), where 
many crucial proteins undergo this posttranslational modification to regulate their 
subcellular localization (Roth et al., 2006). A putative Rho-related protein bearing a 
CAAX box and a possible palmitoylation site is expressed in the fungus Aspergillus 
nidulans (Table 4), but the CINCCKVL motif does not appear in its proteome. To 
explore whether CINCCKVL sorting can take place in this compelling model organism 
for vesicular trafficking, Aspergillus nidulans strains expressing GFP-8 and its 
palmitoylation-deficient mutant were established (Figure 27).  
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Figure 27. GFP-8 and its palmitoylation mutant in Aspergillus nidulans. 
Aspergillus nidulans strains established by transformation with GFP-8 (A) or its palmitoylation 
deficient mutant GFP-8-C240,243S (B) were observed live as described in Methods. Staining 
with the vacuole marker CMAC is shown in the middle panels and overlays in the bottom 
panels. Gray scale insets of yellow boxed-in areas are shown for better contrast. (C) 
Aspergillus nidulans strains expressing the indicated constructs were processed for SDS-PAGE 
and WB using a GFP antibody. Dotted lines indicate a 5-fold shorter exposure time for the 
last lane than the two preceding ones. The 25 kDa marker is shown for reference. 
 
In the wild-type strain, GFP-8 appears at the plasma membrane as well as in late 
endosomes and vacuoles stained by the acidic organelle marker CMAC (Figure 27A). In 
contrast, its palmitoylation-deficient mutant GFP-8-C240,243S is cytosolic and 
excluded from nuclei, the plasma membrane and CMAC-positive compartments 
(Figure 27B). Dependence on posttranslational modifications for targeting is similar to 
that observed in human cells, in which isoprenylation alone is also unable to elicit 
endolysosomal localization. Lack of GFP-8-C240,243S processing is further evidenced 
by the appearance of a doublet of slower migrating bands in SDS-PAGE, as described 
for other Ras superfamily proteins in mammalian cells (Hancock et al., 1989), and 
shown in Figure 27C. Indeed, levels of the mutant are significantly higher than those of 
fully lipidated GFP-8, which could be undergoing constitutive vacuolar degradation 
analogous to its lysosomal degradation in mammalian cells (see Figure 27C, caption). 
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Moreover, GFP-8 and GFP-8-C240,243S localization patterns are distinct from that of 
untagged GFP, which appears diffusely throughout the cytoplasm and nucleus, similarly 
to mammalian cells (not shown).  
The filamentous nature of Aspergillus nidulans makes it a highly suitable model 
for tracking the movement of endocytic organelles by time-lapse microscopy (Peñalva et 
al., 2012). Indeed, GFP-8-positive vesicles could be readily detected travelling within the 
cell, avoiding nuclei and possibly fusing with large vacuoles also presenting GFP-8 
fluorescence (Figure 28A, colored arrows and black arrowhead).  
 
Figure 28. Tracking GFP-8-positive compartments in Aspergillus nidulans. 
(A) The Aspergillus nidulans GFP-8 strain was observed live to follow localization of the 
construct by time-lapse microscopy. The plasma membrane is marked by GFP-8, as well as a 
large, sessile vacuole (black arrowhead in all frames). Smaller, motile vesicles also contain 
GFP-8 (colored arrows). The vesicle marked by a red arrow undergoes both basipetal and 
acropetal movement, whereas the teal-colored arrow follows a vesicle with acropetal 
movement only, which is not detectable in the second frame due to movement along the z-
axis. (B) Kymograph showing GFP-8-positive compartments in motion from a representative 
experiment using a GFP-8-expressing strain. Black arrows highlight fast-moving vesicles, 
whereas black arrowheads mark static vesicles. Asterisks mark possible points of contact or 
fusion between them. (C) Velocities of individual endosomes travelling in both directions 
were tracked and are represented in the graph. See text for details. 
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Fluorescent vesicles can be tracked and their trajectories represented by using 
kymographs, as shown for GFP-8-positive vesicles of a representative cell in Figure 28B. 
Thick, straight lines correspond to large, sessile vacuoles (Figure 28B, arrowheads) 
whereas thin, diagonal lines trace several smaller, fast-moving endosomes (Figure 28B, 
arrows). Both of these contours come together at certain points that could be indicative 
of endosome-vacuole fusions (Figure 28B, asterisks). Furthermore, the speed of 
individual endosomes can be calculated from this type of representation by calculating 
the slope of their trajectory, be it basipetal or acropetal (Figure 28C). Similar average 
speeds of approximately 1 to 3 µm per second for GFP-8-containing endosomes in both 
directions, i.e. fully bidirectional movement, suggests that trafficking of these fast and 
small vesicles is dependent on microtubules, as has been previously described for other 
vesicles (Abenza et al., 2012; Abenza et al., 2009). Taken together, these results highlight 
the presence of GFP-8 along the endocytic pathway in Aspergillus nidulans and imply 
that CINCCKVL sorting occurs through mechanisms conserved in fungi, as well.  
 
 
 
2. Mechanisms potentially involved in RhoB sorting 
 
 
RhoB fluorescent constructs show a very specific subcellular localization at ILV 
of MVB and lysosomes as well as the plasma membrane, as summarized in Section 1.1.1. 
This behavior indicates that RhoB follows an endocytic route and accumulates at late 
compartments to which several sorting machineries escort their cargo, as described in 
the Introduction (see Figure 9). Therefore, this section comprises studies that attempt to 
elucidate specific mechanisms involved in driving RhoB constructs and related chimeras 
to their subcellular destinations, including ILV or the lysosomal lumen, by focusing on 
protein machineries as well as lipid dynamics. 
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2.1 Role of the ESCRT machinery in RhoB sorting 
 
The canonical pathway for proteins that enter MVB to be degraded in the 
lysosome is often represented by ESCRT-mediated internalization of EGFR upon cell 
stimulation with its agonist. Indeed, RhoB has been shown to be involved in EGFR 
trafficking in several cell types and its expression is upregulated by EGF stimulation 
(Canguilhem et al., 2005; Gampel et al., 1999; Lajoie-Mazenc et al., 2008; Tillement et 
al., 2008). It could be the case that RhoB associates with vesicles on which EGFR travels 
and therefore follows a similar ESCRT-mediated internalization pathway. Therefore, 
experiments were carried out in cells in which ESCRT components were altered to study 
potential ESCRT involvement in sorting of RhoB and its related chimeras.  
 
2.1.1 ESCRT-related processes in sorting of RhoB and related chimeras 
ESCRT complexes act sequentially beginning with recognition of ubiquitin by 
Hrs (the core ESCRT-0 protein) and ending with ESCRT-III disassembly mediated by 
the ATPase, Vps4. These two major events were approached experimentally in the 
context of cells expressing RhoB constructs to initially evaluate whether the ESCRT 
machinery could play a role in their sorting. 
There are few studies in which RhoB ubiquitination has been addressed, and 
those in which RhoB has been found to be ubiquitinated show that this is a cell type- 
and context-dependent process (Engel et al., 1998; Wang et al., 2014). To establish 
whether the fluorescent constructs used throughout this study were ubiquitinated, they 
were expressed in HeLa cells and immunoprecipitated to assay ubiquitin association, as 
shown in Figure 29. Neither GFP-RhoB nor GFP-8 samples presented signals 
compatible with ubiquitinated forms of these constructs. Interestingly, the construct 
GFP-22, which contains a lysine residue potentially susceptible to ubiquitination, was 
the only sample showing a putative mono-ubiquitinated species, marked by an asterisk 
in Figure 29A.  
 
Results 
 
 82 
 
Figure 29. Ubiquitination assays by immunoprecipitation of RhoB constructs. 
(A) HeLa cells were transfected with the indicated agents and immunoprecipitated using GFP 
antibodies conjugated with agarose beads (GFP-Trap) as described in the Methods section. 
Immunoblots were performed against the indicated proteins. Arrowheads highlight unspecific 
signals, possibly representing keratin doublets. The asterisk marks faint signals detected 
consistently in GFP-22 samples. (B) Whole cell lysates (WCL) of samples shown in (A). 
Arrows mark the GFP and GFP-8 signals. 
 
Therefore, if GFP-RhoB and/or GFP-8 are ubiquitinated, they are so at levels 
that are undetectable under basal conditions in this type of assay.  However, ubiquitin-
independent, ESCRT-dependent sorting into ILV of MVB has been previously 
described (Babst, 2011), as discussed in the Introduction. The ESCRT-associated 
component, Vps4, was consequently addressed in cells in which the last step of ILV 
formation was impaired, namely, HeLa cells transfected with a dominant negative form 
of this protein (Figure 30).  
In HeLa cells, transfection of the wild-type GFP-Vps4 construct presents a 
diffuse pattern throughout the cytosol and does not affect localization at endolysosomes 
of tRFP-T-RhoB (Figure 30A, top panels) or tRFP-T-8 (not shown), either under 
control conditions or upon treatment with chloroquine. However, overexpression of 
dominant negative GFP-Vps4 hinders tRFP-T-RhoB entry into vesicular structures, as 
shown in the bottom panels of Figure 30A and its profiles. Instead, fluorescent RhoB 
constructs are mislocalized to the limiting membrane of vesicles formed upon GFP-
Vps4 DN expression, defined as aberrant Class E compartments (Bishop and 
Woodman, 2000), recapitulating the results obtained in BAEC (Pérez-Sala et al., 2009). 
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Figure 30. Effect of GFP-Vps4 DN overexpression on RhoB and CINCCKVL chimera 
localization. 
HeLa cells were co-transfected with the indicated constructs and treated with chloroquine for 
24 h where specified prior to live confocal microscopy observation. Underneath the panels 
of cells expressing GFP-Vps4 DN, fluorescence intensity profiles along a section marked by 
dotted lines and asterisks are shown. F.I., fluorescence intensity. 
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In contrast, the CINCCKVL construct, tRFP-T-8 is able to enter into the lumen 
of these compartments in cells expressing the dominant negative mutant of Vps4, as 
shown in Figure 30B (see profiles). These results point to a possible role for ESCRT 
proteins in RhoB sorting, so that further studies concerning the ESCRT machinery per 
se were carried out in HeLa cells, as shown below. 
 
2.1.2 ESCRT component depletion in RhoB and –CINCCKVL protein 
sorting 
To further substantiate the role of ESCRT proteins, either control (scr) siRNA or 
siRNA against either the ESCRT-0 component Hrs or the ESCRT-I protein Tsg101 was 
transfected into cells to reduce protein levels prior to expression of GFP-RhoB or GFP-8 
and chloroquine treatment. The efficiency of ESCRT silencing was analyzed in these 
cells by SDS-PAGE and WB. As shown in Figure 31A, cells transfected with Hrs-specific 
siRNA were practically devoid of this ESCRT component as compared to their control 
(scr). In turn, Tsg101 silencing reduced its protein levels by 72.2 ± 5.3% (Figure 31B).  
 
 
 
Figure 31. Depletion of ESCRT components by specific siRNA. 
(A) HeLa cells were transfected with scrambled (scr) or Hrs-targeted siRNA. Cell lysis was 
carried out 48 h later and WB against Hrs is shown. (B) Tsg101 levels were assessed 
similarly to (A). 50 and 100 kDa markers are shown for reference. 
 
As shown by confocal microscopy analysis in Figure 32A, HeLa cells transfected 
with control siRNA (scr) were able to sort GFP-RhoB to LTR-positive vesicles, as seen 
above for several cell types. However, knock-down of the ESCRT-0 component, Hrs or 
the ESCRT-I component, Tsg101 reduced the appearance of GFP-RhoB at acidic 
vesicles (Figure 32A, see profiles). 
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Figure 32. Knock-down of the ESCRT components Hrs or Tsg101 and their effect on 
localization of RhoB fluorescent constructs. 
(A) HeLa cells were transfected with either scrambled siRNA (scr) or siRNA targeting either 
Hrs or Tsg101 to silence these ESCRT components, replated, and transfected with GFP-RhoB. 
Cells were treated with chloroquine to induce accumulation at endolysosomes, stained with 
LTR and observed live by confocal microscopy. Fluorescence intensity profiles along a 
section (marked by dotted lines and asterisks) appear underneath each condition. KD, knock-
down; F.I., fluorescence intensity. (B) HeLa cells transfected with either scrambled siRNA 
(scr) or siRNA targeting Hrs were further co-transfected with tRFP-T-RhoB and Lamp-GFP. 
After 24 h of chloroquine treatment, they were visualized live by structured illumination 
super-resolution microscopy (SIM). Insets show individual MVB and their ILV decorated with 
RhoB fluorescent protein. The right panel inset highlights the emptier MVB that appear upon 
Hrs knock-down.  
 
To explore the effect of Hrs knock-down on sorting of RhoB constructs in more 
detail, the red tRFP-T-RhoB construct was co-transfected with Lamp1-GFP in cells in 
which Hrs was silenced and observed live under a super-resolution microscope (Figure 
32B). Localization of tRFP-T-RhoB at ILV was unmistakably observed in control cells 
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within MVB surrounded by Lamp1-GFP at their limiting membrane (Figure 32B, left 
panel). On the other hand, Hrs knock-down cells presented Lamp1-positive structures 
with a marked reduction of tRFP-T-RhoB inside their lumen, despite treatment with 
chloroquine that usually causes RhoB construct accumulation inside these vesicles 
(Figure 32B, right panel inset). Taken together, these results suggest involvement of 
early ESCRT components in sorting of full-length RhoB constructs. 
In order to study the role of the ESCRT machinery on sorting of CINCCKVL 
constructs, assays analogous to those above were performed on cells transfected with 
GFP-8. Strikingly, GFP-8 seemed unaffected by either Hrs or Tsg101 knock-down and 
was still able to enter the lumen of LTR-positive compartments, analogously to its 
control (Figure 33), in contrast to the marked reduction in endolysosomal localization 
detected above for GFP-RhoB. 
 
 
Figure 33. Knock-down of the ESCRT components Hrs or Tsg101 and their effect on GFP-8 
localization. 
HeLa cells transfected with siRNA targeting ESCRT components, transfected with GFP-8 and 
treated with chloroquine prior to LTR staining were observed live by confocal microscopy, 
similarly to Figure 32A. Profiles along a section traced by dotted lines and marked with 
asterisks show intensity profiles underneath each condition. KD, knock-down. F.I., 
fluorescence intensity. 
 
In sum, there appears to be a differential effect of ESCRT component knock-
down as to the subcellular localization of either full-length RhoB constructs or 
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CINCCKVL chimeras (compare Figure 32A to Figure 33). These findings are the first 
studies in which we have encountered dissimilar behavior between full-length RhoB and 
its sorting motif  –CINCCKVL, suggesting that further regulatory determinants in the 
RhoB protein could be involved in ESCRT interaction, whereas –CINCCKVL bypasses 
this regulation and enters ILV of MVB independently of ESCRT. 
 
 
2.2 Lipid-mediated endolysosomal sorting of CINCCKVL 
 
The results above point to ESCRT involvement in full-length RhoB sorting, 
whereas the C-terminal motif CINCCKVL seems to be targeted to endolysosomes, more 
specifically ILV of MVB, independently of this protein machinery. Considering that ILV 
formation can be ESCRT-dependent or –independent (Section 3.2 of the Introduction), 
other mechanisms possibly involved in CINCCKVL-chimeric protein sorting were 
assessed. Taking advantage of the fact that inward budding from the limiting membrane 
of MVB is regulated by its lipid composition (Matsuo et al., 2004; Trajkovic et al., 2008), 
CINCCKVL chimera subcellular localization was monitored in cells treated with several 
compounds that modulate late endosomal lipid dynamics. 
The precursor mevalonate is used by cells for membrane cholesterol biosynthesis 
and formation of isoprenoid moieties destined towards protein posttranslational 
modification, as schematized in Figure 34. The mevalonate pathway can be disrupted at 
several stages by blocking key enzymes with inhibitors, such as HMG CoA reductase 
inhibition by statin treatment in cells, which inhibits protein isoprenylation (Figure 34). 
Furthermore, the lysosomotropic agent U18666A inhibits cholesterol synthesis as well 
as its trafficking (Figure 34), thus causing its internalization and accumulation into ILV 
of MVB along with the lipid LBPA, eliciting an NPC-like phenotype (Cenedella, 2009; 
Kobayashi et al., 1999; Sobo et al., 2007). In turn, the squalene synthase inhibitor 
zaragozic acid (Figure 34) reduces cellular cholesterol levels and could affect ILV lipid 
composition significantly, since most of the cholesterol of the endocytic pathway is 
contained within these vesicles (Möbius et al., 2003). 
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Figure 34. Schematic of the mevalonate pathway and compounds used for its modulation. 
Simplified schematic of the mevalonate pathway showing formation of the isoprenylation 
precursors farnesylpyrophosphate and geranylgeranylpyrophosphate, used in protein 
modification. The former can be further processed for cholesterol biosynthesis. In red, 
structures of compounds used in this work to disrupt particular steps of the pathway. Statins 
such as simvastatin, shown here, inhibit HMG-CoA reductase and therefore halt both protein 
isoprenylation and cholesterol biosynthesis. In turn, zaragozic acid blocks squalene synthase, 
blocking subsequent steps of the cholesterol pathway. Similarly, the amphiphilic amino-
steroid U18666A hinders cholesterol synthesis and transport. Truncated arrows represent 
intermediate steps that are not shown here for the sake of clarity. 
 
To assess the effect of lipid alterations in CINCCKVL chimera localization, cells 
transfected with these constructs were treated with U18666A or ZGA and observed live 
by confocal microscopy (Figure 35).  
 
Figure 35. Agents modulating lipid dynamics alter GFP-8 localization. 
BAEC transfected with GFP-8 were treated with 10 µM U18666A or 50 µM ZGA for 24 h. 
Insets show zoom-ins and lower panels represent fluorescence intensity profiles (F.I.) along a 
section marked by dotted lines and asterisks. 
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Indeed, these compounds produced drastic phenotypes in several cell types 
including HeLa cells, BAEC and Xenopus laevis cells (Oeste et al., 2014), and the results 
obtained for BAEC are presented here for clarity. As shown in the middle panel of 
Figure 35, cells treated with U18666A displayed intensely compact endolysosomes in 
which GFP-8 accumulated prominently, along with LTR, consistent with results shown 
in Section 1.1. In sharp contrast, ZGA elicited dilated MVB with either scarce, diffuse 
staining with GFP-8 or MVB practically devoid of GFP-8, in which GFP-8 was retained 
at the limiting membranes of MVB and LTR staining was weaker and sometimes patchy 
(Figure 35, right panel profile). However, ZGA treatment of BAEC transfected with 
GFP-RhoB showed dilated MVB with patches of LTR in which this construct seemed to 
enter freely, similarly to its control and conversely to GFP-8, as seen in Figure 36. 
 
 
Figure 36. GFP-RhoB appears inside MVB in cells treated with ZGA. 
BAEC transfected with GFP-RhoB were treated with ZGA and stained with LTR prior to 
confocal microscopy observation, as in Figure 35. Insets show details of vesicles and profiles 
represent fluorescent intensity (F.I.) along sections marked by dotted lines and asterisks. 
 
In order to investigate whether impairment of GFP-8 sorting into the lumen of 
endolysosomes could be due to a reduction of GFP-8 membrane association, we 
performed subcellular fractionation studies (Figure 37). For this we used HeLa cells, in 
which we previously confirmed the inhibitory effect of ZGA on endolysosomal 
internalization of GFP-8 by confocal microscopy (Oeste et al., 2014). As shown in 
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Figure 37, cholesterol depletion does not reduce the levels of membrane-associated 
GFP-8, practically all of which still appears in the particulate (P-100) fraction. 
 
 
 
Figure 37. Subcellular fractionation of HeLa cells treated with ZGA. 
HeLa cells were transfected with GFP or GFP-8, treated with 100 µM ZGA for 24 h, lysed, 
and fractionation was performed as described in the Methods section. Upper panels show 
total cell lysates whereas lower panels correspond to chimeric protein levels in the soluble 
(S-100) or particulate (P-100) fraction, assessed by WB with an anti-GFP antibody. The 25 
kDa marker is shown for electrophoretic reference. 
 
 
2.3 The tetraspanin CD63 in RhoB and CINCCKVL sorting 
 
The results shown above suggest that sorting of full-length RhoB constructs is 
mediated partly by the ESCRT machinery, whereas CINCCKVL chimeras seem to enter 
ILV of MVB regardless of ESCRT disruption. As described in Section 3.1.3 of the 
Introduction, evidence pointing to ESCRT-independent sorting accumulating in recent 
years indicates a role for CD63 in trafficking to ILV as well as in biogenesis of ILV 
destined for release as exosomes (Pols and Klumperman, 2009). Furthermore, the small 
ILV that still form after Hrs depletion carry CD63 and its cargo (Edgar et al., 2014), so 
that the internalization of GFP-8 into MVB in cells after Hrs knock-down observed 
above in Section 2.1.2 could be CD63-mediated. These findings warranted further 
studies to explore the role of CD63 in sorting of CINCCKVL proteins and full-length 
RhoB. 
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2.3.1 Impact of CD63 overexpression on localization of RhoB and 
CINCCKVL constructs 
 
In HeLa cells, RhoB and CD63 constructs co-localize to a very high degree in 
their small endolysosomes, as seen in Figure 18. Therefore, co-transfection studies were 
carried out in BAEC to observe more specific localization inside their larger MVB, 
particularly after chloroquine treatment (Figure 38). Co-localization was apparent in 
cells expressing wild-type mCherry-CD63 and GFP-8 (Pearson coefficient = 0.63 ± 
0.04), and treatment of these cells with chloroquine further increased co-localization 
(Pearson coefficient = 0.81 ± 0.03). In contrast, GFP-RhoB and mCherry-CD63 co-
localization was significantly lower respect to GFP-8 in control cells (Pearson coefficient 
= 0.41 ± 0.04). The large vesicles typical of BAEC also presented several GFP-RhoB- or 
GFP-8-positive structures that did not contain fluorescent CD63 and vice versa (Figure 
38).. 
 
 
Figure 38. Wild-type mCherry-CD63 co-localization with GFP-8 or GFP-RhoB. 
BAEC co-transfected with mCherry-CD63 wild-type (mCh-CD63 WT) and either GFP-RhoB 
or GFP-8 were visualized by live confocal microscopy after treatment with chloroquine, 
where indicated. White arrowheads mark the extracellular material in the lower left panel. 
The graph shows average co-localization between constructs, assessed as described in 
Methods in the image analysis section. *p < 0.01 
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In this cell type, whereas co-transfection of CD63 and full-length RhoB 
constructs was well tolerated under the conditions studied, CD63 in combination with 
CINCCKVL proteins elicited accumulation of extracellular, vesicular material 
throughout the culture dish that was positive for GFP-8 and mCherry-CD63 (marked 
by arrowheads in Figure 38, bottom left panel) 
The differential effect of overexpressing CD63 with full-length RhoB constructs 
versus CINCCKVL proteins could imply that this tetraspanin is involved in sorting, or 
interacts with, the lipidated RhoB motif. To further explore this possibility, similar 
studies were carried out with the mCh-CD63 YA construct in which the tyrosine found 
in the C-terminal lysosomal targeting motif YEVM was mutated to alanine (Figure 39). 
It has been reported that this mutant is unable to interact with the sorting complex AP-3 
and is therefore largely localized to the plasma membrane (Rous et al., 2002). 
 
 
Figure 39. mCherry-CD63 Y235A mutant co-localization with GFP-8 or GFP-RhoB. 
BAEC co-transfected with the mCherry-CD63 lysosomal targeting tyrosine mutant (mCh-
CD63 YA) and either GFP-RhoB or GFP-8 were visualized by live confocal microscopy after 
treatment with chloroquine, where indicated. Note the extracellular material marked by 
arrowheads in the bottom left panel. Co-localization is shown in the graph, as described in 
Figure 38. 
 
Under the conditions used throughout this work, the proportion of plasma 
membrane to endolysosomal localization of the CD63 mutant varies in a cell-type 
dependent manner for, as seen in Figure 39, mCh-CD63 YA is only partially associated 
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with the plasma membrane in BAEC and is still prominently present at endolysosomes. 
GFP-8 co-localization with the mCherry-CD63 YA mutant was significantly reduced 
with respect to the wild-type protein, particularly upon chloroquine treatment (Pearson 
coefficient = 0.66 ± 0.02 versus 0.81 ± 0.03). Furthermore, large amounts of GFP-8-
positive extracellular vesicles were detectable in the medium as well as at the 
extracellular surface of the plasma membrane in many cells, particularly upon 
chloroquine treatment (Figure 39, left panels). In contrast, GFP-RhoB co-localization 
with mCherry-CD63 YA was similar to co-localization with its wild-type form, both for 
control conditions and after chloroquine treatment (Pearson coefficient = 0.41 ± 0.04 
for the YA construct and 0.40 ± 0.05 for the wild-type, control; 0.67 ± 0.04 versus 0.71 ± 
0.08, chloroquine treatment). It is therefore possible that the tetraspanin CD63 is 
involved in CINCCKVL protein sorting, which could potentially result in extracellular 
localization of the chimera under certain conditions.  
 
2.3.2 Effect of C6 ceramide treatment on RhoB construct localization 
 
Targeting to MVB precedes an important step in protein sorting, for ILV 
pinched off into the MVB lumen can be sorted to lysosomes for degradation or be 
secreted into the extracellular milieu by MVB fusion with the plasma membrane, as 
depicted in Figure 40A. Considering CD63 function in the biogenesis of exosomes and 
the extracellular destination detected for CINCCKVL proteins in a scenario of aberrant 
CD63 overexpression, it is possible that this RhoB motif could be preferentially targeted 
for ILV destined for secretion instead of those destined for degradation in the lysosome, 
which are usually associated with ESCRT-dependent mechanisms. Furthermore, cell 
material can be secreted from the cell by direct shedding of microvesicles from the 
plasma membrane. In fact, a closer look by super-resolution imaging at the plasma 
membrane of HeLa cells transfected with GFP-8 shows what appear to be discrete 
compartments possibly corresponding to microvesicles, as well as protruding areas of 
the plasma membrane budding outwards (Figure 40B). Therefore, it is plausible that 
CINCCKVL targets its chimeric proteins to be secreted either directly at the plasma 
membrane or through the late endosomal pathway, into MVB and out of the cell in 
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exosomes. Nevertheless, it must be taken into account that due to the tight z-sections 
obtained by super-resolution microscopy, the structures that appear to be vesicles could 
in fact correspond to undulations still attached to the plasma membrane.  
 
 
Figure 40. Extracellular vesicle release routes as potential destinations for GFP-8. 
(A) Schematic representing pathways for extracellular release of vesicles and their cargo. 
Whereas microvesicles bud directly from the plasma membrane, exosomes are formed by 
inward budding of ILV into MVB that can fuse to the plasma membrane, releasing their 
internal vesicles. MVB can also be destined for fusion with lysosomes for cargo degradation. 
It has not yet been fully established whether whole MVB are either exocytic or degradative or 
if ILV destined for either fate can co-exist within the same MVB. Note that budding of small 
ILV begins at the early endosome stage. Red rods represent transmembrane receptors and 
blue squares depict proteins destined for secretion. Green circles represent GFP-8 and its 
possible destinations. Modified from (Raposo and Stoorvogel, 2013). (B) Detailed inspection 
of the super-resolution image presented in Figure 19 shows GFP-8 at several LTR-positive 
endolysosomes and MVB (bottom left in inset). The inset further shows structures budding 
directly from the membrane, morphologically consistent with shed microvesicles.  
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To approach the possibility of CINCCKVL sorting to extracellular vesicles, cells 
transfected with either GFP-RhoB or GFP-8 were treated with C6 ceramide (Figure 41), 
which has been shown to induce ESCRT-independent formation of ILV that are 
secreted as exosomes (Trajkovic et al., 2008). An inactive form of this compound, 
dihydroceramide C6, was used as a negative control.  
 
 
Figure 41. Effect of C6 ceramide on GFP-8 or GFP-RhoB endolysosomal localization. 
HeLa cells transfected with the indicated agents were treated with either dihydroceramide C6 
(control) or C6 ceramide and stained with LTR prior to live confocal microscopy observation. 
The graph represents co-localization with LTR of either GFP-8 or GFP-RhoB after the 
indicated treatments. *p < 0.001 
 
As seen in the left panels of Figure 41, upon ceramide treatment, GFP-8 
accumulated less at perinuclear, LTR-positive vesicles, its localization at the plasma 
membrane was in part diminished, and GFP-8-positive material was detected in the 
proximity of the plasma membrane as well as throughout the culture dish. This behavior 
was reflected by a significant decrease in co-localization of GFP-8 with LTR upon 
ceramide treatment (Pearson coefficient = 0.71 ± 0.03 for control compared to 0.51 ± 
0.02 after ceramide treatment). However, after treatment with ceramide, GFP-RhoB was 
retained at the plasma membrane in polarized accumulations that were positive for LTR 
and did not seem to reach the extracellular space (Figure 41), hence eliciting a 
significant increase in GFP-RhoB co-localization with LTR (Pearson coefficient = 0.29 ± 
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0.02 control versus 0.59 ± 0.03). Taken together, these results suggest that CINCCKVL 
is able to reach the extracellular medium whereas the full-length protein is retained 
within the cell, possibly due to further sorting signals precluding its secretion or an 
active role in these processes. These results warrant further studies regarding the 
extracellular fate of CINCCKVL chimeras and the involvement of the CINCCKVL 
sequence in this process in the context of full-length RhoB. 
 
 
 
3. Small GTPases in pathological scenarios 
 
 
The plethora of signaling cascades in which small GTPases are involved 
highlights their importance in maintaining cellular homeostasis. Indeed, as described in 
the Introduction, members of this protein family have been found to play roles in many 
pathological processes such as tumorigenesis, inflammation or lysosomal diseases. The 
experiments described in this section are focused first on exploring GTPase involvement 
in lysosomal storage diseases, specifically, Chediak-Higashi Syndrome. Secondly, the 
amenability of several GTPases to be modified by reactive compounds produced during 
inflammatory or oxidative stress conditions was assessed, for these modifications could 
alter their subcellular localization and activation, resulting in unfavorable cellular 
outcomes. 
 
3.1 Endosomal GTPases in cells from patients with lysosomal storage diseases 
 
Cells derived from patients suffering from lysosomal storage disorders are used 
alongside mouse models not only to study the pathogenesis of these diseases, but also to 
study the basic processes involved in general trafficking towards the lysosome. Much 
information about the endocytic route and the trafficking partners involved has been 
obtained by detection of mutations leading to these pathologies (Ballabio and 
Gieselmann, 2009). Therefore, GTPase localization was studied in the context of these 
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models for altered endolysosomal sorting. Several of these cell models have been 
previously employed in other works from the laboratory (Pérez-Sala et al., 2009; Valero 
et al., 2010); hence, attention here is focused on Chediak-Higashi Syndrome. 
3.1.1 Studies in cells from patients with Chediak-Higashi Syndrome 
The enlarged lysosomes found in many cell types of Chediak-Higashi patients 
were detected by optical microscopy early on and have since been found to accumulate 
cellular material of different kinds (Oliver et al., 1976). Several lysosomal storage 
diseases such as NPC present increased cholesterol levels in aberrant compartments as 
part of their pathogenic scenario. Moreover, a study on the lipid composition of CHS 
erythrocyte membranes pointed to higher levels of cholesterol (Chico et al., 2000), but 
to the best of our knowledge, intracellular cholesterol has not been studied in fibroblasts 
from this disease. Since cholesterol homeostasis can affect sorting of RhoB or 
CINCCKVL chimeras, unesterified cholesterol levels were assessed in CHS fibroblasts 
by filipin staining and confocal microscopy observation. As shown in Figure 42, CHS 
fibroblasts contain significantly higher levels of free cholesterol in their endolysosomes 
than control cells, quantified to almost double the value of control cells by fluorescence 
intensity detection. 
 
 
Figure 42. Cholesterol staining in control and Chediak-Higashi fibroblasts. 
Confocal imaging of fixed fibroblasts from control subjects versus CHS cells after filipin 
staining. Images were acquired with identical settings. Quantification of confocal image 
intensities was performed on wide fields containing several cells and is shown to the right of 
the images. F.I., fluorescence intensity. *p, 0.05 versus control. 
 
In addition to lipids, several proteins have been found to accumulate at the 
enlarged endolysosomes of CHS cells, including proteins involved in the endocytic 
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pathway (Burkhardt et al., 1993). In order to further characterize CHS endolysosomes, a 
systematic approach was set up whereby the subcellular localization of several 
endosomal GTPases was compared to endolysosomal markers. Similarly to control 
fibroblasts, in CHS fibroblasts GFP-Rab7 and Lamp-GFP co-localized with LTR, 
whereas GFP-Rab5 appeared at smaller, more peripheral vesicles consistent with early 
endosomes (Oeste et al., unpublished observations). As shown in Figure 43, GFP-RhoB 
is internalized into the enlarged endolysosomes that appear in CHS cells and co-
localizes with LTR at these vesicles. However, GFP-Rab9 elicited an even further 
enlargement of CHS endolysosomes and was retained at their limiting membrane, in 
sharp contrast to the normal-sized endolysosomes that contain GFP-Rab9 in control 
fibroblasts. 
 
 
Figure 43. GFP-Rab9 subcellular localization in CHS fibroblasts. 
Fibroblasts from control subjects or from CHS patients were transfected with GFP-RhoB or 
GFP-Rab9 and treated with 25 nM LTR for 15 min prior to live observation by confocal 
microscopy. 
 
Taken together, these results suggest that the endolysosomal malfunction 
derived from LYST mutations involves an alteration in lipid composition, as seen by 
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cholesterol accumulation, that could be responsible for the inadequate localization of 
Rab9 constructs, as seen in NPC1 cells (Ganley and Pfeffer, 2006).   
 
3.1.2 CINCCKVL localization in cells from lysosomal storage disease 
patients 
Taking into account the aberrant behavior observed in late endolysosomal 
pathways of lysosomal storage diseases and the results shown above in Chediak-Higashi 
cells, it was deemed necessary to explore CINCCKVL localization in these lysosomal 
pathologies. As shown in Figure 44, the distribution of GFP-8 reflected the 
morphological alterations affecting lysosomal compartments in various diseases.  
 
 
Figure 44. GFP-8 localization in lysosomal storage diseases. 
Fibroblasts from control subjects or from patients with the indicated lysosomal diseases were 
transfected with GFP-8 and treated with 25 nM LTR for 15 min prior to live confocal 
microscopy observation. 
 
Whereas in control cells, GFP-8 co-localized substantially with lysosomes 
detected by LTR staining, in fibroblasts from Chediak-Higashi patients, GFP-8 was 
located at the edge of the abnormally dilated acidic compartments typical of this 
condition. Interestingly, CHS cells present defects in regulated secretion (Ward et al., 
2000). The inset shows that even LTR has difficulty entering the dense lysosomes that 
accumulate large amounts of ceroid-like material (Figure 44, second panel). On the 
other hand, as we previously observed (Pérez-Sala et al., 2009), fibroblasts from 
Niemann Pick type C1 patients, a disease characterized by alterations in intracellular 
cholesterol traffic, showed increased accumulation of GFP-8 inside lysosomes, probably 
arising from the altered late endosomal lipid dynamics in this disease. Similarly, 
fibroblasts from Hermansky-Pudlak Syndrome patients also showed an increase in the 
Results 
 
 100
appearance of GFP-8 at LTR-positive compartments. Considering the possible 
mechanisms responsible for CINCCKVL sorting described in Section 2 of the Results 
and the altered GFP-8 localization found in CHS cells, further studies could shed light 
on the sorting mechanisms that are defective in this disease and could find their 
correlation in other endolysosomal malfunctions. 
 
 
3.2 Modifications of small GTPase cysteine residues by electrophilic 
compounds 
 
As described throughout this dissertation, several small GTPases contain 
cysteine residues at their C-terminal ends that are amenable to palmitoylation and 
mediate their association with endomembranes of different nature. However, in 
situations associated with oxidative or electrophilic stress, as occurs in many 
pathological conditions such as inflammatory processes, diabetes or neurodegeneration, 
cysteines can suffer non-enzymatic modifications. These include direct oxidation or 
addition of compounds of electrophilic nature that could preclude palmitoylation and 
thus proper localization, as previously described for cyPG binding to H-Ras in works 
from the laboratory (Oeste et al., 2011; Renedo et al., 2007). The assays presented in this 
section explore whether other small GTPases bearing lipidation cysteines additionally to 
that of their CAAX box could also be directly modified by cyPG or other small cysteine-
reactive compounds, hence eliciting conformation changes in their C-termini that could 
spread to other areas of the protein, changing their biochemical properties. 
 
3.2.1 Direct binding of cyPG to small GTPases 
 
Previous results from the laboratory established that dienone cyPG such as 15d-
PGJ2 and Δ12-PGJ2 covalently modify H-Ras at its C-terminal peptide, which bears the 
palmitoylation cysteines, i.e. C181 and C184 (Renedo et al., 2007). Therefore, binding of 
biotinylated 15d-PGJ2 (15d-PGJ2-B) to other small GTPases containing two 
palmitoylation cysteines at their C-terminus was assessed. As shown in Figure 45, the 
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negative control K-Ras4B, which does not have palmitoylatable cysteines in its C-
terminus, does not present a detectable biotin signal, as previously reported in cell 
assays (Renedo et al., 2007). However, binding of 15d-PGJ2-B was readily observable in 
the case of H-Ras, RhoB and Rap2B (Figure 45), all of which contain palmitoylation 
cysteines near the isoprenylation site (see Table 3). Therefore, of the GTPases studied, 
only those containing cysteine residues that are known to undergo palmitoylation are 
modified by 15d-PGJ2-B in vitro. 
 
 
 
Figure 45. Binding of biotinylated 15d-PGJ2 to small GTPases. 
Human recombinant K-Ras4B, H-Ras, RhoB or His-tagged Rap2B at 5 µM were incubated 
with 15d-PGJ2-B at 10 µM for 2 h at room temperature. Incorporation of the biotinylated 
cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish peroxidase 
(HRP)-streptavidin (upper panel) or WB with anti-pan Ras, anti-RhoB or anti-Rap2 antibodies. 
The dashed gray line indicates different exposures due to saturation of the K-Ras4B signal. 20 
and 25 kDa markers are shown for reference. 
 
To assess binding of other cyPG to RhoB, in vitro studies were carried out with 
either single enone cyPG or dienone cyPG, as shown in Figure 46. Detection of the 
biotin signal shows binding of the biotinylated single enones PGA1 and PGA2. 
Interestingly, the trans side chain isomer of PGA2, i.e. the isoprostane 8-iso-PGA2, 
displayed a higher biotin signal than its cis isomer. Similarly to above, binding of the 
dienone cyPG 15d-PGJ2-B was detected, as well. A biotinylated PG devoid of 
electrophilic carbons, PGE2, did not bind to RhoB, as expected for this negative control.  
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Figure 46. Binding of several cyPG to recombinant RhoB in vitro. 
Recombinant RhoB at 5 µM was incubated with the indicated biotinylated cyPG at 10 µM for 
2 h at room temperature prior to SDS-PAGE analysis, as in Figure 45. The gray dashed line 
represents two different exposures due to higher biotin levels in the last two lanes. 
 
3.2.2 Binding of small reactive compounds to H-Ras and RhoB 
 
It is possible that other small, bifunctional, thiol-reactive molecules could mimic 
the behavior of dienone cyPG with respect to binding to GTPases with C-terminal 
cysteines amenable to palmitoylation. A compound that meets these criteria and is 
commonly used in cell signaling studies, phenylarsine oxide (PAO, mass 168.02, 
structure shown in Figure 49B), acts as a tyrosine phosphatase inhibitor that forms 
adducts with proteins containing sulfhydryl groups close enough to form thioarsine 
rings (Gerhard et al., 2003; Wang et al., 2003). Indeed, as shown by MALDI-TOF MS in 
Figure 47A, PAO binding to H-Ras results in a mass increment compatible with 
addition of a single PAO molecule, which MS-MS analysis detected to be at the C-
terminal palmitoylatable cysteines (Oeste et al., 2011). Additionally, since biotinylated 
15d-PGJ2 (15d-PGJ2-B) binds to full-length H-Ras at its C-terminus, competition assays 
were performed to determine whether PAO could abrogate dienone cyPG addition. 
Figure 47B shows that pre-incubation with PAO reduced 15d-PGJ2-B binding to H-Ras, 
as reflected by a reduction in biotin detection (28%±7 reduction for PAO versus vehicle-
treated Ras). Similarly, the small reactive thiol cross-linker, dibromobimane (DBB, mass 
350.01, structure shown in Figure 49B), also elicited a decrease in the biotin signal 
corresponding to 15d-PGJ2-B (55% reduction, Figure 47C). The distance between the 
bromide ions in DBB that are lost upon binding to thiols of cysteines within close range 
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has been calculated to be approximately 3-6 Å (Sinz and Wang, 2001). Furthermore, 
DBB is known to undergo a fluorescent shift after bromine loss resulting from cysteine 
cross-linking (Kim and Raines, 1995), and can indeed be detected directly in gels when 
incubated with H-Ras (Figure 47C). 
 
 
Figure 47. PAO and DBB binding to recombinant H-Ras in vitro. 
(A) MALDI-TOF MS analysis of human recombinant H-Ras incubated with PAO. (B) 
Recombinant H-Ras at 5 µM was incubated for 30 min with 50 µM PAO before addition of 1 
µM biotinylated 15d-PGJ2 (15d-PGJ2-B) for 1 h, where indicated. Incorporation of the 
biotinylated cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish 
peroxidase (HRP)-streptavidin (upper panel) or WB with anti-pan Ras antibody (lower panel). 
(C) Competition of 15d-PGJ2-B binding to H-Ras by DBB. Full-length H-Ras was incubated 
similarly to (B) with DBB. Incorporation of DBB was assessed by UV fluorescence detection 
(middle panel). 
 
In light of the results obtained by SDS-PAGE analysis of RhoB modification by 
15d-PGJ2-B, competition experiments between 15d-PGJ2-B and PAO or DBB were 
performed with RhoB, as well. There is a clearly detectable reduction in the biotin signal 
representing 15d-PGJ2-B binding when the protein is pre-incubated with either PAO 
(Figure 48A) or DBB (Figure 48B). Similarly to the results obtained with H-Ras, UV gel 
fluorescence indicating direct DBB binding was also observed. 
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Figure 48. 15d-PGJ2, PAO and DBB binding to recombinant RhoB in vitro. 
(A) Recombinant RhoB at 5 µM was incubated for 30 min with 50 µM PAO before addition 
of 10 µM biotinylated 15d-PGJ2 (15d-PGJ2-B) for 1 h, where indicated. Incorporation of the 
biotinylated cyPG was assessed by SDS-PAGE, protein blot and detection with horseradish 
peroxidase (HRP)-streptavidin (upper panel) or western blot with anti-RhoB antibody (lower 
panel). (B) Competition of 15d-PGJ2-B binding to RhoB by DBB. Full-length RhoB was 
incubated similarly to (A) with DBB. Incorporation of DBB was assessed by UV fluorescence 
detection (middle panel). 
 
Several bifunctional reagents have therefore been shown to bind to either full-
length H-Ras or RhoB (Figure 47 and Figure 48). Since these proteins contain vicinal 
cysteines, these compounds could be binding to both cysteine residues simultaneously. 
Moreover, as mentioned above, direct detection of DBB fluorescence upon incubation 
of H-Ras or RhoB with this compound indicates that it is bound to two cysteines within 
3-6 Å of each other (Kim and Raines, 1995).  To directly observe the cross-linking of 
palmitoylation cysteines elicited by bifunctional compounds, a synthetic peptide 
corresponding to the H-Ras C-terminus was used as a model in MALDI-TOF MS 
analyses. This peptide is equivalent to the fragment obtained by tryptic digestion of H-
Ras, namely K170-K185 (m/z 1662.7, sequence in Figure 49B), which contains the 
palmitoylatable cysteines, and presents a more favorable sequence than the equivalent 
peptide of RhoB, in which the tryptic fragment would include the isoprenylation 
cysteine in addition to those amenable to palmitoylation. Peptide incubation with 15d-
PGJ2 presents a predominant peak corresponding to the addition of one PG molecule 
(m/z 1979.80,), as well as two oxidation peaks (m/z 1994.9 and 2010.7), as described in 
earlier works (Oliva et al., 2003; Renedo et al., 2007).  
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Figure 49. Modification of the K170-K185 H-Ras C-terminal peptide by 15d-PGJ2, PAO and 
DBB. 
(A) Sequence of the K170-K185 peptide with the modified cysteines in larger, bold font and 
summary of the theoretical peptide adducts for which compatible peaks were observed by 
MALDI-TOF mass spectrometry. (B) Incubation of the synthetic H-Ras C-terminal peptide, 
K170-K185, with either 15d-PGJ2, PAO or DBB resulted in adducts detected by MALDI-TOF 
MS. Structures of the compounds employed are shown to the right of the spectra, with a 
schematic of adduct formation with two thiol groups in the case of PAO and DBB.  
 
Incubation of the K170-K185 peptide with PAO gave rise to a single peak with 
m/z 1812.7 that represents the simultaneous binding to both cysteines, as depicted to 
the right of the PAO spectrum (Figure 49B). Likewise, DBB bound to the K170-K185 
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peptide, resulting in the appearance of a single peak of m/z 1850.81, compatible with a 
1:1 adduct of peptide:DBB (Figure 49B). The small span of the DBB reactive groups and 
the fact that peptide dimers were not detected upon DBB incubation (Oeste et al., 2011) 
suggest that C181 and C184 are within close range of each other and hence amenable to 
intramolecular cross-linking by DBB (Figure 49B, bottom).  
It should be noted that the H-Ras hypervariable domain does not present a well-
defined structure in solution (Thapar et al., 2004), whereas membrane binding induces a 
more rigid conformation (Gorfe et al., 2007). Therefore, cross-linking of C181 and C184 
by 15d-PGJ2, PAO or DBB binding could potentially stabilize a fixed conformation and 
disturb H-Ras membrane interactions. These results pave the way for studies in cells to 
determine the functional repercussion of direct modification by small electrophilic 
moieties. Assays performed on cells transfected with H-Ras constructs have shown that, 
indeed, its localization and activation shift from the plasma membrane to 
endomembranes upon treatment with PAO or DBB (Oeste et al., 2011). Preliminary 
assays using RhoB have proven unfruitful due to its rapid degradation and low basal 
levels in cells, though further studies are warranted to determine the cellular effect of 
binding of these compounds to RhoB. 
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1. Role of the hypervariable motif in small GTPase 
subcellular localization  
 
Many small GTPases are singly or doubly isoprenylated and some of them 
undergo further post-translational modifications by palmitoylation. In addition to C-
terminal lipidation, the hypervariable region of some Ras superfamily proteins contain 
basic residue patches that interact with anionic phospholipids that accumulate at 
particular subcellular membranes and others include further sorting elements such as 
motifs recognized by adaptors (Bonifacino and Traub, 2003). Significantly, these 
structural motifs determine subcellular localization patterns that derive from or elicit 
conformational changes extending to the totality of the protein, which ultimately govern 
GTPase activation states and signaling functions. In fact, hypervariable regions 
containing very similar motifs can give rise to different endomembrane sorting on the 
basis of distinct lipid moiety spacing or even the nature of a few neighboring amino 
acids. 
 
1.1 Endosomal GTPases appear at distinct subcellular membranes 
 
Studies regarding the hypervariable region sequences of several small GTPases 
were carried out to assess the structural determinants involved in subcellular 
localization. Previous studies from the laboratory established the RhoB C-terminal 
sequence as a motif for sorting to endolysosomes and lysosomal degradation (Pérez-Sala 
et al., 2009). This behavior depends on its isoprenylation and double palmitoylation, 
which begged the question of whether other similarly lipidated small GTPases such as 
H-Ras, Rap2A and B, or TC10 presented similar subcellular localization. As has been 
performed in detail for H-Ras (Gorfe et al., 2007), short constructs bearing sequences 
pertaining only to the isoprenylation and palmitoylation motifs of these proteins aided 
in determining the impact on sorting and degradation of their full-length counterparts.  
The results shown in Section 1.1 of the Results indicate that sorting into MVB 
and subsequent lysosomal degradation is highly specific for RhoB. Though the TC10 C-
terminus is very similar to that of RhoB, a basic amino acid patch upstream of the 
palmitoylation cysteines is responsible for retention at limiting membranes of MVB and 
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hampers inclusion into ILV (Valero et al., 2010). Indeed, this basic residue motif could 
mediate an electrostatic interaction of TC10 with the most abundant negatively charged 
phospholipid, i.e. phosphatidylserine, which is found mainly on the cytosolic surface of 
endosomes and the plasma membrane (Leventis and Grinstein, 2010; Urade et al., 1988; 
Yeung et al., 2008), hence obstructing entry into the lumen of MVB and subsequent 
degradation. Other bipalmitoylated proteins were found similarly retained at the 
limiting membranes of endolysosomes, such as the Rap2 isoforms (Valero et al., 2010). 
In this case, the alternate spacing between lipidated residues could confer a distinct 
overall three-dimensional conformation at the C-terminus of Rap2 proteins that 
promotes association with membrane microdomains of singular properties. Short 
constructs derived from the H-Ras C-terminal sequence were mainly present at the 
plasma membrane, as previously described (Gorfe et al., 2007). It could therefore be 
postulated that combinations of electrostatic interactions and reversible palmitoylation 
are responsible for endowing C-termini with conformations that allow binding to 
membrane regions of well-defined characteristics. Taken together, these results indicate 
that the isoprenylation and palmitoylation motif of RhoB constitutes a precise structure 
with affinity for particular membrane domains that determines its selective sorting 
through the endolysosomal pathway into the lumen of MVB. 
 
1.2 The RhoB C-terminus CINCCKVL is an MVB and endolysosomal marker 
 
Several studies from our laboratory have shown that the fully processed RhoB C-
terminal sequence CINCCKVL co-localizes with endolysosomal probes such as LTR, 
Lamp1, Rab7, Rab9 and CD63 constructs, or LBPA, as well as appearing directly at ILV 
of MVB (Oeste et al., 2014; Pérez-Sala et al., 2009; Valero et al., 2010). These results 
were confirmed through the use of several fusion proteins containing this sequence, 
including varied fluorescent constructs such as GFP, RFP and its photostable forms 
(tagRFP, tagRFP-T), mCherry, or photoswitchable Dendra2. Intracellular live markers 
are not devoid of pitfalls, such as endosome enlargement induced by overexpression of 
Lamp1 or Rab7 constructs and induction of stress fibers by transfecting with full-length 
RhoB fusion proteins (unpublished observations). In the case of CINCCKVL chimeras, 
no detectable morphological abnormalities have been encountered during its use, so far. 
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Furthermore, work from the laboratory in live BAEC and HeLa reported a lack of 
overlap with several autophagy probes after induction of autophagy such that 
independent GFP-8-positive structures were clearly distinct from RFP-LC3 
autophagosomes (Oeste et al., 2013). CINCCKVL localization to Golgi compartments is 
also negligible when full modification is allowed (Oeste et al., 2014). As will be discussed 
below, lipidation status is crucial to CINCCKVL sorting through the endocytic pathway, 
and can hence be regulated to track subcellular organelles or detect overall 
isoprenylation precursor status through statin switch assays. Therefore, CINCCKVL 
fusion proteins may be used as markers amenable to pharmacological modulation for 
dynamic tracking of MVB and endolysosomes in live cells. 
 
1.3 CINCCKVL localization at endolysosomes depends on lipid modifications  
 
The presence of CINCCKVL proteins at endolysosomes is completely dependent 
on full post-translational processing by lipids. It is shown in this work that isoprenylated 
but non-palmitoylated constructs are diffuse within the cytoplasm but exclude the 
nucleus and are in part retained at the Golgi apparatus, where palmitoyl transferases are 
usually accumulated, which could represent species that are awaiting palmitoylation, 
(Aicart-Ramos et al., 2011). In contrast, non-lipidated forms spread throughout the cell, 
leaving some small, LTR-positive vesicles empty. It therefore becomes apparent that 
palmitoylation is a sine qua non for CINCCKVL entry into endolysosomes, as shown 
schematically in Figure 50. Similarly, studies involving the Ca2+ sensor synaptotagmin 7 
described that its palmitoylation elicits association with CD63 and subsequent sorting to 
lysosomes, whereas non-palmitoylated forms are retained in the Golgi (Flannery et al., 
2010). However, these instances are in contrast with the more numerous cases of 
proteins in which palmitoylation precludes access to lysosomes, as seen in (McCormick 
et al., 2008; Pérez-Sala et al., 2009). For example, recycling of the M6P receptor from 
lysosomes to the Golgi is dependent on its N-terminal palmitoylation, for 
palmitoylation-defective mutants accumulate into dense lysosomes (Schweizer et al., 
1996). 
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Figure 50. GFP-8 subcellular localization depends on its lipid modifications. 
The GFP structure appears as a ribbon diagram in green, with the CINCCKVL motif 
represented as a green squiggle attached to it. Totally unlipidated forms are completely 
diffuse throughout the cytoplasm and the nucleus (gray font), whereas isoprenylated forms 
exclude the nucleus, are predominantly cytosolic and are sometimes associated with the 
Golgi apparatus (red font). However, isoprenylated and bipalmitoylated GFP-8 appears at 
late endosomes/MVB and the plasma membrane (blue font). See text for details. 
 
Concerning the GPCR, PAR-1 (protease-activated receptor 1), there seems to be 
an interplay between its YXXΦ sorting motifs and palmitoylation, such that correct 
sorting mediated by the tyrosine motif requires correct modification by palmitate and 
PAR-1 mutants lacking palmitoylation cysteines are degraded in lysosomes to a higher 
extent (Canto and Trejo, 2013). The yeast protein Vac8 is localized at the vacuolar 
membrane in yeast, though internalization into this compartment has not been 
described (Peng et al., 2006). Hence, a general role for palmitoylation in protein sorting 
is lacking, since the consequences of modification by this lipid seem to be protein-
specific and cell-type dependent. Additionally, palmitoylation of RhoB constructs is 
probably accountable for the lack of interaction between either GFP-8 or GFP-RhoB 
with RhoGDIα as compared to that detected for GFP-RhoA (Oeste et al., unpublished 
observations), as previously hypothesized (Michaelson et al., 2001). Nevertheless, it still 
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remains to be established whether non-palmitoylated RhoB constructs interact with 
RhoGDI in the cytosol (Ho et al., 2008). 
Upon isoprenylation inhibition, full-length RhoB-derived constructs behave as 
cytosolic proteins, similarly to unprenylated GFP-8 (see Figure 50). Therefore, both 
membrane and RhoGDI binding cannot occur and RhoB could be degraded through the 
expected proteasomal pathway followed by soluble proteins. In fact, excessive 
overexpression of fluorescent RhoB constructs elicits diffuse accumulation in the 
cytosol, most likely due to saturation of the lipidation machinery and subsequent lack of 
precursors. Such “extra” proteins could become ubiquitinated and degraded through the 
proteasome, which is a putative scenario for a study detecting RhoB ubiquitination 
upon overexpression of RhoB and ubiquitin in cells treated with proteasomal inhibitors 
(Engel et al., 1998). Indeed, RhoB is an early response gene and its levels can rise quickly 
within the cell to overcome damage by UV exposure (Canguilhem et al., 2005). It would 
be interesting to detect whether, following this stimulus, the newly synthesized proteins 
are capable of becoming isoprenylated and bipalmitoylated to follow the endolysosomal 
pathway described herein, or whether full lipidation occurs to maintain low RhoB levels 
principally in resting state conditions.  
Pharmacological statin treatment, which is widely prescribed for 
hypercholesterolemia, greatly increases levels of unprocessed RhoB in the cytosol 
(Stamatakis et al., 2002). Another report determined that an increase in non-prenylated 
Rho protein translates into overall elevated levels of GTP-bound Rho as compared to 
untreated cells expressing normal levels, suggesting that Rho-dependent signaling 
pathways are more active in statin-treated cells (Turner et al., 2008). Furthermore, it has 
been previously described that accumulation of unprocessed, soluble forms of Rho 
proteins (mostly RhoA) are partly responsible for the serious side effects resulting from 
abrupt statin withdrawal, which implies a sudden lift of the blockade on isoprenoid 
precursor formation. The accumulated Rho protein is rapidly modified by newly 
synthesized geranylgeranyl moieties and translocates to the plasma membrane, strongly 
activating its signaling cascades, including repression of endothelial nitric oxide 
synthase (eNOS). This phenomenon causes a dangerously abrupt drop in nitric oxide 
production in cardiac endothelial cells, hence impairing vascular function (Laufs et al., 
2000). These effects were studied in detail in the context of RhoA, but the concomitant 
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increase in unprocessed RhoB concentration in cells from patients undergoing statin 
treatment warrants further investigation.  
 
1.4 CINCCKVL sorting is conserved from fungi to human cell models 
 
Cells from very diverse species including ascomycetous fungi, insects, 
amphibians and several mammals are all able to sort RhoB C-terminus constructs to the 
vacuole or endolysosomes. However, they endogenously express different sets of Ras 
superfamily proteins, and in some cases a clear RhoB homolog has not been identified 
or is not localized to endosomes. Mammals and birds express identical RhoB proteins, 
but organisms studied in this work that are lower on the evolutionary scale differ in 
their C-terminal RhoB sequence or do not encode a RhoB homolog, as seen in insect 
cells. In the case of Schizosaccharomyces pombe, there is a RhoB homolog termed Rho2 
that appears at the plasma membrane, the septation site and growing ends (Hirata et al., 
1998). However, this protein contains only one palmitoylated cysteine close to the 
isoprenylation site (Roth et al., 2006), which is modified by a farnesyl moiety (Ma et al., 
2006) in lieu of the preferential geranylgeranylation that takes place on RhoB in cells 
(Roberts et al., 2008). RhoB can become alternatively isoprenylated, though studies with 
constructs containing CAAX boxes more inclined to either modification, namely GFP-
CINCCKVL and GFP-CINCCLVM (geranylgeranylated or farnesylated, respectively), 
did not present detectable differences as to their endolysosomal localization, so that a 
crucial role for the length of the C-terminal isoprenoid is not likely (Oeste et al., 
unpublished observations). Another yeast protein, RasA, is indeed bipalmitoylated, but 
it accumulates at the plasma membrane and disrupting its palmitoylation elicits a 
patchy intracellular distribution (Fortwendel et al., 2012). Aspergillus nidulans codes for 
a putative Rho2-like protein expected to be geranylgeranylated and palmitoylated, 
though a homolog for GGTase I has not yet been biochemically identified in this 
species.  
The instances of lipidated proteins in lower organisms described above highlight 
the fact that, though these species are able to sort CINCCKVL to endolysosomes, none 
of their endogenous proteins have been described to follow this route directly. It is 
therefore worth examining whether the sorting machineries potentially responsible for 
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RhoB construct sorting in mammals, i.e. Rabs, ESCRT or the tetraspanin CD63, are 
conserved from fungi to human cells. Indeed, the basic Rab components of the 
endocytic route are conserved throughout metazoan evolution. In-depth phylogenetic 
studies on Rab family proteins highlight the existence of a large number of Rabs early on 
in evolution (Elias et al., 2012; Klöpper et al., 2012). Moreover, it has been proposed that 
the latest eukaryotic common ancestor (LECA) contained more than 20 core Rab 
proteins that have suffered expansions by gene duplication or losses throughout 
eukaryotic evolution (Klöpper et al., 2012). Further human Rabs have arisen from gene 
duplication of the fundamental Rabs associated either to early endosomes (Rab5), late 
endosomes (Rab7 and Rab9) recycling endosomes (Rab11) and so on, up to the ten 
subfamilies identified through phylogenetic studies of mammalian Rabs (Pereira-Leal 
and Seabra, 2000). Interestingly, CINCCKVL chimeras are present inside vesicles that 
are marked at their limiting membranes by proteins included in a category containing 
late endosomal LECA Rabs (group III), such as Rab7.  
As is the case for Rab proteins, at least one component from each of the ESCRT-
I, -II or –III complexes is present in fungi and metazoans (Wideman et al., 2014). 
However, outside Ophisthokonta, ESCRT-0 is completely absent, so that other 
mechanisms for ubiquitin recognition must exist in organisms present before the LECA 
branched off from other life forms (Leung et al., 2008). Considering the role of ESCRT 
proteins in MVB biogenesis, it would be expected that organisms with defined 
intracellular compartments would require their action for correct endosomal sorting. 
However, Archaea have also been shown to contain ESCRT components, though only 
ESCRT-III and Vps4 (Samson et al., 2008). Such is the case due to the vital role of 
several ESCRT proteins in membrane abscission during cytokinesis (Rusten et al., 2012). 
Furthermore, ESCRT proteins are also involved in virus budding, such as human 
immunodeficiency virus-1 (HIV-1) egress from the plasma membrane, which follows an 
“inside-out” route from the cytoplasm that is topologically similar to ILV formation 
(Garrus et al., 2001; Morita and Sundquist, 2004).  
Therefore, the Rab and ESCRT proteins found to co-localize with CINCCKVL 
and RhoB constructs or involved in their sorting could potentially be present in the 
diverse species studied. In the case of tetraspanin proteins, fungi have been found to 
contain homologs, though in Aspergillus nidulans only a tetraspanin-like protein has 
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been proposed by sequence homology but has not been characterized (Lambou et al., 
2008).  
 
2. RhoB subcellular sorting mechanisms 
 
The structural determinants guiding endosomal small GTPase sorting include 
lipidation motifs and amino acids of specific characteristics. In the case of RhoB, its C-
terminus CINCCKVL represents a unique structure upon lipidation that attaches to the 
very specific subcellular localization of late endosomal pathway vesicle lumina that is 
conserved in cells from many organisms. In human cells, targeting to ILV of MVB such 
as occurs for RhoB does not necessarily mean degradation at lysosomes, though RhoB 
constructs are indeed degraded mainly through this pathway (Pérez-Sala et al., 2009). As 
described previously, proteins present at MVB can also be exocytosed by fusing with the 
plasma membrane or recycled back to the Golgi apparatus as well as being delivered to 
the lysosome (Futter et al., 1996; Lu and Hong, 2014; Murk et al., 2002; Vlassov et al., 
2012). However, there is still debate as to whether the same MVB contains ILV directed 
towards different sites or if there are specialized MVB that deliver all their ILV to the 
same subcellular destination (Edgar et al., 2014; van Niel et al., 2011; Vlassov et al., 
2012). Therefore, it was crucial to investigate some of the trafficking pathways that lead 
proteins to and from MVB in eukaryotic cells to determine their role in sorting of RhoB 
and its last eight amino acids. The interplay between protein sequence and lipid 
modifications in sorting of these proteins warranted the study not only of protein 
complexes involved in shuttling material within the cell, but also of the lipid features of 
the membranes to which they attach. 
 
2.1 Differential role of the ESCRT machinery in sorting of RhoB versus 
CINCCKVL constructs 
 
Protein sorting into MVB is at the convergence of several endocytic routes, as 
well as a hub towards other intracellular destinations. ESCRT proteins regulate the 
canonical pathway described for entry into MVB of many proteins, such as the EGF 
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receptor. Previous work from the laboratory suggested the involvement of this 
machinery in RhoB sorting through the use of Vps4 dominant negative constructs in 
BAEC (Pérez-Sala et al., 2009). Furthermore, other routes to the MVB such as 
autophagy, microautophagy or chaperone-mediated autophagy are highly unlikely 
routes for trafficking this GTPase, as discussed in (Oeste et al., 2014). It was therefore 
possible that the ESCRT machinery played a role in RhoB sorting.  
ESCRT-mediated sorting into MVB, when dependent on the whole machinery, 
begins by ubiquitination of cargo such as EGFR. Ubiquitin-independent mechanisms 
also exist, but these usually involve only late ESCRT components and ESCRT-III-
associated proteins such as Alix. Many attempts at detecting ubiquitination of RhoB 
constructs were undertaken for this work, including stimulation with EGF, treatment 
with proteasomal or lysosomal degradation inhibitors, or simvastatin treatment to 
accumulate RhoB, though none of them resulted in a clear signal of ubiquitinated full-
length RhoB or CINCCKVL proteins, rendering these results inconclusive (not shown). 
Interestingly, the GFP-22 construct that showed a faint ubiquitin signal contains a lysine 
residue that could become ubiquitinated, but might be less exposed in full-length RhoB, 
such that regulated processes could mediate its amenability to ubiquitination. However, 
use of ESCRT siRNA to silence some components of the machinery and observation of 
GFP-RhoB and GFP-8 by live microscopy revealed differential phenotypes, so that 
ESCRT could be involved regardless of ubiquitination. Strikingly, by using these 
constructs in parallel, a distinctive subcellular localization was observed upon depletion 
of the ESCRT components Hrs and Tsg101. These were the first studies to show 
differential behavior between full-length RhoB, which showed impaired sorting in cells 
depleted of these ESCRT, and its chimera, GFP-8, which was sorted into endolysosomes 
in these cells. It is possible that RhoB is in fact ubiquitinated but we have not achieved 
its detection, either because its ubiquitination is fast and transient or because it is 
rapidly degraded in the lysosome upon ubiquitination, or both. In any case, our results 
suggest that GFP-RhoB would follow an ESCRT-mediated pathway into the lumen of 
endolysosomes, be it ubiquitin-dependent or -independent. In contrast, GFP-8 would 
not become ubiquitinated and could therefore follow ceramide and CD63-driven 
budding into MVB and pinch off to become ILV regardless of alterations in the ESCRT 
machinery. 
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Differences encountered between GFP-8 and GFP-RhoB give rise to a working 
hypothesis for the molecular players involved in RhoB and CINCCKVL localization and 
sorting. This view is schematized in Figure 51 and will aid in discussing the possible 
sorting mechanisms throughout the following sections, as well as in future studies.  
 
 
Figure 51. Schematic of possible membrane platforms for GFP-RhoB and GFP-8. 
Zoom-in on putative differential ILV of MVB containing either GFP-RhoB or GFP-8. The 
results shown in this work point to a possible role for the ESCRT proteins Hrs and Tsg101 in 
GFP-RhoB sorting (left membrane), but not for that of GFP-8. The larger ILV into which GFP-
RhoB enters would contain the late endosome lipid, LBPA (light green). In contrast, CD63 
could be involved in GFP-8 sorting, as well as cholesterol dynamics (right membrane). 
Furthermore, ceramide treatment could induce the appearance of GFP-8 in small ILV 
containing CD63, which could putatively be secreted to the extracellular space. 
 
2.2 Effects of agents altering cellular lipid dynamics on CINCCKVL and full-
length RhoB sorting 
 
Apart from the protein machineries involved in intracellular sorting, the lipid 
composition of endosomal membranes plays a key role in cargo trafficking and MVB 
biogenesis (Bissig and Gruenberg, 2013; Bissig et al., 2012). In fact, lipid microdomains 
in the Saccharomyces cerevisiae vacuole were recently found to mediate protein 
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segregation (Toulmay and Prinz, 2013). On one hand, bulk lipids can convey specific 
conformations to membranes according to their three-dimensional properties, so that 
conical lipids induce curvature and straight molecules increase membrane order, i.e. 
diacylglycerol and cholesterol, respectively (Bigay and Antonny, 2012). Altering 
cholesterol dynamics in several cell types by pharmacological treatment indeed disrupts 
the association of CINCCKVL constructs to endolysosomes. On one hand, treatment 
with U18666A, which increases membrane invagination into MVB (Marchetti et al., 
2004), gives rise to prominent accumulations of CINCCKVL chimeras within 
endolysosomes containing LBPA, cholesterol and delimited by markers such as Lamp1-
GFP, GFP-Rab7 or -Rab9 (Valero et al., 2010), reflecting their specific association with 
ILV. On the other hand, inhibiting cholesterol biosynthesis by ZGA treatment induced 
MVB dilation and a striking retention of proteins at MVB limiting membranes, i.e. 
GFP-8 or CD63 constructs, which normally internalize into ILV in control cells (Oeste 
et al., 2014), though this retention was not observed for GFP-RhoB, which still entered 
endolysosomes upon ZGA treatment (Figure 36). 
The results observed for GFP-8 agree with previous reports describing ILV as the 
major cholesterol-containing vesicles in the endosomal pathway (Möbius et al., 2003). It 
is possible that overall cholesterol depletion would therefore affect these structures more 
markedly, hampering the route followed by GFP-8 for invagination into MVB (see 
Figure 51). In fact, endothelial cells have been shown to contain cholesterol-rich 
membrane domains in their MVB (Amiya et al., 2013). Moreover, mice deficient in the 
last enzyme of the cholesterol biosynthetic pathway (Δ24 sterol reductase) present 
reduced ILV material within their MVB, which follows the same pattern as the 
reduction of GFP-8 and CD63 constructs in the lumen of MVB upon ZGA treatment 
(Gilk et al., 2013). Cholesterol has also been found to stabilize particular microdomains 
containing specialized phosphoinositides (Jiang et al., 2014), so that altering its 
dynamics could affect these small signaling platforms, as well. Furthermore, specific 
lipids exist at defined membrane microdomains, as is the case for the curvature-
inducing lipid LBPA in endolysosomes (Matsuo et al., 2004), or particular 
phosphoinositides along the endocytic pathway (Di Paolo and De Camilli, 2006). In this 
regard, full-length RhoB constructs co-localize to a large extent with LBPA in the 
endolysosomal lumen (Pérez-Sala et al., 2009), whereas the PI(3)P marker 2xFYVE 
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appears at small, dispersed vesicles that do not overlap with RhoB or CINCCKVL 
constructs (Oeste et al., unpublished observations). Therefore, sorting of RhoB 
constructs is dependent on lipid-mediated mechanisms of ILV formation for which 
cholesterol and LBPA are essential.  
 
2.3 CD63 overexpression has differential effects on full-length RhoB and 
CINCCKVL localization 
 
Sorting mediated by tetraspanins and TEM are a telling example of the intrinsic 
relationship between protein sequence, lipid modifications and membrane organization. 
In the case of CD63, its four transmembrane domains direct insertion into membranes, 
its YXXΦ motif guides intracellular trafficking, and palmitoylation at cysteine residues 
determines attachment to membranes of specific characteristics in a cholesterol-
dependent manner (Charrin et al., 2003; Israels and McMillan-Ward, 2010; Pols and 
Klumperman, 2009; Yang et al., 2002). These features give rise to CD63 sorting to 
specific membrane microdomains, which are also the destination for RhoB chimeras, 
i.e. ILV of MVB and the plasma membrane, to a varying extent. In fact, co-localization 
studies in resting cells show almost total overlap between wild-type CD63 constructs 
and CINCCKVL chimeras, and to a lesser degree with full-length RhoB constructs. As 
depicted in Figure 51, it could be hypothesized that GFP-8 is intimately connected to 
TEM through its palmitate residues by a similar cholesterol-dependent mechanism that 
keeps CD proteins together (Charrin et al., 2003). The lack of further sorting 
determinants in GFP-8 would render the protein quite dependent on TEM dynamics. 
Therefore, disruption of CD63 intracellular trafficking such as that which could take 
place upon overexpression of CD63 constructs, particularly the Y235A mutant, would 
hinder binding to AP-3 complexes, which could alter CD63 sorting to TEM at MVB and 
therefore result in a concomitant misplacement of GFP-8. AP-3 has been shown to 
contribute to the regulated secretory pathway, as AP-3 depletion reduces regulated 
secretion of secretogranin II, though it elicits an increase in its constitutive secretion as a 
compensatory mechanism (Asensio et al., 2010). Therefore, a putative indirect 
association of GFP-8 to AP-3 via CD63 could be abolished in a scenario of altered CD63 
sorting such as cells overexpressing CD63 constructs, sending CINCCKVL proteins 
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towards constitutive exocytosis. In contrast, additional sorting motifs, interactions with 
effectors, or an active role in endosomal dynamics could be responsible for full-length 
RhoB localization at endolysosomes without partaking in secretion mechanisms, 
regardless of changes in CD63 sorting. In any case, these results set forth the possibility 
that CINCCKVL chimeras could also appear in the extracellular space, which is 
congruent with their localization at ILV of MVB containing CD63 and possibly destined 
for exocytosis. 
Biogenesis of ILV destined towards exocytosis, which contain CD63, can occur 
independently of the ESCRT machinery; instead, the curvature-inducing lipid, 
ceramide, mediates inward budding from the MVB limiting membrane (Trajkovic et al., 
2008). Follow-up studies to determine whether CINCCKVL proteins can be delivered to 
the extracellular space were performed by exogenous treatment with C6 ceramide. 
These studies revealed that this lipid elicits an “emptying out” of cells co-transfected 
with GFP-8 and CD63, with a concomitant appearance of fluorescent extracellular 
material and reduction of GFP-8/mCherry-CD63 co-localization. On the other hand, 
GFP-RhoB was retained at several subcortical sites below the plasma membrane and did 
not appear in secreted membranous structures. Full-length RhoB could therefore 
contain a motif(s) upstream from the CINCCKVL sequence acting as a retention signal 
to bar its exit from the cell. Indeed, very few instances of human extracellular vesicle-
associated RhoB have been described, including one report in exosomes of colorectal 
cancer cells, another report describing RhoB in exosomes from urine, and three studies 
in which microvesicles were found to contain RhoB (www.microvesicles.org). 
Furthermore, under the conditions employed in preliminary assays for isolating an 
extracellular vesicle fraction by sequential ultracentrifugation, we were unable to detect 
RhoB (unpublished observations). 
It is worth noting that a study using numerous chimeric proteins postulates that 
cytosolic proteins with a tendency to oligomerize, when attached to a lipid anchor, 
become secreted into the extracellular medium. Indeed, a GFP-tagged, oligomeric, 
cytosolic protein with a RhoB-related isoprenylation and mono-palmitoylation 
sequence attached (CCKVL) is detectable in an exosome/microvesicle fraction, albeit to 
a much lesser degree than the positive controls containing either an N-myristoylation 
tag or a PIP2-binding domain (Shen et al., 2011). However, throughout this work we 
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have used different fluorescent proteins besides GFP, some of which are theoretically 
expressed as monomers and therefore would not necessarily follow this oligomerization 
trend per se, e.g. mCherry, which stands for monomeric Cherry (Shaner et al., 2004). 
Interestingly, the Hrs domain 2xFYVE is practically incapable of eliciting a secretory 
phenotype in the study mentioned above. It could be hypothesized that the potential 
RhoB-Hrs interaction hinted at by Hrs KD cells guides RhoB constructs into ILV 
destined towards degradation at the lysosome, hindering its entry into exocytic ILV into 
which GFP-8 is sorted and retaining GFP-RhoB within the cell, as described above. 
These distinct phenotypes only appear upon altering cellular homeostasis, such as 
ESCRT depletion or C6 ceramide treatment, but not under resting conditions. Whether 
these distinct ILV subpopulations exist within the same MVB will be the subject of 
further studies, though co-transfection of CINCCKVL and RhoB constructs has proven 
highly toxic, perhaps due to lipid precursor depletion (results not shown). 
Considering that lipidated CINCCKVL constructs are fused directly to GFP and 
have no other RhoB-derived sequences, the differences encountered between these 
proteins and full-length RhoB constructs point to other sorting, signaling, or interaction 
sequences upstream of the lipidation sites. A close look at the RhoB sequence does 
indeed bring up interesting sequences and residues as hypothetical recognition motifs, 
as shown in Figure 52.  
 
 
Figure 52. RhoB sequence and possible sorting motifs upstream of its lipidation region. 
The full-length human RhoB sequence is shown. The lipidation motif, CINCCKVL is 
highlighted in blue, while possible AP-interaction motifs are boxed in red or black. The 
YDYLE sequence fits with a putative motif recognized by AP-4, namely “YX[FYL][FL]E”. The 
second is a putative YXXΦ motif that is recognized by several AP complexes. The “KRXX” 
sequence is a hypothetical AP-3 binding motif. Arrows mark a possibly ubiquitinated lysine 
residue and a serine that becomes phosphorylated. See text for details. 
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Indeed, it has been reported that serine 185 of RhoB, close to its palmitoylation 
cysteines (see Figure 52), is phosphorylated by casein kinase-1, which hampers stress 
fiber formation and EGF receptor stabilization (Tillement et al., 2008). As discussed 
above, a few amino acids upstream, there is a lysine residue included in the GFP-22 
construct that could be amenable to ubiquitination. RhoB also possesses a sequence 
matching a recently described, non-canonical AP-3 interaction motif of interferon-
induced transmembrane (IFITM) protein 1, i.e. the dibasic patch “KRXX”, as shown in 
Figure 52. Interestingly, two possible YXXΦ motifs appear in regions upstream of the 
CAAX box that are unique to RhoB. As seen in Figure 52, that which is closest to the C-
terminus, “YGSQ”, follows a rather canonical pattern and could hence be recognized by 
several AP complexes (Bonifacino and Traub, 2003).  Furthermore, this sequence 
includes the phosphorylatable serine and its recognition by AP complexes could 
therefore depend on its phosphorylation state. The other YXXΦ motif, “YDYLE”, 
appears further upstream (Figure 52), beginning with Tyr154, and is a striking match to 
the motif that mediates AP-4 binding for trans-Golgi to endosome sorting of the 
amyloid precursor protein, namely YX[FYL][FL]E (Burgos et al., 2010; Park and Guo, 
2014). RhoB interaction with AP-4 would hypothetically be consistent with exit from 
the Golgi after palmitoylation, en route towards its endosomal localization. 
Preliminary localization studies were carried out with mutants of tyrosines 
belonging to these hypothetical YXXΦ motifs, namely, GFP-RhoB-Y154A and GFP-
RhoB-Y183A. However, there were no apparent changes in subcellular localization in 
basal conditions compared to wild-type GFP-RhoB by live confocal microscopy 
observation. Further studies are needed to address the possibility that response to 
stimuli such as EGF or alteration of endocytic components such as those used 
throughout this work would yield discrete phenotypes, or to assess the behavior of these 
mutants at different time points to detect whether their trafficking is delayed or 
expedited due to hypothetical disruption with AP complexes.  
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3. Small GTPases in pathological scenarios 
 
3.1 RhoB constructs appear at endolysosomes in cell models with impaired 
endolysosomal dynamics 
 
Mutations in several proteins involved in intracellular sorting or lipid 
homeostasis give rise to an array of lysosomal storage diseases characterized by 
oculocutaneous albinism, deficiencies in immune processes and neurodegenerative 
defects (Ballabio and Gieselmann, 2009). These cell models have been widely studied to 
elucidate intracellular sorting machineries and the routes followed by particular 
proteins, so that it was deemed necessary to benefit from this approach in the context of 
RhoB trafficking. Among these disorders, Niemann-Pick Type C Disease is clearly 
linked to altered cholesterol dynamics, since the mutated protein NPC-1 is responsible 
for shuttling cholesterol at endolysosomes (Mukherjee and Maxfield, 2004). In turn, 
Hermansky-Pudlak Syndrome patients develop this disease due to mutation of several 
proteins, including AP-3 or Rab27, both involved in LRO biogenesis and transport 
(Wei, 2006). In both of these diseases, GFP-8 appears at intra-endolysosomal 
accumulations co-localizing with LTR. However, Chediak-Higashi cells, which contain 
enlarged endolysosomes, show GFP-8 accumulation at their limiting membrane instead 
of inside the lumen, in spite of the elevated intraluminal cholesterol and LBPA content 
of these compartments in CHS. Point mutations responsible for CHS occur on the very 
large scaffolding protein LYST (Karim et al., 2002), of mostly unknown function, 
though recent studies suggest it could regulate lysosomal size and quantity but not 
trafficking (Holland et al., 2014). Interestingly, reports using expression constructs of 
LYST fragments have detected a direct interaction of LYST and the ESCRT component 
Hrs (Tchernev et al., 2002), further substantiating its involvement in late endosomal 
dynamics. Considering the results presented in this work with respect to the possible 
dependence of RhoB sorting on Hrs function, retention of CINCCKVL constructs at the 
periphery of CHS vesicles could also be due to indirect LYST-mediated mechanisms. 
However, full-length RhoB constructs do internalize into enlarged CHS endolysosomes, 
which questions this interpretation.  
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Another striking phenotype found in CHS fibroblasts was the endolysosomal 
dilation caused by GFP-Rab9 overexpression, indicating a potential impairment of 
Rab9-mediated shuttling of material from the trans Golgi network to late endosomes 
and vice versa. In fact, there seems to be an overall entrapment of many small GTPases, 
i.e. RhoB, Rab7, TC10 and Rab9, co-localizing in endolysosomal compartments, hinting 
at impaired traffic from that point onwards, be it towards the plasma membrane by 
exocytosis or endocytic recycling, or towards the Golgi apparatus in biosynthetic 
recycling (Huynh et al., 2004; Zhang et al., 2007). Another possibility would be that CHS 
lysosomes possess inefficient degradation mechanisms, though studies with EGFR or 
RhoB argue against this hypothesis. Recently, degradation of EGFR was found to occur 
normally in LYST knock-down HeLa cells (Holland et al., 2014). These findings are in 
line with preliminary studies from the laboratory that showed similar degradation rates 
for several GTPase constructs in CHS and control fibroblasts (results not shown). These 
results merit further studies regarding the subcellular functions of the large LYST 
protein in the context of GTPase involvement in subcellular traffic, ultimately aiming at 
new therapeutic opportunities for CHS patients.  
 
3.2 Small GTPases as targets for electrophilic lipids 
 
The plethora of posttranslational modifications that can occur on Ras proteins is 
largely responsible for their ability to act as stimulus sensors from different sites in the 
cell. In addition to CAAX processing, isoprenylation, palmitoylation or phosphorylation 
(Hancock et al., 1989; Kim et al., 2009), it has also been established that Ras family 
proteins (H-Ras, N-Ras or K-Ras) undergo non-enzymatic modifications including 
nitrosylation, thiolation or addition of lipid electrophiles (Mallis et al., 2001; Oliva et al., 
2003). However, the results presented in this work are the first to detect modification by 
cyPG of RhoB and Rap2B. 
Previous results from the laboratory have reported that H-Ras is a target for 
modification by cyPG and isoprostanes (Oliva et al., 2003; Renedo et al., 2007). 
Specifically, single enone compounds preferentially modified C118, whereas the 
dienone compound, 15d-PGJ2, bound preferentially to C181 and 184 of its C-terminal 
peptide. Since these latter cysteine residues represent the palmitoylation sites of H-Ras, 
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binding of 15d-PGJ2 to RhoB and Rap2B, which also contain palmitoylatable cysteines 
close to each other at their C-termini, could represent cross-linking of these two 
residues, similarly to that detected for H-Ras and its synthetic C-terminal peptide (Oeste 
et al., 2011). In assays addressing modification of RhoB by other cyPG, results showed 
that biotinylated 15d-PGJ2 bound to a great extent, as determined by WB. Furthermore, 
incubation with biotinylated 8-iso-PGA2 elicited a stronger signal than that of its cis 
isoform, PGA2. These results suggest that single enones can also bind to RhoB cysteines 
and that the isoprostane form of PGA2 is more easily accessible to the cysteine to which 
it binds. Further experiments are required to ascertain the binding sites of these cyPG 
and the molecular characteristics responsible for the different signal intensities detected 
for each cyPG. 
As has been described in detail for H-Ras (Oeste et al., 2011), if it is the case in 
cells that these bipalmitoylated and prenylated proteins are modified by dienone cyPG 
at the cysteines in their C-termini, their subcellular localization and signaling properties 
could become significantly altered. The half-life of H-Ras palmitoylation has been 
estimated as approximately 20 min, which is a small timeframe compared to its 20 h 
half-life or even the 2-3 h half-life of RhoB, if its palmitoylation dynamics are assumed 
to be of a similar magnitude (Pérez-Sala et al., 2009; Rocks et al., 2005). Furthermore, 
Ras activation can induce its depalmitoylation (Omerovic et al., 2007), so that during 
the palmitoylation-depalmitoylation cycle of H-Ras, it could be that C181 and C184 
become available for chemical modification by cyPG or other agents. These 
modifications could obstruct subsequent rounds of palmitoylation and the 
microdomain partitioning or subcellular localization prompted by palmitate binding to 
H-Ras. As will be discussed below, modification of H-Ras by several agents does indeed 
disrupt its activation patterns and subcellular localization (Oeste et al., 2011). However, 
whether this is also the case for the other bipalmitoylated and isoprenylated GTPases 
explored in this work will be the subject of further investigations.  
cyPG production is significantly increased upon oxidative stress, suggesting that 
GTPases that can be modified by these compounds in vitro could do so in cells in an 
oxidative scenario.  Furthermore, increased generation of reactive oxygen or nitrogen 
species that takes place within cells in situations such as inflammation affects 
unsaturated lipids with a tendency for oxidation (Koenitzer and Freeman, 2010). This is 
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the case for polyunsaturated fatty acids at membranes, which suffer non-enzymatic 
oxidations to produce compounds of diverse structure that can modify proteins and 
affect their subcellular functions (Ceaser et al., 2004). Since the structures and 
electrophilic groups of these reactive endogenous compounds are similar to those of 
cyPG, the possibility is set forth that the GTPases studied in this work could become 
targets for species such as nitrated fatty acids or oxidized phospholipids, which could 
have a profound impact on their biological actions. 
 
3.3 Electrophilic reagents bind to C-terminal cysteines in H-Ras and RhoB 
 
Additionally to reactive lipids that can be found in biological systems, we have 
used exogenous, small, bifunctional cysteine reagents as biochemical tools to 
characterize the structural requirements and functional consequences of C-terminal 
modification of H-Ras and RhoB. Binding of DBB to two cysteines is only feasible if 
these are within 3-6 Å of each other, so that the results shown in this work place the 
palmitoylation cysteines within that range. As addressed above, cyPG could interfere 
with palmitoylation cycles of H-Ras and hence elicit changes in its subcellular behavior. 
Similarly, binding of small reactive compounds such as PAO and DBB to C-terminal 
cysteines can abrogate palmitoylation, though their effects on GTPase activation and 
localization need not match those of cyPG. Indeed, cells transfected with a fluorescent 
construct of the Ras binding domain (RBD) of the Ras effector, Raf, and treated with 
PAO or DBB show that active Ras is recruited to endomembranes. Treatment with these 
compounds also hampers Ras translocation to the plasma membrane upon EGF 
stimulation (Oeste et al., 2011). Interestingly, depalmitoylated H-Ras has been shown to 
travel back to the Golgi complex for addition of new palmitate moieties, and 
palmitoylation cysteine mutants signal from this localization upon stimulation with 
growth factors (Chiu et al., 2002). It is therefore possible that PAO or DBB bind to 
depalmitoylated H-Ras at the Golgi and induce its activation at this site, as summarized 
in Figure 53. Another approach resulting in alteration of the H-Ras hypervariable region 
structure is the mutation of C184 for a leucine residue, as appears naturally in N-Ras, 
which was suggested to replace the palmitate chain that is usually present and results in 
H-Ras association with the plasma membrane and recycling endosomes (Misaki et al., 
Discussion 
 
 128
2010). Taken together, cyPG and bifunctional cysteine reagent modification of H-Ras 
highlights the relevance of hypervariable cysteines and the proximity between them as 
crucial structural determinants for selectivity of posttranslational modifications. 
 
 
Figure 53. H-Ras C-terminal modifications and their functional outcomes. 
The three C-terminal H-Ras cysteine residues are shown in red, the last of which becomes 
irreversibly farnesylated (blue chain). The “-AAX” amino acids removed upon CAAX box 
processing are shown in gray. Palmitoylation cysteines, i.e. C181 and 184, can undergo 
modification by electrophilic compounds with varying structures (shown in black), resulting 
in diverse functional outcomes. 
 
Modification of H-Ras at its C-terminus by compounds with distinct structural 
features and the functional outcomes that result from them have been explored by our 
laboratory and others (Figure 53). As described above, binding of several cyPG, 
including 15d-PGJ2, elicits H-Ras activation at the plasma membrane, whereas addition 
of PAO or DBB molecules to the C-terminal cysteines results in activation at 
endomembranes. Similarly, guanylation of C184 induces Ras activation at the plasma 
membrane (Nishida et al., 2012). In contrast, glutathionylation of the H-Ras C-terminus 
in cells hinders palmitoylation and concomitant plasma membrane binding, as well as 
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inducing apoptosis (Burgoyne et al., 2012). Additionally, this study showed that 
metabolic stress induces oxidation of reactive cysteine thiolates, which also alters H-Ras 
palmitoylation, both in cells and mouse models (Burgoyne et al., 2012). Hence a 
scenario is set forth in which the physicochemical characteristics of the agents that 
modify palmitoylation cysteines determine the specificity of GTPase subcellular 
localization or activation. 
As seen in this work, small differences in amino acid sequences can have a 
profound impact on binding to membranes of distinct nature, illustrated by TC10 and 
RhoB. Furthermore, processed lipidation motifs endow each of these proteins with a 
defined structural membrane-binding unit. Modification with reactive lipids occurring 
in pathological settings adds another layer of complexity to the determinants driving 
intracellular localization of small GTPases such as RhoB. Binding of cyPG or reactive 
compounds with varied structures to RhoB in vitro paves the way for studies in cells to 
define putative impediments in RhoB palmitoylation due to these modifications, which 
could alter its subcellular localization pattern and hence its biological actions. 
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As a result of the work presented in this dissertation, in which localization and 
subcellular trafficking of endosomal GTPases have been assessed in the context of their 
posttranslational modifications, the following conclusions have been arrived at: 
 
1.1. Structural determinants present at the hypervariable region of the endosomal 
GTPases RhoB and TC10, when exchanged, interconvert their behavior 
regarding association with distinct subcellular membranes.  
 
1.2. Endolysosomal targeting of RhoB and chimeras of its lipidation motif 
(CINCCKVL) depends on isoprenylation and palmitoylation at C-terminal 
cysteines. 
 
1.3. RhoB and CINCCKVL chimeras appear inside endolysosomes and are detected 
at intraluminal vesicles of multivesicular bodies by super-resolution microscopy. 
 
1.4. CINCCKVL sorting is conserved in cells from diverse model organisms, 
including fungi, insects, amphibians, and mammals. 
 
These results shed light on the interplay between lipidated residues and other 
structural determinants in subcellular targeting of GTPases. 
 
2.1 In cells depleted of the ESCRT components Hrs and Tsg101, sorting of full-
length RhoB into endolysosomal compartments is impaired, but not that of 
CINCCKVL chimeras. 
 
2.2 Agents altering late endosomal lipid dynamics differentially disturb RhoB and 
CINCCKVL chimera localization inside endolysosomes. 
 
2.3 Overexpression of CD63 constructs alters CINCCKVL chimera localization, but 
not that of full-length RhoB. 
 
Taken together, these results imply that sorting of full-length RhoB and CINCCKVL 
constructs could be regulated by distinct subcellular trafficking machineries. 
 
3.1 RhoB or CINCCKVL constructs recapitulate endolysosomal defects in cells of 
patients with lysosomal storage diseases. 
 
3.2 The palmitoylation cysteines of the small GTPases RhoB and H-Ras are targets 
for modification by structurally diverse electrophilic lipids in vitro. 
 
These results suggest that subcellular localization of endosomal GTPases could 
become altered in pathological scenarios such as genetic diseases or processes 
involving the generation of reactive species. 
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Small GTPases of the Ras superfamily are key to cellular processes such as 
differentiation, proliferation or regulation of the cytoskeleton (Takai et al., 2001). These 
proteins undergo lipid modifications that elicit their attachment to membranes and are 
crucial to their activity. Specifically, Ras protein isoprenylation serves as an anchor to 
the membrane, and Ras proteins are further amenable to reversible palmitoylation, 
which contributes to their dynamic localization at distinct subcellular compartments 
(Hancock et al., 1989). Lipid modifications take place at cysteine residues in the C-
terminal region. Furthermore, these cysteines can undergo oxidation or addition of 
electrophilic compounds, e.g. cyclopentenone prostaglandin binding. These compounds 
are formed by non-enzymatic oxidation of arachidonic acid or from dehydration of 
other prostaglandins, which endows them with electrophilic carbons (Funk, 2001). 
Rho proteins are a group of Ras superfamily proteins that are crucial to cell 
adhesion and migration, hence modulating cardiovascular pathophysiology and 
tumorigenic processes (Ridley, 2001). RhoB is a member of this family with roles in 
vesicular trafficking, tumor suppression and localization of signaling proteins. RhoB 
lipid modifications (isoprenylation and double palmitoylation) are necessary for its 
localization to endolysosomes and its degradation through this pathway (Pérez-Sala et 
al., 2009; Stamatakis et al., 2002). The last eight amino acids of RhoB, which correspond 
to the lipidation motif, constitute an endolysosomal localization and degradation 
sequence for chimeric proteins to which this extension is added at their C-terminal end 
(Pérez-Sala et al., 2009). 
In the context of this dissertation, in vitro and cell models have been used to 
study mechanistic and structural aspects of Ras and Rho protein modification, 
particularly that of RhoB, and its influence on localization and trafficking of these 
proteins or their chimeras modified by lipids and other compounds. Though lipid 
modifications of Ras proteins have been described as important regulatory factors, the 
involvement of lipidation and its interplay with other structural determinants in 
subcellular targeting of GTPases has not been fully elucidated. Therefore, the role of 
lipid modifications of RhoB cysteine residues and other important residues at the 
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hypervariable region on its intracellular sorting has been analyzed. Furthermore, studies 
were carried out to determine whether the RhoB lipidation motif per se (CINCCKVL) is 
able to mimic the full-length protein. Cell models from different species were used to 
evaluate whether the latent sorting mechanisms for CINCCKVL proteins are conserved 
in these model organisms. Using this C-terminal construct in parallel to the full-length 
protein, the potential involvement of key molecular machineries, i.e. ESCRT complexes, 
CD63 or lipid dynamics, in their sorting was assessed. Considering the potential 
alteration of subcellular localization of Ras proteins by modification, targeting of 
lipidation sequences by other structurally diverse moieties, including reactive species 
arising in pathological scenarios, was also explored. In addition, assays were carried out 
to study the potential alteration of endosomal GTPase localization in genetic models of 
lysosomal disease. 
In order to characterize the precise subcellular localization of RhoB, constructs 
of fluorescent proteins fused to this protein were compared to those of other small 
GTPases used as markers of endocytic vesicles. Co-localization with fusion proteins of 
Rab7, Rab9 or Lamp and negligible overlap with early endosome markers, i.e. Rab5 
fusion proteins, or the Golgi marker, giantin, underscore RhoB localization within the 
endolysosomal lumen. These studies also include assays with autophagy probes, with 
which RhoB or its chimeras show negligible co-localization. The small GTPase, TC10, 
contains a C-terminal sequence that is very similar to that of RhoB, though a basic 
amino acid patch upstream of the lipidation sequence elicits retention at the limiting 
membrane of endolysosomes. Insertion of this basic patch into the RhoB sequence 
hinders its entry into endolysosomes, highlighting that exchange of structural 
determinants between these proteins elicits interconversion of their subcellular 
localization patterns. Furthermore, it has been determined that chimeras bearing the 
RhoB C-terminal sequence, CINCCKVL, are also internalized into endolysosomes.  
It was also described that chimeric proteins fused to the C-terminal sequence of 
RhoB (CINCCKVL) enter into the endolysosomal lumen. Therefore, studies were 
carried out to assess whether the CINCCKVL sequence can travel to endolysosomes in 
cells from diverse species, which in some cases lack an endogenous RhoB homolog 
sequence. The universality of endolysosomal localization of chimeras bearing the RhoB 
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C-terminus was set forth by detection of these proteins in endolysosomes of cells as 
phylogenetically distant as amphibians, insects and fungi. 
In order to explore the possible localization mechanisms of RhoB, advanced 
confocal and super-resolution techniques were employed. By means of these tools, 
RhoB and CINCCKVL chimeras were unequivocally detected at intraluminal vesicles of 
multivesicular bodies. Cells were transfected with small interfering RNA to silence 
components of the ESCRT machinery, which is responsible for endolysosomal 
trafficking and formation of multivesicular bodies (Raiborg and Stenmark, 2009). By 
blocking the function of some of these components, RhoB is not internalized into 
endolysosomes, which reflects a possible role of ESCRT proteins in RhoB endosomal 
trafficking. However, CINCCKVL chimeras are not similarly affected by ESCRT knock-
down. Therefore, other protein and lipid components of multivesicular bodies could 
play a role in localization of these chimeras, e.g. the tetraspanin CD63. This protein 
presents a high degree of co-localization with RhoB and related chimeras at 
multivesicular bodies. Interestingly, it was shown that overexpression of fluorescent 
constructs of CD63 alter the subcellular localization pattern of CINCCKVL proteins, 
possibly towards extracellular destinations, but not that of RhoB. To explore the role of 
lipid dynamics in localization of these proteins, cells were treated with compounds that 
alter cholesterol dynamics at membranes. In these cells, internalization of C-terminal 
RhoB chimeras into endolysosomes was reduced, whereas the full-length protein was 
able to access these compartments. Furthermore, ceramide treatment induced changes 
in cell morphology that affect RhoB and related protein localization. Taken together, 
these results suggest that CINCCKVL chimeras can follow a subcellular destination 
mediated by machineries that are different to those responsible for sorting of full-length 
RhoB, which implies that RhoB contains further structural determinants for localization 
or interaction, beyond those that appear at its lipidation sequence. 
It has been previously described that RhoB is involved in diverse pathologies 
such as tumorigenic processes and cardiovascular malfunction (Prendergast, 2001). The 
results obtained showing RhoB localization to endolysosomal membranes warranted 
studies in models of lysosomal diseases such as Chediak-Higashi or Niemann-Pick. 
These disorders result in oculocutaneous albinism, immunodeficiency and cognitive 
impairment of varying degree (Huizing et al., 2008). Comparing RhoB to other 
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endosomal GTPases in cells of patients suffering from these diseases, confocal laser 
microscopy shows that RhoB is localized to the dilated endolysosomes typical of these 
diseases. 
In many pathological scenarios, proteins suffer modifications due to alterations 
in overall cellular redox status. By means of electrophoretic assays (SDS-PAGE) or 
proteomic approaches (MALDI-TOF), it was shown that proteins of the Ras 
superfamily, particularly H-Ras and RhoB, could be modified in vitro at their C-
terminal cysteine residues by structurally diverse electrophilic lipids. Specifically, 
dienone cyclopentenone prostaglandins, derived from non-enzymatic oxidation of 
arachidonic acid or dehydration of other prostaglandins, bind to these residues. 
Recombinant RhoB protein is also selectively modified by biotinylated dienone 
cyclopentenone prostaglandins, as well as by other bifunctional cysteine reagents such 
as phenylarsine oxide and dibromobimane. It is therefore possible that regulation of 
small GTPases can occur through processes related to cellular redox status that can have 
implications beyond the canonical signaling pathways that are mediated by these 
proteins. 
As a result of the work presented in this dissertation, in which localization and 
subcellular trafficking of endosomal GTPases have been assessed in the context of their 
posttranslational modifications, several conclusions have been arrived at. Regarding 
localization sequences at the hypervariable regions of small GTPases, these studies have 
shown that interplay between lipidated residues and other structural determinants such 
as basic residue patches elicits specific patterns of subcellular targeting. Furthermore, in 
the case or RhoB, endolysosomal targeting of full-length or CINCCKVL chimeras 
depends on isoprenylation and palmitoylation at C-terminal cysteines. These proteins, 
when fully lipidated, appear inside endolysosomes and are detected at intraluminal 
vesicles of multivesicular bodies by super-resolution microscopy. Endolysosomal or 
vacuolar sorting of CINCCKVL chimeras was shown to be conserved in cells from 
diverse model organisms, including fungi, insects, amphibians, and mammals. As 
referred to the molecular mechanisms involved in sorting, results imply that sorting of 
full-length RhoB and CINCCKVL constructs could be regulated by distinct subcellular 
trafficking machineries, for full-length RhoB sorting is impaired upon ESCRT 
component depletion, whereas CINCCKVL construct localization is altered in cells 
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overexpressing CD63 constructs or after treatment with cholesterol-reducing agents. 
Experiments performed in pathological scenarios such as genetic models of 
endolysosomal malfunction or processes involving the generation of reactive species 
show that RhoB or CINCCKVL constructs recapitulate endolysosomal defects in cells of 
patients with lysosomal storage diseases and that the palmitoylation cysteines of the 
small GTPases RhoB and H-Ras are targets for modification by structurally diverse 
electrophilic lipids in vitro. These results pave the way for exploring the extent to which 
diverse modifications of Ras proteins at C-terminal cysteines can disturb their 
subcellular localization and consequently alter their functional outcomes.  
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1. Introducción 
 
Las GTPasas de bajo peso molecular comprendidas en la superfamilia Ras son 
proteínas fundamentales para procesos celulares como la diferenciación celular, la 
regulación del citoesqueleto y la proliferación (Takai et al., 2001). Estas proteínas sufren 
modificaciones lipídicas que les permiten asociarse con las membranas celulares y son 
clave para su actividad. En concreto, las proteínas Ras están isopreniladas para anclarse 
a la membrana, además de ser susceptibles de palmitoilación reversible, lo cual 
contribuye a su localización dinámica en distintos compartimentos subcelulares 
(Hancock et al., 1989). Estas modificaciones lipídicas tienen lugar sobre residuos de 
cisteína en la región carboxilo-terminal (C-terminal). Además, estas cisteínas pueden 
sufrir oxidaciones o adición de compuestos de naturaleza electrofílica, como por 
ejemplo, la unión de prostaglandinas ciclopentenonas (Oeste and Pérez-Sala, 2014). 
Estos compuestos se forman por oxidación no enzimática del ácido araquidónico o por 
deshidratación de otras prostaglandinas, lo cual las dota de carbonos electrófilos (Funk, 
2001). 
Las proteínas Rho juegan papeles cruciales en la adhesión y migración celular 
que repercuten sobre la fisiopatología cardiovascular y procesos tumorigénicos (Ridley, 
2001). RhoB es un miembro de esta familia con funciones reguladoras del tráfico 
vesicular, la supresión de tumores y la localización de proteínas señalizadoras. Las 
modificaciones lipídicas de RhoB (isoprenilación y doble palmitoilación) son necesarias 
para su localización endolisosomal y posterior degradación por esta vía (Pérez-Sala et 
al., 2009; Stamatakis et al., 2002). Los últimos ocho amino ácidos de RhoB, zona donde 
se encuentran las cisteínas que se lipidan, comprenden una secuencia de localización y 
degradación endolisosomal para proteínas quiméricas a las que se les añade esta 
extensión en su extremo carboxilo-terminal (Pérez-Sala et al., 2009). 
En el contexto de esta tesis se han estudiado, tanto in vitro como en modelos 
celulares, aspectos mecanísticos y estructurales de la modificación de proteínas Ras y 
Rho, en concreto RhoB, y su repercusión sobre la localización y tráfico de estas 
proteínas o sus quimeras modificadas por lípidos y otros compuestos. 
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2. Objetivos 
 
Las GTPasas de bajo peso molecular ejercen diversas funciones celulares desde 
localizaciones de membrana específicas. Entre los factores que las regulan, la 
modificación en secuencias C-terminales juegan un papel crucial, aunque la 
participación de la lipidación y su interacción con otros determinantes estructurales en 
la localización subcelular de las GTPasas no ha sido completamente dilucidado. Por ello, 
el trabajo presentado en esta tesis se centra en analizar el papel de las modificaciones 
lipídicas en residuos de cisteína de RhoB sobre su tráfico intracelular y determinar si el 
motivo de lipidación per se es capaz de reproducir el comportamiento de la proteína 
completa. Además, la posibilidad de que las secuencias de lipidación puedan ser dianas 
de modificación por otros compuestos de estructura diversa, incluidas especies reactivas 
que se producen en situaciones patológicas, no se ha explorado. Por tanto, los siguientes 
objetivos fueron planteados: 
 
! Estudiar el papel de las secuencias C-terminales de GTPasas endosomales en su 
localización subcelular. 
! Valorar la importancia de la isoprenilación y la palmitoilación en la asociación 
de estas proteínas a vesículas intracelulares. 
! Determinar la localización subcelular de quimeras que contienen la secuencia 
de lipidación del C-terminal de RhoB. 
! Evaluar si los mecanismos latentes de localización del C-terminal de RhoB 
están conservados en células de diversas especies. 
! Explorar el posible rol de maquinarias moleculares clave, tales como los 
complejos ESCRT, CD63 o la dinámica lipídica, en la localización de RhoB y 
quimeras relacionadas. 
! Asentar las bases para estudiar posibles alteraciones en la localización y 
modificación de GTPasas endosomales en modelos experimentales de 
enfermedad. 
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3. Resultados 
 
Se ha llevado a cabo una caracterización de RhoB fusionada a proteínas 
fluorescentes en el contexto de las endomembranas al comparar su localización y 
degradación con las de otras GTPasas pequeñas. Su colocalización con proteínas 
fluorescentes fusionadas a Rab7, Rab9 o Lamp y falta de coincidencia con marcadores 
de endosomas tempranos (GFP-Rab5) o aparato de Golgi (giantin) atestiguan su 
localización en el lumen endolisosomal. Los estudios aquí presentados incluyen también 
la utilización de sondas de la vía autofagocítica, con las cuales ni RhoB ni sus proteínas 
quimera colocalizan de forma detectable. La GTPasa de bajo peso molecular, TC10, cuya 
secuencia C-terminal es muy similar a la de RhoB, contiene unos amino ácidos básicos 
que sin embargo la retienen en la membrana limitante de dichas vesículas. La inserción 
de la secuencia polibásica de TC10 en la secuencia de RhoB impide su entrada a  
endolisosomas, lo cual pone de manifiesto que hay determinantes estructurales que al 
intercambiarse entre estas proteínas dan lugar a patrones subcelulares específicos.  
Se describió además que las proteínas quimera fusionadas a la secuencia C-
terminal de RhoB (CINCCKVL) también acceden al lumen endolisosomal. Por lo tanto, 
se exploró si la secuencia CINCCKVL accede a los endolisosomas no sólo en células de 
mamíferos, sino en células de organismos que pueden contener o no una secuencia 
endógena para proteínas homólogas a RhoB. La universalidad de la localización 
endolisosomal de quimeras con el C-terminal de RhoB se pone de manifiesto al 
detectarse en endolisosomas de células de organismos muy alejados entre sí en la escala 
filogenética, tales como anfibios, insectos y hongos. 
Para explorar los posibles mecanismos de localización de RhoB, se emplearon 
técnicas de microscopía láser avanzada confocal y de superresolución. Por medio de 
estas potentes herramientas se ha podido establecer la localización inequívoca de RhoB 
y quimeras CINCCKVL en vesículas intraluminales de cuerpos multivesiculares. Se 
transfectaron células con RNA de interferencia para así silenciar componentes de la 
maquinaria ESCRT, responsable del tráfico endolisosomal y la formación de cuerpos 
multivesiculares (Raiborg and Stenmark, 2009). Al bloquear la función de algunos de 
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estos componentes, RhoB no se internaliza en los endolisosomas, lo cual refleja un 
posible papel de las proteínas ESCRT en el tráfico endosomal de RhoB. Sin embargo, las 
quimeras CINCCKVL no se ven igualmente afectadas por el bloqueo de componentes 
ESCRT. Se estudiaron pues otros componentes proteicos y lipídicos de los cuerpos 
multivesiculares que podrían jugar también un papel en la localización de proteínas 
CINCCKVL, como por ejemplo la tetraspanina CD63. Esta proteína presenta una alta 
colocalización con RhoB y quimeras relacionadas en cuerpos multivesiculares. 
Curiosamente, se observó que la sobreexpresión de construcciones fluorescentes de 
CD63 cambian el patrón de localización subcelular de quimeras CINCCKVL, 
posiblemente hacia destinos extracelulares, pero no así el de RhoB. Para explorar el 
papel de la dinámica lipídica en la localización de estas proteínas, se realizaron ensayos 
de tratamiento celular con compuestos que alteran la dinámica de colesterol en las 
membranas. En estas células, se redujo la internalización de quimeras del C-terminal de 
RhoB hacia el lumen de cuerpos multivesiculares, mientras que la proteína completa 
siguió su camino hacia el interior de estos compartimentos. Además, el tratamiento con 
ceramida indujo cambios en la morfología celular que afectan la localización de RhoB y 
proteínas relacionadas. En conjunto, estos resultados sugieren que las quimeras 
CINCCKVL pueden seguir un destino subcelular mediado por maquinarias distintas a 
las responsables del transporte de RhoB completa, lo cual sugiere que RhoB contiene 
determinantes estructurales de localización o interacción más allá de los que aparecen 
en su secuencia de lipidación.  
Se ha descrito que RhoB interviene en diversas patologías como procesos 
tumorigénicos y afecciones cardiovasculares (Prendergast, 2001). Debido a los 
resultados obtenidos sobre la localización de RhoB en membranas endolisosomales, se 
quiso estudiar su papel en modelos de enfermedades lisosomales como Chediak-Higashi 
o Niemann-Pick. Estas patologías cursan con albinismo oculocutáneo, 
inmunodeficiencias y retrasos cognitivos de severidad variada (Huizing et al., 2008). Al 
comparar RhoB con otras GTPasas endosomales en células de pacientes que sufren estas 
enfermedades, se detectó por microscopía láser confocal la localización de RhoB en los 
endolisosomas dilatados típicos de estas patologías.  
En muchos escenarios patológicos, las proteínas sufren modificaciones al verse 
alterado el estado redox global de las células. Se determinó que proteínas de la 
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superfamilia Ras, en concreto H-Ras y RhoB, se pueden modificar in vitro en sus 
residuos de cisteína del extremo carboxilo-terminal por compuestos electrófilos de 
diversa índole utilizando ensayos de electroforesis (SDS-PAGE) o métodos proteómicos 
(MALDI-TOF). En concreto, las prostaglandinas ciclopentenonas dienonas, derivadas 
de la oxidación no enzimática del ácido araquidónico o deshidratación de otras 
prostaglandinas, se unen a estos residuos. La proteína recombinante RhoB también se 
modifica por derivados biotinilados de prostaglandinas ciclopentenonas dienonas de 
manera selectiva, además de por otros reactivos bifuncionales de unión a cisteínas, 
como el óxido de fenilo arsénico o el dibromobimano. Se establece así una capacidad 
reguladora de GTPasas pequeñas por medio de procesos relacionados con el estado 
redox de la célula que puede tener implicaciones más allá de las vías de señalización 
canónicas mediadas por estas proteínas. 
 
 
4. Conclusiones 
 
Como resultado del trabajo presentado en esta tesis, en la que la localización y 
tráfico subcelular de GTPasas endosomales se han evaluado en el contexto de sus 
modificaciones postraduccionales, se ha llegado a las siguientes conclusiones: 
 
1.1. Ciertos determinantes estructurales de la región hipervariable de las GTPasas 
endosomales RhoB y TC10, al intercambiarse, permutan su comportamiento en 
cuanto a la asociación con membranas subcelulares concretas. 
1.2. La localización endolisosomal de RhoB y quimeras de su secuencia de lipidación 
(CINCCKVL) depende de la isoprenilación y palmitoilación en las cisteínas C-
terminales. 
1.3. Quimeras de RhoB y CINCCKVL aparecen en el interior de endolisosomas y se 
detectan en vesículas intraluminales de cuerpos multivesiculares mediante 
microscopía de superresolución. 
1.4. La localización de proteínas CINCCKVL está conservada en células de diversos 
organismos modelos, incluidos modelos de hongo, insecto, anfibio y mamíferos. 
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Estos resultados ponen de manifiesto la interacción entre residuos modificados por 
lípidos y otros determinantes estructurales a la hora de guiar la localización 
subcelular de GTPasas.  
 
2.1.  En células en las que componentes ESCRT (Hrs y Tsg101) han sido silenciados 
mediante RNA de interferencia, disminuye la localización de la proteína RhoB 
completa en endolisosomas, pero no así la de quimeras CINCCKVL. 
2.2. El uso de compuestos que perturban la dinámica lipídica de endosomas tardíos 
altera diferencialmente la localización de quimeras de RhoB o CINCCKVL 
dentro de los endolisosomas. 
2.3. La sobreexpresión de construcciones de CD63 altera la localización de quimeras 
CINCCKVL, pero no así la de RhoB completa. 
En conjunto, estos resultados sugieren que la localización de RhoB completa y de 
construcciones de CINCCKVL podría verse regulada por diferentes maquinarias de 
tráfico subcelular.  
 
3.1. Las quimeras de RhoB o CINCCKVL recapitulan los defectos endolisosomales 
en células de pacientes con enfermedades por almacenamiento lisosomal. 
3.2. Las cisteínas de palmitoilación de las GTPasas pequeñas RhoB y H-Ras son 
dianas de modificación in vitro por lípidos electrófilos de estructura variada. 
Estos resultados sugieren que la localización subcelular de GTPasas endosomales 
podría verse alterada en situaciones patológicas como enfermedades genéticas o 
procesos que cursan con generación de especies reactivas. 
 
 
5. Aportaciones fundamentales 
 
Este trabajo muestra resultados obtenidos mediante técnicas de microscopía 
avanzada como la microscopía láser confocal y de superresolución, para determinar las 
localizaciones subcelulares concretas de la proteína RhoB fusionada a diversas proteínas 
fluorescentes, además de quimeras fluorescentes fusionadas a una secuencia corta 
derivada del C-terminal de RhoB. Además, se ha determinado la importancia de la 
lipidación de los residuos de cisteína para la localización endolisosomal de las proteínas 
de fusión mediante la generación de mutantes no susceptibles de modificación. Por 
Summary in Spanish 
 
 151 
primera vez, se ha llevado a cabo el estudio de la distribución de la proteína RhoB y 
quimeras relacionadas en células con alteraciones de la función lisosomal (síndromes de 
Chediak-Higashi, Niemann-Pick y Hermansky-Pudlak). Por medio de las quimeras 
fluorescentes del C-terminal de RhoB, se ha caracterizado la especificidad de la 
localización de dicha secuencia en varias líneas celulares humanas y de especies diversas, 
incluidos insectos y hongos. Además, estos estudios son los primeros en analizar el 
papel de mediadores del tráfico intracelular como los complejos ESCRT, la tetraspanina 
CD63 o la dinámica lipídica en la localización subcelular de RhoB o su secuencia C-
terminal. 
Se han realizado estudios sobre la modificación de GTPasas de bajo peso 
molecular, particularmente H-Ras y RhoB, por compuestos que se unen a cisteínas por 
mecanismos no enzimáticos. Se ha detectado la unión de prostaglandinas 
ciclopentenonas dienonas a dos residuos del C-terminal de H-Ras. Las diversas técnicas 
empleadas han servido para caracterizar los motivos estructurales de GTPasas pequeñas 
que son susceptibles de modificaciones y que pueden repercutir en la actividad o 
localización de dichas proteínas. 
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Rapid control of protein degradation is usually achieved
through the ubiquitin-proteasome pathway. We recently
found that the short-lived GTPase RhoB is degraded in
lysosomes. Moreover, the fusion of the RhoB C-terminal
sequence CINCCKVL, containing the isoprenylation and
palmitoylation sites, to other proteins directs their
sorting into multivesicular bodies (MVBs) and rapid
lysosomal degradation. Here, we show that this process
is highly specific for RhoB. Alteration of late endosome
lipid dynamics produced the accumulation of RhoB,
but not of other endosomal GTPases, including Rab5,
Rab7, Rab9 or Rab11, into enlarged MVB. Other
isoprenylated and bipalmitoylated GTPases, such as H-
Ras, Rap2A, Rap2B and TC10, were not accumulated
into MVB and were stable. Remarkably, although TC10,
which is highly homologous to RhoB, was stable, a
sequence derived from its C-terminus (CINCCLIT) elicited
MVB sorting and degradation of a green fluorescent
protein (GFP)-chimeric protein. This led us to identify
a cluster of basic amino acids (KKH) in the TC10
hypervariable region, constituting a secondary signal
potentially involved in electrostatic interactions with
membrane lipids. Mutation of this cluster allowed TC10
MVB sorting and degradation, whereas inserting it into
RhoB hypervariable region rescued this protein from its
lysosomal degradation pathway. These findings define a
highly specific structural module for entering the MVB
pathway and rapid lysosomal degradation.
Key words: hypervariable domain, isoprenylation, lyso-
somal degradation, palmitoylation, post-translational
modification, protein sorting, RhoB, Rho proteins,
TC10, U18666A
Received 21 February 2010, revised and accepted
for publication 17 June 2010, uncorrected manuscript
published online 21 June 2010, published online 13 July
2010
Lysosomal degradation of proteins plays a key role in
cell homeostasis. It is generally believed that proteins
degraded through the lysosomal pathway are mostly
long-lived proteins, although various short-lived proteins
can be degraded, at least in part, in lysosomes, including
the ubiquitin E3 ligase MARCH1 (1), Jun, the component
of adaptor protein 1 (AP1) transcription factor (2), and
the signalling kinase Traf2 (3). Thus, lysosomal protein
degradation may have important consequences for cell
signalling.
The mechanisms through which proteins may reach lyso-
somes are multiple and in many cases only partially
understood. Often, signals consisting in precise pro-
tein sequences or post-translational modifications, such
as ubiquitination, trigger recognition of the protein by
multiprotein complexes that constitute the endosomal
sorting complexes required for transport (ESCRT) machin-
ery inducing membrane invagination and multivesicular
body (MVB) formation. For instance, monoubiquitination
of cytosolic domains of membrane receptors leads to
their sorting into MVB. Cellular components may also
reach lysosomes through macroautophagy, where pro-
teins and even organelles are engulfed in membranous
structures called autophagosomes that finally will fuse
with lysosomes to degrade their contents (4). In addition,
some proteins reach the lysosomal lumen by specific
interaction of the protein with the chaperone Hsc70 and
the lysosomal receptor Lamp2a as in chaperone-mediated
autophagy (5). Hypothetically, proteins associatedwith the
cytosolic face of endosomes or MVB could also be deliv-
ered to their interior and reach lysosomes where they
would be degraded (6,7).
The small GTPase RhoB is a short-lived protein located
on the cytosolic side of late endosomes, which plays
important roles in the traffic of signalling molecules and in
tumour suppression (8,9). We have recently reported that
RhoB can be sorted into MVB and be rapidly degraded by
lysosomal proteases (7). Although the mechanisms gov-
erning this process are not fully understood, involvement
of the ESCRT system is suggested by the observation
that dominant-negative mutants of the ATPase VPS4
cause RhoB retention at the MVB-limiting membrane
and stabilization of the protein. The lipid composition
of late endosomes is also important for MVB biogen-
esis (10). The late endosome-specific lipid phospholipid
bis(monoacylglycero)phosphate (BMP) (11), also called
2,2′-dioleoyl lysobisphosphatidic acid (LBPA), has been
reported to play a key role in membrane invagination (12).
The composition and dynamics of late endosome lipids are
disrupted in the genetic disorder known as Niemann-Pick
type C type 1 (NPC) disease (13). In this disease, muta-
tions in the NPC1 protein, which regulates cholesterol
transport, cause a massive accumulation of cholesterol in
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late endosomal membranes with a concomitant increase
in BMP (14,15). The hydrophobic amine U18666A mimics
the NPC phenotype causing acute accumulation of choles-
terol and BMP in late endosomes (15) and it is considered
as an in vitro model for this disease (13,16). Interest-
ingly, RhoB becomes trapped in dense endosomes when
lipid dynamics are altered either pharmacologically, with
U18666A, or by genetic disease, as in NPC cells (7).
Lipid modifications of small G-proteins play a key role
in their subcellular localization (17). Several endosome-
associated GTPases involved in the regulation of
membrane traffic belong to the Rab family of small
G-proteins and are mono- or bi-geranylgeranylated at their
C-termini (18). RhoB is an isoprenylated and bipalmitoy-
lated protein (19). RhoB modification by lipids is required
for its association with MVB and its sorting into intralumi-
nal vesicles (7). Importantly, this property is transferable
to other proteins because a sequence containing the iso-
prenylation and palmitoylation sites of RhoB (CINCCKVL)
elicits the lysosomal sorting and rapid degradation of
stable proteins when fused to their C-terminal end (7).
Several other small G-proteins, including H-Ras, TC10,
Rap2A and Rap2B, possess bipalmitoylated and isopreny-
lated C-terminal sequences similar to that of RhoB (20,21).
Of these proteins, H-Ras localizes mainly to the plasma
membrane and various intracellular structures, including
the endoplasmic reticulum, the Golgi complex, recycling
endosomes (22,23), and to randomly moving nanoparti-
cles known as rasosomes (24). TC10 has been detected
at the plasma and perinuclear membranes, identified
as components of the secretory or endosomal com-
partments (20,25), whereas Rap2 has been detected in
secretory granules (26) and recycling endosomes (21).
However, at present it is not known whether these pro-
teins interact with or are degraded through the lysosomal
pathway. To get insight into the specificity of the degra-
dation pathway followed by RhoB, we have studied the
subcellular distribution and stability of various endosome-
associated small GTPases and the behaviour of several
short chimeric proteins containing their C-terminal lipida-
tion sequences.
Here, we describe that lysosomal targeting through iso-
prenylation and palmitoylation is highly specific for RhoB.
Moreover, protein targeting and degradation mediated by
this mechanism can be counteracted by the presence of
basic residues close to the lipidation motif. These results
provide novel insight into the structural determinants
involved in endolysosomal targeting of small GTPases.
Results
RhoB accumulates into Lamp1-positive endosomes
upon disruption of endosomal lipid dynamics
The compound U18666A provokes increased MVB
membrane invagination and accumulation of cholesterol
in BMP-rich MVB internal membranes that resemble
the alterations observed in NPC disease (16). We have
previously shown that treatment of cells with the
compound U18666A induces a strong accumulation of
RhoB inside dense compartments, which are stained
with the probe for acidic compartments Lysotracker red
(LTR) (7). To characterize U18666A-induced RhoB-positive
structures in more detail, we monitored the distribution of
the late endosome/lysosome integral membrane protein
Lamp1 in RhoB-transfected cells. As it can be observed in
Figure 1A, U18666A induced the accumulation of RhoB in
structures that were delimited by Lamp1, indicating that
they are formed from late endosomes/lysosomes, and that
were clearly visible by differential interference contrast
(DIC) as dense structures. Moreover, RhoB colocalized
inside these Lamp1-delimited compartments with BMP
and cholesterol, as revealed by immunofluorescence
and filipin staining, respectively (Figure 1B). Finally,
we confirmed that Lamp1-positive, U18666A-induced
dense structures were acidic as evidenced by staining
with LTR (Figure 1B). Taken together, these results
indicate that dense compartments accumulating RhoB
upon impairment of cholesterol traffic with U18666A
correspond to altered MVB.
Selectivity of RhoB accumulation into MVB upon
treatment with U18666A
Having observed a clear accumulation of RhoB insideMVB
upon treatment with U18666A, we explored whether the
distribution of other small GTPases, known to be asso-
ciated with various endosomal compartments, suffered
similar alterations. For this, we employed green fluores-
cent protein (GFP) constructs and LTR staining (Figure 2),
as well as DIC (not shown) to monitor the dilated MVB
induced by U18666A treatment in live cells. As expected
from the results shown in Figure 1, GFP-RhoB strongly
colocalizedwith LTR inside U18666A-induced dense endo-
somes (Figure 2). In contrast, Rab5, a GTPase associated
with early endosomes (27), did not colocalize with LTR
in control cells and did not accumulate in LTR-positive
dilated structures in U18666A-treated cells. Interestingly,
Rab7, known to associate with late endosomes and lyso-
somes (28), was clearly retained at the limiting membrane
of dense MVB after U18666A treatment. Rab9, which has
been reported to associate with late endosomes (29), par-
tially colocalized with LTR in control cells, but remained
at the periphery of the dilated LTR-positive compartments
in U18666A-treated cells. Rab11, a GTPase described to
be present in recycling endosomes (30), did not colocal-
ize with LTR in control cells and did not accumulate in
U18666A-induced LTR-positive compartments. Analysis
of the fluorescence intensity profiles of the individual chan-
nels along the diameter of U18666A-induced MVB clearly
shows the differential distribution of the various GTPases
(Figure 2A, right panels). Therefore, whereas treatment
of cells with U18666A produces the accumulation of
RhoB inside dilated MVB colocalizing with LTR, a variety
of endosome-associated GTPases, including Rab5, Rab7,
Rab9 and Rab11, do not reach the interior of these struc-
tures in significant amounts. In particular, Rab7 and Rab9
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Figure 1: U18666A induces RhoB accumulation in enlarged
MVB. A) BAECs transfected with tRFP-T-RhoB and Lamp1-GFP
were treated with 10 µM U18666A for 24 h, after which live cells
were visualized by confocal microscopy. Single confocal sections
(upper panels) and DIC images (lower panels) are shown. B)
BAECs transfected as above were treated in the absence or
presence of U18666A after which, BMP was detected by IF,
cholesterol accumulation was evidenced by staining with filipin
and acidic compartments were traced by LTR staining. Cell
contours are indicated by dotted grey lines. Images shown are
representative of four experiments. Bars, 20 µm.
form a defined layer at the periphery of these organelles,
whereas Rab5 is not associated with them. Because colo-
calization between the corresponding GFP constructs and
LTR reflected the extent of accumulation of the respective
proteins inside MVB, we quantified this parameter for the
various GTPases used in this study. Figure 2B shows the
increase in colocalization of the different GFP constructs
with LTR induced by U18666A treatment with respect to
untreated cells. These results clearly confirm the selec-
tive accumulation of RhoB in LTR-positive compartments
in U18666A-treated cells.
Distribution of isoprenylated and bipalmitoylated
GTPases in U18666A-treated cells
RhoB association with endosomal membranes is medi-
ated by isoprenylation and bipalmitoylation (7,20). This
triple-lipid anchor (Figure 3A), which is not present in Rab
GTPases, could be involved in RhoB being trapped in
invaginating vesicles ofMVB. To assesswhether other iso-
prenylated and bipalmitoylated GTPases follow the same
pathway, we explored the subcellular localization of H-Ras,
TC10, Rap2A and Rap2B in control and U18666A-treated
cells. H-Ras appeared distributed at the cell membrane
and intracellular vesicles that showed little or no colo-
calization with LTR, both in the absence and presence
of U18666A (Figure 3B). The other isoprenylated and
bipalmitoylated proteins appeared associated with the
plasma membrane, but above all with intracellular vesi-
cles, showing partial colocalization with LTR, indicative
of their association with acidic compartments (Figure 3C).
Upon treatment with U18666A, TC10, Rap2A and Rap2B
showed a peripheral distributionwith respect to the dilated
MVB compartments, and remained mostly excluded from
the intraluminal space. As shown in Figure 3D, the degree
of colocalization of the various proteins with LTR did not
increase in the presence of U18666A, thereby indicating
the lack of internalization of the various constructs into
LTR-positive compartments (Figure 3D). Therefore, pos-
sessing a sequence for isoprenylation and bipalmitoylation
is not sufficient to confer susceptibility to U18666A-
induced invagination into MVB.
Stability of several isoprenylated and bipalmitoylated
small GTPases
Rapid degradation of RhoB requires both isoprenylation
and palmitoylation (7,31). The possibility that other iso-
prenylated and palmitoylated proteins were subjected
to rapid degradation was addressed by measuring the
decay of the levels of GFP constructs of H-Ras, TC10,
Rap2A and Rap2B, in comparison with GFP-RhoB, after
blocking protein synthesis with cycloheximide (CHX)
(Figure 4). Consistent with previous reports (32,33), GFP-
H-Ras did not suffer rapid degradation. TC10, Rap2A
and Rap2B constructs also showed higher stability than
RhoB. Endogenous proteins followed the same pattern
(results not shown). Taken together, these results indi-
cate that bipalmitoylation and isoprenylation per se are
not sufficient to direct MVB sorting and/or rapid protein
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Figure 2: Effect of U18666A on the
distribution of various endosomal
GTPases. A) BAECs transfected with
the indicated constructs were treated in
the absence or presence of U18666A
for 24 h and incubated with 25 nM
LTR before visualization by confocal
microscopy. Areas in insets are enlarged
for better visualization of the lines along
which fluorescence intensity profiles
(left panels) have been obtained. Results
are representative of four experiments
with similar results. Bar, 20 µm. B) The
extent of colocalization of GFP and LTR
signals in U18666A-treated cells was
used as an index of the internalization of
the corresponding GFP constructs into
acidic compartments and is expressed
as percentage of the values obtained
in untreated cells for each construct.
Results shown as average values of five
determinations from three independent
experiments ± SEM. *p < 0.05 versus
the same condition in the absence of
U18666A by Student’s t-test.
degradation. Therefore, other structural determinants may
contribute to allow MVB delivery and degradation. These
structural determinants could be related to the different
spacing of lipidic modifications or to differences inherent
to the amino acid sequence, which are more substantial in
the hypervariable domains of these proteins. To address
these issues, we decided to explore the behaviour of
short chimeras bearing the lipidation motifs from several
GTPases.
Distribution and stability of chimeric proteins bearing
the isoprenylation and palmitoylation sequences
from small GTPases
We have previously shown that the chimeric protein GFP-
CINCCKVL (GFP-8-RhoB), containing the RhoB C-terminal
sequence, is sorted and degraded through a lysosomal
pathway (7). Therefore, in the case of RhoB all necessary
determinants for degradation are retained in this short
sequence. To assess whether C-terminal sequences from
1224 Traffic 2010; 11: 1221–1233
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Figure 3: Localization of isoprenylated and bipalmitoylated GTPases in control and U18666A-treated cells. A) The C-terminal
sequence of several isoprenylated and bipalmitoylated low-molecular weight GTPases is shown. Basic amino acids are depicted in blue,
palmitoylation cysteines in green, isoprenylation cysteines in orange and amino acids removed by C-terminal proteolysis in grey. B and
C) BAECs transfected with the indicated constructs were treated as above. Bars, 20 µm. D) Colocalization of GFP and LTR signals was
assessed as in Figure 2. *p < 0.05 versus the same condition in the absence of U18666A by Student’s t-test.
other GTPases, isolated from the rest of the protein, could
also follow this pathway, we generated chimeric proteins
consisting of the isoprenylation and palmitoylation motifs
from the various GTPases fused to the C-terminal end of
GFP (Figure 5A). GFP alone showed a diffuse distribution
throughout the cell and was completely excluded from
the enlarged MVB in U18666A-treated cells (Figure 5B).
Consistent with previous observations (7), GFP-8-RhoB,
shown here as control, was clearly accumulated inside
U18666A-induced MVB. The other chimeric proteins
tested were partly associated with the plasma mem-
brane and with intracellular vesicles, showing a variable
degree of colocalization with LTR under control condi-
tions. Interestingly, the construct bearing the C-terminal
sequence from TC10 (GFP-8-TC10), which is highly similar
to that of RhoB, clearly accumulated inside dense MVB
in the presence of U18666A, showing intense colocaliza-
tion with LTR (Figure 5C). In contrast, GFP-9-H-Ras and
GFP-8-Rap2A, bearing the C-terminal sequences of H-Ras
and Rap2A, respectively, did not substantially colocalize
with LTR either in the absence or presence of U18666A,
nor were they accumulated inside dense MVB to extents
similar to GFP-8-RhoB or GFP-8-TC10. Therefore, sorting
of isoprenylated and palmitoylated constructs into MVB
appears to require specific sequences and/or spacing of
lipidated residues. To assess this point, we have explored
the localization of a construct bearing a sequence similar to
that of GFP-8-TC10, in which the spacing between palmi-
toylation cysteines has been altered by substituting the
CINCCLIT sequence for CCINCLIT (Figure S1). The result-
ing construct, GFP-8-TC10m, showed lesser association
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Figure 4: Stability of several fusion proteins of GFP with
isoprenylated and bipalmitoylated proteins. BAECs were
transiently transfected with the indicated constructs. Construct
stability was assessed by blocking protein synthesis with
20 µg/mL CHX and estimating the remaining levels by western
blot with anti-GFP antibody. RhoGDI is used as a loading control.
The graph shows the construct levels remaining after treatment
with CHX for the indicated times. Results are shown as average
values ± SEM of three different experiments. *p < 0.05 GFP-
RhoB versus every other construct by Student’s t-test.
with acidic compartments, it was not effectively accumu-
lated into MVB upon U18666A treatment and displayed
a more diffuse pattern, thus showing that the spacing of
lipidatable residues may be critical for the function of the
sorting signal. Nevertheless, the partition of GFP-8-TC10m
into Triton-X-114was indistinguishable from that of GFP-8-
TC10, thus indicating that its lipidation was not impaired.
We next explored the stability of the various chimeric
proteins (Figure 6). Interestingly, both GFP-8-RhoB and
GFP-8-TC10 showed reduced half-life with respect to
unmodified GFP or to GFP fused to the C-terminal
sequences of H-Ras or Rap2A. Thus, for the constructs
herein studied, a correlation appears to exist between
MVB sorting induced by treatment with U18666A and
the susceptibility to undergo rapid lysosomal degradation.
Therefore, the late endosome lipid environment appears
to be critical for the function of the lysosomal-targeting
signal. To confirm this point, we have used additional
approaches. As we have previously mentioned, the lipid
composition of late endosomes is profoundly altered in
NPC disease (14,15). As it is shown in Figure S2A, the
GFP-8-RhoB construct partially colocalized with acidic
compartments in primary fibroblasts from control sub-
jects. However, colocalization was greatly increased in
fibroblasts from patients with NPC, thus showing that
the distribution of the MVB-targeting construct reflects
the lysosomal alterations occurring in this human genetic
disease. In addition, we studied the effect of an anti-
BMP antibody, which accumulates in late endosomes by
endocytosis blocking BMP-dependent lipid dynamics (15).
Anti-BMP induced a dilation of late endosomes, where
GFP-8-RhoB could be detected both inside and at the
periphery of these structures (Figure S2B). These observa-
tions confirm that the lipid environment of late endosomes
is important for the function of the MVB sorting signal.
Role of basic residues in the hypervariable domains
of GTPases in MVB sorting and rapid degradation
As shown above, a GFP construct bearing the last eight
amino acids of TC10 (GFP-8-TC10) showed a pattern
similar to that of GFP-8-RhoB, and was accumulated
inside U18666A-induced compartments (Figure 5). This
is in striking contrast with the fact that full-length GFP-
TC10 was mainly localized at the limiting membrane of
dense MVB in U18666A-treated cells (Figure 3C). This
indicates that in the case of TC10, the C-terminal CINC-
CLIT sequence may not be sufficient for accumulation of
the protein in intraluminal vesicles of MVB. This could
be because of the presence of other strong localization
determinants in the TC10 molecule that prevented its
intravesicular localization and degradation. Inspection of
the RhoB and TC10 sequences reveals a high degree
of homology (68%) with the main differences concen-
trating in the hypervariable domains (Figure 7A), where
TC10 contains an additional cluster of basic residues
194KKH196. To probe the role of this region in TC10
localization and stability, we substituted these residues
by non-charged residues. The resulting construct, GFP-
TC10-NQN, clearly accumulated inside U18666A-induced
structures (Figure 7B), as evidenced by a marked increase
in the colocalization with LTR in U18666A-treated cells
(Figure 7C), thus showing a sharp contrast with the
behaviour of GFP-TC10 wt. As a proof of concept for
the role of the basic residues in preventing MVB sort-
ing, we designed the opposite experiment by introducing
a cluster of basic amino acids in the equivalent posi-
tion of the RhoB sequence (between aa 179 and 180).
As it can be observed in Figure 7B,C, in clear contrast
with GFP-RhoB wt, the mutant RhoB construct, termed
GFP-RhoB-KKH, was clearly retained at the periphery of
U18666A-induced MVB. Finally, we confirmed that the
wild-type and chimeric proteins also showed a differential
distribution in cells treated with other lysosomal inhibitors,
such as chloroquine (Figure S3). Therefore, these findings
suggest that the presence of basic residues in a position
adjacent to the lipidation sequence trumps the activity of
the isoprenylation/bipalmitoylation MVB-targeting signal.
We next assessed the stability of the wild-type and
mutant RhoB and TC10 proteins. Remarkably, mutation
of the polybasic cluster in TC10, as in GFP-TC10-NQN,
clearly destabilized the protein (Figure 8). Conversely, the
introduction of basic residues in the hypervariable region
of RhoB clearly increased the stability of the resulting
construct, GFP-RhoB-KKH, with respect to that of the
wild-type construct. These results suggest that polybasic
sequences upstream of the bipalmitoylated and isopreny-
lated motifs of certain GTPases, such as TC10, can
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Figure 5: Effect of U18666A on the localization of chimeric proteins derived from the C-termini of isoprenylated and
bipalmitoylated GTPases. A) The C-terminal sequence of the chimeric proteins constructed, consisting of GFP and the last eight
amino acids of RhoB, TC10 or Rap2A or the last nine amino acids of H-Ras, is shown. Palmitoylation cysteines are shown in green,
isoprenylation cysteines in orange and amino acids removed by C-terminal proteolysis in grey. B and C) BAECs transfected with the
indicated constructs were treated as above. D) The extent of colocalization of GFP and LTR signals was used as an index of the
internalization of the corresponding GFP constructs into acidic compartments and is shown as average values of five determinations
from three independent experiments ± SEM. *p < 0.05 versus the same condition in the absence of U18666A by Student’s t-test.
modulate their interaction with specific endosomal com-
partments, precluding their entry into the endolysosomal
pathway and their targeting for degradation.
Role of basic residues in the hypervariable domains
of RhoB or TC10 constructs in subcellular targeting
We next addressed the potential mechanisms by which
the basic amino acid patch prevented the lysosomal-
targeting signal from functioning. Stretches of basic amino
acids at the hypervariable domains of other GTPases,
such as K-Ras or Rac1, have been involved in their
binding to negatively charged lipids at the plasma mem-
brane (34). Therefore, we explored the presence of the
various constructs at the plasma membrane. The results,
shown in Figure 9A, indicate that the fraction of plasma
membrane-associated protein was higher for GFP-RhoB
than for GFP-TC10. The mutant constructs GFP-RhoB
KKH and GFP-TC10 NQN showed an intermediate pattern
with the latter showing more clear membrane associ-
ation. Thus, in this case, basic residues appear not to
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Figure 6: Stability of chimeric proteins consisting of GFP and
the C-terminal sequences of isoprenylated and bipalmitoy-
lated GTPases. BAECs were transiently transfected with the
indicated constructs. Construct stability was assessed by block-
ing protein synthesis with CHX and estimating the remaining
levels by western blot with anti-GFP antibody. Blots show the
levels of the constructs of interest and of RhoGDI, as control.
The graph shows the construct levels remaining after treatment
with CHX for the indicated times. Results are shown as average
values ± SEM of at least three different experiments. *p < 0.05
versus GFP by Student’s t-test.
be sufficient to direct plasma membrane association. As
TC10 is a bipalmitoylated protein, the presence of palmi-
tate moieties could override and/or modulate the plasma
membrane targeting role of basic residues.
To address this point, we explored the distribution of GFP-
RhoB and GFP-TC10 in the presence of a palmitoylation
inhibitor. Treatment with 2-bromopalmitate completely
mislocalized RhoB leading to a diffuse cytosolic distri-
bution, as we previously reported (7). Remarkably, inhibi-
tion of palmitoylation did not abolish plasma membrane
or endomembrane association of GFP-TC10, suggest-
ing a membrane targeting role of the basic residues
present in this protein (Figure 9B). To confirm this, we
studied the distribution of the GFP-RhoB-KKH and GFP-
TC10-NQN mutants. Insertion of the KKH motif into
GFP-RhoB resulted in endomembrane localization being
more resistant to palmitoylation inhibition. Conversely,
elimination of the KKH motif from GFP-TC10, as in the
GFP-TC10-NQN construct, led to reduced plasma mem-
brane binding with preserved endomembrane association
upon 2-bromopalmitate treatment. Thus, these observa-
tions unveil a targeting role of basic residues: in the
non-palmitoylated proteins the KKH motif may contribute
to plasma membrane and/or endomembrane association,
whereas in the palmitoylated proteins it may contribute
to localization on specific endosomal membranes. A sum-
mary of these observations and the resulting hypothesis
is depicted in Figure S4.
Figure 7: Role of basic residues in the hypervariable domains
of TC10 and RhoB in U18666A-induced subcellular localiza-
tion. A) The sequences of the hypervariable domains of RhoB,
TC10 and the two constructs generated by mutating or inserting
basic residues are shown. Basic amino acids are depicted in blue,
palmitoylation cysteines in green and isoprenylation cysteines in
orange. The non-polar residues introduced in TC10 in exchange
for basic residues are shown in brown. B) BAECs transfected with
the indicated constructs were treated in the absence or presence
of U18666A for 24 h and incubated with 25 nM LTR before visu-
alization by confocal microscopy. Bar, 20 µm. Areas in insets are
enlarged for better visualization of the lines along which fluores-
cence intensity profiles (left panels) have been obtained. Results
are representative of four experiments with similar results. C) The
extent of colocalization of GFP and LTR signals is shown. Results
are average values of five determinations from three independent
experiments ± SEM. *p < 0.05 versus the same condition in the
absence of U18666A by Student’s t-test.
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Figure 8: Role of basic residues in the hypervariable domain
of GTPases in protein stability. BAECs were transfected with
the indicated constructs and protein stability was assessed as
described above. Graphs show the construct levels remaining
after treatment with CHX for the indicated times. Results are
shown as average values ± SEM of three different experiments.
*p < 0.05 versus the same condition in thewild-type by Student’s
t-test.
Discussion
Lysosomal sorting and degradation of proteins plays
an important role in cell homeostasis. The short-lived
GTPase RhoB is targeted to a lysosomal pathway by its
isoprenylated and bipalmitoylated C-terminal sequence.
This property can be transferred to other proteins by
fusion of this sequence (CINCCKVL). Small GTPases are
post-translationallymodified by one or two isoprenoidmoi-
eties and in some cases by palmitoylation. Here, we have
studied whether other small GTPases follow a sorting and
degradation pathway similar to that of RhoB. Our results
show that lysosomal sorting is highly specific for RhoB.
Of other sequences, only the closely related C-terminal
sequence of TC10, CINCCLIT, displays a pattern similar to
that of RhoB. Moreover, we have found that the presence
of basic residues upstream of these lipidation sequences
counteracts their effect on protein sorting and degradation.
In this work, we have used a compound blocking
cholesterol dynamics, U18666A, as a tool to achieve
increased membrane invagination of MVB (35). Using
this compound, we have observed accumulation of RhoB
inside organelles with the characteristics of dilated MVB,
i.e. they are delimited by the late endosome/lysosome
integral membrane protein Lamp1, are stained by the
probe for acidic compartments LTR and accumulate
cholesterol and the late endosome lipid BMP. The effect
of U18666A appears to be highly specific of RhoB. First,
none of the Rab endosomal GTPases studied, including
Rab5, 7, 9 and 11, were accumulated in the intraluminal
Figure 9: Role of basic residues in the hypervariable domain
of endosomal GTPases in subcellular membrane targeting.
A) BAECs were transfected with the indicated constructs and
observed live by confocal microscopy. B) Cells were treated
with 20 µM 2-bromopalmitate for 6 h before observation. Results
shown are representative of at least four independent assays for
every experimental condition.
space of U18666A-induced dilated MVB. Instead, Rab7
and 9 appear clearly associated at the periphery of these
structures. It is interesting to note that, in NPC cells, Rab9
has been reported to be less susceptible to extraction
from membranes by RhoGDI (36) and a reduced rate of
dissociation of Rab7 from cholesterol-loaded endosomes
has been evidenced (37). These effects could contribute to
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the accumulation of Rab7 and Rab9 on U18666A-induced
structures (36–38).
The specificity of RhoB internalization into MVB is also
supported by the fact that other small GTPases bearing
lipid moieties similar to those of RhoB, namely, one iso-
prenoid and two palmitate groups, including H-Ras, TC10,
Rap2A and Rap2B, do not accumulate inside MVB upon
U18666A treatment. Noteworthy, none of these proteins
displayed the low stability typical of RhoB. These results
were particularly striking in the case of TC10, because this
protein is highly similar to RhoB. GFP-RhoB and GFP-TC10
showed differential endosomal localization patterns, both
after U18666A and after chloroquine treatment, with the
most obvious difference being the preferential presence
of the construct at the limiting endosomal layer (GFP-
TC10) or at the luminal space (GFP-RhoB). This suggests
that in this experimental model, TC10 may occupy a more
peripheral position in endosomes than RhoB.
It should be noted that although a correlation seems to
exist between susceptibility to U18666A-induced accu-
mulation into MVB of the various proteins and reduced
stability, these two processes do not need to be causally
related. Although access to the MVB compartment may
be necessary for subsequent delivery to lysosomes, it
may not be sufficient for rapid degradation. Certain MVB-
sorted proteins can be recycled to the trans Golgi network
or delivered to the plasma membrane, thus reflecting the
existence of different types of luminal vesicles in MVB,
of which, only a subset is targeted for lysosomal degra-
dation (39,40). It should also be taken into account that
we are employing resting cells throughout this work, thus
we do not exclude the possibility that different localization
and sorting patterns may arise upon cell stimulation.
The generation of short constructs containing only the iso-
prenylation and palmitoylation C-terminal sequences from
these GTPases allowed us to confirm the contribution
of these small structural motifs to protein sorting and
degradation. In this case, both GFP-8-RhoB and GFP-8-
TC10 displayed reduced stability, whereas the constructs
bearing sequences from H-Ras and Rap2A (GFP-9-H-Ras
and GFP-8-Rap2A, respectively) were more stable. The
lipidation motifs from H-Ras and Rap2A differ from that
of RhoB both in the spacing of the lipidated residues
and in the nature of the remaining residues. Our results
show that the spacing of lipidated residues is important
for MVB sorting. This suggests that different positions of
palmitoylatable residues within the sequence may proba-
bly result in a differential three-dimensional conformation
of the lipidated C-terminus. This has been studied in
detail in the case of H-Ras, for which it has been shown
that residues within the lipidation motif establish specific
contacts with the membrane (41). In turn, the lipidation
motifs of RhoB and TC10 are highly similar. The spacing
of the isoprenoid and palmitate moieties is the same.
Moreover, after proteolytic removal of the three amino
acids distal to the isoprenylated cysteine in the mature
protein (17), the remaining sequences would be identi-
cal. Interestingly, with respect to the lipidic modifications,
both RhoB and TC10 can be substrates for GGTase I and
FTase in vitro (42), although RhoB has been shown to be
preferentially geranylgeranylated in cells, whereas TC10
appears to be preferentially farnesylated (42). However,
under our experimental conditions, the behaviour of GFP-
8-RhoB and GFP-8-TC10 was highly similar with respect
to the parameters assessed in this study, namely, suscep-
tibility to U18666A-induced accumulation into MVB and
protein stability. This may indicate that the nature of the
isoprenoid lipid is not critical for lysosomal targeting and
degradation. Future studieswill address this issue in detail.
The fact that, whereas GFP-TC10 is stable in our assay,
GFP-8-TC10 shows reduced stability highlights the impor-
tance of other regions of TC10 in avoiding lysosomal sort-
ing and degradation. Given the high homology between
RhoB and TC10, we delimited the regions bearing the
most important differences to those comprised between
amino acids 137 and 142 and between 192 and 198
of human TC10, the last one including several basic
amino acids. Previous studies addressing the role of the
stretches of basic amino acids located in the hypervari-
able domain of TC10 did not find a significant effect in
TC10 localization and trafficking (25). However, a role for
this region in protein stability had not been assessed pre-
viously. Our results show that these basic residues of
TC10 play key roles in positioning the protein away from
the intraluminal space of MVB and in protein stability. To
assess the specific role of the basic residues, we have
employed a palmitoylation inhibitor. Our results show that
the fully processed TC10 protein preferentially binds to
endomembranes. However, inhibition of palmitoylation
unveils the capability of basic residues in TC10 hypervari-
able domain to preserve plasma membrane binding. The
observation that plasma membrane association is clearly
reduced in the GFP-TC10-NQNmutant indicates that basic
residues in TC10 may be involved in electrostatic interac-
tions with negatively charged lipids at the plasma mem-
brane. Conversely, although introducing basic residues
into RhoB does not appear to be sufficient to promote
localization of the non-palmitoylated protein at the plasma
membrane, it supports association with endomembranes,
in clear contrast with RhoBwt, which is completely diffuse
in 2-bromopalmitate-treated cells. The different extent of
plasma membrane association of GFP-TC10 and GFP-
RhoB-KKH upon inhibition of palmitoylationmay be related
to the different number and/or distribution of basic amino
acids in the C-terminus of these proteins (Figures 7A and
S4), as previously suggested (43). Ionomycin has been
previously used to disrupt the electrostatic interaction of
polybasic motif-bearing proteins with the plasma mem-
brane by promoting Ca2+ entry, which masks negatively
charged phospholipids in the inner leaflet of the plasma
membrane (43). We have observed that ionomycin did not
disrupt plasma membrane association of fully processed
RhoB. Interestingly, ionomycin compromised the asso-
ciation of non-palmitoylated GFP-TC10 with the plasma
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membrane (Valero et al., unpublished observations). This
supports the involvement of the basic patch of TC10 in
electrostatic interactions with negatively charged lipids,
thus acting as a complementary targeting signal.
As palmitoylation is a reversible modification, taken
together our results suggest that there may be an inter-
play between palmitoylation and electrostatic interactions
in modulating protein localization. The presence of phos-
phatidylserine and other anionic lipids has been detected
at the cytosolic side of both plasma membrane and endo-
somes (34,44,45). In the light of our findings, a hypothet-
ical model could be proposed (Figure S4), by which basic
amino acids in the hypervariable region of TC10 would
enhance its interaction with the cytosolic side of endo-
somes, thereby preventing its sorting into MVB, directed
otherwise, as in the case of RhoB, by a specific distribution
of palmitoyl and isoprenoid moieties in resting cells.
Therefore, our observations contribute to the understand-
ing of the role of hypervariable regions of small GTPases
in specific subcellular localization. In the case of H-Ras, an
isoprenylated and bipalmitoylated protein, basic residues
in the hypervariable domain stabilize membrane binding
and constitute a switch for the orientation of the protein
and the interactionwith effectors (46). In the case of RhoB,
the hypervariable region has been involved in interactions
with the microtubule-associated protein MAP1A, which
are dependent on RhoB-GTP binding and affect EGF sig-
nalling (47). Residues in the hypervariable domain of other
Rho proteins have been involved in modulation of protein
degradation. In particular, phosphorylation of Ser188 in
RhoA appears both to negatively regulate protein activity
and protect it from proteasome-mediated degradation by
enhancing its association with RhoGDI (48,49). A potential
interaction with RhoGDI, in this case, secondary to RhoA
silencing, has also been proposed as a mechanism for
RhoB stabilization (50), although the physiological role of
this effect remains to be elucidated.
Taken together, our results show that the absence of
polybasic sequences in the hypervariable region of RhoB
allows its delivery into the luminal space of MVB and
its rapid lysosomal degradation. These results identify an
important structural determinant influencing MVB sorting
and degradation of endosome-associated GTPases. More-
over, they allow formulating the hypothesis that protein
or lipid interactions involving the hypervariable domain of
RhoB could influence its sorting and stability.
Materials and Methods
Reagents and antibodies
U18666A was from Merck4Biosciences (Spain). RPMI-1640 and bovine
serum were from Invitrogen (GIBCO). Filipin, ionomycin and CHX were
from Sigma. LTR was from Molecular Probes (Invitrogen). Anti-RhoB
(sc-180) and anti-RhoGDI (sc-360) were from Santa Cruz Biotechnology.
Anti-LBPA (BMP) was from Echelon Biosciences Inc. Anti-GFP was from
Clontech.
Cell culture and treatments
Bovine aortic endothelial cells (BAECs) were obtained and cultured as
previously described (7,31). Human primary fibroblasts from apparently
healthy subjects and NPC disease patients were from Coriell Institute for
Medical Research and were cultured according to their instructions. For
treatments, cells were cultured in the absence of serum.
Plasmids and transfections
The tagRFP plasmid encoding a monomeric red fluorescent protein
was from Evrogen. An S162T mutation was introduced in the tagRFP
coding sequence using the Quickchange II kit and oligonucleotide
5′-GCCTGGAAGGCAGAACCGACATGGCCCTGAAG-3′ and its complemen-
tary oligonucleotide to generate tagRFP-T, which displays improved
photostability (51). A plasmid for the expression of HA-RhoB was gen-
erously donated by Dr G. C. Prendergast. From this, a GFP-HA-RhoB
plasmid was generated as previously described (31). tRFP-T-HA-RhoB
was generated by cloning HA-RhoB into the BglII/EcoRI sites of tRFP-
T. Lamp1-GFP was provided by Professor Jennifer Lippincott-Schwartz
(NIH). GFP-Rab7 was kindly provided by Professor Cecilia Bucci (University
of Copenhagen). GFP-Rab5 was generously provided by Professor Juan
S. Bonifacino (NIH). GFP-Rab9A, GFP-Rap2A and GFP-Rap2B were from
Genecopoeia. GFP-H-Ras was provided by Dr Jose´ María Rojas (ISCIII).
A plasmid coding for human TC10 with an N-terminal haemagglutinin
(HA) tag was used as template for amplification by polymerase chain
reaction (PCR) with primers containing SacI and EcoRI sites, respectively
(sense: 5′-CCGAGCTCAAATGGGCTACCCCTATGATGTGCC-3′; antisense:
5′-CCGAATTCTCACGTAATTAAACAACAGTTTATAC-3′), for cloning of the
PCR product into the same sites of pEGFP-C1 to generate GFP-HA-
TC10. Constructs encoding chimeric proteins comprising GFP and the
isoprenylation and palmitoylation sequences from the C-terminus of
RhoB, TC10, H-Ras and Rap2A, were generated by PCR using pEGFP-
C1 as a template. The forward primer was common for all constructs:
5′-GAGTAGAAGCTTATGGTGAGCAAGGGCGAGGAG-3′. Reverse primers
were 5′-CCGAATTCTAGAGGACCTTGCAACAGTTGATACACTTGTACAGC
TCGTCCATGC-3′ for generating GFP-CINCCKVL (GFP-8-RhoB); 5′-CC
GAATTCTCACGTAATTAAACAACAGTTGATACACTTGTACAGCTCGTCCAT
GC-3′ for GFP-CINCCLIT (GFP-8-TC10); 5′-CCGAATTCTCACGTAATTAA
ACAGTTGATACAACACTTGTACAGCTCGTCCATGC-3′ for GFP-CCINCLIT
(GFP-8-TC10m); 5′-CCGAATTCTACGACAACACGCATTTGCATGACATGCA
CTTGTACAGCTCGTCCATGC-3′ for GFP-CMSCKCVLS (GFP-9-H-Ras) and
5′-CCGAATTCTACTGGATGTTGCAGGCGCTACAGCACTTGTACAGCTCGT
CCATGC-3′ for GFP-CCSACNIQ (GFP-8-Rap2A). PCR products were
digested with HindIII and EcoRI and cloned into pcDNA3.0. The triple
mutant of GFP-HA-TC10 (K194N, K195Q, H196N; GFP-TC10-NQN) was
prepared by using the Stratagene Quickchange kit with the oligonucleotide
5′-GGCTATCATAGCCATTTTAACTCCAAACCAAAACACTGTAAAAAAAAG
AATAGG-3′ and its complementary reverse, following the instructions
of the manufacturer. The triple mutant of GFP-HA-RhoB (insertion of KKH
after L179, GFP-RhoB-KKH) was generated by annealing synthetic sense
5′-CAAGCGCGCCGCGCTGAAGAAACACCAGAAGCGCTACGGATCCCAG
AATGGCTGCATCAACTGCTGCAAGGTGCTATGAGAATTCAAC-3′ and anti-
sense oligonucleotides containing three inserted triplets, digesting with
BssHII and EcoRI and cloning the product into the same sites of the
GFP-HA-RhoB plasmid. All constructs were confirmed by sequencing. For
transfections, confluent cells in p35 plates were incubated with 1 µg of
DNA construct and 3 µL of Lipofectamine 2000 (Invitrogen), according to
the instructions of the manufacturer. Twenty-four hours after transfection,
cells were treated with the various agents as indicated above.
Assessment of protein stability
Protein stability was estimated from the decay of the levels of the protein
of interest in cells treated with a non-toxic concentration of CHX, as
previously described (7,31). SDS–PAGE and western blot analysis were
performed as described (7,31) using enhanced chemiluminiscence (ECL)
detection (Amersham). Protein levels were estimated by image scanning
of the ECL exposures and corrected by the signal given by an antibody
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against RhoGDI, a protein the levels of which do not change under the
experimental conditions used throughout the manuscript.
Confocal microscopy
For confocal microscopy of live cells, BAECswere cultured on glass bottom
dishes (Mattek Corp.), transfected with fluorescent constructs, treated
with the indicated agents and visualized directly on a confocal microscope
(LEICA DMRE2). For immunofluorescence with anti-LBPA/BMP antibody,
cells were fixed with 4% paraformaldehyde, incubated in the presence of
0.27% NH4Cl, 0.38% glycine for 10 min and permeabilized with 0.05%
saponin in PBS in the presence of anti-LBPA at 1:50 dilution. After washing
with PBS, cells were incubated with anti-mouse Alexa 647 (Invitrogen) at
1:250 in 10%normal goat serum in PBS. For filipin staining, fixed cells were
washed 3×with PBS, incubated with 1.5 mg/mL glycine in PBS for 10 min
at room temperature and subsequently with 0.05 mg/mL filipin in 10%
normal goat serum in PBS for 2 h. Unless otherwise stated, images shown
are single Z-section images for colocalization assessment. All experiments
were repeated at least 3× and representative results are shown.
Quantification and statistics
The degree of colocalization of the different constructs with LTR was
analysed with software from Leica and Scion Corporation for image
analysis. Results are presented as average values ± SD or SEM, as
indicated. Average values were compared by Student’s t-test for unpaired
observations.
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Figure S1: Effect of U18666A on the localization of a chimeric protein
derived from the C-terminus of TC10 in which the spacing between
palmitoylation cysteines has been altered. A) The C-terminal sequence
of the chimeric protein GFP-8-TC10m is shown in comparison with that
derived from wild-type TC10 (GFP-8-TC10). B) Cells transfected with the
constructs indicated were treated in the absence or presence of U18666A
for 24 h and incubated with 25 nM LTR before visualization by confocal
microscopy. Bar, 20 µm. C) BAECs were transfected with the indicated
constructs and lysed in buffer containing 1% Triton-X-114. Partition of the
constructs into the aqueous (a) and detergent (d) phases was performed
as previously described (23) and their levels in each phase were assessed
by western blot with anti-GFP antibody. Results are average values of two
determinations and are presented as percentage of the total. The soluble
protein RhoGDI is shown as a control. Blots shown are representative of
two experiments performed in duplicate.
Figure S2: Effect of alteration of the lipid environment of late
endosomes on the localization of the chimeric protein GFP-8-RhoB.
A) Localization of GFP-8-RhoB in NPC disease cells. Human fibroblasts from
healthy subjects (control) or NPC disease patients were transfected with
GFP-8-RhoB. After 24 h in serum-free medium, the distribution of GFP-8
and LTR was visualized by confocal microscopy in live cells. The extent
of colocalization of GFP and LTR signals in the two cell types is shown in
the lower panel. Results are average values of five determinations from
three independent experiments ± SEM, *p < 0.05 versus control cells by
Student’s t-test. B) Effect of anti-BMP antibodies on the localization of
GFP-8-RhoB. BAECs were transfected with GFP-8-RhoB and incubated
with anti-BMP or control antibody (hybridoma supernatant diluted 1:1 in
culture medium) for 24 h before visualization by confocal microscopy. In
the right panel, single fluorescence channels and overlay images of the
inset are shown. Results are representative of three assays with similar
results.
Figure S3: Role of basic residues in the hypervariable domains of
TC10 and RhoB in subcellular localization in chloroquine-treated
cells. BAECs transfected with the indicated constructs were treated
in the absence or presence of 10 µM chloroquine for 24 h and incubated
with 25 nM LTR before visualization by confocal microscopy. Bar, 20 µm.
Shown are the single fluorescence channels and overlay sections. DIC
images are shown in the right panels. Results are representative of four
experiments with similar results.
Figure S4: Hypothetical model summarizing the subcellular localiza-
tion, observed in this study, of the various GTPases and theirmutants.
In resting control cells, GFP-RhoB localizes to plasmamembrane and endo-
somes whereas GFP-TC10 localizes mainly to endosomes. The GFP-RhoB
KKH mutant shows a lower extent of plasma membrane binding than
GFP-RhoB. The GFP-TC10 NQN mutant shows a higher extent of plasma
membrane binding than TC10. GFP-RhoB and GFP-TC10 NQN are sorted
into MVB, and accumulate in this compartment in U18666A-treated cells,
whereas GFP-TC10 and GFP-RhoB KKH are retained at the limiting mem-
brane of these structures. Upon inhibition of palmitoylation, GFP-RhoB
becomes diffuse and cytosolic, whereas GFP-TC10 is clearly detected at
the plasma membrane and on endosomes. The constructs GFP-RhoB KKH
and GFP-TC10 NQN do not localize significantly to the plasmamembrane in
2-bromopalmitate-treated cells, but retain their localization at endosomes.
Therefore, mutation of the basic patch in TC10 reduces plasma membrane
association in 2-bromopalmitate-treated cells. Plasma membrane associa-
tion of non-palmitoylated GFP-TC10 but not of fully processed GFP-RhoB is
sensitive to ionomycin treatment. Taken together, these observations sug-
gest the existence of electrostatic interactions between the basic residues
in the hypervariable domains of the various constructs (shown in blue) and
the negatively charged lipids (represented by lipids with red ’heads’) at the
different membrane compartments. These interactions would favour the
distribution of GTPases bearing basic hypervariable domains at the cytoso-
lic side of late endosomes, whereas GTPases with less polar hypervariable
domains would reach MVB intraluminal space in a higher proportion.
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to the
corresponding author for the article.
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Abstract
The C-terminal ends of small GTPases contain hypervariable sequences which may be posttranslationally modified by
defined lipid moieties. The diverse structural motifs generated direct proteins towards specific cellular membranes or
organelles. However, knowledge on the factors that determine these selective associations is limited. Here we show, using
advanced microscopy, that the isoprenylation and palmitoylation motif of human RhoB (–CINCCKVL) targets chimeric
proteins to intraluminal vesicles of endolysosomes in human cells, displaying preferential co-localization with components
of the late endocytic pathway. Moreover, this distribution is conserved in distant species, including cells from amphibians,
insects and fungi. Blocking lipidic modifications results in accumulation of CINCCKVL chimeras in the cytosol, from where
they can reach endolysosomes upon release of this block. Remarkably, CINCCKVL constructs are sorted to intraluminal
vesicles in a cholesterol-dependent process. In the lower species, neither the C-terminal sequence of RhoB, nor the
endosomal distribution of its homologs are conserved; in spite of this, CINCCKVL constructs also reach endolysosomes in
Xenopus laevis and insect cells. Strikingly, this behavior is prominent in the filamentous ascomycete fungus Aspergillus
nidulans, in which GFP-CINCCKVL is sorted into endosomes and vacuoles in a lipidation-dependent manner and allows
monitoring endosomal movement in live fungi. In summary, the isoprenylated and palmitoylated CINCCKVL sequence
constitutes a specific structure which delineates an endolysosomal sorting strategy operative in phylogenetically diverse
organisms.
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Introduction
Regulation of vesicular traffic is a key process for many cellular
functions. Signal transduction by membrane receptors, protein
delivery to specific compartments, membrane repair and exosome
shedding or autophagy, among others, depend on compartmen-
talized traffic of molecules within the cell. Intracellular vesicles
constitute a yet not fully characterized array of dynamic
membranous compartments which are in continuous evolution
and transformation, resulting in the acquisition of a specific
protein and lipid composition [1,2]. These components can
regulate the fate of proteins by sorting them through different
types of intracellular vesicles that can come from or recycle back to
the plasma membrane, send proteins along the secretory pathway
from the Golgi or travel along trafficking routes through the late
endosomal pathway to the lysosome to be degraded, among many
other processes.
The endolysosomal pathway is subjected to a complex
regulation by families of proteins or multiprotein structures which
act in a concerted manner. Indeed, small GTPases of the Rab
family play a fundamental role in endosome biogenesis and traffic,
and undergo the so-called ‘‘Rab conversion’’, in which Rab5 from
early endosomes is substituted by Rab7 at late endosomes, thus
allowing progression of endosome maturation [3]. Incorporation
of cytosolic proteins into this pathway is believed to occur through
various mechanisms by recognizing target sequences or modifica-
tions that ultimately may trigger association with or internalization
into endolysosomal vesicles. The endosomal sorting complexes
required for transport (ESCRTs) constitute a well-established
system of protein ‘‘machines’’ that work sequentially to induce the
endosomal delivery of target proteins. Particular components of
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ESCRTs recognize ubiquitinated proteins, induce membrane
invagination and promote formation of multivesicular bodies
(MVB), into which proteins are sorted [4]. Other means of
lysosomal sorting include modification of e.g. soluble acid
hydrolases with mannose 6-phosphate (M6P) and recognition by
M6P receptors in the Golgi apparatus prior to endo-lysosomal
trafficking, or M6P-independent sorting by association with
proteins such as sortilin or LIMP-2 [5,6]. In the case of lysosomal
transmembrane proteins, specific motifs such as dileucine or
tyrosine-containing sequences can interact with clathrin-associated
proteins and trigger lysosomal localization [7]. Furthermore,
modifications such as phosphorylation and acylation of proteins at
particular residues can also serve as vesicle-specific membrane
anchors for peripheral membrane proteins [8].
One of several types of acylation, thioesterification of a
palmitate molecule (C16:0) occurs at specific cysteine residues in
a reversible manner and allows proteins to cycle between different
subcellular localizations. In particular, palmitoylation is important
for the sorting and localization of numerous integral membrane
proteins such as the M6P receptor, tetraspanins (e.g. CD9, CD63
or CD81) or synaptotagmins [9–11]. Small GTPases of the Ras
superfamily are isoprenylated at their C-termini. For several
members of this family, including H-Ras, RhoB or TC10,
isoprenylation is required for the subsequent palmitoylation of
nearby cysteines, which allows their association with the plasma
membrane or specific endolysosomal vesicles [12–15]. Thus,
certain protein sequences, as well as specific types of protein
posttranslational modifications play a key role in targeting proteins
to membranes with subtle differences in protein and/or lipid
composition.
The C-terminal sequence of RhoB (CINCCKVL) is palmitoy-
lated and isoprenylated, and these modifications are required for
its localization at the endolysosomal pathway [16]. Moreover, we
have previously shown that this sequence directs the rapid
lysosomal degradation of chimeric proteins in bovine aortic
endothelial cells (BAEC) [16]. Here we have fused the
CINCCKVL sequence (or ‘‘–8’’) to fluorescent proteins to explore
its potential to promote endolysosomal localization in cells from
different species. From our studies, CINCCKVL chimeras step
forth as tunable targeting sequences which depend on posttrans-
lational lipid modifications that can be regulated pharmacologi-
cally to finely modulate subcellular localization. Our results show
that endolysosomal sorting of the chimeric proteins ending in the
‘‘–8’’ sequence operates in diverse cell types and is preserved in
organisms as distant as fungi and humans.
Materials and Methods
Ethics statement
The study was conducted according to the Declaration of
Helsinki principles and was approved by the Commission of
Bioethics and Biosafety of Centro de Investigaciones Biolo´gicas
(Madrid, Spain) and by the Bioethics Committee of Consejo
Superior de Investigaciones Cientı´ficas (Spain). All cell types used
were from commercial sources (see below) or from established Cell
Repositories (NIGMS Human Genetic Cell Repository at the
Coriell Institute for Medical Research, Camden, NJ).
Materials
Cell culture media RPMI1640, DMEM, TC100 and supple-
ments (Newborn calf serum, penicillin/streptomycin, glutamine,
trypsin-EDTA) were from Gibco Life Technologies (Paisley, UK).
NCTC 109 medium and chloroquine were from Sigma (Stein-
heim, Germany). Foetal bovine serum (FBS) was from Lonza Inc.
(Walkersville, MD, USA). Lipofectamine 2000 and Lysotracker
Red (LTR) were from Life Technologies (Carlsbad, CA, USA).
U18666A was from Merck4Biosciences (Madrid, Spain). Anti-
GFP was from Roche Diagnostics GmbH (Mannheim, Germany).
Anti-Hsp90 (sc-7947), anti-RhoGDI (sc-360), and anti-vimentin
(sc-6260) were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Anti-mouse Igs were from Dako (Copenhagen, Denmark).
Anti-giantin was from Covance (Princeton, NJ, USA).
Plasmids
The following constructs were generous gifts: GFP-Rab7, from
Prof. C. Bucci (University of Copenhagen); Lamp1-GFP, from
Prof. J. Lippincott-Schwartz (NIH); GFP-Rab5, from Prof. J.
Bonifacino (NIH). GFP-Rab11 was from Genecopoeia. The
constructs GFP-8 (GFP-CINCCKVL), GFP-HA-RhoB and
tRFP-T-HA-RhoB have been previously described [14]. The
plasmid tRFP-T-8 containing a S162T mutation to improve
photostability [17] was generated from tRFP-8 [16] by PCR, as
previously described [14]. Dendra-8 (Dendra2-CINCCKVL) was
generated from pDendra2-C (Clontech) by PCR, analogously to
GFP-8, as described [16]. Briefly, the cDNA of Dendra-8 was
generated by PCR using pDendra2-C as template and primers:
forward, 59-GCGCTAGCTCGAGGTACCGC-39, and reverse,
59-CCGAGCTCTAGAGGACCTTGCAACAGTTGATACAC-
CACACCTGGCTGG-39. The product was cloned in the NheI-
SacI sites of pDendra2-C. The constructs GFP-CINCSKVL
(GFP-8-C244S, isoprenylation defective GFP-8 mutant), GFP-
SINSCKVL (GFP-8-C240, 243S, palmitoylation defective GFP-8
mutant) and the corresponding tRFP-T-8 mutants tRFP-T-
CINCSKVL (tRFP-T-8-C242S) and tRFP-T-SINSCKVL
(tRFP-T-8-C238, 241S), as well as the vector GFP-HA-RhoB X
(expressing RhoB from Xenopus laevis, NCBI Acc. No.:
NM_001096461.1), were generated by Genewiz Inc. (South
Plainfield, NJ) by oligonucleotide synthesis and cloning into the
parent vectors. The plasmid p1902 encoding Osmani GFP for
fungi transformation has been previously described [18]. The
vectors encoding GFP-8 and its C239, 242S (palmitoylation
deficient) mutant for expression in fungi were constructed by gene
synthesis and cloned into the HindIII-XmaI sites of p1902
(Genewiz).
Cell culture and transfections
The cell line [AG09309] (primary fibroblasts from control
subjects) was obtained from the NIGMS Human Genetic Cell
Repository (http://ccr.coriell.org/Sections/Collections/NIGMS/
?SsId = 8) at the Coriell Institute for Medical Research (Camden,
NJ) and was cultured according to the instructions provided.
BAEC from Clonetics were cultured in RPMI1640 supplemented
with 10% (vol/vol) newborn calf serum, and antibiotics (100 U/ml
penicillin, 100 mg/ml streptomycin). HeLa adenocarcinoma cells
from ATCC were cultured in DMEM supplemented with serum
and antibiotics. Xenopus laevis A6 cells were obtained from Sigma
and cultured at 28uC in NCTC 109 medium supplemented with
15% distilled H2O, 2 mM glutamine, 10% FBS and antibiotics.
High Five cells, derived from ovarian cells of the cabbage looper,
Trichoplusia ni, were from Invitrogen. These cells were cultured at
28uC in TC100 medium supplemented with 10% FBS, penicillin-
streptomycin as above and 10 mg/ml gentamycin. Transfection of
cells at 80% confluence was performed with Lipofectamine2000
following the instructions of the manufacturer, using 1 mg of DNA
and 3 ml (single transfections) or 4.5 ml (double transfections) of
Lipofectamine per p35 dish. Unless otherwise indicated, after
transfection, cells were allowed to recover for 24 h in complete
medium before treatment with the indicated agents in the absence
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of serum. Imaging of live cells was performed 48 h after
transfection to minimize its effects.
Aspergillus nidulans culture
Aspergillus nidulans was cultured on complete medium (MCA)
or synthetic complete medium (SC) containing 1% glucose and
5 mM ammonium tartrate (i.e. 10 mM NH4+) as carbon and
nitrogen sources, respectively. GFP-8 and GFP-8-C239S, C242S
were expressed under the control of the gpdAmini promoter, using
a single-copy integration construct targeted to pyroA, as described
previously [18]. Strains used in this work: MAD4688: wA2;
pyroA4::[pyroA*-gpdAmini::GFP-8-C239S, C242S]; pantoB100
and MAD4689: wA2; pyroA4::[pyroA*-gpdAmini::GFP-8]; pan-
toB100.
Immunofluorescence
For immunofluorescence with anti-giantin antibody, cells were
fixed in 4% paraformaldehyde for 20 min at r.t., washed twice in
PBS and permeabilized with 0.05% saponin in PEM buffer
(80 mM PIPES, 5 mM EGTA, 1 mM MgCl2 pH 6.8) for 5 min.
Incubation with anti-giantin at 1:500 dilution was carried out in
PBS containing 0.05% saponin for 1 h. After PBS washes, cells
Figure 1. Localization of CINCCKVL chimeras in human cells. (A) Human fibroblasts were transfected with the indicated constructs and
observed live by confocal microscopy after 16 h in serum-depleted medium. To the right of every condition, zoom-ins of original pictures and
fluorescence intensity profiles along a section (see dotted lines marked by asterisks) are shown. The magnification used for zoom-ins is seven-fold
with respect to the corresponding full-sized images. F.I., fluorescence intensity. (B) HeLa cells were transiently transfected with the indicated
constructs and treated with 25 nM LTR for 15 min, where indicated, prior to live confocal microscopy observation. Bottom panels show cells that
were treated with 10 mM chloroquine 24 h post-transfection for a further 24 h. Insets show details of the pictured cells. (C) Cells transfected as in (B)
were visualized live by super-resolution microscopy (SIM). Insets show individual MVB and their ILV decorated with CINCCKVL fluorescent proteins.
Scale bar, 20 mm.
doi:10.1371/journal.pone.0107190.g001
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were incubated with anti-rabbit-Alexa 568 (Invitrogen) at 1:200 in
1% BSA in PBS for a further hour.
Microscopy
For live cell visualization, cells were cultured on glass-bottom
dishes (Mattek Corp., Ashland, MA), transfected with fluorescent
constructs, treated with the indicated agents and visualized directly
on a confocal microscope (LEICA DMRE2 or LEICA SP5
Heidelberg, Germany). Unless otherwise stated, images shown are
single channels or overlays of single Z-sections for co-localization
visualization. All experiments were repeated at least three times
and representative results are shown. Bars represent 20 mm unless
otherwise indicated.
In vivo superresolution 3D structured illumination microscopy
(SIM) imaging was performed on a Deltavision OMX V4 system
(Applied Precision, a GE healthcare company, Issaqua, WA)
equipped with an Olympus 60x NA 1.42 objective, cooled
sCMOS cameras and 405, 488, 568 and 642 nm diode lasers.
Z-stacks covering the whole cell were recorded with a Z-spacing of
125 nm. A total of 15 raw images (5 phases, 3 rotations) per plane
were collected. Reconstruction and alignment of these raw images
Figure 2. Endolysosomal localization of CINCCKVL-chimeric proteins depends on posttranslational processing. (A) HeLa cells were
transiently transfected with the indicated constructs and 24 h later they were cultured in serum-free medium for another 24 h. Cell lysis and
fractionation were achieved as described in the Experimental section. Upper panels show the amount of the constructs in total cell lysates and lower
panels depict the levels of the constructs in S100 (soluble) and P100 (particulate) fractions, assessed by western blot with an anti-GFP antibody.
Hsp90 was used as a loading control, RhoGDI as a marker of the soluble fraction and vimentin as a particulate fraction marker. Results are
representative from three experiments with virtually identical results. The positions of the 25 and 100 kDa markers are shown for reference. (B) HeLa
cells were transfected with GFP-8, its palmitoylation defective mutant (GFP-8-C240, 243S), its isoprenylation defective mutant (GFP-8-C244S) or GFP,
as indicated, and stained with LTR prior to live confocal microscopy imaging. (C) GFP-8-transfected HeLa cells were treated with 20 mM 2-
bromopalmitate for 6 h or 10 mM simvastatin for 24 h in serum-free medium and stained with LTR before live observation by confocal microscopy.
(D) BAEC were transfected with Dendra-8 and treated with simvastatin for 24 h (left panel) prior to eliciting a green-to-red photoswitch using UV light
(middle panel). Immediately after photoswitching simvastatin was removed and the localization of the red, photoconverted protein was assessed
24 h later (right panel). Scale bar, 10 mm.
doi:10.1371/journal.pone.0107190.g002
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was performed using Softworx software. (Applied Precision, a GE
healthcare company, Issaqua, WA).
Dendra-8 photoswitching and isoprenylation inhibition-and-
release experiments were performed on transfected BAEC on
glass-bottom dishes. The transfection medium was removed after 5
hours and replaced with serum-free medium with or without
10 mM simvastatin. Cells were observed 24 hours post-treatment
on a confocal microscope (LEICA SP2) and photoswitching was
performed by exposure to 405 nm UV light. The resulting green-
to-red conversion was recorded in both channels. Simvastatin was
either added or removed to the corresponding dishes in serum-free
medium and photoconverted, red Dendra-8 was tracked 24 hours
later by confocal microscopy.
For microscopy experiments in Aspergillus, hyphae were
cultured in Lab-Tek chambers (Thermo Fischer Scientific,
115411; 0.3 ml of medium per well) at 25–28uC in pH 6.5 ‘watch
minimal medium’ (WMM) containing 100 mM sodium acetate
and 5 mM ammonium tartrate as carbon and nitrogen sources,
respectively. Hyphae were visualized on an inverted fluorescence
microscope (Leica DMI6000B) equipped with an EL6000 external
light source with metal halide lamp epifluorescence excitation,
driven by Metamorph software (Molecular Dynamics) and
coupled to a CCD camera (ORCA ER-II; Hamamatsu). Vacuoles
were detected with CMAC (7-amino-4-chloromethylcoumarin,
CellTracker Blue; Invitrogen C-2110).
Image analysis
Co-localization analysis was performed with LAS-AF software
from Leica on single z-sections of images to obtain co-localization
rates (expressed as percentages) and Pearson coefficients (coeffi-
cient r6100). At least 30 cells were analysed per experimental
condition. Results are presented as average co-localization rates or
Pearson coefficients 6 standard error of mean (SEM) as indicated.
Average values were compared by Student’s t-test for unpaired
observations.
Western blot
SDS-PAGE and Western blot analysis of HeLa cells were
performed as described [16,19], using ECL detection (GE
Healthcare, Buckinghamshire, UK). For analysis of cell fractions,
S100 and P100 fractions were obtained by centrifugation of total
cell lysates at 100,0006g for 1 h at 4uC, essentially as previously
described [20].
Results
Fluorescent CINCCKVL constructs localize at
endolysosomal compartments in human cells
To assess the ability of the CINCCKVL motif to induce
endolysosomal localization in distant species, we first assessed the
distribution of fluorescent CINCCKVL chimeric proteins in
primary human fibroblasts, a species in which these constructs
have not been characterized. Therefore, we co-transfected tRFP-
T-CINCCKVL (tRFP-T-8) with fluorescent constructs of known
components of various endosomal compartments. Fusion proteins
of Rab family GTPases are commonly used as markers of
particular endosomal vesicles, i.e. fluorescent constructs of Rab5
or Rab7 for early and late endosomes, respectively. As can be
observed in Figure 1A, tRFP-T-8 localized inside vesicles delim-
ited by GFP-Rab7 and the late endosome-lysosomal marker
Lamp1-GFP. Under our conditions, tRFP-T-8 showed partial co-
localization with GFP-Rab11, which typically localizes to recycling
endosomes [21], and more limited co-localization with a
fluorescent construct of Rab5 [22]. Thus, the tRFP-T-8 construct
displays a selective localization at late endosomes-lysosomes in this
cell type (Fig. 1A, see profiles).
In the widely used human cell line from cervical adenocarci-
noma HeLa, CINCCKVL-chimeric proteins showed substantial
co-localization with LTR (GFP-8/LTR co-localization rate:
62.662.5%) and tRFP-T-8 localized inside Lamp-1-GFP-positive
vesicles which, as described above, became dilated when treated
with cloroquine (Fig. 1B). GFP-8 also co-localized extensively with
Figure 3. Effects of agents modulating cholesterol synthesis and traffic on the distribution of CINCCKVL constructs. (A) HeLa cells
were transfected with GFP-8 (upper panels) or GFP-CD63 (lower panels). 24 h later cells were treated with 100 mM ZGA or 10 mM U18666A for 24 h
and stained with LTR as above. Insets show enlarged areas of interest. The single channels corresponding to the areas in insets are shown below each
image. (B) BAEC were transfected with GFP-8 and treated with ZGA or U18666A as described in (A). Insets show enlarged areas of interest and lower
panels depict fluorescence intensity profiles along a section (see dotted lines marked by asterisks).
doi:10.1371/journal.pone.0107190.g003
Figure 4. C-terminal sequences of CINCCKVL-chimeric proteins, RhoB homologs and related proteins from diverse species. The C-
terminal sequences of GFP-8 and tRFP-T-8 are shown on top, together with a schematic view of the lipidic modifications; palmitates are shown in
black and the geranylgeranyl moiety in blue. The Pubmed accession numbers of genes coding for proteins bearing C-terminal sequences similar to
that of RhoB are shown in the lower panel. Potential sites for palmitoylation are shown in red and the isoprenylation cysteine in green.
doi:10.1371/journal.pone.0107190.g004
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a fluorescent construct of CD63, a component of MVB that is used
as a marker of intraluminal vesicles (ILV) (Fig. S1A). This
prominent co-localization was confirmed in BAEC (Fig. S1B).
Consistent with this and taking advantage of the higher
localization precision obtained by in vivo super-resolution struc-
tural illumination microscopy (SIM), we further demonstrated the
presence of both GFP-8 and tRFP-T-8 in the ILV of MVB
(Fig. 1C). This suggests that this simple amino acid sequence can
carry proteins to specific domains in endolysosomes, some of
which are ultimately internalized to form vesicles inside MVBs.
Inside these compartments, whereas tRFP-T-8 showed a more
diffuse pattern, GFP-8 outlined the inner membranes, which could
be attributed to the decrease in GFP fluorescence occurring in
acidic pH environments [23].
Lipidation of CINCCKVL acts as an endolysosomal
targeting switch
In RhoB, the CINCCKVL motif is subject to posttranslational
processing at its cysteine residues by irreversible binding of an
isoprenoid to its last cysteine and reversible palmitoylation of its
two remaining cysteines. To explore the importance of these
modifications in endolysosomal localization of CINCCKVL-
chimeric proteins, we generated constructs in which the lipidation
cysteines have been mutated. Total lysates from cells transfected
with these constructs are shown in Figure 2A, upper panels. The
Figure 5. Localization of RhoB-related proteins in amphibian cells. (A) Xenopus laevis RhoB (GFP-RhoB X) or GFP-8 were expressed in Xenopus
laevis A6 cells and acidic compartments were stained with LTR. The right panel depicts the extent of co-localization of GFP and LTR signals shown as
Pearson coefficients (x100) or co-localization rates (in percentages). Results are average values of at least 30 cells per condition 6 standard error of
mean (SEM). *p,161026 vs GFP-8 by Student’s t-test. (B) Effect of agents altering lysosomal function on the distribution of tRFP-T-8. Xenopus A6 cells
were co-transfected with Lamp1-GFP to mark lysosomes and tRFP-T-8, and treated with 10 mM U18666A or 10 mM chloroquine, as indicated. (C)
Dependence of tRFP-T-8 localization on posttranslational modification in Xenopus cells. A6 cells were transfected with tRFP-T or tRFP-T-8 and treated
with 10 mM simvastatin or 20 mM 2-bromopalmitate and imaged live by confocal microscopy.
doi:10.1371/journal.pone.0107190.g005
Figure 6. Localization of tRFP-T-8 in High Five insect cells. High
Five cells were transfected with Lamp1-GFP and tRFP-T-8 and live cells
were visualized by confocal microscopy. The overlays of single
fluorescent z-sections alone and with the Differential Interference
Contrast image are shown.
doi:10.1371/journal.pone.0107190.g006
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degree of membrane association of the different constructs was
assessed by subcellular fractionation into S100 (soluble) and P100
(membrane) fractions, followed by western blot (Fig. 2A, lower
panels). Whereas GFP was fully soluble, GFP-8 was totally
membrane bound. In turn, the isoprenylation and the palmitoyla-
tion defective mutants (GFP-8-C244S and GFP-8-C241, 243S,
respectively) showed a predominant localization in the soluble
fraction with a marginal amount appearing in P100 fractions.
Membrane localization of the different constructs was also
assessed by confocal microscopy (Fig. 2B). Mutation of the
palmitoylation cysteines in GFP-8 altered its typical localization,
leading to the cytoplasmic distribution of the non-palmitoylatable
construct (GFP-8-C241, 243S), which excluded the nucleus. This
pattern has been observed for constructs that can be isoprenylated
but not palmitoylated, such as GFP bearing only a CAAX motif
[16]. In some cells, certain cytoplasmic accumulations of the GFP-
8-C241, 243S construct were observed that corresponded to its
presence at the Golgi, as indicated by their co-localization with the
Golgi component giantin (Fig. S2). In contrast, mutation of the
CAAX box cysteine (GFP-8-C244S) led to a diffuse distribution
throughout the cytoplasm and nucleus, excluding some organelles
(Fig. 2B). This pattern was indistinguishable from that of GFP and
is typical of non-lipidated constructs, thus indicating that
isoprenylation of GFP-8 is required for subsequent palmitoylation
[24]. Similar results were obtained with tRFP-T-8 palmitoylation
or isoprenylation-defective mutants (results not shown). Impor-
tantly, pharmacological inhibition of palmitoylation by means of
treatment with 2-bromopalmitate or of isoprenylation (and
subsequent palmitoylation) with simvastatin, resulted in a cellular
distribution of GFP-8 analogous to that of the corresponding
palmitoylation or isoprenylation-defective mutants (Fig. 2C).
Therefore, association of CINCCKVL chimeras with membranes
can be modulated pharmacologically by blocking lipidation of its
cysteine residues. We took advantage of this feature to address the
key issue of whether a non-lipidated, cytosolic pool of
CINCCKVL protein can undergo lipidation to be sorted to the
aforementioned membranes or whether sorting must occur on
newly synthesized proteins. Using BAEC, which present low
cytotoxicity upon treatment with simvastatin, and Dendra2, a
protein capable of photoswitching from green to red fluorescence
emission after UV light exposure, we set up a simvastatin-based
approach to follow specific pools of a Dendra2-CINCCKVL
fusion protein (Dendra-8, Fig. 2D). Treatment with simvastatin
blocked processing of Dendra-8 rendering a pool of fully cytosolic
green construct. This pool was photoswitched obtaining a soluble,
non-isoprenylated red fluorescent CINCCKVL construct to
follow. Releasing the isoprenylation inhibition by removal of
simvastatin allowed endolysosomal targeting of the previously
diffuse red construct, clearly demonstrating that preexisting
CINCCKVL-chimeric proteins may undergo sorting from a
cytosolic localization, depending on isoprenoid availability
(Fig. 2D). The observed behavior establishes this sequence as a
tunable targeting motif in live cells.
Impaired cholesterol dynamics alters sorting of
CINCCKVL chimeras
Specific combinations of lipidic membrane anchors, such as that
conferred by the CINCCKVL sequence, may promote protein
association with membrane domains of a particular composition
[15]. To address this issue, here we have tackled cholesterol
Figure 7. Localization of GFP-8 in Aspergillus nidulans. Strains of Aspergillus nidulans expressing GFP-8 or its palmitoylation deficient mutant
(GFP-8-C240, 243S) were imaged as described in Methods. (A and B) show co-localization of the constructs with the vacuole marker, CMAC. Insets
show grayscale images for better contrast. (C) Kymograph showing the movements of various GFP-8-positive compartments. Rapidly moving
endosomes (likely corresponding to early endosomes) are marked by arrowheads (red), static vesicles (likely corresponding to vacuoles) are marked
by arrows and potential points of contact between endosomes and vacuoles are depicted by asterisks. (D) Graph representing velocities of individual
endosomes.
doi:10.1371/journal.pone.0107190.g007
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availability and traffic in the HeLa cell model (Fig. 3). Remark-
ably, inhibiting cholesterol biosynthesis with the squalene synthase
inhibitor zaragozic acid (ZGA) induced the appearance of
enlarged endolysosomes showing a diffuse localization of GFP-8,
which in some of them appeared retained at the edge (Fig. 3A,
upper panels). Some of these structures displayed a fainter or
patchy LTR staining. In sharp contrast, U18666A, an agent that
causes accumulation of cholesterol and of the endosomal lipid
2,29-dioleoyl lysobisphosphatidic acid (LBPA), also known as
bis(monoacylglycero)phosphate (BMP) in MVB [25], induced the
formation of dense MVB containing GFP-8, as previously
observed in BAEC [14]. Interestingly, GFP-CD63, a marker of
MVB intraluminal structures, suffered alterations similar to those
of GFP-8 in response to ZGA and U18666A (Fig. 3A, lower
panels). Moreover, CD63 markedly co-localized with
CINCCKVL constructs at the altered endolysosomes under all
experimental conditions (Fig. S1C). In order to substantiate the
importance of cholesterol availability for GFP-8 sorting, we treated
BAEC with ZGA. Inhibition of cholesterol biosynthesis elicited the
appearance of dilated MVB showing a peripheral distribution of
GFP-8 (Fig. 3B) and CD63 (Fig. S1D). This cell type presents large
endosomes, so that the differences between the alterations induced
by ZGA and U18666A (shown here for reference) were more
obvious, clearly showing the reduction of intraluminal content in
ZGA-treated cells (Fig. 3B, see profiles). Taken together these
results suggest that the specific modification of CINCCKVL
chimeras induces their association with defined membrane
domains, in a manner dependent on the presence or distribution
of cholesterol, which appears to be required for their sorting.
Localization of CINCCKVL chimeric proteins in cells from
non-mammalian species
The C-terminal sequence of RhoB is unique for this GTPase
and it is conserved in mammalian species and in birds (Fig. 4). In
lower species, the RhoB sequence displays a higher degree of
variability, and in some cases a bona fide homolog of RhoB has not
been identified (Fig. 4). Although several proteins can be found
which possess CAAX boxes and potential sites for palmitoylation,
the composition and/or spacing of these residues is not conserved
with respect to the CINCCKVL sequence. Therefore, we wanted
to assess whether CINCCKVL constructs would confer endoly-
sosomal localization in more distant non-mammalian species.
The Xenopus laevis RhoB protein C-terminus contains one
isoprenylation and two putative palmitoylation cysteine residues
(Fig. 4). However, the composition of this sequence clearly differs
from that of human RhoB in the presence of a basic amino acid
cluster at position 181–183 (KKH), and in the amino acids located
between the two palmitoylation cysteines (MS). These features are
analogous to motifs present in the C-terminal segments of TC10
(KKH), an endosomal RhoB-related GTPase, and H-Ras (MS),
which preferentially localize to recycling compartments and to the
plasma membrane, respectively [12,14]. Consistent with this, we
observed that GFP-tagged Xenopus laevis RhoB (GFP-RhoB X)
was mainly localized at the plasma membrane in Xenopus A6 cells,
and showed limited co-localization with LTR (Fig. 5A, left panel).
In contrast, transfection of CINCCKVL chimeric proteins in
Xenopus A6 cells resulted in a clear endolysosomal localization of
the constructs, as revealed by the disposition of GFP-8 at LTR-
positive compartments (Fig. 5A, middle panel), showing substan-
tial co-localization with this lysosomal marker (Fig. 5A, right
panel) and the presence of tRFP-T-8 inside vesicles delimited by
Lamp1-GFP (Fig. 5B). Interestingly, human RhoB but not
Xenopus RhoB fluorescent constructs extensively co-localized with
CINCCKVL constructs in A6 cells (Fig. S3), thus stressing the
importance of the differences in the sequence of RhoB from
various species for targeting of the full-length protein. This also
indicates that, although the RhoB C-terminal sequence is not fully
conserved in Xenopus laevis, the mechanisms targeting
CINCCKVL-chimeric proteins to endolysosomes are operative
in this cell type.
We next assessed the distribution of these constructs in response
to agents which disrupt endolysosomal dynamics and cholesterol
traffic [16]. Treatment of A6 cells with U18666A led to a dramatic
compaction of endolysomes, which accumulated tRFP-T-8
(Fig. 5B), and chloroquine caused accumulation of tRFP-T-8
inside enlarged endolysomes (Fig. 5B). Moreover, we confirmed
that in these cells, targeting of CINCCKVL chimeric proteins was
also dependent on their posttranslational processing by isoprenyla-
tion and palmitoylation. As shown in Fig. 5C, treatment with
simvastatin abolished the distribution of tRFP-T-8 in endosomal
vesicles and led to a diffuse distribution throughout the cytosol and
the nucleus, indistinguishable from that of tRFP-T, thus confirm-
ing the importance of isoprenylation for tRFP-T-8 targeting in this
cell type, as well. In contrast, inhibition of palmitoylation with 2-
BP elicited the appearance of the protein in the cytosol, excluding
the nucleus, as shown above for GFP-8 in Hela cells. Similar
experiments were routinely carried out in other cell types used in
this work and yielded analogous results (data not shown).
In order to ascertain the robustness of the CINCCKVL
sequence as a determinant for endolysosomal localization, we
went on to explore its localization in a cell line of an invertebrate.
In High Five insect cells, tRFP-T-8 was fully localized inside
vesicles delimited by Lamp1-GFP, thus suggesting its lysosomal
targeting (Fig. 6). Interestingly, in insect cells the homology of
Rho-related proteins with RhoB is more distant, both in terms of
the number of cysteines located at the C-terminus and the nature
of the surrounding amino acids (Fig. 4). Nevertheless, the sequence
derived from the mammalian protein still promotes localization in
lysosomal compartments.
Tracking endosomes with GFP-CINCCKVL in Aspergillus
nidulans
Palmitoylation plays a key role in protein localization and
sorting in lower eukaryotic organisms such as fungi [26]. Indeed,
yeast have been seminal for the identification and characterization
of the isoprenylation and palmitoylation machinery. The fungus
Aspergillus nidulans expresses a potential Rho-related protein
bearing one putative site for palmitoylation adjacent to the
isoprenylation cysteine (Fig. 4). However, in this organism, the –
CINCCKVL sequence is not conserved. In Aspergillus nidulans
most GFP-8 fluorescence clearly localized in late endosomes and
vacuoles, where it co-localized with 7-amino-4-chloromethyl-
coumarin (CMAC), a marker for hydrolase-containing acidic
organelles (Fig. 7A) [27]. In addition, GFP-8 fluorescence was
detected at endosomes showing bidirectional movement (see Video
S1), which is dependent on microtubules [27]. In this model, GFP-
8 also decorated the plasma membrane (Fig. 7A, inset) and septa
(not shown). GFP-8 localization was dependent on its posttrans-
lational modification since a palmitoylation-deficient mutant,
GFP-8-C240, 243S, was fully cytosolic, excluding plasma mem-
brane, septa, vacuoles and nuclei (Fig. 7B). Therefore, analogously
to the observations in cells from higher organisms, the isoprenyla-
tion motif was not sufficient to promote the specific endolysosomal
localization of this construct, although it led to nuclear exclusion.
Nevertheless, the distribution of the GFP-8-C240, 243S construct
was distinct from that of GFP, which, as observed in mammalian
cells, showed a diffuse pattern throughout the nucleus and cytosol
(not shown).
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Aspergillus nidulans constitutes a well characterized model for
monitorization of the endocytic process. Fluorescent constructs of
endosomal proteins allow following the movement of these
organelles by time-lapse microscopy and representation of their
trajectories as kymographs to calculate endosomal speed [27].
Therefore, we took advantage of these possibilities to characterize
the dynamics of GFP-8-positive compartments in more detail.
Figure 7C shows a representative kymograph where nearly static
traces correspond to vacuoles (arrows). In addition, the movement
of various endosomes, both in basipetal and acropetal directions,
can be monitored (arrowheads). Moreover, points of endosome-
vacuole contact can be observed (asterisks). The velocities of the
endosomes monitored are shown in Figure 7D. As can be
observed, GFP-8-positive compartments show speeds ranging
from less than 1 mm per second, to nearly 3 mm per second, the
average velocities being practically the same for basipetal and
acropetal movements. Therefore, GFP-8 marks the endolysosomal
pathway in Aspergillus nidulans, suggesting that the targeting
mechanisms for CINCCKVL constructs are also conserved in
fungi.
Discussion
The combination of several lipidic modifications, like isopreny-
lation and palmitoylation constitute important determinants for
protein localization in specific subcellular compartments. The
spacing of the lipid moieties and the nature of the non-lipidated
amino acids may contribute to the generation of unique structures
with affinity for membrane domains or protein partners. Here we
have shown that the isoprenylation and palmitoylation motif of the
GTPase RhoB constitutes one such structure per se and is able to
determine protein sorting to lysosomal compartments in cells from
distant species, including fungi and humans.
Several mechanisms for sorting to MVBs have been reported.
The classical mechanism implies ubiquitination of the cargo
protein and association with components of the ESCRT
machinery, which, according to some models may assemble
sequentially to define invagination domains leading to the
formation and ultimately the release of ILV [7,28,29]. Although
under our conditions we have not detected ubiquitination of GFP-
8 (unpublished observations), this mechanism cannot be excluded
since ubiquitination-independent sorting of certain cargo by
ESCRT-mediated processes has also been reported [30]. Recently,
a late-endosome microautophagy-like process has been described,
which depends on ESCRT I and III for vesicle formation and on
Hsc70 for cargo selection, and may mediate the delivery into late
endosomes of various cytosolic proteins [31]. Nevertheless, this
process does not seem to be involved in sorting of CINCCKVL
chimeric proteins since it is disrupted by U18666A, which as
shown above, causes strong accumulation of GFP-8 in MVB. In
turn, although the autophagic and endolysosomal pathways may
converge at several levels, we have previously observed that GFP-8
and the autophagosomal marker RFP-LC3 show different
distribution patterns [32], Moreover, endolysomal targeting of
CINCCKVL constructs occurs also in cells growing in complete
medium, including human, Xenopus and insect cells (unpublished
observations), thus indicating that induction of macroautophagy is
not required for sorting. Lastly, in chaperone-mediated autophagy,
unfolding of the protein occurs prior to entrance in the lysosome,
leading to a loss of fluorescence [33]. Under our conditions,
however, intra-lysosomal fluorescence of CINCCKVL-constructs
is preserved, thus making this potential mechanism unlikely.
The fact that CINCCKVL proteins are targeted to human
lysosomes and fungal vacuoles suggests the presence of conserved
sorting mechanisms in these distant species. Indeed, extensive
phylogenetic studies on Rab family proteins have unveiled the
existence of more than 20 core Rab proteins in the latest
eukaryotic common ancestor (LECA) which have suffered
expansions via gene duplication or losses throughout eukaryotic
evolution giving rise to modern Rabs [34,35]. Under our
conditions, the Rab proteins that co-localize to a greater extent
with CINCCKVL chimeras are encompassed in a proposed late
endosomal LECA Rab family (group III), making it possible that
particular Rabs of this conserved group could be involved in
CINCCKVL sorting. Similarly, the ESCRT protein family is also
conserved throughout eukaryotes, in particular ESCRT-I, -II, -III
and -III-associated proteins, though ESCRT-0 proteins appear to
be specific to Opisthokonta (fungi and animals/metazoans) [36].
Interestingly, although several tetraspanin homologs have been
identified in fungi, including Aspergillus species [37], their location
and/or role in vesicular traffic have not been studied. Therefore,
the species studied here may share many of the MVB sorting
machineries already present in the LECA, underscoring the
conserved character of the fundamental trafficking proteins
involved in later steps of the endolysosomal pathway.
In addition to the roles of proteins or protein complexes, lipids
with a particular structure may contribute to the sorting process by
forming targeting microdomains or through the induction of
curvature which facilitates membrane invagination. This is the
case of the late endosomal lipid LBPA/BMP [38]. Interestingly,
we have observed that pharmacological disruption of MVB lipid
dynamics with U18666A traps GFP-8 in this compartment in
several species, including Xenopus laevis. Remarkably, inhibition
of cholesterol biosynthesis with ZGA led to MVB alterations
consisting in dilation and retention of ILV components, including
CD63 and GFP-8, at the periphery of some of these dilated
compartments. Results obtained recently in mice deficient in 24
sterol reductase, the last enzyme of the cholesterol biosynthetic
pathway, in which a reduction in MVB intraluminal material has
been reported, might serve as a clue to the behavior observed here
in BAEC and HeLa cells [39]. It has been reported that most of
the cholesterol present in endolysosomes is contained in ILV.
Therefore, it is plausible that an overall metabolic cholesterol
reduction would affect ILV more directly than other compart-
ments [40]. Conversely, treatment of cells with methyl-b-
cyclodextrin, widely used to deplete plasma membrane cholesterol,
did not alter GFP-8 distribution, although a non-specific alteration
of cell morphology, prior to cell rounding, was noticed (unpub-
lished observations). Taken together, our results indicate that
interaction with endosomal lipids is an important determinant in
GFP-8 sorting.
In all species studied, palmitoylation appears as a key element
for lysosomal localization of CINCCKVL chimeras. Protein
palmitoylation has been involved in protein sorting, although its
effects appear to be cell-type and protein-specific. The mannose
receptor N-terminus is palmitoylated and blocking this modifica-
tion induces lysosomal accumulation of this protein [9]. In the case
of the protease-activated receptor 1, palmitoylation allows the
correct utilization of tyrosine-based sorting signals, and a
palmitoylation-deficient mutant, shows increased degradation in
lysosomes [41]. In contrast, the Ca2+ sensor synaptotagmin 7 has
been reported to be targeted to lysosomes by its palmitoylation-
dependent association with the tetraspanin CD63 [42], although
the examples of palmitoylation-driven endolysosomal association
in mammalian cells are very scarce. In yeast, the palmitoylated
protein Vac8 is targeted to the vacuolar membrane, although
there is no evidence for vacuolar sorting [43]. Therefore, in most
cases, palmitoylation directs proteins away from lysosomes (see
CINCCKVL Endolysosomal Sorting in Distant Species
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[44] and [16] and references therein), with only a few examples of
palmitoylation-supported ILV sorting. Interestingly, as previously
suggested [45], palmitoylation is also likely responsible for the lack
of interaction of GFP-RhoB or GFP-8 with RhoGDI (Oeste et al.,
unpublished observations). Nevertheless, it would be interesting to
assess whether non-palmitoylated constructs interact with
RhoGDI in the cytosol.
The human RhoB sequence is not conserved in the lower
species, in which its closest homologs are not endosomal proteins.
Yet, CINCCKVL chimeric proteins show endolysosomal locali-
zation analogous to that found in mammalian cells. In insects, a
clear homolog of RhoB has not been identified. However, several
proteins exist that possess sequences for bipalmitoylation, although
their potential lysosomal targeting has not been explored. In
Schizosaccharomyces pombe, the RhoB homolog Rho2 has been
reported to be mainly membrane bound and localize at the
growing end(s) of the cell and the septation site [46]. Rho2 is
isoprenylated and palmitoylated [26], although, as predicted from
its CAAX box sequence, is farnesylated [47], whereas RhoB is
mainly geranylgeranylated in cells [48]. However, when using
constructs directing either farnesylation of geranylgeranylation of
GFP-8, namely, GFP-CINCCKVL and GFP-CINCCLVM, we
did not find significant differences in their lysosomal localization,
thus indicating that the length of the isoprenoid moiety is not a
critical factor (Oeste et al., unpublished observations). In addition,
Rho2 only possesses one palmitoylation cysteine adjacent to the
isoprenylation site. Also in yeast, there are examples of
bipalmitoylated proteins, like RasA, which localizes at the plasma
membrane, but appears in internal patches when palmitoylation is
blocked [49]. However, in this case, the spacing of palmitates is
different from that of CINCCKVL proteins (see Fig. 4). In this
context, we have previously shown than the spacing of palmitates
is key for fine-tuning protein localization. Moving the distal
palmitoylation cysteine away from the isoprenylation site in a
chimeric construct reduces its accummulation in MVB in response
to alterations in lipid dynamics [14]. In Aspergillus nidulans, both
the putative Rho2-like protein (Fig. 4) and GFP-8 would be
expected to be geranylgeranylated and palmitoylated, although, to
the best of our knowledge, a homolog for GGTase I has not been
biochemically identified in this organism and the information
available on potential geranylgeranyltransferases only stems from
sequence homology analysis on database searches. It can be noted
that CINCCKVL chimeras displayed some degree of plasma
membrane localization, although it was dependent on the cell type
under study and on the construct used, with GFP-8 decorating the
plasma membrane to a higher extent than tRFP-T-8. Neverthe-
less, the most consistent localization of CINCCKVL chimeric
proteins, when lipidated, is the endolysosomal compartment. It
could be hypothesized that the specific structure formed upon
CINCCKVL lipidation promotes the interaction with specific
microdomains that require the presence of cholesterol. Indeed,
domains rich in free cholesterol have been described in MVB of
endothelial cells under particular cell culture conditions [50].
Moreover, the presence of lipid microdomains that segregate
proteins in the yeast vacuole has been recently demonstrated in
Saccharomyces cerevisiae [51].
One of the most striking conclusions of this work is that the
CINCCKVL sequence takes a route to endolysosomes present in
the lower species but not used, to the best of our knowledge, by
their endogenous proteins. Our findings may motivate the search
for proteins with analogous sequences that may be sorted through
this pathway, as well as the use of cells from lower species to
completely unveil the sorting mechanism. This information will
allow elucidating whether this sequence has evolved in the higher
species to ensure endolysosomal delivery of specific proteins. In
summary, our observations support the interpretation that the
structures generated by precise lipidation sequences, and in
particular by the CINCCKVL motif, may specifically interact
with defined membrane components for protein targeting and
sorting. These findings may set the basis for exploring the sorting
of lipidated sequences to specific microdomains involved in MVB
biogenesis in diverse species.
Supporting Information
Figure S1 GFP-8 co-localization with the MVB/ILV
marker, mCherry-CD63. (A) HeLa cells were co-transfected
with GFP-8 and mCherry-CD63, serum-starved for 16 h and
observed by live confocal fluorescence microscopy. (B) BAEC were
treated as described for HeLa. Scale bar, 20 mm. (C) HeLa cells
transfected as above were treated with ZGA or U18666A as in
Figure 3. (D) BAEC transfected as in (A) were treated with ZGA as
in Figure 3. Insets show enlarged areas of interest. The single
channels corresponding to the areas in insets are shown below
each image.
(TIF)
Figure S2 Golgi staining of cells transfected with GFP-8
and its mutants.HeLa cells transfected with GFP, GFP-8 or the
mutants featured in Figure 2 were fixed after 16 h of serum
deprivation and the Golgi compartment was stained by anti-
giantin immunofluorescence, as described in Materials & Meth-
ods.
(TIF)
Figure S3 Localization of Xenopus or human RhoB
chimeras in amphibian cells. Xenopus laevis A6 cells were
co-transfected with the indicated constructs and observed live by
confocal microscopy after 16 h in serum-depleted medium. Insets
show enlarged areas of interest.
(TIFF)
Video S1 Aspergillus nidulans expressing GFP-8 and showing
endosome movement.
(MOV)
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Abstract Autophagic and endo-lysosomal degradative
pathways are essential for cell homeostasis. Availability of
reliable tools to interrogate these pathways is critical to
unveil their involvement in physiology and pathophysiol-
ogy. Although several probes have been recently developed
to monitor autophagic or lysosomal compartments, their
specificity has not been validated through co-localization
studies with well-known markers. Here, we evaluate the
selectivity and interactions between one lysosomal (Lyso-
ID) and one autophagosomal (Cyto-ID) probe under con-
ditions modulating autophagy and/or endo-lysosomal
function in live cells. The probe for acidic compartments
Lyso-ID was fully localized inside vesicles positive for
markers of late endosome-lysosomes, including Lamp1-
GFP and GFP-CINCCKVL. Induction of autophagy by
amino acid deprivation in bovine aortic endothelial cells
caused an early and potent increase in the fluorescence of
the proposed autophagy dye Cyto-ID. Cyto-ID-positive
compartments extensively co-localized with the auto-
phagosomal fluorescent reporter RFP-LC3, although the
time and/or threshold for organelle detection was different
for each probe. Interestingly, use of Cyto-ID in combina-
tion with Lysotracker Red or Lyso-ID allowed the
observation of structures labeled with either one or both
probes, the extent of co-localization increasing upon
treatment with protease inhibitors. Inhibition of the endo-
lysosomal pathway with chloroquine or U18666A resulted
in the formation of large Cyto-ID and Lyso-ID-positive
compartments. These results constitute the first assessment
of the selectivity of Cyto-ID and Lyso-ID as probes for the
autophagic and lysosomal pathways, respectively. Our
observations show that these probes can be used in com-
bination with protein-based markers for monitoring the
interactions of both pathways in live cells.
Keywords Endo-lysosomal pathway ! Autophagy !
Amino acid deprivation ! Live cell fluorescence !
Autophagosome marker ! Endothelial cell
Introduction
The degradation of cell components is essential for
homeostasis and it occurs through complex and highly
regulated pathways. Both the endo-lysosomal and the
autophagic pathways proceed through mechanisms linked
to vesicular biogenesis and membrane trafficking.
The endo-lysosomal pathway begins at the plasma
membrane and runs through several endosomal compart-
ments leading to the lysosome, where membrane receptors
and generally long-lived proteins are degraded. Early and
late endosomes, multivesicular bodies and lysosomes bear
distinct proteins such as Rab GTPases or integral mem-
brane proteins (e.g. Lamp1) as well as a particular lipidic
composition and increasingly acidic pH (Stenmark 2009).
However, endo-lysosomal maturation involves molecular
exchanges, fusion and budding events that blur the idea
of distinct compartmentalization. Moreover, lysosomes
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degrade components of endocytic, autophagic or phago-
cytic origin, highlighting the convergence of these path-
ways (Saftig and Klumperman 2009). Given their
pathophysiological importance, the search for selective
markers of these pathways is an on-going task. Well-
established markers of the endo-lysosomal pathway include
fluorescent constructs of Rab5 and Rab7 for early and late
endosomes, respectively (Bucci et al. 1992, 2000), and of
Lamp1, for late endosomes and lysosomes (Patterson and
Lippincott-Schwartz 2002). In addition, we recently
described the localization of chimeric proteins bearing the
C-terminal sequence of the endosomal GTPase RhoB
(-CINCCKVL) in late endosomes and in the intraluminal
vesicles of multivesicular bodies (Pe´rez-Sala et al. 2009).
The dynamics of the endo-lysosomal pathway may be
altered by lysosomotropic drugs. Many of these drugs, like
chloroquine or chlorpromazine, will alter lysosomal flux,
thus impairing also autophagic degradation and giving rise
to enlarged lysosomes or lamellar bodies, which may
represent the fusion of diverse organelles including late
endosomes, lysosomes and autophagic vesicles, as sug-
gested by the presence of markers of these various com-
partments (Pe´rez-Sala et al. 2009; Wang et al. 2011).
In a general sense, autophagy, or ‘‘self-eating’’ refers to
a variety of complex and tightly regulated mechanisms by
which cells sense nutrient levels and degrade cellular
components to obtain molecules essential for cell homeo-
stasis (please see Yang and Klionsky 2010 for review). In
addition, autophagy is a general stress response that also
degrades whole organelles, protein aggregates and intra-
cellular pathogens. Initially considered a death mechanism
it is clear now that autophagy plays critical roles in adap-
tation and survival. Three main types of autophagy have
been defined, namely, macroautophagy (or autophagy),
which involves the sequestration of cytosolic components
into double-membrane vesicles which end up fusing with
lysosomes, microautophagy, by which cytosolic constitu-
ents are directly sequestered into lysosomes, and chaper-
one-mediated autophagy, in which chaperones aid in
transporting proteins bearing a specific sequence into
lysosomes (Lee et al. 2012). The materials arising from
degradation are delivered back to the cytosol for recycling
or energy generation (reviewed in Chen and Klionsky
2011; Lee et al. 2012).
The autophagic and endo-lysosomal pathways may
interact at several levels. Although it is generally accepted
that autophagosomes fuse to lysosomes to deliver their
contents for degradation, fusion at the level of early and
late endosomes has also been reported (Dunn 1994; Liou
et al. 1997; Berg et al. 1998). Given their multiple con-
nections with other vesicular and degradative pathways,
autophagy-specific processes are difficult to delineate.
Therefore, the availability of well-characterized tools and
assays is a critical issue (Klionsky et al. 2008, 2012;
Mizushima et al. 2010).
The most widely used assay to monitor autophagy is the
lipidation of the LC3 protein (microtubule-associated pro-
tein 1 light chain 3) that gives rise to LC3-II (Kabeya et al.
2000; Barth et al. 2010; Mizushima and Yoshimori 2007)
and promotes its insertion into the membranes of auto-
phagosomes (Barth et al. 2010; Mizushima et al. 2010).
However, LC3 processing and dynamics in live cells are
difficult to follow and their assessment requires transfec-
tion procedures, which are not exempt from artifacts
(Klionsky et al. 2008). Therefore, there is an interest for the
development of autophagy probes that can be used in live
cells independently of transfection.
The recently developed Lyso-ID Red detection reagent
(Lyso-ID) is an amphiphilic fluorescent probe that is
actively sequestered in acidic compartments (Coleman
et al. 2010) and is expected to stain lysosomes or lysosome-
derived organelles arising upon block of lysosomal flux.
However, it should not accumulate in early autophago-
somes, which do not possess an acidic pH until the
acquisition or activation of H?-ATPase (Dunn 1994).
Among the tools to monitor autophagy in live cells, the
autofluorescent molecule monodansylcadaverine (MDC),
has been reported to label autophagic vacuoles (Biederbick
et al. 1995) and has been used as an autophagy probe
(Munafo and Colombo 2001; Iwai-Kanai et al. 2008).
MDC is a lysosomotropic agent reportedly showing
increased fluorescence in hydrophobic environments
(Niemann et al. 2000). Nevertheless, MDC specificity is
controversial since in some works MDC staining was
indistinguishable from that of lysosomal probes (Bampton
et al. 2005). The Cyto-ID green reagent (Cyto-ID) is a
cationic amphiphilic dye the fluorescence of which has
been reported to increase upon autophagy induction
(Warenius et al. 2011), hypothetically due to compart-
mentalization in the hydrophobic environment of auto-
phagic vesicles. However, this probe has not been validated
through co-localization studies with probes for auto-
phagosomes. Moreover, its selectivity in combination with
markers of other degradative compartments has not been
assessed.
In this work, we have carried out a detailed study of the
co-localization of Lyso-ID and Cyto-ID with well-known
markers of autophagic and endo-lysosomal pathways in
live cells. Our results show that Lyso-ID specifically stains
acidic compartments bearing late-endosome/lysosome
markers, whereas Cyto-ID fluorescence is highly sensitive
to amino acid deprivation displaying extensive co-locali-
zation with RFP-LC3 and partial co-localization with
lysosomal probes. These observations highlight the poten-
tial of these probes for monitoring both pathways in live
cells.
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Materials and methods
U18666A was from Merck4Biosciences (Spain). Chloro-
quine, 3-methyladenine (3-MA), rapamycin, leupeptin and
E-64d were from Sigma. Culture media and supplements,
Lipofectamine 2000 and Lysotracker Red (LTR) were from
Life Technologies (Carlsbad, CA). Cyto-ID Green Detec-
tion Reagent for autophagy monitoring (Cyto-ID) and
Lyso-ID Red Detection Reagent (Lyso-ID) were from Enzo
Life Sciences.
Cell culture
Bovine aortic endothelial cells (BAEC) were obtained from
Lonza, Inc., (Walkersville, MD) and cultured in RPMI1640
medium supplemented with penicillin/streptomycin and
10 % calf serum from Gibco (Life Technologies). BAEC
were used between passages 5 and 12 and were grown to
near confluence for experiments. HeLa cells were cultured
in high glucose DMEM with 10 % FBS and penicillin/
streptomycin. HeLa cells stably transfected with GFP-LC3
were kindly provided by Dr. Aviva Tolkovsky (Bampton
et al. 2005).
Modulation of autophagy and the lysosomal pathway
Treatment of BAEC with the various agents used was
carried out in serum-free medium. This situation induces a
near-quiescent state and does not reduce cell viability
(Herna´ndez-Perera et al. 1998). Control cells received an
equivalent amount of vehicle as required. For induction of
autophagy, cells were incubated in amino acid-free med-
ium (EBSS) for the times indicated. All further treatments
and staining procedures were performed also in this med-
ium to avoid autophagy reversion. The autophagy inducer
rapamycin was used at 200 nM overnight, whereas the
autophagy inhibitor 3-MA was added at 1.5 mg/ml for 6 h
in medium containing or devoid of amino acids, as indi-
cated. In order to disrupt the endo-lysosomal pathway, cells
were treated with 10 lM U18666A or chloroquine for
20 h. U18666A causes an entrapment of cholesterol and
bis(monoacylglycero)phosphate (BMP)-rich membranes
into late endosomes and an inhibition of the dynamics of
internal vesicles (Kobayashi et al. 1999; Sobo et al. 2007).
At the concentrations used in this study, chloroquine
inhibits lysosomal protein degradation and induces lyso-
some enlargement but does not impair the accumulation of
probes for acidic compartments (Pe´rez-Sala et al. 2009),
nor induces significant changes in lysosomal pH as
estimated with Lysosensor DND-160 (Invitrogen) follow-
ing the instructions of the manufacturer: control 4.4 ±
0.03, chloroquine 4.5 ± 0.09, average ± SD of three
determinations.
Plasmids and transfections
Lamp1-GFP was a gift from Prof. Jennifer Lippincott-
Schwartz (NIH, Bethesda, MD). RFP-LC3 was from Prof.
Tamotsu Yoshimori (Research Institute for Microbial
Diseases, Osaka, Japan). The construct GFP-CINCCKVL
(GFP-8) containing the last eight amino acids from the
GTPase RhoB has been previously described (Pe´rez-Sala
et al. 2009; Valero et al. 2010). Cells at 80 % confluence
were transfected with Lipofectamine 2000 (Life Technol-
ogies) following the manufacturer’s instructions. For
transfection of single constructs, 1 lg of plasmid plus 3 ll
of Lipofectamine were used per 35 mm dish, whereas for
co-transfections, DNA/Lipofectamine mixtures were pre-
pared with 1 lg of each construct plus 4.5 ll of the
transfection reagent. After transfection, cells were allowed
to recover for 24 h in complete medium before treatments.
Unless otherwise stated, imaging of live cells was per-
formed 48 h after transfection to minimize its effects.
Staining with lysosomal or autophagosomal small
molecule probes
Several variations to the manufacturer’s recommended
staining procedures were introduced in order to enhance
probe performance. Lyso-ID andCyto-IDwere diluted in the
total volume of serum-free culture medium to be used for
staining at 37 !C for 30 min. This was found to improve the
maintenance of endothelial cell morphology and viability
during cell imaging. Incubation in the presence of serum
reduced the intensity of the staining in BAEC. In experi-
ments in which autophagy was induced by incubation of
cells with EBSS, staining and washing (for autophagy
reversion experiments) was also performed in this medium.
LTR staining was performed by incubation of cells with
25 nMLTR for 15 min at 37 !C. In the case of Cyto-ID/LTR
co-staining, LTR was added to the medium of cells that had
been incubated with Cyto-ID for 15 min, left for an addi-
tional 15 min to co-stain and visualized immediately after-
wards. For MDC staining, cells were incubated with 50 lM
MDC (Sigma) for 10 min at 37 !C, and washed three times
with the medium used for treatment before visualization.
Confocal microscopy
For live cell confocal microscopy, cells were cultured on
glass bottom dishes (Mattek Corp., Ashland, MA, USA),
transfected with fluorescent constructs, treated with the
indicated agents and visualized directly on a confocal
microscope (LEICA DMRE2, Heidelberg, Germany).
Unless otherwise stated, images shown are single Z-section
images for co-localization assessment and scale bars rep-
resent 20 lm. Images were obtained shortly after staining
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to minimize loss of fluorescence. Care was taken to briefly
observe cells under the UV lamp before imaging to mini-
mize fading of the probes. In the case of Lyso-ID, this was
also important to avoid organelle damage, as it has been
described for other lysosomal dyes (Jaiswal et al. 2007;
Alvarez et al. 2011). For MDC visualization, the excitation
and emission wavelengths were set at 351 and 500 nm,
respectively.
Image analysis
Co-localization analysis was performed with LAS-AF
software from Leica as follows. Single Z-sections of ima-
ges with multiple cells were analyzed to obtain co-locali-
zation rates and Pearson coefficients. For stained cells,
whole-field images were analyzed, whereas in the case of
transfected cells, ROIs including transfected cells and
excluding non-transfected cells were delimited prior to
image analysis. At least 30 cells, for co-localization studies
or 100 cells, for RFP-LC3 distribution were analysed per
experimental condition. Results are presented as mean
co-localization rates expressed as percentages, which were
comparable to the corresponding mean Pearson coefficients
(not shown).
Western blot
In preparation for SDS-PAGE, cells were homogenized by
forced passes through a 261/2-gauge needle in 50 mM Tris,
pH 6.8, 10 % glycerol, 2 % SDS, 0.1 mM b-mercap-
toethanol, 50 mM sodium fluoride and 0.1 mM sodium
orthovanadate containing 2 lg/ml of the protease inhibitors
leupeptin and aprotinin as well as 1.3 mM Pefablock. Pro-
tein concentration was estimated by the BCA method
(Pierce Chemical, Rockford, IL, USA). Volumes equivalent
to 30 lg of protein were run on 15 % SDS-polyacrylamide
gels and transferred to Immobilon-P membranes (Millipore,
Bedford, MA, USA) using a semi-dry transfer method.
Blots were incubated with monoclonal anti-LC3B (Cell
Signaling Technologies, Beverly, MA, USA) or anti-actin
(Sigma-Aldrich Chemicals, St Louis, MO, USA) antibodies
at 1:1,000 dilution and proteins of interest were detected by
ECL (GE Healthcare, Buckinghamshire, UK). Blots were
quantified using ImageJ software (US National Institutes of
Health, Bethesda, MD, USA).
Results
Lyso-ID is localized in late-endosomes/lysosomes
In order to assess the performance of Lyso-ID, we used it in
combination with Lamp1-GFP, a fluorescent construct of
the well-known protein constituent of late endosomes and
lysosomes and with GFP-CINCCKVL (GFP-8), a protein-
based probe that localizes to the endosomal pathway in
endothelial cells (Pe´rez-Sala et al. 2009; Valero et al.
2010). We observed that Lyso-ID was accumulated inside
vesicles that were delimited by Lamp1-GFP (Fig. 1a) and
by GFP-8 (Fig. 1b) thus indicating their endo-lysosomal
nature. Incubation of BAEC with chloroquine led to the
formation of giant vesicular bodies, as we previously
reported (Pe´rez-Sala et al. 2009), in which Lyso-ID was
accumulated. In addition, this probe accumulated in the
dense bodies induced by U18666A, an agent which dis-
rupts late endosome dynamics (Valero et al. 2010). The
patterns obtained with Lyso-ID were similar to those
observed with the widely used lysosomal probe LTR
(Fig. S1). Therefore, these observations indicate that in
living cells Lyso-ID is confined to a late-endosomal/lyso-
somal compartment.
Characterization of Cyto-ID distribution
upon autophagy induction by amino acid
deprivation in BAEC
Bovine aortic endothelial cells have been reported to
undergo autophagy in response to nutrient deprivation
induced by incubation in the presence of 2-deoxy-glucose
or by incubation in glucose-deficient medium (Wang et al.
2011; Du et al. 2012). However, autophagy induction by a
classical stimulus such as amino acid deprivation, to the
best of our knowledge, has not been reported. Interestingly,
in this model, amino acid deprivation by incubation in
EBSS medium resulted in a time-dependent decrease of
endogenous LC3-I and II levels (Fig. 2a). This was likely
due to consumption caused by degradation, as previously
reported in other models (Sato et al. 2007; Mizushima and
Yoshimori 2007). Consistent with this, inhibition of lyso-
somal degradation with protease inhibitors (leupeptin plus
E-64d, Fig. 2a, right panels) or with chloroquine (not
shown) attenuated the disappearance of LC3-I/II and
increased the proportion of LC3-II. Control cells for these
assays were serum starved. Serum deprivation per se
induced only minor changes in LC3 levels (Fig. 2a). A
detailed assessment of the kinetics and distribution of the
autophagosomal fluorescent reporter RFP-LC3 and the
fluorescent probe Cyto-ID upon autophagy induction in
live cells is shown in Fig. S2. In control cells, transfected
RFP-LC3 (Fig. S2a) showed a predominantly diffuse dis-
tribution, although cells with some localized accumulations
of RFP-LC3 could also be observed (21 ± 2 % of cells,
average ± SEM of a least four experiments). Amino acid
deprivation induced an increase in the proportion of cells
showing bright RFP-LC3 aggregates (49 ± 5 % of cells
after 6 h, p\ 0.01 by Student’s t test vs. control, and
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79 ± 1 % of cells after 24 h, p\ 0.01 by Student’s t test
vs. control and 3 h EBSS). Interestingly, Cyto-ID staining
was negligible in control cells and increased rapidly upon
amino acid deprivation (Fig. S2b), in such a way that vir-
tually all cells showed a bright particulate fluorescent
pattern as early as 30 min after amino acid withdrawal.
This pattern was consistent up to 24 h incubation in EBSS.
Quantitation of Cyto-ID fluorescence by flow cytometry
showed a maximal increase 3 h after amino acid with-
drawal followed by a slow decline, with intensity remain-
ing 2.7-fold higher than that of control cells after 24 h (not
shown). Taken together, these observations show that both
transfected RFP-LC3 and Cyto-ID reflect autophagy
induction but with different kinetics, with the pattern
obtained with Cyto-ID being more homogeneous in the cell
population and with a more rapid induction reflecting
alterations induced by amino acid deprivation under our
experimental conditions.
To assess the nature of Cyto-ID-labeled structures, we
next performed Cyto-ID-RFP-LC3 co-localization studies
(Fig. 2b). Co-localization of Cyto-ID with RFP-LC3-
positive accumulations was obvious from 3 h (38 ± 9.5 %
co-localization, average ± SEM of at least six determina-
tions, p\ 0.01 by Student’s t test vs. control), and was
substantial after 20 h (80 ± 3.7 % co-localization,
p\ 0.01 by Student’s t test vs. control and 3 h EBSS).
Treatment in the presence of protease inhibitors, leupeptin
plus E-64d, increased the size of vesicles positive for both
probes, indicative of RFP-LC3/autophagosomal material
accumulation after blocking lysosomal degradation
(Fig. 2c).
In order to substantiate the correlation between autoph-
agy and Cyto-ID staining, we assessed this parameter after
modulation of autophagy induction by well-known agents
(Fig. 3). Reversion of autophagy by incubation with amino
acid-containing medium for 30 min was sufficient to lose
most of the Cyto-ID signal. On the other hand, treatment of
BAEC in the presence of the autophagy inhibitor 3-MA
during amino acid deprivation clearly reduced Cyto-ID
fluorescence. Finally, the autophagy inducer rapamycin
elicited a detectable increase in the Cyto-ID signal, which
could be evidenced also by flow cytometry (not shown). In
contrast, staining with MDC was undistinguishable in
control and amino acid-deprived cells (Fig. S3), and overlap
with the Cyto-ID signal was absent in control cells, which
were not stained with Cyto-ID, and partial in amino acid-
deprived cells. Taken together, these observations indicate
the existence of a good correlation between autophagy
induction and Cyto-ID staining.
Localization of Cyto-ID in combination
with lysosomal probes
Next, we assessed whether Cyto-ID and Lyso-ID or LTR
could be used in combination, and if so, if these probes
retained selectivity for autophagosomal or lysosomal
pathways (Fig. 4). Upon autophagy induction by incuba-
tion in EBSS, co-localization between Cyto-ID and either
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Fig. 1 Distribution of Lyso-ID dye, Lamp1-GFP and GFP-8. BAEC transiently transfected with Lamp1-GFP (a) or GFP-8 (b) were treated with
the indicated agents in the absence of serum for 20 h. After treatment, cells were stained with Lyso-ID. Scale bar 20 lm
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lysosomal probe was partial (60 ± 4.1 % with LTR and
30 ± 4.8 % with Lyso-ID) and compartments positive only
for Cyto-ID or for LTR or Lyso-ID could be detected, as
well as compartments with mixed staining suggestive of
fusion events (Fig. 4a, b, see detail). To obtain additional
evidence of the existence of independent autophagosomal
and endo-lysosomal structures under these experimental
conditions we co-transfected cells with RFP-LC3 and
GFP-8 (Fig. 4c). These constructs showed different distri-
bution patterns, both under control conditions and after
autophagy induction (see co-localization profiles). Taken
together, these results indicate that Cyto-ID stains defined
compartments, some of which are non-acidic. Whether
these compartments represent early autophagosomes not
yet fused with lysosomes warrants further investigation.
Finally, we explored the distribution of these probes in
cells treated with agents known to disrupt the lysosomal
pathway. The giant acidic vesicles induced by chloroquine
showed a weak diffuse Cyto-ID signal (Fig. 5a, b), which
increased after autophagy induction with EBSS. Interest-
ingly, RFP-LC3 also gave a faint signal in chloroquine-
induced vesicles, which increased in EBSS-cultured cells
(Fig. 5c). However, although co-localization of Cyto-ID
and lysosomal probes was extensive in these compartments,
individual lysosomes (stained with lysosomal probes only)
could still be detected. A stronger Cyto-ID signal was also
observed in most, but not all, of the compartments induced
by treatment with U18666A (Fig. S4a, b). Thus, disruption
of the lysosomal pathway affects Cyto-ID and Lyso-ID
staining differently.
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Fig. 2 Induction of autophagy by amino acid deprivation in BAEC
and characterization of Cyto-ID distribution. a Western blotting was
performed as described in ‘‘Materials and methods’’ to detect
endogenous LC3B levels upon amino acid starvation (EBSS) and/or
treatment with 10 lg/ml of the protease inhibitors leupeptin and
E-64d (PI) for the times indicated. Results are representative of three
experiments. The ratio of LC3 II/actin (average values ± standard
error of mean) is shown below (pairs of symbols indicate conditions
between which statistically significant differences were found,
p\ 0.05 by Student’s t test). CT ? CS control medium plus calf
serum,CT - CS control mediumminus calf serum. b, c Co-localization
of Cyto-ID and RFP-LC3 was assessed in BAEC transfected with
RFP-LC3 and incubated in serum-free medium or EBSS in the
absence (b) or presence (c) of protease inhibitors. Cyto-ID staining
was performed as indicated in ‘‘Materials and methods’’ and cells
were immediately imaged by confocal microscopy. Individual
sections are shown
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Remarkably, we observed that staining with Cyto-ID in
the presence of Lyso-ID resulted in a weaker Cyto-ID
staining than with Cyto-ID alone or Cyto-ID plus LTR
(Fig. S4c). This could account for the lower values
obtained for Cyto-ID/Lyso-ID co-localization compared to
the Cyto-ID/LTR combination. Although this observation
does not preclude the use of both probes in combination
since the quenching effect can be overcome by adjusting
the settings for data acquisition, the detection conditions
are not optimal, and in this case combination of Cyto-ID
with other lysosomal probes may offer better performance.
Localization of Lyso-ID and Cyto-ID in HeLa cells
In order to assess the behaviour of Cyto-ID and Lyso-ID in
a different cell type, we used HeLa cells. As it is shown in
Fig. 6a, Lyso-ID showed little overlap with GFP-LC3
under control conditions or upon amino acid deprivation,
the co-localization increasing, as expected, in the presence
of chloroquine. In turn, Cyto-ID staining was negligible
under control conditions and increased upon amino acid
deprivation showing a clear overlap with RFP-LC3
(Fig. 6b).
Discussion
Autophagy is a key process in cell homeostasis which
involves de novo generation of organelles in a short time
frame along with traffic and fusion processes with other
vesicular compartments, i.e., endo-lysosomes. Therefore,
there is great interest in the development of tools that allow
monitoring autophagy in live cells in real time. In this
work, we have assessed the distribution of various probes
intended to monitor lysosomal and autophagic pathways.
Our results show that in live BAEC, endo-lysosomes and
autophagosomes can be distinguished using various probes,
including LTR, Lyso-ID and GFP-8 for endo-lysosomes
and RFP-LC3 for autophagosomes. Moreover, the Cyto-ID
probe labels structures distinct from acidic vesicles and
responds to various stimuli which modulate autophagy,
displaying a substantial co-localization with RFP-LC3 in
this experimental model. Therefore, more detailed identi-
fication of the precise target(s) of Cyto-ID may provide key
information for the study of autophagy.
Under our experimental conditions, Lyso-ID showed
high selectivity for acidic compartments as demonstrated
by its localization inside vesicles delimited by Lamp1-GFP
and GFP-8. Moreover, it reflected the alterations induced
by disrupting lysosomal function with chloroquine or
inhibiting late endosome dynamics with U18666A. Mech-
anistically, the recently developed probe Cyto-ID is based
upon similar principles as MDC. Analogously to MDC,
selective labelling of autophagic vesicles by Cyto-ID is
thought to arise from its interaction with the hydrophobic
lamellar structures associated with autophagic vesicles
(Niemann et al. 2000). However, MDC may accumulate
into acidic compartments due to an ion trapping-mediated
mechanism and yield substantial basal labelling overlap-
ping with acidic vesicles (Munafo and Colombo 2001,
Bampton et al. 2005). Indeed, we observed that MDC gave
intense vesicle staining which was undistinguishable under
control conditions and upon autophagy induction. In con-
trast, staining with Cyto-ID under control conditions was
negligible. This may be due to the titratable functional
EBSS 6 h EBSS +3-MA 6 h
EBSS 24 h
EBSS 24 h
+ aa 30 min
control Rapamycin 20 h
Fig. 3 Effect of modulators of autophagy on Cyto-ID staining in
BAEC. Top panels BAEC treated with EBSS for 24 h and stained
with Cyto-ID were incubated with amino acid-containing medium
(aa) for 30 min, as indicated, and immediately imaged by confocal
microscopy. Middle panels BAEC were incubated in EBSS with or
without 1.5 mg/ml of 3-methyladenine (3-MA) for 6 h and stained
with Cyto-ID as previously described. Bottom panels BAEC were
incubated in serum-free medium with vehicle or 200 nM rapamycin
overnight and stained with Cyto-ID immediately before confocal
imaging
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groups introduced in this dye to prevent its accumulation
within lysosomes. After autophagy induction, the overlap
between Cyto-ID and MDC labelling was only partial.
Moreover, upon amino acid deprivation, it was possible to
detect bright Cyto-ID compartments, which were not
stained by lysosomal probes, thus indicating that Cyto-ID
stains more than just acidic vesicles. Conversely, under
all experimental conditions, acidic (LTR- or Lyso-ID-
positive) vesicles were observed that were not stained by
Cyto-ID, probably reflecting a different lipidic composi-
tion. Nevertheless, care should be exercised when using
these probes and ideally they should be used in combina-
tion with compartment-specific markers. However, it
should be taken into account that protein-based fluorescent
probes for autophagy are not free of potential artifacts since
both RFP and GFP tend to oligomerize when overexpres-
sed in cells, and the use of constitutive expression plasmids
may not reflect effects related to transcriptional or post-
transcriptional regulation.
In contrast to glucose deprivation-induced autophagy in
BAEC (Wang et al. 2011; Du et al. 2012), we found that
the most obvious effect of amino acid deprivation in this
cell type is a decrease in the levels of both endogenous
proteins LC3-I and II, probably due to an increase in
degradation dynamics, since it was attenuated by treatment
with protease inhibitors. Noteworthy, serum starvation in
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Fig. 4 Co-localization of autophagic and endo-lysosomal probes in
BAEC. a, b BAEC were incubated in serum-free medium (control)
or EBSS for 20 h prior to staining with Cyto-ID and LTR (a) or Lyso-
ID (b) as described in ‘‘Materials and methods’’. c BAEC were
co-transfected with RFP-LC3 and GFP-CINCCKVL (GFP-8). Right
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BAEC did not result in increased autophagy, as revealed by
the LC3 blot and by the absence of RFP-LC3 accumula-
tions, nor altered Cyto-ID staining. Interestingly, the three
different assays shown in Figs. 2a and S2 revealed differ-
ent features of amino acid deprivation-induced BAEC
autophagy: endogenous LC3 decreased from 3 h, exoge-
nous RFP-LC3 illustrated the punctate distribution typical
of association with autophagosomes, which increased
clearly after 3–6 h and the putative small molecule probe
for autophagic vesicles Cyto-ID readily formed bright dots
upon amino acid starvation. This may indicate that Cyto-ID
partitions more rapidly and homogeneously than exoge-
nous RFP-LC3 into membranous structures upon autoph-
agy induction. This could also account for the differences
in fluorescence intensity of the RFP-LC3 and Cyto-ID
signals in compartments positive for both probes. The
pattern obtained with Cyto-ID did not vary in transfected
and non-transfected cells, thus ruling out the possibility
that it could be influenced by transfection-related
membrane perturbations. It should be noted that transient
transfection was performed here due to the impossibility of
establishing stably transfected cell lines from primary cul-
ture BAEC. Nevertheless, being a putative lipid-binding
probe, labelling with Cyto-ID could be affected by agents
altering vesicle membrane composition. In this vein,
impairment of cholesterol traffic by treatment with
U18666A, a pharmacological model of Niemann–Pick Type
C disease, induced the appearance of dense acidic bodies.
Nevertheless, not all of these dense structures were labelled
by Cyto-ID. Interestingly, similarly to our observations,
previous studies showed that only some of the dense com-
partments induced by U18666A treatment were positive for
LC3 (Ishibashi et al. 2009), although at present there is no
agreement as to whether U18666A induced-alterations
reflect increased autophagy (Ishibashi et al. 2009; Pacheco
et al. 2007). Treatment of cells with chloroquine may also
pose some questions. The observation that the Cyto-ID
signal inside chloroquine-induced compartments appears to
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Fig. 5 Effect of chloroquine on the distribution of endo-lysosomal
and autophagy probes in BAEC. a, b Cells were treated with
chloroquine in serum-free medium or EBSS, as indicated. Chloroquine
was used at 10 lM. c BAEC transfected with RFP-LC3 were treated
with chloroquine as in (a, b). Staining with Cyto-ID and LTR or Lyso-
ID was performed as detailed in ‘‘Materials and methods’’
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be lower than that of EBSS-induced vesicles could be due to
a lesser accumulation of the probe, this in turn being related
to chloroquine-induced minor pH changes and/or to the
heterogeneous nature of membranes accumulated in these
structures.
One important observation of this work is that indepen-
dent structures labeled selectively with autophagy probes or
with endo-lysosomal probes can be observed under our
experimental conditions. Moreover, merging structures
were observed, which could be indicative of fusion events
between autophagosomes and endo-lysosomes.
In view of the numerous assays for monitoring the
autophagic pathway being developed, the results herein
presented provide novel information on the usefulness and
limitations of several widely accepted as well as recently
developed autophagy probes and stress the importance of
using various approaches in combination in order to min-
imize misinterpretations in the analysis of this complex
process.
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Abstract
Ras proteins are crucial players in differentiation and oncogenesis and constitute important drug targets. The localization
and activity of Ras proteins are highly dependent on posttranslational modifications at their C-termini. In addition to an
isoprenylated cysteine, H-Ras, but not other Ras proteins, possesses two cysteine residues (C181 and C184) in the C-terminal
hypervariable domain that act as palmitoylation sites in cells. Cyclopentenone prostaglandins (cyPG) are reactive lipidic
mediators that covalently bind to H-Ras and activate H-Ras dependent pathways. Dienone cyPG, such as 15-deoxy-D12,14-
PGJ2 (15d-PGJ2) and D
12-PGJ2 selectively bind to the H-Ras hypervariable domain. Here we show that these cyPG bind
simultaneously C181 and C184 of H-Ras, thus potentially altering the conformational tendencies of the hypervariable
domain. Based on these results, we have explored the capacity of several bifunctional cysteine reactive small molecules to
bind to the hypervariable domain of H-Ras proteins. Interestingly, phenylarsine oxide (PAO), a widely used tyrosine
phosphatase inhibitor, and dibromobimane, a cross-linking agent used for cysteine mapping, effectively bind H-Ras
hypervariable domain. The interaction of PAO with H-Ras takes place in vitro and in cells and blocks modification of H-Ras
by 15d-PGJ2. Moreover, PAO treatment selectively alters H-Ras membrane partition and the pattern of H-Ras activation in
cells, from the plasma membrane to endomembranes. These results identify H-Ras as a novel target for PAO. More
importantly, these observations reveal that small molecules or reactive intermediates interacting with spatially vicinal
cysteines induce intramolecular cross-linking of H-Ras C-terminus potentially contributing to the modulation of Ras-
dependent pathways.
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Introduction
Ras proteins are key regulators of cellular proliferation, survival
or senescence. In addition to their role in cellular physiology, Ras
proteins are involved in many pathophysiological processes. In
fact, mutations in the Ras genes are found in 30% of human
cancers [1]. Therefore, since their discovery, Ras oncogenes have
been the subject of intense research. The three Ras genes, H-, N-,
and K-Ras display extensive homology but also important
distinctive features (reviewed in [2,3]).
Ras proteins are GTP-binding proteins which hydrolyze GTP
with the concourse of GTPase activating proteins. Ras activity is
controlled by a cycle between the GTP-bound active state and the
GDP-bound inactive state. In the GTP-bound state, Ras proteins
may interact with effectors including Raf, PI3K and RalGDS,
among others [3,4], to activate various signaling pathways with
impact on cell cycle regulation, cytoskeleton organization,
transcriptional regulation or membrane trafficking. Ras activity
is subjected to a complex modulation at many different levels. Ras
activation, requiring the exchange of bound GDP for GTP, can
occur by interaction with GTP exchange factors (GEFs), which in
turn may transduce signals from growth factor receptors or sense
levels of intracellular mediators, including calcium and diacylgly-
cerol. In addition, GDP-GTP exchange can be favoured by the
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direct action of reactive oxygen or nitrogen species, such as nitric
oxide, on Ras proteins [5].
Posttranslational modifications of Ras proteins play a key role in
their localization and activity. All Ras proteins are isoprenylated at
a cysteine residue present in the CAAX box located at the C-
termini [6]. In addition, whereas H-Ras is palmitoylated at two
cysteine residues present in the hypervariable domain (C181 and
C184), N-Ras contains a single palmitoylation site (C181) and K-
Ras4B possesses no cysteine residues but its interaction with
cellular membranes is favoured by the presence of a polybasic
domain. These differences are critical to determine the traffic and
site of action of Ras proteins (reviewed in [4,7]). Thus, H-Ras is
located mainly at the plasma membrane and in endosomes and
traffics to the plasma membrane through the conventional
secretory pathway. In contrast, K-Ras4B has been reported to
interact with microtubules, although the pathway by which it
reaches the plasma membrane is not well characterized. In the
case of H-Ras, a palmitoylation-depalmitoylation cycle regulates
recycling of the protein between the plasma membrane and the
Golgi. Moreover, palmitate groups are important for determining
the interaction of H-Ras with specific membrane microdomains,
its membrane insertion and orientation and its presence in internal
membranes, which in turn may influence the engagement of
various signaling pathways [8,9].
Cyclopentenone prostaglandins (cyPG) are reactive lipidic
mediators that are generated by dehydration of their parent PG.
PGE-type PG give rise to cyPG of the A-series. The J series of
cyPG arise from dehydration of PGD2 by a sequence of well
characterized steps giving rise to the single enone PGJ2 and to the
dienone PG 15d-PGJ2 and D
12-PGJ2 [10,11]. These prostanoids
are produced in increased amounts in situations associated with
inflammation or oxidative stress and they have been shown to
influence cell proliferation and contribute to the resolution of
inflammation [12]. cyPG contain an a,b-unsaturated carbonyl
group in the cyclopentenone ring. Electrophilic carbons conjugat-
ed with this group can suffer the attack of nucleophiles, such as
sulphur atoms, and form Michael adducts. Through this
mechanism, cyPG may covalently modify proteins, leading to
alteration of protein structure and function [13]. We have
previously shown that several cyPG may bind to Ras proteins,
and that this correlates with Ras activation, as evidenced by an
increase in the levels of Ras in its active conformation, and an
activation of Ras dependent pathways [14]. Interestingly, we
observed that modification and activation of Ras proteins by cyPG
with different structure are site-selective. Single enone PG, like
PGA1 or PGJ2 preferentially bound to C118 in H-Ras, which is
located in the GTP binding site, whereas cyPG with dienone
structure preferentially bound to the C-terminal segment contain-
ing C181 and C184 [15]. Interestingly, this preferential binding
resulted in the selective modification of the different Ras proteins:
while dienone cyPG selectively bound to H-Ras, single enone
cyPG could bind to the three Ras proteins, H-, N- and K-Ras4B,
because all three possess the C118 residue. In light of these data,
we formulated the hypothesis that, dienone cyPG, possessing two
electrophilic carbons, could react simultaneously with two different
cysteine residues. The fact that H-Ras is the only Ras protein
possessing two nearby cysteine residues could constitute the
structural basis for its selective modification by cyPG with dienone
structure. Moreover, this observation raised the possibility that the
C-terminus of H-Ras could be the target for other bifunctional
cysteine reagents. Here we have characterized the modification of
the C-terminal region of H-Ras by cyPG dienones as well as by
other bifunctional cysteine reagents and explored the functional
consequences of this modification. Since palmitoylation is a
reversible modification, our results suggest that the reactive
cysteines present in the H-Ras C-terminus may also be targeted
by various small molecules or biological intermediates with
reactivity towards vicinal thiols, with diverse consequences on
H-Ras localization and function.
Results
cyPG with dienone structure bind simultaneously to
C181 and C184 of H-Ras C-terminus
cyPG dienones, such as 15d-PGJ2 and D
12-PGJ2, can covalently
modify H-Ras by preferentially binding the C-terminal peptide
containing C181 and C184 [15]. Given the bifunctional nature of
these dienones, the possibility exists that they simultaneously bind
to both cysteine residues. To investigate this point we have used a
synthetic peptide corresponding to the tryptic fragment K170-
K185 (m/z 1662.7) from H-Ras C-terminus.
Incubation of K170-K185 with 15d-PGJ2 gave rise to the
appearance of a peak of m/z 1979.80 corresponding to the
addition of one PG molecule (Fig. 1A). Moreover, as previously
noted [14,15], several peaks compatible with the oxidation of the
modified peptide (m/z 1994.9 and 2010.7) were observed.
Reduction and alkylation of the control peptide by subsequent
treatment with DTT and iodoacetamide gave the expected peaks
(m/z 1719.6 and 1776.6) corresponding to the carbamidomethyla-
tion of one and two cysteines, respectively. Addition of 15d-PGJ2
to the K170-K185 peptide was not reversed by DTT. Interest-
ingly, carbamidomethylation of the 15d-PGJ2-modified peptide
upon treatment with iodoacetamide was nearly undetectable,
suggesting that the 15d-PGJ2-modified peptide was basically
devoid of free cysteines. Similar results were obtained when the
H-Ras C-terminal peptide was modified by D12-PGJ2, another
cyPG with dienone structure giving rise to a modified peptide with
m/z 1997.5. These results, summarized in Fig. 1B, contrast with
the behavior of PGJ2, a single enone cyPG, which we have
previously shown to form one- or two-cyPG adducts (m/z 1997.4
and 2331.7, respectively) with the H-Ras C-terminal peptide, thus
showing binding to single cysteine residues [15]. Taken together
these results indicate that modification of K170-K185 by cyPG
dienones may involve intramolecular cross-linking of both C181
and C184. The C-terminal peptide of H-Ras does not show a
defined structure in solution [16], but it adopts a precise
conformation upon interaction with membranes [17]. Cross-
linking between C181 and 184 could impose a more rigid
conformation and potentially alter H-Ras membrane interactions.
A theoretical molecular model illustrating the feasibility of 15d-
PGJ2-induced intramolecular cross-linking of the K170-K185
peptide is shown in Fig. 1C.
The small molecule bifunctional reagent phenylarsine
oxide cross-links C181 and C184 of the H-Ras C-terminal
peptide
In view of the ability of cyPG with dienone structure to
simultaneously bind the cysteine residues of the H-Ras hypervari-
able domain, we tested other small bifunctional molecules for
cross-linking of these two cysteines. The tyrosine phosphatase
inhibitor phenylarsine oxide (PAO, mass 168.02), widely used in
signal transduction studies and as an endocytosis inhibitor [18,19],
is also known to form adducts with proteins by reacting with
vicinal sulfhydryl groups of proteins forming thioarsine rings
[20,21,22]. Incubation of K170-K185 with PAO resulted in the
formation of an adduct of m/z 1812.7 (Fig. 2A), with a mass
increment of 150, compatible with the formation of a cross-link
between C181 and C184 and one PAO molecule, which implies
Intramolecular Cross-Linking of H-Ras C-Terminus
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the loss of the oxygen atom of the PAO molecule plus two
hydrogen atoms (Fig. 2B). Analysis of this 1812.7 peak by MALDI-
TOF-TOF MS/MS gave fragments compatible with the incor-
poration of PAO at the proposed sites (Fig. 2C). The smallest
fragment detected containing the mass increment compatible with
PAO addition corresponded to ion y5 of sequence CMSCK,
confirming the site of modification. Figure 2D depicts a homology
molecular model of the H-Ras C-terminal peptide after cross-
linking elicited by PAO binding.
In contrast with the cross-linking by cyPG with dienone
structure, PAO addition was fully reversible upon treatment with
excess DTT. Thus, PAO-modified K170-K185 underwent
carbamidomethylation at one or two cysteines after incubation
with DTT and iodoacetamide (Fig. 3A, upper panels). Given the
reversibility of PAO addition by competing agents like DTT, we
were interested in exploring whether PAO-induced modification
of the K170-K185 H-Ras peptide would occur in the presence of a
biologically relevant thiol compound at concentrations close to
those encountered in vivo. Interestingly, the presence of
glutathione (GSH) in the incubation mixture reduced the
proportion of PAO-peptide adduct formed in a concentration-
dependent manner, as it can be deduced from the abundance of
modified (m/z 1812.7) vs parent (m/z 1662.7) peptide (Fig. 3A,
lower panels). However, a substantial proportion of PAO-peptide
adduct could still be detected at GSH concentrations of up to
10 mM, thus suggesting that H-Ras modification by PAO could
occur in cells. Remarkably, at 10 mM GSH, peaks of m/z 1967. 7
and 2272.8, compatible with the mono and di-glutathiolation of
K170-K185 were also observed. A summary of the species
encountered in the MS analysis of the K170-K185 peptide adducts
after treatment with the various agents used is shown in Fig. 3B.
PAO binds to H-Ras C-terminus in vitro and in intact cells
In view of the above results we explored whether PAO could
bind to the full length H-Ras protein in vitro, and if so, whether
the peptide containing C181 and C184 was the preferred site for
interaction. As it can be observed in Fig. 4A incubation of full-
length H-Ras with PAO resulted in the formation of an adduct
containing one PAO molecule bound to H-Ras, as clearly detected
by MALDI-TOF MS analysis. Moreover, tryptic digestion of the
modified protein revealed the appearance of a peak with m/z
1812.7 as the main modified peptide, which corresponded to the
addition of one PAO molecule to the K170-K185 tryptic peptide
(Fig. 4B). We have previously reported that biotinylated 15d-PGJ2
(15d-PGJ2-B) binds to H-Ras in vitro and in intact cells at the same
peptide [14,15]. Therefore, we explored the capacity of PAO to
block the binding of 15d-PGJ2-B to H-Ras, by using a gel-based
assay. Pre-incubation with PAO clearly reduced the incorporation
of 15d-PGJ2-B into H-Ras in vitro (Fig. 4C). This could be
evidenced both by the reduction of the H-Ras-associated biotin
signal (28%67 reduction with respect to vehicle-treated Ras,
mean 6 standard deviation of three assays), and by the reduction
Figure 1. Modification of the K170-K185 peptide from the C-terminal region of H-Ras by cyPG. (A) The synthetic K170-K185 peptide was
incubated with the indicated cyPG and the resulting adducts analyzed by MALDI-TOF MS. When indicated, incubation mixtures were treated with
50 mM iodoacetamide after addition of 10 mM DTT. Spectra presented are representative from at least three independent assays per experimental
condition. Structures of the cyPG used are shown in insets. Electrophilic carbons are marked by asterisks. (B) Summary of the theoretical peptide
adducts for which compatible peaks were observed experimentally. +CAM indicates that the peak is compatible with the formation of
carbamidomethyl cysteine subsequent to iodoacetamide treatment. (C) Ribbon diagram for the theoretical backbone structure of the H-Ras K170-
K185 peptide (in green) modified by addition of 15d-PGJ2 to cysteines 181 and 184. The side-chains of the cysteine residues and the 15d-PGJ2 ligand
are displayed in yellow and a default atom-type color scheme, respectively.
doi:10.1371/journal.pone.0015866.g001
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of the amount of 15d-PGJ2-B modified protein, which appears as a
higher molecular weight band (marked by an asterisk), as we have
previously described [15]. We next explored the effect of PAO on
15d-PGJ2-B binding to H-Ras in intact cells by using COS-7 cells
transiently transfected with an expression vector for AU5-tagged
H-Ras. Consistent with previous reports, AU5-H-Ras appeared in
cell lysates as a doublet, reflecting different degrees of posttrans-
lational processing, with the lower band corresponding to the fully
processed H-Ras protein [6]. Incubation with PAO markedly
reduced the extent of modification of H-Ras by 15d-PGJ2-B in
COS-7 cells (Fig. 4D). Quantification of the biotin signal corrected
by AU5-H-Ras protein levels yielded a 55%66 reduction (mean6
standard deviation of three experiments) in 15d-PGJ2-B incorpo-
ration into H-Ras in PAO pre-treated cells. These results indicate
that PAO binds to the C-terminus of H-Ras in intact cells.
Functional consequences of H-Ras modification by PAO
Binding of dienone cyPG or of PAO, as displayed in the
theoretical models, would likely alter the conformational tenden-
cies, and, more importantly, the chemical nature of H-Ras C-
terminus. In addition, since the hypervariable domain cysteine
residues are sites of palmitoylation, incorporation of PAO could
have consequences for the membrane binding or the hydropho-
bicity of the modified protein. Therefore, we explored whether
treatment of cells with PAO led to alterations in H-Ras subcellular
distribution. Treatment of AU5-H-Ras transfected COS-7 cells
with PAO led to a decrease in the amount of membrane associated
H-Ras, as evidenced by cell fractionation into P100 and S100
fractions (Fig. 5A). Partition into the detergent Triton-X114 has
been shown to constitute an assay for protein hydrophobicity [23]
and it has been used as an index of H-Ras lipidation [24]. Indeed,
isoprenylation has been shown to increase the proportion of H-
Ras partitioning into the Triton-X114 phase, this being further
increased by palmitoylation [6]. A Triton X-114 partition assay
showed that treatment of AU5-H-Ras transfected cells with PAO
reduced the amount of H-Ras protein in the detergent phase in a
concentration-dependent manner, mostly at the expense of the
upper component of the AU5-H-Ras doublet, with a concomitant
increase in the protein recovered in the aqueous fraction (Fig. 5B).
Therefore, these results suggest that PAO impairs lipidation of H-
Ras in cells. We were then interested in assessing the effect of PAO
on H-Ras function. Given the reversible nature of PAO binding
we employed a Raf Ras binding domain (Raf-RBD) redistribution
assay, which allows exploring Ras activation in intact cells. The
Figure 2. Modification of the K170-K185 peptide by PAO. (A) The K170-K185 peptide was incubated with PAO and analyzed by MALDI-TOF
MS. Results are representative from at least four assays. (B) Scheme of the formation of a PAO adduct with two thiol groups. (C) Analysis of the PAO-
peptide adduct by MALDI-TOF-TOF MS/MS analysis. The sequence of the peptide with the fragments generated is shown for reference. (D) Ribbon
diagram for the theoretical backbone structure of H-Ras K170-K185 peptide model (in green) modified by PAO addition. The side-chains of the
cysteine residues and PAO are displayed in yellow and a default atom-type color scheme, respectively.
doi:10.1371/journal.pone.0015866.g002
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YFP-RBD construct showed a diffuse distribution in transiently
transfected COS-7 cells. Treatment with EGF led to a more
irregular intracellular YFP-RBD pattern and, above all, to the
appearance of defined accumulations of the fluorescent construct
at the cell periphery, in some cases at the edge of membrane ruffle-
like structures, thus indicating the recruitment of YFP-RBD by
activated Ras at the plasma membrane (Fig. 6A). Incubation with
PAO caused intracellular redistribution of YFP-RBD, resulting in
a more particulate pattern. Interestingly, pre-treatment with PAO
completely blocked EGF-induced recruitment of YFP-RBD to the
plasma membrane. This indicates that Ras activation at the
plasma membrane is blocked by PAO. Quantitation of these
results is shown in Fig. 6B.
We next explored Ras activation by means of a RBD pull-down
assay (Fig. 6C). EGF clearly activated H-Ras in this assay, as
deduced from the increase in the retention of AU5-H-Ras on RBD
beads. No AU5 signal was detected in the pull-down from cells
transfected with empty vector (results not shown). Notably,
treatment with PAO alone induced the retention on RBD beads
of the slower migrating AU5-H-Ras band and did not reduce
EGF-induced Ras activation in this assay. Taken together these
results suggest that PAO treatment targets H-Ras in intact cells
and alters H-Ras-mediated signaling by selectively blocking EGF-
mediated Ras activation at the cell membrane and potentially
inducing Ras-Raf interaction at other locations.
The cysteine cross-linking agent dibromobimane targets
H-Ras hypervariable domain
The results shown above suggest that small molecules
interacting with spatially vicinal cysteines may induce an
intramolecular cross-linking of H-Ras hypervariable domain and
alter Ras distribution and signaling. To further substantiate this
point, we studied the effect of dibromobimane (DBB, mass
350.01), a reagent known to cross-link cysteine residues within 3–
6 A˚ distance [25]. DBB was shown to bind K170-K185 by MS
analysis (Fig. 7A). The m/z of the modified peptide (1850.81) was
compatible with addition of one DBB molecule to C181 and
C184, according to the reaction depicted in Fig. 7B (expected mass
increment 188.0). Formation of peptide dimers was not detected,
again suggesting the occurrence of intramolecular cysteine cross-
linking by DBB. Moreover, reduction and alkylation with
iodoacetamide did not result in carbamidomethylation of the
DBB-modified peptide, thus ruling out the presence of free
cysteines. As observed for PAO, treatment of full length H-Ras
with DBB reduced the modification of the protein by 15d-PGJ2-B,
suggesting that DBB binds to H-Ras at the C-terminal peptide
Figure 3. Effect of reducing agents on PAO modification of the K170-K185 peptide. (A) In the upper panels, the K170-K185 peptide was
incubated with PAO and analyzed by MALDI-TOF MS. In the right panel, the incubation mixture was treated with 10 mM DTT and subsequently with
50 mM iodoacetamide. In the lower panels, the K170-K185 peptide was incubated with PAO in the presence of the indicated concentrations of GSH
before analysis by MALDI-TOF MS. (B) Summary of the theoretical m/z of peptides for which compatible peaks were observed experimentally in the
assays shown in (A).
doi:10.1371/journal.pone.0015866.g003
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(Fig. 7C). Indeed, direct binding of DBB to H-Ras could be
evidenced by fluorescence detection of the gels, taking advantage
of the fluorogenic properties of this compound upon replacement
of both bromines [25] (Fig. 7C). Although DBB has been widely
used in cysteine mapping studies in vitro, its effects in cultured cells
have not been explored. Therefore, at this point we went on to
assess whether DBB recapitulated some of the effects of PAO in
intact cells. A concentration of 50 mM DBB was required to detect
binding of this compound to intracellular components, as observed
by confocal fluorescence microscopy (results not shown). This
concentration did not affect cell viability nor elicited morpholog-
ical changes. Under these conditions, treatment of AU5-H-Ras-
transfected cells with DBB reduced the levels of the upper
component of AU5-H-Ras doublet (Fig. 7D) and led to the virtual
disappearance of this band from the detergent phase in the Triton
X-114 partition assay (Fig. 7E). Finally, using the Raf-RBD
redistribution assay, we observed that in the presence of DBB,
YFP-RBD adopted a particulate intracellular pattern and EGF
failed to induce the translocation the YFP-RBD construct to the
cell periphery or to membrane ruffle-like structures (Fig. 7F).
Therefore, DBB markedly alters H-Ras homeostasis and function.
Discussion
Ras proteins are critical signaling molecules that integrate
information from growth factor receptors and intracellular
mediators. Ras proteins may sense changes in calcium concentra-
tion or redox state and engage various signaling pathways leading
to the regulation of basic cellular functions. The ability of Ras
proteins to act as sensors of various stimuli in different cell
compartments relies in part in the complex array of posttransla-
tional modifications they can undergo. Ras proteins may be
subjected to isoprenylation and accompanying modifications,
proteolysis and carboxyl methylation, phosphorylation, palmitoy-
lation, ubiquitination and various non-enzymatic modifications
including nitrosylation, thiolation or addition of lipid electrophiles
[14,26,27,28]. Here we show that the C-terminal end of H-Ras
proteins may be the target for both endogenous reactive molecules
Figure 4. PAO binds to the C-terminal peptide of H-Ras in vitro and in cells. (A) Full length H-Ras was incubated with PAO and analyzed by
MALDI-TOF MS. (B) Control or PAO-treated H-Ras was subjected to tryptic digestion and the resulting peptides analyzed by MALDI-TOF MS. The peak
of m/z 1812.27, corresponding to the formation of an adduct between PAO and the K170-K185 peptide, is marked by an asterisk. Dotted lines mark
the positions equivalent to those of the modified species in the untreated samples. (C) H-Ras at 5 mM was incubated with 50 mM PAO for 30 min
before addition of 1 mM biotinylated 15d-PGJ2 (15d-PGJ2-B) for 1 h. (D) COS-7 cells were transiently transfected with empty vector or a plasmid
coding for AU5-H-Ras. 24 h after transfection cells were pre-treated with vehicle or 1 mM PAO for 90 min before incubation with 5 mM 15d-PGJ2-B for
90 min. Incubation mixtures from (C) and cell lysates from (D) were analysed by SDS-PAGE followed by transfer to membrane and detection of
incorporated biotin with horseradish peroxidase (HRP)-streptavidin and of the Ras protein by immunoblot with anti-pan Ras or anti-AU5 antibody
and enhanced chemiluminescence (ECL). Results shown are representative of at least three assays.
doi:10.1371/journal.pone.0015866.g004
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and exogenous chemicals that cross-link nearby cysteines, thus
opening new possibilities for the regulation of Ras proteins and
potentially for H-Ras-selective signaling.
In this and previous works we have reported that Ras proteins
are targets for modification by endogenous electrophilic eicosa-
noids, like cyPG and isoprostanes [14,15]. From a structural point
of view, different patterns of modification by eicosanoids with
different structure were encountered, with single enone com-
pounds preferentially modifying C118, which is present in all three
Ras proteins, and dienone compounds, like 15d-PGJ2, binding
preferentially to the C-terminal peptide containing C181 and 184,
present only in H-Ras. Analogously to the selective modification
and activation of H-Ras, but not N-Ras or K-Ras4B, by 15d-PGJ2
[15], we have observed that PAO, shown here to modify H-Ras,
did not affect the electrophoretical mobility or activation of AU5-
K-Ras4B (results not shown). This suggests that the presence of
two close cysteine residues in the hypervariable domain of H-Ras
may be the main determinant for its selective modification by
cyPG dienones, and possibly by other bifunctional cysteine
reagents.
In this context, various recent evidences suggest that cyPG
dienones could preferentially modify proteins containing cysteines
in close proximity. Given the stability of this modification, this
could result in intra- or inter-molecular cross-linking. Indeed, we
have recently reported that dienone cyPG, like 15d-PGJ2 and D
12-
PGJ2 induce cross-linking of the P1-1 isoform of glutathione S-
transferase (GST), which is involved in cancer chemoresistance,
through a mechanism likely involving cysteine residues present in
different GSTP1-1 monomers [29]. Moreover, 15d-PGJ2 has also
been shown to directly cross-link c-Jun monomers in vitro [30]. In
view of these findings it would be interesting to explore whether
proteins with neighboring cysteines important for function, such as
thioredoxins, tyrosine phosphatases, Rho proteins or Hsp90
constitute preferential targets for cyPG with dienone structure
[20,31,32].
It should be taken into account that the cysteine residues of H-
Ras targeted by the agents used in this study are the palmitoylation
cysteines located in the hypervariable domain. Since H-Ras
palmitoylation plays a key role in subcellular localization [8],
modification of these cysteine residues could be expected to alter H-
Ras distribution.We previously observed that treatment of cells with
15d-PGJ2 did not disrupt membrane association of H-Ras, although
an increased extractability in detergent was noted, indicative of
potential changes in H-Ras membrane microdomain distribution
[15]. The results presented here indicate that C181 and C184 of H-
Ras can be targeted by several bifunctional molecules of diverse
structure, such as PAO and DBB. Our results indicate that H-Ras
modification by these agents takes place in vitro and in cells.
Moreover, treatment with PAO decreases H-Ras hydrophobicity
and membrane binding. In turn, the most obvious effect of DBB
under the conditions studied is a reduction in the levels of the upper
component of the H-Ras doublet, putatively the non-palmitoylated
form, causing its disappearance from the detergent fraction. A
reduction in the levels of the slower migrating form of H-Ras was
also observed with high (10 mM) PAO concentrations (results not
shown). Whether the decrease in the detection of the upper H-Ras
band is due to protein aggregation, degradation or other
mechanisms, it will be the subject of further studies.
Palmitoylation is a reversible modification, with a half-life that
has been measured as approximately 20 min compared to the
20 h half-life of the protein [33]. In addition, Ras depalmitoylation
can be stimulated by Ras activation [4], whereas S-nitrosocysteine
treatment has been reported to modulate palmitate turnover by
stimulating H-Ras deacylation and allowing subsequent reacyla-
tion [34]. It is possible therefore, that during the palmitoylation-
depalmitoylation cycle of H-Ras, C181 and C184 may become
Figure 5. Effect of PAO on H-Ras subcellular localization. (A) COS-7 cells were transiently transfected with expression vectors coding for AU5-
H-Ras wt. After serum starvation for 16 h, cells were treated with vehicle or 1 mM PAO for 1 h. Cells were lysed and postnuclear supernatants were
separated into S100 and P100 fractions by ultracentrifugation at 200,0006 g for 30 min. (B) AU5-H-Ras transfected cells were treated with the
indicated concentrations of PAO for 90 min and cell lysates were subjected to fractionation in Triton-X114. The amount of AU5-H-Ras present in the
various fractions was estimated by western blot with anti-AU5 antibody (upper panels). The upper component of the H-Ras doublet is indicated by an
arrowhead. Levels of actin were assessed as control (lower panels). Blots shown are representative of three assays.
doi:10.1371/journal.pone.0015866.g005
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available for chemical modification by various agents or by
oxidation. Depending on its stability, this modification could
interfere with subsequent palmitoylation and palmitoylation-
dependent subcellular localization or microdomain partitioning
of H-Ras. According to the current knowledge, depalmitoylation
of H-Ras would occur subsequently to activation and allow
recycling of the protein towards the Golgi complex, where it would
be re-palmitoylated. Indeed, non-palmitoylatable versions of H-
Ras have been found to localize primarily on the Golgi and signal
mainly from this platform in response to growth factor stimulation
[8]. In addition, active H-Ras has been detected at the
endoplasmic reticulum and on recycling endosomes in route
towards the plasma membrane [35]. Interestingly, mutation of
C184 for a more hydrophobic leucine residue has been proposed
to be able to substitute for the presence of palmitate at this position
and support binding of H-Ras to plasma membrane and recycling
endosomes [35]. In light of our data, it would be tempting to
hypothesize that the modification of C181 and C184 of H-Ras
through the addition of electrophilic endogenous mediators or
chemical agents could differentially affect the site of action of this
GTPase depending on the structure and/or hydrophobicity of the
bound molecule.
We have previously shown that modification of Ras proteins by
various eicosanoids, including 15d-PGJ2, PGA1 [15], D
12-PGJ2 or
8-iso-PGA1 (Oeste et al., unpublished results), correlates with
activation of Ras-dependent pathways, although the precise site of
H-Ras activation by these various eicosanoids needs to be studied
in detail. Here we have observed that PAO induces an increase in
H-Ras binding to RBD. Moreover, the observations that both
PAO and DBB induce a cytosolic particulate pattern of YFP-RBD
in cells could be indicative of the activation of Ras proteins in
endomembranes. Although further work is needed to establish this
point, our results with PAO selectively blocking redistribution of
YFP-RBD towards the plasma membrane (live cell assay), but not
the total RBD binding capacity of H-Ras after EGF stimulation
(pull-down assay) would support this hypothesis. Moreover, we
observed retention of the slower migrating form of H-Ras on RBD
beads upon treatment with PAO. Whether this band represents
PAO-modified protein and its precise subcellular localization will
be the subject of future studies.
In this work we have used various electrophilic agents as tools to
target the palmitoylation cysteines of H-Ras. However, it should
be kept in mind that the compounds used may bind to multiple
cellular targets. Moreover, thiol-reactive compounds may alter the
Figure 6. Effect of PAO on Ras activation. (A) COS-7 cells were transfected with YFP-RBD, serum starved for 16 h and pre-incubated with vehicle
or 1 mM PAO for 1 h before stimulation with 100 nM EGF. Cells were visualized live by confocal fluorescence microscopy. Shown are representative
images from at least five experiments with similar results. Dotted inserts show enlarged areas from the same cells for better visualization. Arrowheads
mark the accumulation of YFP-RBD at defined locations of the cell periphery. Bar, 20 mm. At least 40 cells were monitored per experimental condition
and the percentage of cells showing accumulations of YFP-RBD at the cell periphery is shown in (B) as average values6 standard error of mean (SEM)
of five independent experiments. (C) Cells were treated as above and cell lysates were subjected to pull-down on GST-RBD beads for collection of Ras
in its active conformation. Levels of RBD-bound and total AU5-H-Ras were assessed by western blot. Results shown are representative of three assays.
The lower panel presents the quantitation of RBD-bound AU5-H-Ras/total AU5-H-Ras ratios from three independent experiments as average values6
SEM. *p,0.05 vs vehicle.
doi:10.1371/journal.pone.0015866.g006
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cellular redox state and have an impact on the oxidative
modifications of proteins [21,36]. In particular, PAO, widely used
as a tyrosine phosphatase inhibitor in cells, may interfere with
numerous signaling pathways [20,21]. Indeed, interaction of PAO
with Ras signaling pathways has been reported to lead to diverse
effects, in some cases of complex interpretation. PAO has been
reported to block Ras activation by insulin in murine fibroblasts
[37], but not to reduce EGF-induced Ras activation in HEK-293
cells [38]. Our results showing that H-Ras proteins can be direct
targets for modification by this compound add further complexity
to this picture and call attention to the need of interpreting these
results cautiously.
In summary, our results show that bifunctional cysteine reagents
can target the hypervariable region of H-Ras and that this
interaction may have multifaceted consequences for Ras distribu-
tion and signaling.
Materials and Methods
Materials
The prostanoids used throughout this study were from Cayman
Chemical (Ann Arbor, MI). Human recombinant H-Ras was from
Calbiochem-Novabiochem (San Diego, CA). Anti-AU5 monoclo-
nal antibody was from Berkeley Antibody Company (Berkeley,
CA), anti-pan Ras (Ab-3) was from Merck. Phenylarsine oxide
(PAO), dibromobimane (DBB) and epidermal growth factor (EGF)
were purchased from Sigma-Aldrich (St. Louis, MO). Raf-Ras
binding domain (Raf-RBD) protein agarose beads were from
Cytoskeleton, Inc.
Synthesis of H-Ras C-terminal peptide
Peptide KLNPPDESGPGCMSCK, corresponding to amino
acids K170 to K185 of human H-Ras, henceforth referred to as
Figure 7. Interaction of the bifunctional reagent DBB with H-Ras. (A) Modification of the K170-K185 peptide by DBB. The K170-K185 peptide
was incubated with DBB, as described in the Methods section. When indicated the incubation mixture was subjected to reduction and alkylation with
iodoacetamide to modify free cysteines. Results are representative of three independent assays. (B) Scheme of the cross-linking of two thiol groups
by DBB. (C) Competition of 15d-PGJ2-B binding to H-Ras by DBB. H-Ras at 5 mM was incubated with 50 mM DBB for 30 min before addition of 1 mM
15d-PGJ2-B for 1 h. Incorporation of the biotinylated PG was assessed by SDS-PAGE, protein blot and detection with horseradish peroxidase (HRP)-
streptavidin (upper panel). Incorporation of DBB (middle panel) and total H-Ras levels (lower panel) were assessed by fluorescence detection and
western blot with anti-pan Ras antibody, respectively. (D) COS-7 cells transfected with the AU5-H-Ras vector were treated in the absence or presence
of 50 mM DBB for 1 h. Aliquots from total cell lysates (10 mg of protein) were analyzed by SDS-PAGE. The upper component of the AU5-H-Ras doublet
is indicated by an arrowhead. (E) COS-7 cells transfected with the AU5-H-Ras vector were treated with DBB and subjected to fractionation in Triton-
X114 as above. In (D) and (E) levels of AU5-H-Ras were assessed by western blot with anti-AU5 antibody. The dotted line marks where lanes from the
same gel have been cropped. (F) COS-7 cells transfected with YFP-RBD as above were treated with 50 mM DBB for 1 h before stimulation with 100 nM
EGF, as indicated, and visualized live by confocal fluorescence microscopy. Dotted inserts show enlarged areas from the same cells for better
visualization. Arrowheads mark the accumulation of YFP-RBD at defined locations of the cell periphery. Bar, 20 mm. Shown are representative images
from three experiments with similar results.
doi:10.1371/journal.pone.0015866.g007
Intramolecular Cross-Linking of H-Ras C-Terminus
PLoS ONE | www.plosone.org 9 January 2011 | Volume 6 | Issue 1 | e15866
K170-K185, was chosen as a model because it is the major
modified peptide detected after tryptic digestion of 15d-PGJ2- and
D12-PGJ2-treated H-Ras [15]. The peptide was produced by solid
phase methods [39] in an ABI 433A synthesizer (Applied
Biosystems, Foster City, CA), using Fmoc (9-fluorenylmethoxy
carbonyl) chemistry and 0.1-mmol-scale FastMoc protocols. After
chain assembly, it was cleaved from the resin by acidolysis
with trifluoroacetic acid/water/ethanedithiol/triisopropylsilane
(94:2.5:2.5:1 v/v, 90 min, 25uC), precipitated with chilled methyl
tert-butyl ether, redissolved in 10% (v/v) acetic acid and
lyophilized. Purification by preparative HPLC (Phenomenex C18
column, 21.26250 mm, 10 mm particle size, linear gradient of
solvent B into A –solvent A, 0.045% TFA in H2O; solvent B,
0.036% in acetonitrile– over 35 min, 25 ml/min flow rate) yielded
fractions containing the target dithiol peptide in highly pure form,
with a mass of 1662.73 by MALDI-TOF mass spectrometry.
Plasmids and transfections
The plasmids pCEFL-KZ-AU5 and pCEFL-KZ-AU5-H-Ras
wt have been previously described [14]. An expression plasmid
containing the Ras-binding domain of cRaf (RBD) fused to the
Yellow Fluorescent Protein (pEYFP-RBD) was prepared from a
RBD-pECFP plasmid generously donated by Dr. MR Philips.
COS-7 cells were grown in DMEM supplemented with 10% fetal
bovine serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/
ml streptomycin. Transient transfections were performed using
Lipofectamine 2000 (Invitrogen), according to the instructions of
the manufacturer. Treatments with the various agents used were
performed in the absence of serum. Prostanoids and PAO were
added in DMSO (vehicle) and control cells received an equivalent
amount of vehicle.
Analysis of the interaction between H-Ras and small
molecules in vitro
H-Ras or K170-K185 Ras peptide were incubated at 5 mM in
the presence of prostanoids, DBB or PAO at 50 mM or vehicle
(DMSO), as previously described [15]. For some experiments, H-
Ras incubation mixtures were then subjected to digestion with
trypsin for 4 h at 37uC. When indicated, aliquots of H-Ras, tryptic
digests or K170-K185 peptide were subsequently incubated with
10 mM DTT for 30 min followed by 50 mM iodoacetamide for
30 min at r.t. before purification on ZipTip C18 (Millipore) and
MALDI-TOF MS analysis on an AUTOFLEX III MALDI-TOF-
TOF instrument (Bruker-Franzen Analytik, Bremen, FRG)
operated in the positive mode, as reported in detail [15]. Selected
peptides were further analyzed by MALDI-TOF-TOF MS/MS.
Interaction of 15d-PGJ2-B and recombinant H-Ras was also
explored by SDS-PAGE, protein transfer to Immobilon-P
membranes and detection of incorporated biotin with horseradish
peroxidase (HRP)-Streptavidin and enhanced chemiluminescence
(ECL), as previously described [14]. Direct binding of DBB to H-
Ras was assessed by visualization of the gel under UV light on a
Gel-Doc XR Imaging System (Bio-Rad), as described [25].
Unreacted DBB, which is essentially non-fluorescent, becomes
fluorescent upon cross-linking (excitation maximum 385 nm,
emission, 477 nm).
Molecular-building procedure
Structural studies on H-Ras indicate that the C-terminal
segment lacks a defined structure in solution [16]. Therefore, we
used a molecular-building approach for modelling this peptide.
The recognition of an overall fold for the H-Ras K170-K185
peptide was based on the threading prediction from the
THREADER program [40]. A three-dimensional model for the
sequence of the K170-K185 peptide was built using a knowledge-
based protein modelling method based on the given pair-wise
target-template sequence alignment to the 156-171 spanning
region of the 2.4 A˚ resolution X-ray structure of a CRISP family
Ca2+-blocker (PDB code 1wvr) as template. This particular
template was chosen on the basis of its high sequence identity
with the Ras C-terminal peptide (sequence alignment shows a 44%
sequence identity with a ratio of aligned/gap positions of 16/0 as
yielded by a global alignment algorithm), its low-density map of
inter-residues interactions and a relatively high relation of surface/
buried residues. Nevertheless, it should be taken into account that
the structure obtained is a theoretical homology model, which
serves the purpose, not of defining a structure for the K170-K185
H-Ras peptide, but of illustrating the feasibility of the modifica-
tions described. The 3D-configurations of 15d-PGJ2 and PAO
ligands were obtained from the PubChem database (http://
pubchem.ncbi.nlm.nih.gov, CID codes 5280885 and 4778,
respectively). Computational resources from the SWISS-MODEL
homology modeling server [41] were used to achieve the final
structural model for the K170-K185 peptide. The structure
alignment of the 156–171 spanning region of 1wvr with the K170-
K185 peptide model shows a likely identical fold, with a backbone-
atoms root-mean-square deviation of 0.12 A˚. The stereochemical
quality of that model and its structural self-consistency were
assessed with PROCHECK [42] and Verify-3D [43] programs,
respectively. The initial molecular conformations for the adducts
were subjected to a constrained energy minimization step in order
to remove steric clashes. Computations were performed with the
MacroModel 9.5 software (Schro¨dinger Suite 2007 Update 2,
2007). Final figures were carried out with the Swiss-Pdb Viewer
v4.0 program (http://www.expasy.org/spdbv/).
Binding of 15d-PGJ2-B to Ras proteins in intact cells
COS-7 cells transiently transfected with Ras plasmids were
incubated with 15d-PGJ2-B for 2 h. Cells were lysed in 50 mM
Tris-HCl, pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.1 mM 2-
mercaptoethanol, 0.5% SDS containing protease inhibitors (2 mg/
ml each of leupeptin, aprotinin and pepstatin, and 1.3 mM
ABMSF), and incorporation of 15d-PGJ2-B into Ras proteins was
assessed by western blot with HRP-streptavidin, essentially as
described [14].
Analysis of H-Ras localization and activation
The effect of PAO on H-Ras subcellular localization was
assessed by obtaining S100 and P100 fractions, as described [44].
H-Ras hydrophobicity was assessed by partition in Triton X-114,
as previously described [45]. Briefly, COS-7 cells transfected with
AU5-H-Ras and treated with the indicated agents were lysed in
20 mM Tris HCl, pH 7.5, 150 mM MaCl, 1% Triton X-114,
containing protease inhibitors as above, for 1 h at 4uC with
occasional shaking. After 3 min incubation at 37uC lysates were
centrifuged at 12000 rpm for 3 min for phase separation. Aqueous
phase was collected and the detergent phase was re-extracted with
lysis buffer without Triton X-114. The second aqueous phase was
discarded and the detergent phase was resuspended in a volume of
buffer, without detergent, equal to the starting volume of lysate
used for fractionation. Equal volumes of aqueous and detergent
phases were analyzed by SDS-PAGE and western blot.
H-Ras activation in intact cells was monitored by two
complementary assays. For a Ras activation-redistribution assay,
COS-7 cells cultured on glass bottom dishes from Mattek Corp.
(Ashland, MA) were transiently transfected with YFP-RBD and
serum starved for 16 h, after which they were stimulated with the
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indicated compounds. The distribution of YFP-RBD was observed
by confocal fluorescence microscopy in live cells using a Leica
DMRE2 microscope (LEICA, Heidelberg, Germany). In this
assay, YFP-RBD shows a diffuse distribution in non-stimulated
cells, whereas Ras activation recruits YFP-RBD causing its
accumulation in defined areas [8]. For quantitation, the
proportion of cells showing plasma membrane-associated YFP-
RBD was assessed. All experiments were repeated at least three
times and representative results are shown. For a Raf RBD pull-
down assay, cells were lysed in 25 mM Hepes, pH 7.5, 150 mM
NaCl, 10% glycerol, 10 mM MgCl2, 1% NP-40, 1 mM EDTA,
0.25% deoxycholic acid containing 25 mM FNa, 1 mM sodium
orthovanadate, 10 mg/ml leupeptin and aprotinin and 1.3 mM
ABMSF. Cell lysates were incubated with Raf-RBD agarose beads
with rotary shaking for 1 h at 4uC. After extensive washing, bound
proteins were eluted by incubation for 5 min at 95uC in Laemmli
sample buffer. The amount of AU5-H-Ras retained on Raf-RBD
beads and that present in total cell lysates used for pull-down was
assessed by western blot.
Statistical analysis
The data shown are the mean 6 SE of at least three
experiments. Statistical significance was estimated with the
Student’s t test for unpaired observations. A p value of less than
0.05 was considered significant.
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